<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005351.pub2" GROUP_ID="VASC" ID="951504083014220866" MERGED_FROM="" MODIFIED="2013-04-23 08:39:10 +0100" MODIFIED_BY="Diane Horsley" REVIEW_NO="0416" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.2">
<COVER_SHEET MODIFIED="2013-04-23 08:37:19 +0100" MODIFIED_BY="Diane Horsley">
<TITLE MODIFIED="2013-04-10 12:38:55 +0100" MODIFIED_BY="[Empty name]">Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema</TITLE>
<CONTACT>
<PERSON ID="19302" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Flávia</FIRST_NAME>
<MIDDLE_INITIALS>MR</MIDDLE_INITIALS>
<LAST_NAME>Vital</LAST_NAME>
<SUFFIX/>
<POSITION>Chief of Physiotherapy</POSITION>
<EMAIL_1>fvital@fcv.org.br</EMAIL_1>
<EMAIL_2>flaviavital@bol.com.br</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Physiotherapy</DEPARTMENT>
<ORGANISATION>Muriaé Cancer Hospital</ORGANISATION>
<ADDRESS_1>Cristiano Ferreira Varella, 555</ADDRESS_1>
<ADDRESS_2/>
<CITY>Muriaé</CITY>
<ZIP/>
<REGION>Minas Gerais</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 32 3729 7040 Ramal: 7803</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2013-04-23 08:36:46 +0100" MODIFIED_BY="Diane Horsley">
<PERSON ID="19302" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Flávia</FIRST_NAME>
<MIDDLE_INITIALS>MR</MIDDLE_INITIALS>
<LAST_NAME>Vital</LAST_NAME>
<SUFFIX/>
<POSITION>Chief of Physiotherapy</POSITION>
<EMAIL_1>fvital@fcv.org.br</EMAIL_1>
<EMAIL_2>flaviavital@bol.com.br</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Physiotherapy</DEPARTMENT>
<ORGANISATION>Muriaé Cancer Hospital</ORGANISATION>
<ADDRESS_1>Cristiano Ferreira Varella, 555</ADDRESS_1>
<ADDRESS_2/>
<CITY>Muriaé</CITY>
<ZIP/>
<REGION>Minas Gerais</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 32 3729 7040 Ramal: 7803</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="A6E1CC4A82E26AA201ACDCB9D3B8A0E2" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Magdaline</FIRST_NAME>
<MIDDLE_INITIALS>T</MIDDLE_INITIALS>
<LAST_NAME>Ladeira</LAST_NAME>
<SUFFIX/>
<POSITION>Postgraduate Student</POSITION>
<EMAIL_1>magdalineladeira@yahoo.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Internal and Therapeutic Medicine</DEPARTMENT>
<ORGANISATION>Escola Paulista de Medicina, Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Istambul, 20/casa 07. Trevo. 31370-470 Belo Horizonte - MG</ADDRESS_1>
<ADDRESS_2>Rua Pedro de Toledo, 598. Vila Clementino.</ADDRESS_2>
<CITY>São Paulo</CITY>
<ZIP>04039-001</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 31 3498 9932</PHONE_1>
<PHONE_2>+55 31 9874 9434</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5183" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Álvaro</FIRST_NAME>
<MIDDLE_INITIALS>N</MIDDLE_INITIALS>
<LAST_NAME>Atallah</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION>Director of Brazilian Cochrane Centre</POSITION>
<EMAIL_1>atallahmbe@uol.com.br</EMAIL_1>
<EMAIL_2>alvaro.atallah@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE>+55 11 8173 0404</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Brazilian Cochrane Centre</DEPARTMENT>
<ORGANISATION>Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde</ORGANISATION>
<ADDRESS_1>R. Borges Lagoa, 564 cj 63</ADDRESS_1>
<ADDRESS_2>Vila Clementino</ADDRESS_2>
<CITY>São Paulo</CITY>
<ZIP>04038000</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 5571 4721</PHONE_1>
<PHONE_2>+55 11 5575 2970</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2013-02-27 18:33:56 +0000" MODIFIED_BY="Flavia Vital">
<UP_TO_DATE>
<DATE DAY="5" MONTH="4" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="20" MONTH="4" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="7" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2013-04-23 08:37:19 +0100" MODIFIED_BY="Liz Bickerdike">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-04-23 08:37:19 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="11" YEAR="2012"/>
<DESCRIPTION>
<P>New search in April 2011 found 11 new studies</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2013-03-06 13:56:54 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="12" YEAR="2011"/>
<DESCRIPTION>
<P>Eleven new studies have been included in this review update.</P>
<P>Background section has been updated.</P>
<P>No changes have been made to the methodology. The search strategies have been modified in MEDLINE and EMBASE, and the dates over which the databases were searched were updated.</P>
<P>The conclusions have been amended slightly. The use of CPAP produces fewer adverse events compared to the standard treatment or compared the Bilevel NPPV, but the main thrust of the review has not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-05-02 15:22:14 +0100" MODIFIED_BY="Liz Bickerdike">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-05-02 15:22:04 +0100" MODIFIED_BY="Liz Bickerdike">
<DATE DAY="17" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Department of Urgency Medicine, Universidade Federal de São Paulo</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Brazilian Cochrane Centre</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-04-23 08:39:10 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-04-16 13:07:04 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2013-04-16 13:06:58 +0100" MODIFIED_BY="Liz Bickerdike">Non-invasive positive pressure ventilation for cardiogenic pulmonary oedema</TITLE>
<SUMMARY_BODY MODIFIED="2013-04-16 13:07:04 +0100" MODIFIED_BY="[Empty name]">
<P>Acute heart failure has a high incidence in the general population and may lead to  the accumulation of fluid in the lungs, which is called acute cardiogenic pulmonary oedema (ACPE). This review aimed to determine the effectiveness and safety of non-invasive positive pressure ventilation (NPPV) (continuous positive airway pressure (CPAP) or bilevel NPPV) plus standard medical care, compared with standard medical care alone in adults with ACPE. We included 32 studies (2916 participants) of generally low or uncertain risk of bias. Results from randomised controlled trials indicate that NPPV can significantly reduce mortality as well as the need for endotracheal intubation rate, the number of days spent in the intensive care unit without increasing the risk of having a heart attack during or after treatment. We identified fewer adverse events with NPPV use (in particular progressive respiratory distress and neurological failure [coma]) when compared with standard medical care. In our comparison of CPAP and bilevel NPPV, CPAP may be considered the first option in selection of NPPV due to more robust evidence for its effectiveness and safety and lower cost compared with bilevel NPPV. The evidence to date on the potential benefit of NPPV in reducing mortality is entirely derived from small-trials and further large-scale trials are needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-04-16 13:06:56 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-04-16 13:06:35 +0100" MODIFIED_BY="[Empty name]">
<P>This is an update of a systematic review previously published in 2008 about non-invasive positive pressure ventilation (NPPV). NPPV has been widely used to alleviate signs and symptoms of respiratory distress due to cardiogenic pulmonary oedema. NPPV prevents alveolar collapse and helps redistribute intra-alveolar fluid, improving pulmonary compliance and reducing the pressure of breathing.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-04-16 13:06:35 +0100" MODIFIED_BY="[Empty name]">
<P>To determine the effectiveness and safety of NPPV in the treatment of adult patients with cardiogenic pulmonary oedema in its acute stage.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-04-16 13:06:42 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the following databases on 20 April 2011: CENTRAL and DARE, (<I>The Cochrane Library, </I>Issue 2 of 4, 2011); MEDLINE (Ovid, 1950 to April 2011); EMBASE (Ovid, 1980 to April 2011); CINAHL (1982 to April 2011); and LILACS (1982 to April 2011). We also reviewed reference lists of included studies and contacted experts and equipment manufacturers. We did not apply language restrictions.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-04-16 13:06:47 +0100" MODIFIED_BY="Liz Bickerdike">
<P>We selected blinded or unblinded randomised or quasi-randomised clinical trials, reporting on adult patients with acute or acute-on-chronic cardiogenic pulmonary oedema and where NPPV (continuous positive airway pressure (CPAP) or bilevel NPPV) plus standard medical care was compared with standard medical care alone.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-04-16 13:06:48 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors independently selected articles and abstracted data using a standardised data collection form. We evaluated study quality with emphasis on allocation concealment, sequence generation allocation, losses to follow-up, outcome assessors, selective outcome reporting and adherence to the intention-to-treat principle.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-04-16 13:06:55 +0100" MODIFIED_BY="Liz Bickerdike">
<P>We included 32 studies (2916 participants), of generally low or uncertain risk of bias. Compared with standard medical care, NPPV significantly reduced hospital mortality (RR 0.66, 95% CI 0.48 to 0.89) and endotracheal intubation (RR 0.52, 95% CI 0.36 to 0.75). We found no difference in hospital length of stay with NPPV; however, intensive care unit stay was reduced by 1 day (WMD -0.89 days, 95% CI -1.33 to -0.45). Compared with standard medical care, we did not observe significant increases in the incidence of acute myocardial infarction with NPPV during its application (RR 1.24, 95% CI 0.79 to 1.95) or after (RR 0.70, 95% CI 0.11 to 4.26). We identified fewer adverse events with NPPV use (in particular progressive respiratory distress and neurological failure (coma)) when compared with standard medical care.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-04-16 13:06:56 +0100" MODIFIED_BY="Liz Bickerdike">
<P>NPPV in addition to standard medical care is an effective and safe intervention for the treatment of adult patients with acute cardiogenic pulmonary oedema. The evidence to date on the potential benefit of NPPV in reducing mortality is entirely derived from small-trials and further large-scale trials are needed.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-04-16 13:30:23 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-04-16 13:27:02 +0100" MODIFIED_BY="[Empty name]">
<P>This is an update of a systematic review previously published in 2008 about non-invasive positive pressure ventilation (NPPV) in acute cardiogenic pulmonary oedema (ACPE) (<LINK REF="REF-Vital-2008" TYPE="REFERENCE">Vital 2008</LINK>).</P>
<P>Recent publications showed that about 5.7 million Americans and 15 million Europeans have heart failure (HF) (<LINK REF="REF-AHA-2012" TYPE="REFERENCE">AHA 2012</LINK>; <LINK REF="REF-Dickstein-2008" TYPE="REFERENCE">Dickstein 2008</LINK>). In the United States, the estimate annual rates per 1000 population of new HF events for white men are 15.2 for those 65 to 74 years of age, 31.7 for those 75 to 84 years of age, and 65.2 for those 85 years of age. For white women in the same age groups, the rates are 8.2, 19.8, and 45.6, respectively. For black men, the rates are 16.9, 25.5, and 50.6, and for black women, the estimated rates are 14.2, 25.5, and 44.0, respectively (<LINK REF="REF-AHA-2012" TYPE="REFERENCE">AHA 2012</LINK>). Acute HF is defined as the rapid onset of signs and symptoms secondary to abnormal cardiac function. HF may occur in the presence or absence cardiac disease and may culminate in acute cardiogenic pulmonary oedema (ACPE) manifested by severe respiratory distress. The most common causes of ACPE are ischaemia, acute coronary syndromes, hypertensive crisis, valvular dysfunction, acute arrhythmias, pericardial disease, increased filling pressures or elevated systemic resistance and dilated cardiomyopathy (<LINK REF="REF-Dickstein-2008" TYPE="REFERENCE">Dickstein 2008</LINK>; <LINK REF="REF-Gibelin-2002" TYPE="REFERENCE">Gibelin 2002</LINK>; <LINK REF="REF-Guimar_x00e3_es-2004" TYPE="REFERENCE">Guimarães 2004</LINK>; <LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>; <LINK REF="REF-Williams-1995" TYPE="REFERENCE">Williams 1995</LINK>). ACPE typically presents with severe respiratory distress, tachypnoea,orthopnoea, crackles on auscultation, and oxygen desaturation (<LINK REF="REF-Dickstein-2008" TYPE="REFERENCE">Dickstein 2008</LINK>; <LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>). Patients with acute HF have a poor prognosis. The one-year mortality rate associated with acute myocardial infarction complicated by acute HF is nearly 30% (<LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>). Furthermore, the in-hospital and one-year mortality rates associated with ACPE are 12% and 40%, respectively (<LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>). The incidence and burden of illness imposed by acute HF and ACPE are substantial, underscoring the need for effective preventative and treatment strategies.</P>
<P>In ACPE, cardiac failure results in increased back pressure on the pulmonary circulation which in turn, precipitates extravasation of fluid into the alveoli. In addition to overwhelming the capacity of the lymphatics for fluid removal (<LINK REF="REF-Allison-1991" TYPE="REFERENCE">Allison 1991</LINK>), the oedema fluid dilutes surfactant and neutralises its lubricating properties. Consequently, the lungs become less compliant and the effort of breathing increases (<LINK REF="STD-Chadda-2002" TYPE="STUDY">Chadda 2002</LINK>; <LINK REF="REF-Mart_x00ed_nez-1995" TYPE="REFERENCE">Martínez 1995</LINK>; <LINK REF="REF-Meyer-1998" TYPE="REFERENCE">Meyer 1998</LINK>; <LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>). In the upright patient, most oedema fluid collects at the lung bases. The oedema fluid causes intrapulmonary shunting and, consequently, ventilation-perfusion (V-Q) mismatch and redistribution of blood flow to the upper lobes. ACPE presents clinically with difficulty breathing, hypoxaemia and anxiety. The resulting sympathetic nervous system activation manifests clinically with tachycardia, hypertension, peripheral vasoconstriction and diaphoresis (<LINK REF="REF-Allison-1991" TYPE="REFERENCE">Allison 1991</LINK>).</P>
<P>Clinicians treat patients with ACPE with supplemental oxygen, diuretics, nitrates, nitroglycerin and morphine sulfate. Additional treatments may be required to address the etiology of ACPE and may include antihypertensive therapy, inotropic agents, thrombolysis or urgent surgery (<LINK REF="REF-Dickstein-2008" TYPE="REFERENCE">Dickstein 2008</LINK>; <LINK REF="REF-Guimar_x00e3_es-2004" TYPE="REFERENCE">Guimarães 2004</LINK>; <LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>; <LINK REF="REF-Remme-1997" TYPE="REFERENCE">Remme 1997</LINK>; <LINK REF="REF-Williams-1995" TYPE="REFERENCE">Williams 1995</LINK>). A subset of patients with ACPE may require endotracheal intubation and mechanical ventilation (<LINK REF="REF-Meyer-1998" TYPE="REFERENCE">Meyer 1998</LINK>). Mechanical ventilation supports oxygenation by recruiting previously collapsed alveoli (<LINK REF="STD-Levitt-2001" TYPE="STUDY">Levitt 2001</LINK>; <LINK REF="REF-Williams-1995" TYPE="REFERENCE">Williams 1995</LINK>) and thereby improves lung compliance. However, invasive ventilation increases the risk for complications including nosocomial infections (pneumonia, sinusitis) and tracheal injury (<LINK REF="REF-Gay-2009" TYPE="REFERENCE">Gay 2009</LINK>; <LINK REF="REF-Keenan-1997" TYPE="REFERENCE">Keenan 1997</LINK>). Consequently, may prolong intensive care unit (ICU) and hospital stay (<LINK REF="STD-Pang-1998" TYPE="STUDY">Pang 1998</LINK>). Patients with ACPE can be supported with NPPV, which has been shown to improve mortality and endotracheal intubation rate (ETI) as an initial treatment for patients with acute exacerbations of chronic obstructive pulmonary disease (<LINK REF="REF-Ram-2004" TYPE="REFERENCE">Ram 2004</LINK>).</P>
<P>NPPV includes forms of ventilatory support applied without the use of an endotracheal tube, and is considered to include continuous positive airway pressure (CPAP), without or with inspiratory pressure support (bilevel NPPV or BiPAP<SUP>®</SUP> - Respironics, Inc, Murrysville, PA). The goals of NPPV use in the treatment of ACPE are to improve oxygenation, reduce the effort of breathing and increase cardiac output (<LINK REF="STD-Evans-2001" TYPE="STUDY">Evans 2001</LINK>). CPAP achieves these goals by maintaining positive airway pressure throughout the respiratory cycle thereby preventing alveolar collapse at end-expiration. CPAP increases lung compliance and decreases the effort of breathing, while decreasing cardiac preload and afterload (<LINK REF="REF-Allison-1991" TYPE="REFERENCE">Allison 1991</LINK>; <LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>). CPAP improves arterial oxygenation (PaO<SUB>2</SUB>) by increasing the functional residual capacity of the lungs and reducing intrapulmonary shunt (<LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>). With CPAP high mean airway pressures are avoided and lower mean intra-thoracic pressures develop during inspiration with favourable effects on venous return and a lower risk of barotrauma (<LINK REF="REF-Covelli-1982" TYPE="REFERENCE">Covelli 1982</LINK>; <LINK REF="REF-Kelly-1997" TYPE="REFERENCE">Kelly 1997</LINK>). Treatment with CPAP has beneficial effects on haemodynamics by ameliorating hypertension and tachycardia (<LINK REF="REF-V_x00e4_is_x00e4_nen-1987" TYPE="REFERENCE">Väisänen 1987</LINK>). Unlike CPAP, bilevel NPPV combines inspiratory positive airway pressure with positive end-expiratory pressure. Consequently, bilevel NPPV differs from CPAP in providing inspiratory assistance to rest the muscles of respiration (<LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>). CPAP and bilevel NPPV are applied with either a nasal or oronasal mask at the patient-ventilator interface (<LINK REF="STD-Chadda-2002" TYPE="STUDY">Chadda 2002</LINK>; <LINK REF="REF-Keenan-1997" TYPE="REFERENCE">Keenan 1997</LINK>). Complications associated with NPPV use include air leaks, mask discomfort, skin breakdown, eye irritation, sinus congestion, oronasal drying and patient-ventilator dyssynchrony. Pneumothoraces and pneumonias can occur with NPPV administration but are less frequent compared to invasive ventilation (<LINK REF="REF-Bach-1997" TYPE="REFERENCE">Bach 1997</LINK>; <LINK REF="REF-Gay-2009" TYPE="REFERENCE">Gay 2009</LINK>). NPPV may also delay endotracheal intubation with patient deterioration in the intervening time period (<LINK REF="STD-Wood-1998" TYPE="STUDY">Wood 1998</LINK>).</P>
<P>Over the past 30 years, numerous reports have appeared in the literature regarding the potential effectiveness of NPPV for patients with ACPE (<LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK>; <LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>). The delay in uptake of the evidence may be due to the need for increased patient supervision, the experience of staff with NPPV, NPPV availability and concerns regarding potential adverse effects (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Pang-1998" TYPE="STUDY">Pang 1998</LINK>). Evidence from at least one randomised trial supports that NPPV accelerates recovery of vital signs and blood gases while avoiding intubation (<LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>). The role of bilevel NPPV in patients with ACPE remains controversial. In a comparison of CPAP with bilevel NPPV, the latter demonstrated more rapid recovery of respiratory and haemodynamic parameters (<LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK>), but bilevel NPPV was also associated with an increased incidence of acute myocardial infarction (<LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>).</P>
<P>In spite of the potential advantages of NPPV for the management of ACPE, there appears to be a lack of high quality clinical evidence to support use of these interventions. The purpose of this systematic review was to identify, critically appraise and summarise the evidence for NPPV use for ACPE.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-03-06 13:29:30 +0000" MODIFIED_BY="[Empty name]">
<P>The primary objective of this review was to determine the effectiveness and safety of NPPV (CPAP and/or bilevel NPPV) plus standard medical care compared to standard medical care in adults with ACPE on hospital mortality and other clinically important outcomes. The second objective of this review was to directly compare the effects of CPAP and bilevel NPPV on clinically important outcomes.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-04-16 13:27:39 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-04-16 13:27:10 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-04-16 13:27:03 +0100" MODIFIED_BY="Liz Bickerdike">
<P>We included blinded or unblinded randomised controlled trials (RCTs) or quasi-randomised controlled trials (QRCTs) in our review. We defined QRCTs as those in which the allocation procedure was unlikely to be adequately concealed (i.e. randomisation according to odd or even numbers, day of the week, social security number, or medical record number).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-04-16 13:27:06 +0100" MODIFIED_BY="Liz Bickerdike">
<P>We included trials reporting on adult patients (<U>&gt;</U>18 years) with acute or acute-on-chronic cardiogenic pulmonary oedema. We used the criteria of the American Heart Association (AHA) and/or the European Society of Cardiology (ESC) to define ACPE (<LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>; <LINK REF="REF-Williams-1995" TYPE="REFERENCE">Williams 1995</LINK>). Alternatively, a diagnosis of acute HF was based upon symptoms and clinical signs including dyspnoea, shortness of breath, nonproductive or cough productive of sputum), pallor, cyanosis, normal or elevated blood pressure, rales on auscultation and the presence of cold clammy skin. The diagnosis had to be supported by a chest radiograph, electrocardiograms, serum biomarkers of acute myocardial infarction or acute HF or echocardiography.</P>
<P>We excluded trials investigating NPPV for patients with a primary diagnosis of pneumonia, alternative etiologies of respiratory failure and its use as a weaning strategy.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-04-16 13:27:06 +0100" MODIFIED_BY="Liz Bickerdike">
<P>The control group included any form of standard medical care (SMC) provided for the management of cardiogenic pulmonary oedema (<LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>), excluding NPPV or alternative methods of ventilatory support.</P>
<P>The intervention group was standard medical care for the management of cardiogenic pulmonary oedema plus NPPV (CPAP and/or bilevel NPPV) applied through a nasal or facemask.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-04-16 13:27:10 +0100" MODIFIED_BY="Liz Bickerdike">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-04-16 13:27:07 +0100" MODIFIED_BY="Liz Bickerdike">
<UL>
<LI>Hospital mortality</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-04-16 13:27:10 +0100" MODIFIED_BY="Liz Bickerdike">
<UL>
<LI>ETI</LI>
<LI>Incidence of acute myocardial infarction during and after intervention (during the hospital stay)</LI>
<LI>Intolerance to the allocated treatment (patients with criteria for intubation, but this situation did not happen, because they could get another type of ventilatory support)</LI>
<LI>Hospital length of stay (between admission to hospital up to death event or hospital leaving)</LI>
<LI>Intensive care unit (ICU) length of stay (time length in between admission to ICU up to death event or ICU leaving)</LI>
<LI>Arterial blood gases (PaCO<SUB>2</SUB>, PaO<SUB>2</SUB>) and pH one-hour post intervention</LI>
<LI>Vital signs: respiratory rate, heart rate, blood pressure 1-hour post intervention</LI>
<LI>Treatment failure (the combination of mortality and intubation and intolerance to the allocated treatment)</LI>
<LI>Adverse events</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-04-16 13:27:13 +0100" MODIFIED_BY="Liz Bickerdike">
<ELECTRONIC_SEARCHES MODIFIED="2013-04-16 13:27:13 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) and the Database of Abstracts of Reviews Effectiveness (DARE) on <I>The Cochrane Library</I> (Issue 2, 2011), MEDLINE (Ovid, 1950 to 20 April 2011), EMBASE (Ovid, 1980 to 20 April 2011), Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO, 1982 to 20 April 2011) and LILACS (1982 to 20 April 2011) . When the searches were run in 2009 we combined the search strategies with the highly sensitive search strategies to identify RCTs in MEDLINE (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>), EMBASE (<LINK REF="REF-Lefebvre-1996" TYPE="REFERENCE">Lefebvre 1996</LINK>), and LILACS (<LINK REF="REF-Castro-1999" TYPE="REFERENCE">Castro 1999</LINK>). When the searches were re-run in 2011 the MEDLINE and EMBASE searches used the most current highly sensitive search filters for RCTs (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>).</P>
<P>The search strategies for each database are presented in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> (and <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> (2009 and 2011 searches, respectively).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-12-14 11:29:11 +0000" MODIFIED_BY="Liz Bickerdike">
<P>We reviewed the bibliographies of retrieved articles to identify related published and unpublished studies.<BR/>We contacted authors of included RCTs, experts in NPPV and ventilator manufacturers to obtain information on other published and unpublished studies. No language restrictions were applied.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-04-16 13:27:39 +0100" MODIFIED_BY="[Empty name]">
<P>We followed the recommendations outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> in preparing this review (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<STUDY_SELECTION MODIFIED="2011-11-22 16:26:52 +0000" MODIFIED_BY="[Empty name]">
<P>Two authors (FV and ML) independently screened citations and selected trials meeting the inclusion criteria. Disagreements were resolved by a third author (AA).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-04-16 13:27:16 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors (FV and ML) abstracted data using a standardised data collection form which highlighted characteristics of the study (design, methods of randomisation, withdrawals and dropouts, intention-to-treat analysis (ITT), informed consent, place and multicenter study), participants (age, gender, number, diagnostic criteria, inclusion and exclusion criteria) and interventions (type of NPPV, timing and duration of therapy, co-interventions, SMC (intervention and dose)) and the outcomes reported. We requested unpublished data from primary authors to supplement outcomes where needed. A third author (ANA) resolved disagreements. If consensus could not be reached, we contacted the author of the trial for additional information.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-04-16 13:27:30 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed the methodological quality of the included trials with emphasis on allocation concealment, generation of allocation sequence, detection bias, attrition bias, selective outcome reporting and adherence to ITT as follows (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>; <LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>):</P>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<UL>
<LI>Low risk of bias: randomisation method described that would not allow investigator/participant to know or influence intervention group before eligible participant entered in the study</LI>
<LI>Moderate risk of bias: randomisation stated but no information on method used is available</LI>
<LI>High risk of bias: method of randomisation used such as alternate medical record numbers or unsealed envelopes; any information in the study that indicated that investigators or participants could influence intervention group (quasi-randomised studies)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Generation of allocation sequence</HEADING>
<UL>
<LI>Low risk of bias: adequate sequence generation</LI>
<LI>Moderate risk of bias: not reported in the paper or by contacting authors</LI>
<LI>High risk of bias: not adequate (quasi-randomised studies)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Detection bias</HEADING>
<UL>
<LI>Low risk of bias: outcome assessors were independent from the individuals administering/supervising the assigned treatments</LI>
<LI>Moderate risk of bias: not reported in the paper or by contacting authors</LI>
<LI>High risk of bias: outcome assessors aware about the assigned treatments</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Attrition bias</HEADING>
<UL>
<LI>Low risk of bias: drop-outs without substantial (statistically significant) difference between the two comparison groups and/or a substantial drop-out rate within the sample as a whole</LI>
<LI>Moderate risk of bias: not reported in the paper or by contacting authors</LI>
<LI>High risk of bias: drop outs with substantial (statistically difference) between the two treatment groups and/or a substantial drop-out rate within the sample as a whole</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Selective outcome reporting</HEADING>
<UL>
<LI>Low risk of bias: reports of the study free of suggestion of selective outcome reporting</LI>
<LI>Moderate risk of bias: not reported in the paper or by contacting authors</LI>
<LI>High risk of bias: reports of the study with suggestion of selective outcome reporting</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adherence to the intention-to-treat principle</HEADING>
<UL>
<LI>Yes: specifically reported by authors that intention-to-treat analysis was undertaken and this was confirmed on study assessment</LI>
<LI>No: not reported and lack of intention-to-treat analysis confirmed on study assessment (patients who were randomised were not included in the analysis because they did not receive the study intervention, they withdrew from the study or were not included because of protocol violation)</LI>
</UL>
<P>We also noted whether informed consent was obtained and whether the study was blinded.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-04-16 13:27:33 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed the impact of heterogeneity using the I<SUP>2</SUP> test (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). This test illustrates the percentage of variability in effect estimates resulting from heterogeneity, as opposed to sampling error. In the presence of the significant heterogeneity (&gt;50%) and a sufficient number of studies reporting the outcome of interest, we conducted exploratory analyses to investigate potential sources of heterogeneity (e.g. participants, treatments and study quality). We hypothesised that age, gender and comorbidities may represent potential sources of heterogeneity among participants. Heterogeneity may be related to the initial treatment(s) used, the levels of pressure applied with NPPV or treatment duration. We considered P values &lt; 0.10 to be statistically significant.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-04-16 13:27:36 +0100" MODIFIED_BY="[Empty name]">
<P>We pooled dichotomous and continuous variables using relative risk (RR) and weighted mean difference (WMD), respectively, using random-effects models. We presented the number needed to treat (NNT) and risk difference (RD) for statistically significant results and assessed their robustness using a fixed-effect model. We report summary estimates of treatment effect with their associated 95% confidence intervals (CIs). All analyses were performed using the Cochrane Collaboration's statistical software, (<LINK REF="REF-Review-Manager-2013" TYPE="REFERENCE">Review Manager 2013</LINK>). We considered P values &lt; 0.05 to be statistically significant.</P>
</DATA_SYNTHESIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-04-16 13:27:39 +0100" MODIFIED_BY="[Empty name]">
<P>We decided <I>a priori </I>to conduct sensitivity analysis to assess the impact of excluding QRCTs on the outcomes of mortality and endotracheal intubation. Finally, we constructed funnel plots to assess for publication bias (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality of the evidence</HEADING>
<P>We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess the overall quality of evidence (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>; <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-04-16 13:29:47 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-04-16 13:28:17 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Study search</HEADING>
<P>We identified 1248 citations from our electronic searches (250 in MEDLINE, 427 in EMBASE, 378 in CENTRAL, 137 in CINAHL, 37 in LILACS, and 19 in DARE). We identified two additional studies through searches in bibliographic references and through correspondence with authors. Two authors (FV, ML) pre-selected 35 references for more detailed review through abstract and title screening (see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). All disagreements were resolved by a third reviewer (ANA). We have included 11 new studies with 21 previously included studies, totaling 32 studies involving 2,916 participants (<LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>; <LINK REF="STD-Bellone-2004" TYPE="STUDY">Bellone 2004</LINK>; <LINK REF="STD-Bellone-2005" TYPE="STUDY">Bellone 2005</LINK>; <LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>; <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>; <LINK REF="STD-Ferrari-2007" TYPE="STUDY">Ferrari 2007</LINK>; <LINK REF="STD-Ferrari-2010" TYPE="STUDY">Ferrari 2010</LINK>; <LINK REF="STD-Ferrer-2003" TYPE="STUDY">Ferrer 2003</LINK>; <LINK REF="STD-Fontanella-2010" TYPE="STUDY">Fontanella 2010</LINK>; <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>; <LINK REF="STD-Kelly-2002" TYPE="STUDY">Kelly 2002</LINK>; <LINK REF="STD-Levitt-2001" TYPE="STUDY">Levitt 2001</LINK>; <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK>; <LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>; <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK>; <LINK REF="STD-Lin-1995" TYPE="STUDY">Lin 1995</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>; <LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK>; <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK>; <LINK REF="STD-Nava-2003" TYPE="STUDY">Nava 2003</LINK>; <LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>; <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>; <LINK REF="STD-Takeda-1997" TYPE="STUDY">Takeda 1997</LINK>; <LINK REF="STD-Takeda-1998" TYPE="STUDY">Takeda 1998</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). This included 23 RCTs comparing NPPV plus standard medical care (CPAP and/or bilevel NPPV) to standard medical care and 14 RCTs comparing CPAP plus standard medical care and bilevel NPPV plus standard medical care directly. One of the studies was a mega trial (<LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>). Further details of the included studies are available in the section <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and justifications for studies excluded are described in <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Study design</HEADING>
<P>Of the 32 parallel design studies, 30 were RCTs and 2 were QRCTs (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). Twenty seven studies were reported in full and five studies were reported in abstract form (<LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>; <LINK REF="STD-Fontanella-2010" TYPE="STUDY">Fontanella 2010</LINK>; <LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Population</HEADING>
<P>The 32 studies were based in several countries including Finland, Australia, Taiwan, Japan, Spain, Israel, USA, Brazil, UK, Belgium, Egypt, Russian, Germany, France and Italy. Eight studies were multicentre studies (<LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>; <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>; <LINK REF="STD-Ferrari-2010" TYPE="STUDY">Ferrari 2010</LINK>; <LINK REF="STD-Ferrer-2003" TYPE="STUDY">Ferrer 2003</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>; <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK>; <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK>; <LINK REF="STD-Nava-2003" TYPE="STUDY">Nava 2003</LINK>). All studies reported on adult patients with acute or acute-on-chronic cardiogenic pulmonary oedema. The number of patients recruited in each study ranged from 8 to 1069 with similar numbers of patients in the intervention and control groups. We have included in the systematic review one mega trial (<LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>); however, only their adverse events and the outcome intolerance to the allocated treatment were recorded. The average age of participants was 74 years. The prevalence of cardiogenic pulmonary oedema for men and women was 47% and 53%, respectively.</P>
<P>While nine studies were conducted in the ICU (<LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>; <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>; <LINK REF="STD-Ferrer-2003" TYPE="STUDY">Ferrer 2003</LINK>; <LINK REF="STD-Fontanella-2010" TYPE="STUDY">Fontanella 2010</LINK>; <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>; <LINK REF="STD-Takeda-1997" TYPE="STUDY">Takeda 1997</LINK>; <LINK REF="STD-Takeda-1998" TYPE="STUDY">Takeda 1998</LINK>), four studies were undertaken in the emergency department and included patients referred to the ICU after being on a ward (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK>; <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>). Additionally, <LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK> reported that it was conducted in the hospital without reference to a specific location, two studies did not report the venue (<LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>), and two other studies reported that the interventions were initiated in a mobile ICU and continued in the emergency department (<LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK> reported that the interventions were initiated in a mobile ICU and continued in ICU. The remaining studies were solely undertaken in the emergency department.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intervention</HEADING>
<P>Of the studies identified, ten compared CPAP to SMC (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>; <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK>; <LINK REF="STD-Kelly-2002" TYPE="STUDY">Kelly 2002</LINK>; <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK>; <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK>; <LINK REF="STD-Lin-1995" TYPE="STUDY">Lin 1995</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>; <LINK REF="STD-Takeda-1997" TYPE="STUDY">Takeda 1997</LINK>; <LINK REF="STD-Takeda-1998" TYPE="STUDY">Takeda 1998</LINK>), and eight compared bilevel NPPV to SMC (<LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>; <LINK REF="STD-Ferrer-2003" TYPE="STUDY">Ferrer 2003</LINK>; <LINK REF="STD-Levitt-2001" TYPE="STUDY">Levitt 2001</LINK>; <LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK>; <LINK REF="STD-Nava-2003" TYPE="STUDY">Nava 2003</LINK>; <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK> ). Additionally, there were five three-arm studies comparing CPAP to bilevel NPPV and to SMC (<LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>; <LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>). Finally, nine studies directly compared CPAP with bilevel NPPV (<LINK REF="STD-Bellone-2004" TYPE="STUDY">Bellone 2004</LINK>; <LINK REF="STD-Bellone-2005" TYPE="STUDY">Bellone 2005</LINK>; <LINK REF="STD-Ferrari-2007" TYPE="STUDY">Ferrari 2007</LINK>; <LINK REF="STD-Ferrari-2010" TYPE="STUDY">Ferrari 2010</LINK>; <LINK REF="STD-Fontanella-2010" TYPE="STUDY">Fontanella 2010</LINK>; <LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>; <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK>).</P>
<P>In <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>, we present, where reported, the different IPAP and EPAP levels used and the duration of NPPV administration. The choice of patient-ventilator interface for NPPV administration varied among the included studies with three studies using nasal masks exclusively (<LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Takeda-1997" TYPE="STUDY">Takeda 1997</LINK>; <LINK REF="STD-Takeda-1998" TYPE="STUDY">Takeda 1998</LINK>). Two studies offered a choice between nasal and face masks based on patient effort (<LINK REF="STD-Ferrer-2003" TYPE="STUDY">Ferrer 2003</LINK>; <LINK REF="STD-Levitt-2001" TYPE="STUDY">Levitt 2001</LINK>). One study used nasal masks for bilevel NPPV administration and face masks for CPAP administration (<LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>). Four studies did not report the patient-ventilator interface used (<LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>; <LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>; <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>). The remaining studies reported using face masks for NPPV administration.</P>
<P>In addition to supplemental oxygen, studies reported the use of pharmacologic treatments including furosemide, morphine, diamorphine, sodium nitroprusside, glyceryl trinitrate, nitrate, isosorbide dinitrate, nitroglycerin, digoxin, digitalis, dopamine, dobutamine, epinephrine, norepinephrine, diazepam, chlorpromazine and antibiotics. Generally the medical team was free to choose the type of medication and its dose for the management of pulmonary oedema. However, one study used high doses of isosorbide dinitrate in the control group (<LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<P>Almost all studies reported hospital mortality, except for <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK>, <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> and <LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>. <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK> reported mortality after 30 days. <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> reported mortality after 7 and 30 days from the beginning of the intervention. In order to perform a meta-analysis taking into considering the weight of the mega-trial (which presented opposite results to the first version of this review), we included data on mortality in a separate meta-analysis. However, we were unable to consider the total number after randomisation by group in this meta-analysis since <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> did not provide this information, which precluded intention-to-treat analysis according to dichotomous outcomes expected. The remaining outcomes were variably reported by the included studies. All dichotomous outcomes were described in adherence with the intention-to-treat principle. All authors reported their studies using mean and standard deviations for continuous outcomes. We transformed units from kilo pascals to millimetres of mercury in pooling results reported for arterial blood gases in two studies (<LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>; <LINK REF="STD-Kelly-2002" TYPE="STUDY">Kelly 2002</LINK>).</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-04-16 13:29:21 +0100" MODIFIED_BY="[Empty name]">
<P>The summary of risk of bias can be viewed illustratively in <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>.</P>
<ALLOCATION MODIFIED="2013-04-16 13:28:18 +0100" MODIFIED_BY="[Empty name]">
<P>All studies included stated that treatment allocation was made randomly. The following studies, which adequately reported the method of allocation concealment, were classified as "low risk of bias": <LINK REF="STD-Bellone-2004" TYPE="STUDY">Bellone 2004</LINK>; <LINK REF="STD-Bellone-2005" TYPE="STUDY">Bellone 2005</LINK>; <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>; <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>; <LINK REF="STD-Ferrari-2007" TYPE="STUDY">Ferrari 2007</LINK>; <LINK REF="STD-Ferrari-2010" TYPE="STUDY">Ferrari 2010</LINK>; <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>; <LINK REF="STD-Kelly-2002" TYPE="STUDY">Kelly 2002</LINK>; <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>; <LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK>; <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK>; <LINK REF="STD-Nava-2003" TYPE="STUDY">Nava 2003</LINK>; <LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>; <LINK REF="STD-Takeda-1998" TYPE="STUDY">Takeda 1998</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>. The following studies did not describe the method of allocation concealment and were classified as "moderate risk of bias": <LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>; <LINK REF="STD-Ferrer-2003" TYPE="STUDY">Ferrer 2003</LINK>; <LINK REF="STD-Fontanella-2010" TYPE="STUDY">Fontanella 2010</LINK>; <LINK REF="STD-Levitt-2001" TYPE="STUDY">Levitt 2001</LINK>; <LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>; <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK>; <LINK REF="STD-Lin-1995" TYPE="STUDY">Lin 1995</LINK>; <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>; <LINK REF="STD-Takeda-1997" TYPE="STUDY">Takeda 1997</LINK>. The following two studies had an inadequate (quasi-randomised) method and were classified as "high risk of bias": <LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>.</P>
<P>In 19 studies sequence generation was described in an appropriate way (<LINK REF="STD-Bellone-2004" TYPE="STUDY">Bellone 2004</LINK>; <LINK REF="STD-Bellone-2005" TYPE="STUDY">Bellone 2005</LINK>; <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>; <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>; <LINK REF="STD-Ferrari-2007" TYPE="STUDY">Ferrari 2007</LINK>; <LINK REF="STD-Ferrari-2010" TYPE="STUDY">Ferrari 2010</LINK>; <LINK REF="STD-Ferrer-2003" TYPE="STUDY">Ferrer 2003</LINK>; <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>; <LINK REF="STD-Levitt-2001" TYPE="STUDY">Levitt 2001</LINK>; <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>; <LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK>; <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK>; <LINK REF="STD-Nava-2003" TYPE="STUDY">Nava 2003</LINK>; <LINK REF="STD-Park-2001" TYPE="STUDY">Park 2001</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>). <LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK> and <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK> did not describe sequence generation.</P>
</ALLOCATION>
<EXCLUSIONS MODIFIED="2013-04-16 13:28:19 +0100" MODIFIED_BY="[Empty name]">
<P>Just two studies have presented significant losses during follow up: <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK> had lost 9 of the 36 (25%) randomised patients due to infections, exacerbation of COPD and delay in obtaining the informed permission or to initiate intervention; and <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK> lost 35 of the 80 (44%) randomised patients for having fulfilled the exclusion criteria or having failed to receive the intervention.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-04-16 13:28:22 +0100" MODIFIED_BY="[Empty name]">
<P>The majority of the studies planned and reported the outcomes analysed. Two studies omitted some information (<LINK REF="STD-Ferrari-2010" TYPE="STUDY">Ferrari 2010</LINK>; <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK>
<U>)</U>. <LINK REF="STD-Ferrari-2010" TYPE="STUDY">Ferrari 2010</LINK> planned to analyse the effect of NPPV on systemic blood pressure but did not report this outcome. <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK> did not present the results in relation to autonomy for activities of daily living, patient comfort and adverse effects.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-04-16 13:29:21 +0100" MODIFIED_BY="[Empty name]">
<P>Detection bias was the domain that generated more uncertainty in risk analysis of bias. The majority of studies did not report on blinding. Given the nature of the intervention, blinding of participants and personnel to the intervention was not feasible. Studies by Mehta and Thys were reported as being single-blinded, but in these instances the patient was reportedly blinded to his/her intervention (<LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>), which appears inconsistent with blinding. Only <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>, <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>, <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK> and <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK> reported that the evaluators were independent.</P>
<P>Twenty-one studies performed analysis by ITT. For our analysis, we performed the analysis of all dichotomous variables by intention-to-treat.</P>
<P>Five studies were stopped early due to preliminary analysis which demonstrated significant differences between groups (<LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK>; <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>). For examples, differences were seen in <LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK> and <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK> due to the incidence of acute myocardial infarction, in <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK> due to a batch of failures of treatment and clinical decline, in <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK> due to a greater number in deaths and complications in the control group and in <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK> due to a difference in the frequency of intubations. Seven studies did not explicitly report that informed consent was obtained (<LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>; <LINK REF="STD-Fontanella-2010" TYPE="STUDY">Fontanella 2010</LINK>; <LINK REF="STD-Liesching-2003" TYPE="STUDY">Liesching 2003</LINK>; <LINK REF="STD-Lin-1995" TYPE="STUDY">Lin 1995</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>).</P>
<P>Sharon's study used different doses of isosorbide dinitrate as standard treatment in the different randomised groups, which may have influenced its results.</P>
<P>The analysis of funnel plot for the outcome hospital mortality demonstrates the indicates asymmetry and the potential risk of publication bias (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality of the evidence  </HEADING>
<P>About 50% of the studies were considered as low risk of bias (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). The sole domain of quality that most studies did not report on was whether the analysis of outcomes was undertaken by the same person who applied the interventions (detection bias) (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). As such, we believe that the quality of the evidence included in this review is at moderate risk of bias.</P>
<P>More specifically, we defined seven relevant outcomes in order to assess the quality of evidence by GRADE (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>; <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The primary outcome (mortality) was supported by high quality evidence, two outcomes (incidence of acute myocardial infarction during intervention and intolerance to the allocated treatment) were considered to be supported by moderate quality evidence. Two outcomes (endotracheal intubation rate and ICU length of stay) were considered to be supported by low quality of evidence and for incidence of acute myocardial infarction after intervention and hospital length of stay were considered to be supported by very low quality evidence (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-04-16 13:29:47 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Higher than what? How much lower?&lt;/p&gt;" NOTES_MODIFIED="2013-04-16 13:29:47 +0100" NOTES_MODIFIED_BY="[Empty name]">
<P>For studies comparing NPPV to SMC, we report our results as NPPV (CPAP and bilevel NPPV) versus SMC, CPAP alone versus SMC and bilevel NPPV alone versus SMC. In addition, we report results for studies directly comparing CPAP to bilevel NPPV. We report the pooled results for all primary and secondary analyses and sensitivity analyses conducted to explore potential sources of heterogeneity on the outcomes of hospital mortality and endotracheal intubation. The summary of our findings can be seen in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">Hospital mortality</HEADING>
<P>In 20 trials involving 1107 patients, we found a reduction in hospital mortality for patients treated with NPPV plus SMC compared with SMC care alone (RR 0.66, 95% CI 0.48 to 0.89). This translates into a RD of - 0.07 or 7% (95% CI -0.12 to -0.02) and NNT of 14 (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Sensitivity analysis with the exclusion of quasi-randomised studies (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>), did not change the results (RR 0.65, 95% CI 0.46 to 0.91; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). However if we consider <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> and <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK> that analysed the mortality in 7 and/or 30 days, our meta-analysis of hospital mortality indicates that these studies reinforce the favourable use of NPPV in ACPE (RR 0.72, 95% CI 0.55 to 0.94 and RR 0.75, 95% CI 0.60 to 0.95, respectively <LINK REF="CMP-015.01" TYPE="ANALYSIS">Analysis 15.1</LINK> and <LINK REF="CMP-016.01" TYPE="ANALYSIS">Analysis 16.1</LINK>).This result could have been anticipated using cumulative meta-analysis techniques (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="REF-MIX-2006" TYPE="REFERENCE">MIX 2006</LINK>).</P>
<P>Comparing CPAP plus SMC with SMC alone (13 trials, 699 patients) there was a lower hospital mortality rate in CPAP-treated patients (RR 0.60, 95% CI 0.39 to 0.94; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). The beneficial effect of CPAP translates into a RD of -11% (95% CI -0.18 to -0.04) and a NNT of 9. The effect of CPAP on hospital mortality remained significant after exclusion of a single QRCT (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>) (RR 0.57, 95% CI 0.35 to 0.94; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>).</P>
<P>However, we found no benefit of bilevel NPPV plus SMC compared with SMC care alone on hospital mortality (11 trials, 506 patients, RR 0.65, 95% CI 0.39 to 1.09; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>), and after exclusion of quasi-randomised studies (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>) (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). However, the similar effect size and wider confidence intervals for bilevel NPPV compared to the overall NPPV and CPAP-specific results is noted.</P>
<P>We found no differences in hospital mortality comparing CPAP plus SMC and bilevel NPPV plus SMC directly (12 trials, 694 patients, RR 1.10, 95% CI 0.61 to 1.97; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ETI rate</HEADING>
<P>In 22 trials (1261 patients) we found a lower ETI rate for patients treated with NPPV plus SMC compared with SMC (RR 0.52, 95% CI 0.36 to 0.75; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). This translates into a RD of - 0.12 or 12% (95% CI -0.19 to -0.04) and a NNT of 8. Exclusion of two QRCTs (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>) also revealed beneficial effect of NPPV compared to SMC (RR 0.53, 95% CI 0.37 to 0.78; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). This remained in <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> and <LINK REF="STD-Frontin-2010" TYPE="STUDY">Frontin 2010</LINK> that analysed the frequency intubation in seven days (RR 0.55, 95% CI 0.38 to 0.78; <LINK REF="CMP-017.01" TYPE="ANALYSIS">Analysis 17.1</LINK>).</P>
<P>When we compared CPAP plus SMC with SMC (14 trials, 825 patients) we found a significantly lower endotracheal intubation favouring CPAP-treated patients (RR 0.47, 95% CI 0.33 to 0.67, RD -15%, 95% CI -0.24 to -0.06, NNT 7; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>). This result remained robust after exclusion of a single quasi-randomised trial (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>) (RR 0.48, 95% CI 0.34 to 0.67; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</P>
<P>We found no benefit of bilevel NPPV plus SMC compared with SMC alone on ETI rate (12 trials, 536 patients, RR 0.55, 95% CI 0.26 to 1.17; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). However with significant heterogeneity and after exclusion of the QRCT (<LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>) and <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK> (whose patients received different doses of drugs) this altered the results: lower ETI favouring bilevel NPPV-treated patients (RR 0.45, 95% CI 0.26 to 0.80; <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>).</P>
<P>In 13 trials (721 patients) comparing CPAP plus SMC to bilevel NPPV plus SMC care, there did not appear to be any difference between the two techniques in reducing ETI (RR 1.04, 95% CI 0.55 to 1.97; <LINK REF="CMP-002.10" TYPE="ANALYSIS">Analysis 2.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Incidence of acute myocardial infarction</HEADING>
<P>In eight trials (461 patients) we found non-significant differences in the occurrence of acute myocardial infarction during treatment with NPPV plus SMC compared to SMC (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). A similar non-significant differences were found in comparisons of CPAP plus SMC compared to bilevel NPPV plus SMC (<LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>), CPAP plus SMC care compared to SMC or bilevel NPPV plus SMC compared to SMC (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>).<BR/>
<BR/>Only four studies (154 patients) comparing NPPV plus SMC to SMC alone reported no difference in the incidence of acute myocardial infarction after intervention (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>); two studies reported no difference after CPAP plus SMC care compared to SMC (RR 1.08, 95% CI 0.11 to 10.23; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>); three studies with bilevel NPPV plus SMC to SMC reported no difference in the incidence of acute myocardial infarction after intervention (RR 0.52, 95% CI 0.02 to 11.54; <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>); two studies compared CPAP plus SMC to bilevel NPPV plus SMC and demonstrated no difference (RR 1.57, 95% CI 0.57 to 4.32; <LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intolerance to the allocated treatment</HEADING>
<P>Thirteen studies (1848 patients) found a lower incidence of intolerance in the NPPV plus SMC (16%) compared to SMC (23%) (RR 0.47, 95% CI 0.29 to 0.77; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>), The grouping of the studies demonstrated relevant heterogeneity, which was eliminated with the exclusion of <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>). We have not found plausible justification for this result. Nine studies (1304 patients) noted significantly lower intolerance with CPAP plus SMC compared to SMC (RR 0.55, 95% CI 0.36 to 0.85; <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>); seven studies (995 patients) found no difference related with intolerance to bilevel NPPV plus SMC care compared to SMC (RR 0.58, 95% CI 0.24 to 1.42; <LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>). Three studies (894 patients) found no difference between CPAP plus SMC and bilevel NPPV plus SMC with respect to intolerance (RR 0.94, 95% CI 0.35 to 2.53; <LINK REF="CMP-005.05" TYPE="ANALYSIS">Analysis 5.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Length of hospital and ICU stay</HEADING>
<P>Ten trials (542 patients) demonstrated no significant difference in hospital length of stay between NPPV plus SMC compared to SMC (WMD -0.80 days, 95% CI -2.10 to 0.51; <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>). Though heterogeneity diminished after exclusion of one QRCT (<LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>), it did not change the significance of our results (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>). Five studies (337 patients) demonstrated no differences CPAP plus SMC compared to SMC (WMD -0.51 days, 95% CI -1.69 to 0.67; <LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>). Seven studies (311 patients) showed no difference between bilevel plus SMC and SMC alone (WMD -1.38 days, 95% CI -3.38 to 0.62; <LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>), and similar results were obtained between CPAP plus SMC and bilevel NPPV plus SMC (WMD -0.46 days, 95% CI -1.99 to 1.07; <LINK REF="CMP-006.05" TYPE="ANALYSIS">Analysis 6.5</LINK>).</P>
<P>Six studies (222 patients) comparing NPPV plus SMC to SMC alone demonstrated significantly shorter ICU stay favouring the NPPV group (WMD -0.89 days, 95% CI -1.33 to -0.45; <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>). Three studies (169 patients) indicated a significantly shorter ICU stay for patients treated with CPAP plus SMC (WMD -1.09 days, 95% CI -1.63 to -0.56; <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>). A further three studies (53 patients) showed no difference between bilevel NPPV plus SMC and SMC (WMD -0.65 days, 95% CI -1.37 to 0.06; <LINK REF="CMP-007.03" TYPE="ANALYSIS">Analysis 7.3</LINK>) while no difference was seen between CPAP plus SMC and bilevel NPPV plus SMC (WMD 0.31 days, 95% CI -0.78 to 1.40; <LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Vital signs one hour after intervention</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Respiratory rate</HEADING>
<P>Nine studies (438 patients) revealed significantly lower respiratory rates in patients on NPPV plus SMC in comparison with SMC (WMD -2.86 bpm, 95% CI -3.85 to -1.87; <LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>). Seven studies (300 patients) had lower respiratory rate on CPAP plus SMC compared to SMC (WMD -2.39 bpm, 95% CI -3.70 to -1.07; <LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>), while six studies (254 patients) showed lower respiratory rate in patients on bilevel NPPV plus SMC in comparison with those receiving SMC (WMD -3.52 bpm, 95% CI -4.80 to -2.23; <LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>). Five studies (218 patients) did not show a significant difference between CPAP plus SMC and bilevel NPPV plus SMC (WMD 0.57 bpm, 95% CI -1.00 to 2.13; <LINK REF="CMP-008.04" TYPE="ANALYSIS">Analysis 8.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Heart rate (HR)</HEADING>
<P>Nine studies (438 patients) showed no significant difference between NPPV plus SMC and SMC in terms of heart rate (WMD -4.01 bpm, 95% CI -8.16 to 0.15; <LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>). Seven studies (300 patients) found no difference between CPAP plus SMC and SMC (WMD -4.45 bpm, 95% CI -10.81 to 1.92; <LINK REF="CMP-009.03" TYPE="ANALYSIS">Analysis 9.3</LINK>). The grouping of the studies in these two analyses demonstrated heterogeneity, which was eliminated with the exclusion of Rasanen's and L'Her's studies and we have not found plausible justification for this result (<LINK REF="CMP-009.02" TYPE="ANALYSIS">Analysis 9.2</LINK> and <LINK REF="CMP-009.04" TYPE="ANALYSIS">Analysis 9.4</LINK>). Six studies (254 patients) revealed lower heart rate in patients on bilevel NPPV plus SMC in comparison with SMC (WMD -4.21bpm, 95% CI -7.77 to -0.65; <LINK REF="CMP-009.05" TYPE="ANALYSIS">Analysis 9.5</LINK>) and no significant results were seen in four studies (182 patients) comparing CPAP plus SMC and bilevel NPPV plus SMC (WMD 0.56 bpm, 95 %CI -5.22 to 4.11; <LINK REF="CMP-009.06" TYPE="ANALYSIS">Analysis 9.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Systolic blood pressure (SBP)</HEADING>
<P>Six studies (182 patients) found no statistically significant difference between NPPV plus SMC and SMC groups in SBP (WMD -1.64 mmHg, 95% CI -7.83 to 4.56; <LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>). Six studies (211 patients) found no statistically significant difference between CPAP plus SMC and SMC groups in SBP (WMD -0.12 mmHg, 95% CI -6.56 to 6.81; <LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>). Similar non-significant differences were seen in comparison of bilevel NPPV plus and SMC (WMD 1.93 mmHg, 95% CI -7.94 to 11.80; <LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>), and CPAP plus SMC versus bilevel NPPV plus SMC (WMD -1.17 mmHg, 95% CI -10.79 to 8.44; <LINK REF="CMP-010.04" TYPE="ANALYSIS">Analysis 10.4</LINK>). However, the last analysis showed significant heterogeneity, which was resolved after removing <LINK REF="STD-Bellone-2004" TYPE="STUDY">Bellone 2004</LINK>, which showed higher baseline SBP value than other studies (<LINK REF="CMP-010.05" TYPE="ANALYSIS">Analysis 10.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Diastolic blood pressure (DBP)</HEADING>
<P>Five studies (138 patients) compared NPPV plus SMC and SMC care on DBP but found no difference (WMD -1.49 mmHg, 95% CI -6.43 to 3.45; <LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>). Five studies (167 patients) compared CPAP plus SMC and SMC on DBP but found no difference (WMD -0.92 mmHg, 95% CI -9.10 to 7.27; <LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>). However, heterogeneity was observed, which diminished after excluding studies <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK> and <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK> (there was a lower value for baseline DBP (mean and SD) in the latter studies in comparison with the others). After excluding those studies, the remaining three studies (107 patients) showed statistically significant lower DBP in patients on CPAP in comparison with those receiving SMC (WMD -7.32 mmHg, 95% CI -12.79 to -1.86; <LINK REF="CMP-011.03" TYPE="ANALYSIS">Analysis 11.3</LINK>). No difference was seen when bilevel NPPV plus SMC care was compared to SMC (four studies; 87 patients) (WMD -0.96 mmHg, 95% CI -6.09 to 4.16; <LINK REF="CMP-011.04" TYPE="ANALYSIS">Analysis 11.4</LINK>) or CPAP plus SMC vs bilevel NPPV plus SMC (WMD -2.60 mmHg, 95% CI -9.58 to 4.37; <LINK REF="CMP-011.05" TYPE="ANALYSIS">Analysis 11.5</LINK>). A change was observed when <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK> and <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK> were excluded, showing statistically significant better DBP in patients (n=62) on CPAP plus SMC in comparison with those receiving bilevel NPPV plus SMC, but we have not found plausible justification for this result (WMD -7.86 mmHg, 95% CI -13.03 to -2.70; <LINK REF="CMP-011.06" TYPE="ANALYSIS">Analysis 11.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mean blood pressure (MBP)</HEADING>
<P>Three studies (256 patients) found no statistically significant difference between NPPV plus SMC compared to SMC (WMD -2.41 mmHg, 95% CI -8.27 to 3.45; <LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>); similar non-significance was seen in comparison of CPAP plus SMC and SMC (one study, 89 patients) (WMD 3.00 mmHg, 95% CI -5.31 to 11.31; <LINK REF="CMP-012.02" TYPE="ANALYSIS">Analysis 12.2</LINK>), in bilevel NPPV plus SMC compared to SMC (two studies, 167 patients) (WMD -5.42 mmHg, 95%CI -11.60 to 0.76; <LINK REF="CMP-012.03" TYPE="ANALYSIS">Analysis 12.3</LINK>), and in comparison of CPAP plus SMC and Bilevel NPPV plus standard medical care (one study, 80 patients) (WMD -4.40 mmHg, 95% CI -13.25 to 4.45; <LINK REF="CMP-012.04" TYPE="ANALYSIS">Analysis 12.4</LINK>) .</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Arterial blood gases and pH one hour after intervention</HEADING>
<P>Four studies (140 patients) showed significantly higher PaO<SUB>2</SUB> levels being found in NPPV plus SMC patients in comparison with those receiving SMC (WMD 10.04 mmHg, 95% CI 1.09 to 19.00; <LINK REF="CMP-013.01" TYPE="ANALYSIS">Analysis 13.1</LINK> ). Five studies (177 patients) found no difference in arterial oxygen levels (PaO<SUB>2</SUB>) between CPAP plus SMC and SMC alone (WMD -2.64 mmHg, 95% CI -25.87 to 20.59; <LINK REF="CMP-013.02" TYPE="ANALYSIS">Analysis 13.2</LINK>). Pooling of these five studies showed significant heterogeneity. Exclusion of the <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK> and <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK> studies, which were conducted in ICU settings, showed significantly better PaO<SUB>2 </SUB>after one hour of intervention in SMC care patients in comparison with those receiving NPPV (WMD -22.09 mmHg, 95% CI -34.35 to -9.83; <LINK REF="CMP-013.03" TYPE="ANALYSIS">Analysis 13.3</LINK>). Three studies (79 patients) comparing bilevel NPPV plus SMC versus SMCe did not show any significant difference between the groups (WMD 4.79 mmHg, 95% CI -11.11 to 20.69; <LINK REF="CMP-013.04" TYPE="ANALYSIS">Analysis 13.4</LINK>). Three studies showed significantly higher PaO<SUB>2</SUB> levels being found in bilevel NPPV plus SMC patients in comparison with those receiving CPAP plus SMCe (WMD -27.00 mmHg, 95% CI -44.75 to -9.25; <LINK REF="CMP-013.05" TYPE="ANALYSIS">Analysis 13.5</LINK>).</P>
<P>We did not pool PaCO<SUB>2</SUB> and pH one hour after intervention as these outcomes require assessment with respect to baseline values (normal for each patient). Pooling of these parameters may not be meaningful.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Treatment failure</HEADING>
<P>We defined treatment failure as a composite of mortality, endotracheal intubation and intolerance to the allocated treatment. No study in this review reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse events</HEADING>
<P>
<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> summarises the types and number of reported adverse events for both CPAP and bilevel NPPV, where they were reported, regardless of comparative intervention.</P>
<P>Fifteen studies reported adverse events with 232 events occurring in 1109 NPPV plus SMC treated patients and 154 events occurring in 751 SMC care treated patients. The adverse events reported were: skin damage, pneumothorax, pulmonary aspiration, gastric distension, vomiting, mask discomfort, hypotension, arrhythmia, progressive respiratory distress, gastrointestinal bleeding, asphyxia, conjunctivitis, sinusitis, eyes irritation, stroke, seizure, neurological failure (coma) and cardiorespiratory arrest. Participants receiving SMC had less skin damage and those treated with  NPPV had less progressive respiratory distress and neurological failure (coma). Confining the analysis to trials published after 2000 did not alter these results. A detailed description of these complications can be found in <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>, <LINK REF="CMP-014.01" TYPE="ANALYSIS">Analysis 14.1</LINK> and <LINK REF="CMP-014.02" TYPE="ANALYSIS">Analysis 14.2</LINK>.</P>
<P>Ten studies reported adverse events with 88 events complications in the 544 CPAP plus SMC treated patients and 146 events in the 572 SMC treated patients. The adverse events reported were: skin damage, pneumonia, pulmonary aspiration, gastrointestinal bleeding, gastric distension, vomiting, asphyxia, pneumothorax, conjunctivitis, sinusitis, mask discomfort, hypotension, arrhythmia, progressive respiratory distress, cardiorespiratory arrest and neurological failure (coma). The CPAP group had fewer  progressive respiratory distress, cardiorespiratory arrest and neurological failure (coma). Details of adverse events in patients receiving CPAP and standard medical care are provided in <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK> and <LINK REF="CMP-014.03" TYPE="ANALYSIS">Analysis 14.3</LINK>.</P>
<P>Eight studies reported adverse events with 144 events occurring in 368 bilevel NPPV plus SMC care patients and 136 events occurring in 384 SMC. The adverse events reported were: skin damage, pneumonia, gastrointestinal bleeding, gastric distension, vomiting, pneumothorax, eyes irritation, sinusitis, mask discomfort, claustrophobia, cardiac arrest, stroke, seizure, gastric aspiration, hypotension, arrhythmia and progressive respiratory distress. Participants in the SMC group had a lower rate of skin damage  Details of the adverse events in people receiving bilevel NPPV plus SMC are provided in <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK> and <LINK REF="CMP-014.04" TYPE="ANALYSIS">Analysis 14.4</LINK>.</P>
<P>Five studies reported adverse events with 156 events occurring in 389 bilevel NPPV plus SMC treated patients and 126 events occurring in 376 CPAP plus SMC treated patients. The adverse events reported were: skin damage, pneumothorax, pulmonary aspiration, gastric distension, vomiting, mask discomfort, increased breathing discomfort, hypotension, arrhythmia, progressive respiratory distress, cardiorespiratory arrest, pharyngeal damage and cough. Patients treated with CPAP had fewer arrhythmias. A detailed description of the complications can be found in <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK> and <LINK REF="CMP-014.05" TYPE="ANALYSIS">Analysis 14.5</LINK>.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-04-16 13:30:23 +0100" MODIFIED_BY="[Empty name]">
<P>The inclusion of eleven new studies in this review did not change significantly the results for the effectiveness of the use of NPPV compared with SMC, but it was possible to identify modest differences between CPAP and bilevel NPPV.</P>
<SUMMARY_OF_RESULTS MODIFIED="2013-04-16 13:30:08 +0100" MODIFIED_BY="[Empty name]">
<P>Our meta-analysis demonstrates the effectiveness of NPPV and CPAP compared to SMC in reducing hospital mortality. Our results support that one death can be avoided for every 14 ACPE patients treated with NPPV. Similarly, one death can be prevented for every nine ACPE patients treated with CPAP. This means that 69 lives out of 1000 could be saved with the addition of NPPV to SMC. The reduction in mortality was supported by studies comparing CPAP to SMC but not by studies comparing bilevel NPPV to SMC or CPAP to bilevel NPPV. The effect size of bilevel NPPV was notably similar to CPAP compared to SMC, but these results were more imprecise. Potential reasons for these discordant findings may include the relatively small number of patients experiencing events in these studies leading to low power; incorporating more recent studies that may have led to reduced mortality from SMC; or a true difference between CPAP and bilevel NPPV, which is corroborated by the findings from studies that directly compare CPAP and bilevel NPPV in patients with ACPE. However, the mega trial published by <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> analysed mortality 7 and 30 days after the NPPV initiation in patients with ACPE and did not identify any important differences between the NPPV groups compared to the SMC. Nonetheless, when we include these data in a meta-analysis of our primary outcome (in-hospital mortality), we find a persistent benefit of NPPV in reducing mortality in patients with ACPE. We do identify limitations in <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> that may contribute with findings divergences. First, <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> reported that it used ITT analyses but its analysis did not include all randomised patients (follow-up bias). Second, the study did not report the total distribution of randomisation by group, which impeded the meta-analysis of various outcomes and could be considered as a potential source of heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Third, the reporting of continuous variables included only mean value of the difference between zero and one hour after the intervention and not as mean and standard deviation. However, it has not been possible to obtain these data for our meta-analysis.</P>
<P>We also found that NPPV significantly reduced endotracheal intubation compared to SMC. Only eight patients need to be treated with NPPV to avoid 1 intubation. We noted similar results in studies comparing CPAP to SMC where the NNT was 7. Although NPPV has demonstrated to effectively reduce the intubation rate, it was not possible to assess if NPPV could postpone this outcome, as suggested in the study of <LINK REF="STD-Wood-1998" TYPE="STUDY">Wood 1998</LINK>. This randomised study reported significant delay in intubation and mechanical ventilation of acute respiratory distress syndrome (ARDS) patients treated with bilevel NPPV compared with SMC. The difference however was not found to be statistically significant (P=0.06), perhaps due to a low event rate (seven in the bilevel NPPV group and five in the SMC group). Likewise, the outcomes of mortality and intubation rate did not show statistically significant difference between the groups. In contrast to Confaloniere`s study of patients with pneumonia, although bilevel NPPV reduced the intubation rate, no difference in the time to intubate and initiate mechanical ventilation was observed (<LINK REF="REF-Confalonieri-1999" TYPE="REFERENCE">Confalonieri 1999</LINK>).<BR/>
<BR/>An additional important finding of our review was that the incidence of acute myocardial infarction was not increased either during or after NPPV use. This is an important finding, as some studies (<LINK REF="STD-Mehta-1997" TYPE="STUDY">Mehta 1997</LINK>; <LINK REF="STD-Rusterholtz-1999" TYPE="STUDY">Rusterholtz 1999</LINK>; <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>) had noted an increased incidence of acute myocardial infarction in patients treated with bilevel NPPV. To this end, few studies clearly distinguished between acute myocardial infarction at randomisation or evolving during or after NPPV initiation. Consistent with our results, Bellone and colleagues applied stringent criteria to detect acute myocardial infarction (<LINK REF="STD-Bellone-2004" TYPE="STUDY">Bellone 2004</LINK>) and noted non-significant differences in acute myocardial infarction among CPAP and bilevel NPPV treated patients. Recent RCTs (<LINK REF="STD-Ferrari-2007" TYPE="STUDY">Ferrari 2007</LINK>; <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>) have also shown no significant differences on the incidence of acute myocardial infarction and other relevant outcomes when compared CPAP to bilevel NPPV.</P>
<P>NPPV also appears to reduce the risk of progression of respiratory failure and neurological failure (coma) compared to SMC. These results were mainly influenced by studies conducted with CPAP, which additionally demonstrated a reduction in cardiovascular arrest and adverse events risk in general when compared to SMC. NPPV is associated with increased risk for skin damage, but this adverse event is not generally considered major. This adverse event outcome was primarily influenced by Nava's studies, which may be related to the particular time and use of NPPV mask in that study. CPAP demonstrated a lower risk of developing arrhythmias when compared to using bilevel NPPV. It is possible that this reduced risk of adverse events with the use of CPAP could be related to lower positive pressure levels than those used in the bilevel NPPV, which may influence haemodynamics and/or O<SUB>2 </SUB>consumption. Despite similar effect sizes between CPAP and bilevel NPPV in terms of our primary outcome, these safety data are notable.</P>
<P>Our review did not reveal a significant difference between NPPV and SMC in terms of hospital length of stay. However, our review supports about one-day reduction in ICU length of study with NPPV compared to SMC, and CPAP, in particular, compared to SMC. These differences were not supported in comparisons of bilevel NPPV to SMC and CPAP to bilevel NPPV. Some studies such as <LINK REF="STD-Holt-1994" TYPE="STUDY">Holt 1994</LINK> have shown a reduction in hospital length of stay in ACPE patients using CPAP. We postulate that the reductions in ICU length of stay may be related to the reduction in intubation, as <LINK REF="STD-Wysocki-1995" TYPE="STUDY">Wysocki 1995</LINK> related the smaller intubation rate to shorter hospital stay in a post-hoc analysis. Although our review found NPPV and CPAP to be better tolerated than SMC, future studies should assess whether a trade-off exists between treatment intolerance and other important outcomes such as mortality. In <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>, while a large number of CPAP treated patients were intolerant of treatment, patients in this group also had lower mortality compared to bilevel NPPV and SMC.</P>
<P>NPPV was introduced to emergency departments in the early 1990s and became a relatively common place by approximately 2001 (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>). In our review we noted similar reductions in mortality in patients treated with NPPV in the emergency department (RR 0.55, 95% CI 0.36 to 0.86; <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>) and in the ICU (RR 0.48, 95% CI 0.28 to 0.83; <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). This finding supports initiation of NPPV in patients with ACPE in the emergency department. Additionally in our analysis, a cross-over RCTof 124 patients with out-of-hospital diagnosis of ACPE and use of CPAP demonstrated faster improvements in dyspnoea, faster improvements in PaO2, lower intubation rates, lower use of dobutamine, and lower hospital mortality (<LINK REF="STD-Plaisance-2007" TYPE="STUDY">Plaisance 2007</LINK>). These results reinforce the positive pressure concept considered as non-pharmacologic treatment and not a simple measure of support in ACPE cases.</P>
<P>We did find consistent effects of NPPV compared SMC and bilevel NPPV compared CPAP on PaO<SUB>2</SUB> in patients with ACPE in first hour. However, it would be interesting if future studies analyse the existence of a direct relation among an early PaO2 improvements with outcomes such as mortality and need for intubation.</P>
<P>Some studies have postulated that patients with ACPE and hypercapnia (increased amount of carbon dioxide in the blood &gt; 45 mmHg) may benefit to a greater extent from bilevel NPPV treatment (<LINK REF="STD-Hoffmann-1999" TYPE="STUDY">Hoffmann 1999</LINK>; <LINK REF="STD-Rusterholtz-1999" TYPE="STUDY">Rusterholtz 1999</LINK>; <LINK REF="STD-Wysocki-1995" TYPE="STUDY">Wysocki 1995</LINK>; <LINK REF="STD-Wysocki-1999" TYPE="STUDY">Wysocki 1999</LINK>). In a post-hoc analysis, we pooled studies including ACPE patients with hypercapnia at admission (mean values of PaCO<SUB>2</SUB>) and compared NPPV to SMC on the outcomes of mortality and endotracheal intubation. Compared to all population with ACPE patients, we found significant reductions in mortality (RR 0.60, 95% CI 0.40 to 0.88; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK> and ETI rate (RR 0.44, 95% CI 0.25 to 0.77; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>) favouring hypercapnic patients although the between-group differences were not statistically significant. Similarly, we found favourable reductions in mortality and intubation in among patients treated with bilevel NPPV versus standard medical care (RR 0.59, 95% CI 0.34 to 1.02 and RR 0.47, 95% CI 0.22 to 0.97, respectively; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK> and <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>) and no difference in mortality (RR 0.98, 95% CI 0.45 to 2.14; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK> ) or intubation (RR 1.17, 95% CI 0.58 to 2.33; <LINK REF="CMP-002.11" TYPE="ANALYSIS">Analysis 2.11</LINK>) in hypercapnic patients compared with all population with ACPE patients treated with bilevel NPPV versus CPAP; although the between group differences are not statistically significant. These analysis are reinforced by the meta-analysis studies by <LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>, <LINK REF="STD-Moritz-2007" TYPE="STUDY">Moritz 2007</LINK>; <LINK REF="STD-Nava-2003" TYPE="STUDY">Nava 2003</LINK> and <LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK> who realised the mortality analysis and/or endotracheal intubation rate in the subgroup of hypercapnics patients and the results were more favourable to the use of bilevel compared to SMC in mortality and intubation (RR 0.20, 95% CI 0.04 to 0.86 and RR 0.28, 95% CI 0.12 to 0.69, respectively; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK> and <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>), but no significant differences between CPAP and bilevel (RR 1.06, 95% CI 0.33 to 3.37 and RR 0.92, 95% CI 0.26 to 3.21, respectively; <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK> and <LINK REF="CMP-002.12" TYPE="ANALYSIS">Analysis 2.12</LINK>). Though these comparisons didn't report significant difference to the meta-analysis results conducted in patients with ACPE in general. Our analyses have demonstrated that patients with ACPE and hypercapnia seem to benefit even more from the usage of NPPV, particularly from bilevel NPPV.<BR/>
</P>
<P>Once the benefits of NPPV have been demonstrated, cost-benefit analyses, like the one conducted by Newberry et al. showing that NPPV cost less than mechanical ventilation (<LINK REF="STD-Newberry-1995" TYPE="STUDY">Newberry 1995</LINK>), are important. In another study, the cost of respiratory services were lower with NPPV compared with SMC, but total cost with NPPV was higher than in the SMC group (<LINK REF="STD-Kramer-1995" TYPE="STUDY">Kramer 1995</LINK>).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-04-16 13:30:09 +0100" MODIFIED_BY="[Empty name]">
<P>In this review, we pooled the results of 32 RCTs (27 comparing NPPV and SMC and 14 comparing CPAP and bilevel NPPV) in patients with ACPE on important clinical outcomes, or eleven studies additional than the first version of this systematic review. This update maintains the results of the previous version where both NPPV and CPAP reduce hospital mortality, endotracheal intubation, ICU length of stay and respiratory rate compared to SMC. We did not observe the same beneficial effects on important clinical outcomes among studies comparing bilevel NPPV to SMC and CPAP to bilevel NPPV, though these results were similar in their effect size yet more imprecise. We also found that NPPV, CPAP and bilevel NPPV were better tolerated than SMC alone. Importantly, compared to SMC, use of NPPV, bilevel NPPV and CPAP in patients with ACPE did not increase the incidence of acute myocardial infarction during or after intervention. However this update identified a lower incidence of important adverse events in patients receiving NPPV plus SMC, as lower risk of progression of respiratory failure and coma. If we consider only CPAP, also a lower risk of cardiorespiratory arrest is also demonstrated. Among the studies that made the direct comparison between CPAP and bilevel NPPV a significantly lower incidence of arrhythmias with CPAP was observed. The only adverse event significantly unfavourable to the use of NPPV identified was skin damage. Our results demonstrate the effectiveness and safety of NPPV, especially CPAP, as adjuvant therapy to SMC in patients with ACPE.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-04-16 13:30:11 +0100" MODIFIED_BY="[Empty name]">
<P>We considered the quality of the evidence to be moderate, although there may be some potential for publication bias. We defined seven relevant outcomes in order to assess the quality of evidence by GRADE (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>; <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), and the primary outcome of mortality was considered to supported by quality evidence, where incidence of acute myocardial infarction during intervention and intolerance to the allocated treatment were considered to supported by only moderate quality of evidence. The remaining (endotracheal intubation rate and ICU length of stay, incidence of acute myocardial infarction after intervention and hospital length of stay) were unsupported by adequate evidence.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-04-16 13:30:13 +0100" MODIFIED_BY="[Empty name]">
<P>The major weakness of our review is the comparatively small number of events within trials comparing bilevel NPPV to SMC and CPAP to bilevel NPPV, thus limiting the inferences that can be made from them. It is important to note that SMC varied widely among the studies and included different drugs at different dosages. This disparity may have influenced treatment effect across studies. For example, <LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK> used high doses of isosorbide dinitrate, which was related to better results in important outcomes such as acute myocardial infarction incidence and need for intubations when compared with low doses of isosorbide. Another potential source of bias is the variable inclusion criteria across studies. Disparities in baseline characteristics may have influenced patient response to treatment. A final source of bias may be the different thresholds or criteria used for reintubation in the included studies.</P>
<P>Strengths of this review include methods to reduce bias (multimodal search strategy without language restrictions, duplicate independent screening and data abstraction and prespecified criteria for appraising methodologic quality) with the quantitative differential of the Cochrane reviews (<LINK REF="REF-Jadad-2000" TYPE="REFERENCE">Jadad 2000</LINK>; <LINK REF="REF-McKibbon-2004" TYPE="REFERENCE">McKibbon 2004</LINK>). To this end, we obtained additional information from 17 authors (<LINK REF="STD-Agmy-2008" TYPE="STUDY">Agmy 2008</LINK>; <LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>; <LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Bellone-2005" TYPE="STUDY">Bellone 2005</LINK>; <LINK REF="STD-Crane-2004" TYPE="STUDY">Crane 2004</LINK>; <LINK REF="STD-Delclaux-2000" TYPE="STUDY">Delclaux 2000</LINK>; <LINK REF="STD-Ferrari-2007" TYPE="STUDY">Ferrari 2007</LINK>; <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>; <LINK REF="STD-Kelly-2002" TYPE="STUDY">Kelly 2002</LINK>; <LINK REF="STD-Martin_x002d_Bermudez-2002" TYPE="STUDY">Martin-Bermudez 2002</LINK>; <LINK REF="STD-Masip-2000" TYPE="STUDY">Masip 2000</LINK>; <LINK REF="STD-Nava-2003" TYPE="STUDY">Nava 2003</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-R_x00e4_s_x00e4_nen-1985" TYPE="STUDY">Räsänen 1985</LINK>; <LINK REF="STD-Takeda-1998" TYPE="STUDY">Takeda 1998</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). As a result, our meta-analysis includes the largest number of trials exploring the role of NPPV in ACPE and consequently had increased power in pooling outcomes (<LINK REF="REF-Potts-2009" TYPE="REFERENCE">Potts 2009</LINK>). We analysed the impact of NPPV on a broad set of physiological and clinical outcomes. Although there was heterogeneity in some analyses, it was possible to observe that the exclusion of low quality studies did not influence the results (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). The generalisability of our findings is enhanced by the diverse nature of the trials included in our review, representing international experience with NPPV use for ACPE.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-04-16 13:30:23 +0100" MODIFIED_BY="[Empty name]">
<P>The first systematic review on the role of NPPV for ACPE reported a lower intubation rate with CPAP <LINK REF="STD-Pang-1998" TYPE="STUDY">Pang 1998</LINK>. <LINK REF="STD-Hess-2004" TYPE="STUDY">Hess 2004</LINK> subsequently suggested that bilevel NPPV may benefit patients with ACPE with hypercapnia. <LINK REF="STD-Nadar-2005" TYPE="STUDY">Nadar 2005</LINK> then found that bilevel NPPV decreased intubation, improved oxygenation, and was better tolerated compared to CPAP in patients with ACPE. However, because of the concern regarding the potential for acute myocardial infarction, bilevel NPPV could not be recommended for treatment of ACPE. Our review supports the use of NPPV, and especially CPAP, in the treatment of ACPE. These findings are important as current ACPE management guidelines do not recommend NPPV use in the absence of A level of evidence (<LINK REF="REF-Nieminen-2005" TYPE="REFERENCE">Nieminen 2005</LINK>). The results of our review could make this recommendation possible.</P>
<P>However, newer meta-analyses have found results similar to ours (<LINK REF="REF-Collins-2006" TYPE="REFERENCE">Collins 2006</LINK>; <LINK REF="REF-Ho-2006" TYPE="REFERENCE">Ho 2006</LINK>; <LINK REF="REF-Masip-2005" TYPE="REFERENCE">Masip 2005</LINK>; <LINK REF="REF-Peter-2006" TYPE="REFERENCE">Peter 2006</LINK>;<LINK REF="REF-Weng-201O" TYPE="REFERENCE">Weng 201O</LINK>; <LINK REF="REF-Winck-2006" TYPE="REFERENCE">Winck 2006</LINK>), although with small differences in methodological and included studies, all conclude that NPPV is effective in reducing mortality in patients with ACPE. However, a mega-trial conducted in patients with ACPE was published and concluded that NPPV does not reduce mortality compared to SMC (<LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>); however, it is possible to observe several important differences in this study that differ from the others included in systematic reviews and meta-analysis as: mortality was evaluated after 7 or 30 days from the beginning of the intervention, while other studies have analysed mortality during the period of hospitalisation. <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> excluded patients who were more seriously ill. Approximately one in five patients in the SMC arm crossed over to NPPV within two hours of randomisation in <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK>, suggesting contamination that would attenuate the apparent effect of NPPV on mortality. <LINK REF="STD-Gray-2008" TYPE="STUDY">Gray 2008</LINK> also had a 40% lower event rate than found in our meta-analysis, which may be due to differences in patient characteristics, SMC, or other unmeasured differences that could influence the size of the treatment effect of NPPV. The quality of the studies that had evaluated the primary outcome mortality was high, as of can be visualised in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>, which strengthens our inference of the benefit of NPPV in reducing mortality in patients with ACPE.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-04-16 13:30:23 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-04-16 13:30:23 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Data from RCTs have demonstrated that NPPV (CPAP and bilevel NPPV) is effective in reducing hospital mortality, intubation rate and ICU length of stay. In addition, NPPV resulted in faster improvement and was better tolerated than SMC. Further, our meta-analysis did not demonstrate an increase in the incidence of acute myocardial infarction during and after NPPV application. We show a lower risk of progressive respiratory distress and neurological failure (coma) when compare NPPV to SMC and cardiorespiratory arrest when compare only CPAP to SMC as well as a lower risk of arrhythmia when comparing CPAP to bilevel NPPV. CPAP can be considered the first option in selection of NPPV due to more robust evidence for its effectiveness and safety and lower costs compared with bilevel NPPV.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-04-16 13:30:23 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Further studies are required to reduce uncertainty regarding length of hospital stay, long-term mortality, costs and the time required to manage NPPV. Additional research is required to elucidate if hypercapnic patients with ACPE may benefit to a greater extent than non-hypercapnic patients and if bilevel NPPV confers similar benefit or risks compared to CPAP.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-04-23 08:39:10 +0100" MODIFIED_BY="[Empty name]">
<P>We are grateful to the authors of the studies we reviewed and who kindly answered our e-mails or correspondence regarding additional data (Räsänen, Bersten, Kelly, Nava, Park, Takeda, Thys, Masip, Bellone, Crane, Delclaux, Ferrari, Bautin, Agmy, Gray and Weitz). We are also thankful for the critical evaluation of the professors Dr. Velasco IT, Dr. Scalabrini Neto A, Dr. Gonçalves AJ, Dr. Godoy MF and by the collaboration of the following co-authors in the first version of the publication of this systematic review: Burns K, Saconato H, Sen A, Hawkes CA and Soares B. We thank Joey Kwong by Chinese translation paper. Finally the Cochrane heart group for suggested improvements.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-05-08 17:01:02 +0100" MODIFIED_BY="Liz Bickerdike">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-11-20 12:44:08 +0000" MODIFIED_BY="[Empty name]">
<P>Flávia Vital did the protocol conceiving, designing, coordinating and writing and did the following tasks: selection of studies, quality evaluation, extraction and analysis data, final report and completion of the Cochrane publication and updating.</P>
<P>Álvaro Atallah did the protocol writing and did the following tasks: data analysis, final report and completion of the Cochrane publication and updating. Expertise advice.</P>
<P>Magdaline Ladeira did the protocol writing and the following tasks: selection of studies, quality evaluation, completion of the Cochrane publication and updating.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-04-16 14:42:40 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-04-16 14:19:43 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-04-16 14:10:18 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Agmy-2008" MODIFIED="2013-02-20 16:54:05 +0000" MODIFIED_BY="[Empty name]" NAME="Agmy 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-17 16:16:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Agmy G, Makhlouf H, Mohammed A, Ghanem M, Mohammed H</AU>
<TI>CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients [Abstract]</TI>
<SO>European Respiratory Society Annual Congress</SO>
<YR>2008</YR>
<VL>8</VL>
<PG>1937</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-10-06 21:05:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agmy G</AU>
<TI>The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure [Abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>2007</YR>
<VL>30</VL>
<NO>Suppl 51</NO>
<PG>321</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-02-20 16:54:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agmy GM</AU>
<TI>The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure [Abstract]</TI>
<SO>American Thoracic Society International Conference</SO>
<YR>2007</YR>
<VL>1</VL>
<PG>A963</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bautin-2005" MODIFIED="2013-04-16 13:32:04 +0100" MODIFIED_BY="[Empty name]" NAME="Bautin 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-04-16 13:32:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bautin A, Khubulava G, Naumov A, Garifzjanov A, Etin V</AU>
<TI>NPPV in the treatment of the cardiogenic edema (CPE) after heart surgery [Abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>2005</YR>
<VL>26</VL>
<NO>Suppl 49</NO>
<PG>3112</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bellone-2004" MODIFIED="2013-04-16 13:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Bellone 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-04-16 13:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bellone A, Monari A, Cortellaro F, Vetorello M, Arlati S, Coen D</AU>
<TI>Myocardial infarction rate in acute pulmonary edema: noninvasive support ventilation versus continuous positive airway pressure</TI>
<SO>Critical Care Medicine</SO>
<YR>2004</YR>
<VL>32</VL>
<NO>9</NO>
<PG>1860-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bellone-2005" MODIFIED="2013-04-16 13:32:30 +0100" MODIFIED_BY="[Empty name]" NAME="Bellone 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-04-16 13:32:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bellone A, Vettorello M, Monari A, Cortellaro F, Coen D</AU>
<TI>Noninvasive pressure support ventilation vs. continuous positive airway pressure in acute hypercapnic pulmonary edema</TI>
<SO>Intensive Care Medicine</SO>
<YR>2005</YR>
<VL>31</VL>
<PG>807-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bersten-1991" MODIFIED="2013-04-16 13:32:46 +0100" MODIFIED_BY="[Empty name]" NAME="Bersten 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-04-16 13:32:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bersten AD, Holt AW, Vedig AE, Skowronski GA, Bagooley CJ</AU>
<TI>Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask</TI>
<SO>New England Journal of Medicine</SO>
<YR>1991</YR>
<VL>325</VL>
<NO>26</NO>
<PG>1825-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Crane-2004" MODIFIED="2013-04-16 13:33:01 +0100" MODIFIED_BY="[Empty name]" NAME="Crane 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-04-16 13:33:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Crane SD, Elliott MW, Gilligan P, Richards K, Gray AJ</AU>
<TI>Randomized controlled comparison of continuous positive airway pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2004</YR>
<VL>21</VL>
<PG>155-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delclaux-2000" MODIFIED="2010-11-10 16:56:50 +0000" MODIFIED_BY="[Empty name]" NAME="Delclaux 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-11-10 16:56:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Delclaux C, L'Her E, Alberti C, Mancebo J, Abroug F, Conti G, et al</AU>
<TI>Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivery by a face mask</TI>
<SO>JAMA</SO>
<YR>2000</YR>
<VL>284</VL>
<PG>2352-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferrari-2007" MODIFIED="2010-10-01 21:40:30 +0100" MODIFIED_BY="[Empty name]" NAME="Ferrari 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-10-01 21:40:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ferrari G, Olliveri F, De Filippi G, Milan A, Apra F, Boccuzzi A, et al</AU>
<TI>Noninvasive positive airway pressure and risk of myocardial infarction in acute cardiogenic pulmonary edema: continuous positive airway pressure vs noninvasive positive pressure ventilation</TI>
<SO>Chest</SO>
<YR>2007</YR>
<VL>132</VL>
<NO>6</NO>
<PG>1804-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferrari-2010" MODIFIED="2013-04-16 13:33:37 +0100" MODIFIED_BY="[Empty name]" NAME="Ferrari 2010" YEAR="2009">
<REFERENCE MODIFIED="2013-04-16 13:33:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ferrari G, Groff P, De Filippi G, Giostra F, Mazzone M, Potale G, et al</AU>
<TI>Continuous positive airway pressure (CPAP) vs. noninvasive positive pressure ventilation (NIV) in acute cardiogenic pulmonary edema (ACPE): A prospective randomized multicentric study</TI>
<SO>Journal of Emergency Medicine</SO>
<YR>2006</YR>
<VL>30</VL>
<PG>246-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-16 13:33:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ferrari G, Milan A, Groff P, Pagnozzi F, Mazzone M, Molino P, et al</AU>
<TI>Continuous positive airway pressure vs. Pressure support ventilation in acute cardiogenic pulmonary edema: a randomized trial</TI>
<SO>Journal of Emergency Medicine</SO>
<YR>2010</YR>
<VL>39</VL>
<NO>5</NO>
<PG>676-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferrer-2003" MODIFIED="2013-04-16 13:34:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ferrer 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-04-16 13:34:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A</AU>
<TI>Non-vasive Ventilation in Severe Acute Hypoxemic Respiratory Failure. A Randomized Clinical Trial</TI>
<SO>Intensive Care Medicine</SO>
<YR>2002</YR>
<VL>28</VL>
<PG>S68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-16 13:33:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A</AU>
<TI>Noninvasive Ventilation in Severe Hypoxemic Respiratory Failure: A Randomized Clinical Trial</TI>
<SO>American Journal of Respiratory and Critical Care Medicin</SO>
<YR>2003</YR>
<VL>168</VL>
<PG>1438-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fontanella-2010" MODIFIED="2013-04-16 13:34:19 +0100" MODIFIED_BY="[Empty name]" NAME="Fontanella 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-01-17 16:08:00 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (NIPSV) in acute cardiogenic pulmonary edema.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Barcelona Spain. Conference Start: 20090829 Conference End: 20090902. Conference: European Society of Cardiology, ESC Congress 2009 Barcelona Spain. Conference Start: 20090829 Conference End: 20090902. Conference Publication: (var.pagings). ( 2009. Date of Publication: September 2009&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2012-01-17 16:08:00 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bordonali T, Fontanella B, Affatato A, Saporetti A, Carubelli V, Ciccarese C, et al</AU>
<TI>Comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (NIPSV) in acute cardiogenic pulmonary edema</TI>
<SO>European Heart Journal</SO>
<YR>2009</YR>
<VL>30</VL>
<PG>369</PG>
<CY>Conference: European Society of Cardiology, ESC Congress 2009 Barcelona Spain</CY>
<IDENTIFIERS>
<IDENTIFIER TYPE="EMBASE" VALUE="797"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-16 13:34:19 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Prospective comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (BPAP) in acute cardiogenic pulmonary edema.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Copenhagen Denmark. Conference Start: 20101016 Conference End: 20101019. Conference: 4th Official Congress of the Working Group on Acute Cardiac Care, Acute Cardiac Care 2010 Copenhagen Denmark. Conference Start: 20101016 Conference End: 20101019. Conference Publication: (var.pagings). ( 2010. Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2013-04-16 13:34:19 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fontanella B, Affatato A, Ciccarese C, Sacchini M, Volpini M, Bianchetti F, et al</AU>
<TI>Prospective comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (BPAP) in acute cardiogenic pulmonary edema</TI>
<SO>European Heart Journal Supplements</SO>
<YR>2010</YR>
<VL>12 (supplement F)</VL>
<PG>F37-F38</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frontin-2010" MODIFIED="2013-04-16 13:34:28 +0100" MODIFIED_BY="[Empty name]" NAME="Frontin 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-04-16 13:34:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frontin P, Bounes V, Houzé-Cerfon CH, Charpentier S, Houzé-Cerfon V, Ducassé JL</AU>
<TI>Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>2011</YR>
<VL>29</VL>
<NO>7</NO>
<PG>775-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gray-2008" MODIFIED="2013-04-16 13:35:01 +0100" MODIFIED_BY="[Empty name]" NAME="Gray 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-16 13:35:01 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;It is the same study publish in Health Technology Assessment 2009; 13(33):1-106. The data about side-effects and complications it is published there.&lt;/p&gt;" NOTES_MODIFIED="2013-04-16 13:35:01 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J</AU>
<TI>Noninvasive Ventilation in AcuteCardiogenic Pulmonary Edema</TI>
<SO>New England Journal of Medicine</SO>
<YR>2008</YR>
<VL>359</VL>
<PG>142-51</PG>
<IDENTIFIERS MODIFIED="2010-10-01 21:37:41 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-16 13:34:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gray AJ, Goodacre S, Newby DE, Masson MA, Sampson F, Dixon S, et al</AU>
<TI>A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial</TI>
<SO>Health Technology Assessment</SO>
<YR>2009</YR>
<VL>13</VL>
<NO>33</NO>
<PG>1-106</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-08-27 15:28:01 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kelly-2002" MODIFIED="2013-04-16 13:35:11 +0100" MODIFIED_BY="[Empty name]" NAME="Kelly 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-04-16 13:35:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kelly CA, Newby DE, McDonagh TA, MacKay TW, Barr J, Boon NA, et al</AU>
<TI>Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema</TI>
<SO>European Heart Journal</SO>
<YR>2002</YR>
<VL>23</VL>
<PG>1379-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-L_x0027_Her-2004" MODIFIED="2013-04-16 13:35:16 +0100" MODIFIED_BY="[Empty name]" NAME="L'Her 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-04-16 13:35:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>L'Her E, Duquesne F, Girou E, Rosiere XD, Le Conte P, Renault S, et al</AU>
<TI>Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients</TI>
<SO>Intensive Care Medicine</SO>
<YR>2004</YR>
<VL>30</VL>
<PG>882-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levitt-2001" MODIFIED="2013-04-16 13:35:29 +0100" MODIFIED_BY="[Empty name]" NAME="Levitt 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-04-16 13:35:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Levitt MA</AU>
<TI>A prospective, randomized trial of BiPAP in severe acute congestive heart failure</TI>
<SO>Journal of Emergency Medicine</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>4</NO>
<PG>363-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liesching-2003" MODIFIED="2013-04-16 14:04:02 +0100" MODIFIED_BY="[Empty name]" NAME="Liesching 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-04-16 14:04:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Liesching TN, Cromier K, Nelson D, Short K, Sucov A, Hill NS</AU>
<TI>Bilevel noninvasive ventilation vs continuous positive airway pressure to treat acute pulmonary edema</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2003</YR>
<VL>167</VL>
<NO>Suppl 7</NO>
<PG>27</PG>
<PB>American Thoracic Society 99th International Conference</PB>
<CY>Seattle</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-1991" MODIFIED="2013-04-16 14:04:12 +0100" MODIFIED_BY="[Empty name]" NAME="Lin 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-04-16 14:04:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lin M, Chiang H</AU>
<TI>The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema</TI>
<SO>Journal of the Formosan Medical Association</SO>
<YR>1991</YR>
<VL>90</VL>
<NO>8</NO>
<PG>736-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-1995" MODIFIED="2010-10-01 21:48:30 +0100" MODIFIED_BY="[Empty name]" NAME="Lin 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-10-01 21:48:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lin M, Yang Y, Chiang H, Chang M, Chiang BN, Cheitlin MD</AU>
<TI>Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema</TI>
<SO>Chest</SO>
<YR>1995</YR>
<VL>107</VL>
<PG>1379-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Martin_x002d_Bermudez-2002" MODIFIED="2013-04-16 14:04:19 +0100" MODIFIED_BY="[Empty name]" NAME="Martin-Bermudez 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-04-16 14:04:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Martin-Bermudez R, Rodr&#305;´guez-Portal J, Garc&#305;´a-Garmendia J</AU>
<TI>Noninvasiveventilation in cardiogenic pulmonay edema. Preliminary results of a randomizedtrial [Abstract]</TI>
<SO>Intensive Care Medicine</SO>
<YR>2002</YR>
<VL>28</VL>
<PG>S68</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Masip-2000" MODIFIED="2013-04-16 14:04:28 +0100" MODIFIED_BY="[Empty name]" NAME="Masip 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-04-16 14:04:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Masip J, Betbesé AJ, Paéz J, Vecilla F, Cañizares R, Padró J, et al</AU>
<TI>Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial</TI>
<SO>Lancet</SO>
<YR>2000</YR>
<VL>356</VL>
<PG>2126-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehta-1997" MODIFIED="2013-04-16 14:04:38 +0100" MODIFIED_BY="[Empty name]" NAME="Mehta 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-04-16 14:04:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mehta S, Jay GD, Woolard RH, Hipona RA, Connolly EM, Cimini DM, et al</AU>
<TI>Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema</TI>
<SO>Critical Care Medicine</SO>
<YR>1997</YR>
<VL>25</VL>
<NO>4</NO>
<PG>620-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moritz-2007" MODIFIED="2013-04-16 14:04:46 +0100" MODIFIED_BY="[Empty name]" NAME="Moritz 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-04-16 14:04:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Moritz F, Brousse B, Gellee B, Chajara A, L'Her E, Hellot MF, et al</AU>
<TI>Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>2007</YR>
<VL>50</VL>
<NO>6</NO>
<PG>666-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Nava-2003" MODIFIED="2013-04-16 14:05:06 +0100" MODIFIED_BY="[Empty name]" NAME="Nava 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-04-16 04:16:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carbone G, Di Battista N, Nava S</AU>
<TI>Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study</TI>
<SO>European Respiratory Journal</SO>
<YR>2000</YR>
<VL>16</VL>
<PG>A3815</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-16 14:05:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nava S, Carbone G, DiBattista N, Bellone A, Baiardi P, Cosentini R, et al</AU>
<TI>Noninvasive ventilation in cardiogenic pulmonary edema</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2003</YR>
<VL>168</VL>
<PG>1432-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-16 14:05:06 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nava S</AU>
<TI>Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy</TI>
<SO>European Respiratory Journal</SO>
<YR>2001</YR>
<VL>18</VL>
<PG>A184s</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Park-2001" MODIFIED="2013-04-16 14:05:27 +0100" MODIFIED_BY="[Empty name]" NAME="Park 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-04-16 14:05:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Park M, Lorenzi-Filho G, Feltrim MI, Viecili PRN, Sangean MC, Volpe M, et al</AU>
<TI>Oxygen therapy, continuous positive airway pressure, or noninvasive bilivel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema</TI>
<SO>Arquivos Brasileiros de Cardiologia</SO>
<YR>2001</YR>
<VL>76</VL>
<NO>3</NO>
<PG>226-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-16 14:05:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park M</AU>
<TI>Randomized prospective trial of oxygen, continuos and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2002</YR>
<VL>165</VL>
<NO>Suppl 8</NO>
<PG>A27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Park-2004" MODIFIED="2013-04-16 14:07:09 +0100" MODIFIED_BY="[Empty name]" NAME="Park 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-04-16 14:07:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Park M, Sangean MC, Volpe MS, Feltrim MIZ, Nozawa E, Leite PF, et al</AU>
<TI>Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema</TI>
<SO>Critical Care Medicine</SO>
<YR>2004</YR>
<VL>32</VL>
<NO>12</NO>
<PG>2407-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-R_x00e4_s_x00e4_nen-1985" MODIFIED="2013-04-16 14:07:20 +0100" MODIFIED_BY="[Empty name]" NAME="Räsänen 1985" YEAR="1985">
<REFERENCE MODIFIED="2013-04-16 14:07:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Räsänen J, Heikkilä J, Downs J, Nikki P, Väisänen I, Viitanen A</AU>
<TI>Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema</TI>
<SO>American Journal of Cardiology</SO>
<YR>1985</YR>
<VL>55</VL>
<PG>296-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharon-2000" MODIFIED="2013-04-16 14:07:27 +0100" MODIFIED_BY="[Empty name]" NAME="Sharon 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-04-16 14:07:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milanov O, Polak R, et al</AU>
<TI>High-dose intravenous Isosorbide-dinitrate is safer and better than Bi-PAP ventilation for severe pulmonary edema</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>2000</YR>
<VL>36</VL>
<NO>3</NO>
<PG>832-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Takeda-1997" MODIFIED="2013-04-16 14:09:48 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Takeda 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-04-16 14:09:48 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Takeda S, Takano T, Ogawa R</AU>
<TI>The effect of nasal continuous positive airway pressure on plasma endothelin-1 concentrations in patients with severe cardiogenic pulmonary edema</TI>
<SO>Anesthesia &amp; Analgesia</SO>
<YR>1997</YR>
<VL>84</VL>
<PG>1091-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Takeda-1998" MODIFIED="2013-04-16 14:09:58 +0100" MODIFIED_BY="[Empty name]" NAME="Takeda 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-04-16 14:09:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Takeda S, Neijima J, Takano T, Nakanishi K, Takayama M, Sakamoto A, et al</AU>
<TI>Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction</TI>
<SO>Circulation Journal</SO>
<YR>1998.</YR>
<VL>62</VL>
<PG>553-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Thys-2002" MODIFIED="2013-04-16 14:10:09 +0100" MODIFIED_BY="[Empty name]" NAME="Thys 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-04-16 14:10:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Thys F, Roeseler J, Reynaert M, Liistro G, Rodenstein DO</AU>
<TI>Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial</TI>
<SO>European Respiratory Journal</SO>
<YR>2002</YR>
<VL>20</VL>
<PG>545-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Weitz-2007" MODIFIED="2013-04-16 14:10:18 +0100" MODIFIED_BY="[Empty name]" NAME="Weitz 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-04-16 14:10:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weitz G, Struck J, Zonak A, Balnus S, Perras B, Dodt C</AU>
<TI>Prehospital noninvasive pressure support ventilation for acute cardiogenic pulmonary edema</TI>
<SO>European Journal of Emergency Medicine</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>5</NO>
<PG>276-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-01-16 19:43:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-01-16 19:43:44 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-04-16 14:19:43 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Acosta-2000" MODIFIED="2013-04-16 14:10:27 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Acosta 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-04-16 14:10:27 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Acosta B, DiBenedetto R, Rahimi A, Acosta MF, Cuadra O, Van Nguyen A, et al</AU>
<TI>Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction</TI>
<SO>Chest</SO>
<YR>2000</YR>
<VL>118</VL>
<NO>4</NO>
<PG>1004-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Albert-2000" NAME="Albert 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Albert RK</AU>
<TI>Turnabout may be more than fair play</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<NO>2</NO>
<PG>571-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alper-2007" MODIFIED="2010-05-07 20:29:16 +0100" MODIFIED_BY="[Empty name]" NAME="Alper 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-05-07 20:29:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alper BS</AU>
<TI>Evidence-based medicine. Noninvasive ventilation reduces mortality in cardiogenic pulmonary edema</TI>
<SO>Clinical Advisor for Nurse Practitioners</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>5</NO>
<PG>158</PG>
<IDENTIFIERS MODIFIED="2010-05-07 20:29:16 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-05-07 20:26:56 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alper-2008" MODIFIED="2012-01-17 16:27:13 +0000" MODIFIED_BY="[Empty name]" NAME="Alper 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-17 16:27:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alper BS</AU>
<TI>Evidence-based medicine. Noninvasive ventilation may improve respiratory distress in acute heart failure</TI>
<SO>Clinical Advisor for Nurse Practitioners</SO>
<YR>2008</YR>
<VL>11</VL>
<NO>11</NO>
<PG>118</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Andrade-1998" MODIFIED="2013-04-16 14:10:47 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Andrade 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-04-16 14:10:47 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andrade CLV, Mendoza JN</AU>
<TI>Acute respiratory distress of the adult</TI>
<TO>Distress respiratorio agudo del adulto</TO>
<SO>Boletín del Hospital San Juan de Dios</SO>
<YR>1998</YR>
<VL>45</VL>
<NO>1</NO>
<PG>13-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Antonelli-2001" MODIFIED="2008-05-09 13:03:08 +0100" MODIFIED_BY="[Empty name]" NAME="Antonelli 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-05-09 13:03:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Antonelli M, Conti G, Moro ML, Esquinas A, Gonzalez-Diaz G, Confalonieri M, et al</AU>
<TI>Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: A multi-center study</TI>
<SO>Intensive Care Medicine</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>11</NO>
<PG>1718-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aronow-2007" MODIFIED="2013-04-16 14:10:54 +0100" MODIFIED_BY="[Empty name]" NAME="Aronow 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-04-16 14:10:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aronow WS</AU>
<TI>Heart-Failure-Complicating Acute Myocardial Infarction</TI>
<SO>Clinics in Geriatric Medicine</SO>
<YR>2007</YR>
<VL>23</VL>
<NO>1</NO>
<PG>123-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barach-1938" MODIFIED="2013-04-16 14:11:04 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Barach 1938" YEAR="1938">
<REFERENCE MODIFIED="2013-04-16 14:11:04 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barach AL Martin J, Eckman M</AU>
<TI>Positive pressure respiration and its application to the treatment of acute pulmonary edema</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1938</YR>
<VL>12</VL>
<PG>754-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baratz-1992" MODIFIED="2013-04-16 14:11:13 +0100" MODIFIED_BY="[Empty name]" NAME="Baratz 1992" YEAR="1992">
<REFERENCE MODIFIED="2013-04-16 14:11:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baratz DM, Westbrook PR, Shah PK, Mohsenifar Z</AU>
<TI>Effect of nasal continuous positive airway pressure on cardiac output and oaxygen delivery in patients with congestive heart failure</TI>
<SO>Chest</SO>
<YR>1992</YR>
<VL>102</VL>
<NO>5</NO>
<PG>1397-401</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bavry-2008" MODIFIED="2012-01-17 16:30:18 +0000" MODIFIED_BY="[Empty name]" NAME="Bavry 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-17 16:30:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bavry AA</AU>
<TI>Effect of continuous positive airway pressure and noninvasive positive pressure ventilation in acute cardiogenic pulmonary oedema (3CPO)</TI>
<SO>ACC Cardiosource Review Journal</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>9</NO>
<PG>37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bellone-2002" MODIFIED="2008-05-09 13:02:33 +0100" MODIFIED_BY="[Empty name]" NAME="Bellone 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-05-09 13:02:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bellone A, Barbieri A, Ricci C, Iori E, Donateo M, Massobrio M, et al</AU>
<TI>Acute effects of non-invasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure</TI>
<SO>Intensive Care Medicine</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>9</NO>
<PG>1348-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blomqvist-1991" MODIFIED="2013-04-16 14:11:25 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Blomqvist 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-04-16 14:11:25 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blomqvist H</AU>
<TI>Does PEEP facilitate the resolution of extravascular lung water after experimental hydrostatic pulmonary edema?</TI>
<SO>European Respiratory Journal</SO>
<YR>1991</YR>
<VL>4</VL>
<PG>1053-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bollaert-2002" MODIFIED="2008-05-09 13:03:40 +0100" MODIFIED_BY="[Empty name]" NAME="Bollaert 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-05-09 13:03:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bollaert PE, Sauder PH, Girard F, Rusterholtz TH, Feissel M, Harlay ML, et al</AU>
<TI>Continuous positive airway pressure (CPAP) VS proportional assist ventilation (PAV) for noninvasive ventilation in cardiogenic pulmonary edema</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2002</YR>
<VL>165</VL>
<NO>Suppl 8</NO>
<PG>A387</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bouquin--1998" MODIFIED="2013-04-16 14:11:35 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Bouquin  1998" YEAR="1998">
<REFERENCE MODIFIED="2013-04-16 14:11:35 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bouquin V, L'Her E, Moriconi M, Jobic Y, Matheu B, Guillo P, et al</AU>
<TI>Spontaneous ventilation in positive expiratory pressure in cardiogenic pulmonary edema</TI>
<SO>Archives des maladies du Coeur et des Vaisseaux</SO>
<YR>1998</YR>
<VL>91</VL>
<NO>10</NO>
<PG>1243-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bradley--2000" NAME="Bradley  2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bradley TD</AU>
<TI>continuous positive airway pressure for congestive heart failure</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>2000</YR>
<VL>162</VL>
<NO>4</NO>
<PG>535-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brezins-1993" NAME="Brezins 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brezins M, Benari B, Papo V, Cohen A, Bursztein S, Markiewicz W</AU>
<TI>Left ventricular function in patients with acute myocardial infarction, acute pulmonary edema, and mechanical ventilation: Relationship to prognosis</TI>
<SO>Critical Care Medicine</SO>
<YR>1993</YR>
<VL>21</VL>
<NO>3</NO>
<PG>380-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brijker-1999" MODIFIED="2008-05-09 13:04:33 +0100" MODIFIED_BY="[Empty name]" NAME="Brijker 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-05-09 13:04:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brijker F, van den Elshout FJ, de Rijk A, Folgering HT, Bosch FH</AU>
<TI>Use of noninvasive mechanical ventilation to avoid intubation during acute respiratory insufficiency</TI>
<SO>Nederlands Tijdschrift voor Geneeskunde</SO>
<YR>1999</YR>
<VL>143</VL>
<NO>36</NO>
<PG>1819-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brochard-1998" MODIFIED="2013-04-16 14:11:45 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Brochard 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-04-16 14:11:45 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brochard L</AU>
<TI>Use of non-invasive positive pressure ventilation for cardiogenic pulmonary edema in emergency care unit</TI>
<SO>Presse Medicale</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>22</NO>
<PG>1105-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chadda-2002" NAME="Chadda 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chadda K, Annane D, Hart N, Gajdos P, Raphael JC, Lofaso F</AU>
<TI>Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema</TI>
<SO>Critical Care Medicine</SO>
<YR>2002</YR>
<VL>30</VL>
<NO>11</NO>
<PG>2457-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2008" MODIFIED="2013-04-16 14:11:51 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-16 14:11:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen Y, Chen P, Hanaoka M, Huang X, Droma Y, Kubo K</AU>
<TI>Mechanical ventilation in patients with hypoxemia due to refractory heart failure</TI>
<SO>Internal Medicine</SO>
<YR>2008</YR>
<VL>47</VL>
<NO>5</NO>
<PG>367-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crane-2002" MODIFIED="2013-04-16 14:12:02 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Crane 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-04-16 14:12:02 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crane SD</AU>
<TI>Epidemiology, treatment and outcome of acidotic, acute, cardiogenic pulmonary oedema presenting to and Emergency department</TI>
<SO>European Journal of Emergency Medicine</SO>
<YR>2002</YR>
<VL>9</VL>
<PG>320-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Craven-2000" MODIFIED="2013-04-16 14:12:12 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Craven 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-04-16 14:12:12 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Craven RA, Singletary N, Bosken L, Sewell E, Payne M, Lipsey R</AU>
<TI>Use of bilevel positive airway pressure in out-of-hospital patients</TI>
<SO>Academic Emergency Medicine</SO>
<YR>2000</YR>
<VL>7</VL>
<NO>9</NO>
<PG>1065-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cross-2000" NAME="Cross 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cross AM</AU>
<TI>Review of the role of non-invasive ventilation in the emergency department</TI>
<SO>Journal of Accident &amp; Emergency Medicine</SO>
<YR>2000</YR>
<VL>17</VL>
<NO>2</NO>
<PG>79-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cross-2003" NAME="Cross 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cross AM, Cameron P, Kierce M, Ragg M, Kelly AM</AU>
<TI>Non-invasive ventilation in acute respiratory failure: a randomized comparison of continuous positive airway pressure and bi-level positive airway pressure</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2003</YR>
<VL>20</VL>
<NO>6</NO>
<PG>531-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cydulka-2005" NAME="Cydulka 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cydulka RK</AU>
<TI>Noninvasive ventilation in cardiogenic pulmonary edema: A multicenter randomized trial</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>2005</YR>
<VL>45</VL>
<NO>2</NO>
<PG>227-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Domenighetti-2002" MODIFIED="2008-05-09 13:05:18 +0100" MODIFIED_BY="[Empty name]" NAME="Domenighetti 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-05-09 13:05:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Domenighetti G, Gayer R, Gentilini R</AU>
<TI>Noninvasive pressure support ventilation in non-COPD patients with acute cardiogenic pulmonary edema and severe community-acquired pneumonia: acute effects and outcome</TI>
<SO>Intensive Care Medicine</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>9</NO>
<PG>1226-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Du-Cailar-1975" MODIFIED="2008-05-09 13:05:40 +0100" MODIFIED_BY="[Empty name]" NAME="Du Cailar 1975" YEAR="1975">
<REFERENCE MODIFIED="2008-05-09 13:05:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Du Cailar J, Huguenard P, Kielen J, Griffe D</AU>
<TI>Justification, methods and indications for positive-pressure respiration in controlled and spontaneous ventilation in lesional pulmonary edeman</TI>
<SO>Annales de l'Anesthesiologie Francaise</SO>
<YR>1975</YR>
<VL>2</VL>
<PG>196-206</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eaton-2002" NAME="Eaton 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eaton S. Martin G</AU>
<TI>Clinical developments for treating ARDS</TI>
<SO>Expert Opinion on Investigational Drugs</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>1</NO>
<PG>37-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-2001" MODIFIED="2013-04-16 14:12:24 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Evans 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-04-16 14:12:24 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evans TW, Albert RK, Angus DC, Bion JF, Chiche J, Epstein SK, et al</AU>
<TI>International Consensus conferences in intensive care medicine: noninvasive positive pressure ventilation in acute respiratory failure</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2001</YR>
<VL>163</VL>
<PG>283-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fromm-1995" NAME="Fromm 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fromm Jr RE, Varon J, Gibbs LR</AU>
<TI>Congestive heart failure and pulmonary edema for emergency physician</TI>
<SO>Journal of Emergency Medicine</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>1</NO>
<PG>71-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giacomini-2003" MODIFIED="2008-05-09 13:06:28 +0100" MODIFIED_BY="[Empty name]" NAME="Giacomini 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 13:06:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giacomini M, Iapichino G, Cigada M, Minuto A, Facchini R, Noto A, et al</AU>
<TI>Short-term noninvasive pressure support ventilation prevents ICU admittance in patients with acute cardiogenic pulmonary edema</TI>
<SO>Chest</SO>
<YR>2003</YR>
<VL>123</VL>
<NO>6</NO>
<PG>2057-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Girou-2003" MODIFIED="2008-05-09 13:06:59 +0100" MODIFIED_BY="[Empty name]" NAME="Girou 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 13:06:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Girou E, Brun-Buisson C, Taille S, Lemaire F, Brochard L</AU>
<TI>Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema</TI>
<SO>JAMA</SO>
<YR>2003</YR>
<VL>290</VL>
<NO>22</NO>
<PG>2985-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gorbunova-2005" MODIFIED="2013-02-20 16:58:01 +0000" MODIFIED_BY="[Empty name]" NAME="Gorbunova 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-02-20 16:58:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gorbunova M, Babak S, Tatrskiy A</AU>
<TI>Effect of nasal continuous positive airway pressure on respiratory failure and left ventricular dysfunction complicating acute myocardial infarction [Abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>2005</YR>
<VL>26</VL>
<NO>Suppl 49</NO>
<PG>1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gray-2009" MODIFIED="2010-08-23 21:00:04 +0100" MODIFIED_BY="[Empty name]" NAME="Gray 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-08-23 21:00:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gray AJ, Goodacre S, Newby DE, Masson MA, Sampson F, Dixon S</AU>
<TI>A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial</TI>
<SO>Health Technology Assessment</SO>
<YR>2009</YR>
<VL>13</VL>
<NO>33</NO>
<PG>1-106</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guerra-2005" MODIFIED="2013-04-16 14:12:33 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Guerra 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-04-16 14:12:33 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guerra JF</AU>
<TI>Noninvasive ventilation in acute cardiogenic pulmonary edema</TI>
<TO>Ventilación no invasiva en el edema pulmonar agudo cardiogénico: debe individualizarse?</TO>
<SO>Medicina Clínica</SO>
<YR>2005</YR>
<VL>124</VL>
<NO>4</NO>
<PG>142-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guntupalli-1984" NAME="Guntupalli 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guntupalli KK</AU>
<TI>Acute pulmomnary edema</TI>
<SO>Cardiology Clinics</SO>
<YR>1984</YR>
<VL>2</VL>
<NO>2</NO>
<PG>183-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gust-1998" NAME="Gust 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gust R, Bohrer H</AU>
<TI>Changes in crdiac output do not explain the higher rate of myocardial infarction associated with the use of bilevel compared with continuous positive airway pressure</TI>
<SO>Critical Care Medicine</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>2</NO>
<PG>415-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hao-2002" NAME="Hao 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hao CX, Luo XR, Liu YM</AU>
<TI>Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask</TI>
<SO>Acta Academiae Medicinae Jiangxi</SO>
<YR>2002</YR>
<VL>42</VL>
<NO>5</NO>
<PG>48-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hess-2004" MODIFIED="2013-04-16 14:12:43 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Hess 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-04-16 14:12:43 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hess DR</AU>
<TI>The evidence for noninvasive positive-pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature</TI>
<SO>Respiratory Care</SO>
<YR>2004</YR>
<VL>49</VL>
<NO>7</NO>
<PG>810-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hilberg-1997" NAME="Hilberg 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hilberg RE, Johnson DC</AU>
<TI>Noninvasive ventilation</TI>
<SO>New England Journal of Medicine</SO>
<YR>1997</YR>
<VL>337</VL>
<NO>34</NO>
<PG>1746-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hipona-1996" NAME="Hipona 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hipona RA, Jay GD, Woolard RH, Hill NS, Mehta S</AU>
<TI>Positive airway pressure suppor and myocardial ischemia</TI>
<SO>Academic Emergency Medicine</SO>
<YR>1996</YR>
<VL>3</VL>
<NO>7</NO>
<PG>729-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoffman-B-1999" NAME="Hoffman B 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hoffmann B. Welte F</AU>
<TI>The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema</TI>
<SO>Pneumologie</SO>
<YR>1999</YR>
<VL>53</VL>
<NO>6</NO>
<PG>316-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoffmann-1999" NAME="Hoffmann 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hoffmann B. Welte T</AU>
<TI>The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema</TI>
<SO>Intensive Care Medicine</SO>
<YR>1999</YR>
<VL>25</VL>
<NO>1</NO>
<PG>15-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holt-1994" MODIFIED="2013-04-16 14:12:52 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Holt 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-04-16 14:12:52 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holt AW, Bersten AD, Fuller S, Piper RK , Worthley LI, Vedig AE</AU>
<TI>Intensive care costing methodology: cost benefit analysis of mask continuous positive airway pressure for severe cardiogenic pulmonary oedema</TI>
<SO>Anaesthesia and Intensive Care</SO>
<YR>1994</YR>
<VL>22</VL>
<NO>2</NO>
<PG>170-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hotchkiss-1998" MODIFIED="2008-05-09 13:08:09 +0100" MODIFIED_BY="[Empty name]" NAME="Hotchkiss 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-05-09 13:08:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hotchkiss JR, Marini JJ</AU>
<TI>Noninvasive ventilation: An emerging supportive technique for the emergency department</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>1998</YR>
<VL>32</VL>
<NO>4</NO>
<PG>470-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hubble-2006" MODIFIED="2013-04-16 14:12:59 +0100" MODIFIED_BY="[Empty name]" NAME="Hubble 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-04-16 14:12:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hubble MW, Richards ME, Jarvis R, Millikan T, Young D</AU>
<TI>Effectiveness of prehospital continuous positive airway pressure in the management of acute pulmonary edema</TI>
<SO>Prehospital Emergency Care</SO>
<YR>2006</YR>
<VL>10</VL>
<NO>4</NO>
<PG>430-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hughes-1999" NAME="Hughes 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hughes CM</AU>
<TI>Review: continuous positive airway pressure support reduces the need for intubation in patients with cardiogenic pulmonary edema</TI>
<SO>ACP Journal Club</SO>
<YR>1999</YR>
<VL>130</VL>
<NO>3</NO>
<PG>58</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iapichino-2004" NAME="Iapichino 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iapichino G, Giacomini M, Bassi G, Borotto E, Minuto A</AU>
<TI>Non invasive mechanical ventilation in acute cardiogenic pulmonary edema: is it all done?</TI>
<SO>Minerva Anestesiologica</SO>
<YR>2004</YR>
<VL>70</VL>
<NO>4</NO>
<PG>151-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-2000" NAME="Jackson 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson P</AU>
<TI>Continuous positive airway pressure: the need for prehospital research and clinical trials</TI>
<SO>Australasian Journal of Emergency Care</SO>
<YR>2000</YR>
<VL>7</VL>
<NO>3</NO>
<PG>22-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-2001" NAME="Jackson 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson R, Carley S</AU>
<TI>CPAP in acute left ventricular failure</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>1</NO>
<PG>63-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-R-2001" NAME="Jackson R 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson R, Jones S</AU>
<TI>NIPPV for acute cardiogenic pulmonary oedema</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>6</NO>
<PG>464-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kallio-2003" MODIFIED="2008-05-09 13:09:01 +0100" MODIFIED_BY="[Empty name]" NAME="Kallio 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 13:09:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kallio T, Kuisma M, Alaspaa A, Rosenberg PH</AU>
<TI>The use of prehospital continuous positive airway pressure treatment in presumed acute severe pulmonary edema</TI>
<SO>Prehospital Emergency Care</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>2</NO>
<PG>209-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keenan-2004" MODIFIED="2008-05-09 13:09:17 +0100" MODIFIED_BY="[Empty name]" NAME="Keenan 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-05-09 13:09:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keenan SP, Sinuff T, Cook DJ, Hill NS</AU>
<TI>Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review</TI>
<SO>Critical Care Medicine</SO>
<YR>2004</YR>
<VL>32</VL>
<NO>12</NO>
<PG>2516-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kelly-2001" NAME="Kelly 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kelly C, Newby DE, Boon NA, Douglas NJ</AU>
<TI>Support ventilation versus conventional oxygen</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<PG>1126</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kiely-1998" MODIFIED="2008-05-09 13:10:39 +0100" MODIFIED_BY="[Empty name]" NAME="Kiely 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-05-09 13:10:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kiely JL, Deegan P, Buckley A, Shiels P, Maurer B, McNicholas WT</AU>
<TI>Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: Importance of underlying cardiac rhythm</TI>
<SO>Thorax</SO>
<YR>1998</YR>
<VL>53</VL>
<NO>11</NO>
<PG>957-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kindgen_x002d_Milles-2000" NAME="Kindgen-Milles 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kindgen-Milles D, Buhl R, Gabriel A, Bohner H, Muller E</AU>
<TI>Nasal continuous positive airway pressure: A method to avoid endothracheal reintubation in postoperative high-risk patients with severe nonhypercapnic oxygenation failure</TI>
<SO>Chest</SO>
<YR>2000</YR>
<VL>117</VL>
<NO>4</NO>
<PG>1106-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kosowsky-2000" MODIFIED="2013-04-16 14:13:50 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Kosowsky 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-04-16 14:13:50 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kosowsky JM, Storrow AB, Carleton SC</AU>
<TI>Continuous and bilevel positive airway pressure in the treatment of acute cardiogenic pulmonary edema</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>2000</YR>
<VL>18</VL>
<NO>1</NO>
<PG>91-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kosowsky-2001" MODIFIED="2013-04-16 14:14:01 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Kosowsky 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-04-16 14:14:01 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kosowsky JM, Stephanides SL, Branson RD, Sayre MR</AU>
<TI>Prehospital use of continuous positive airway pressure (CPAP) for presumed pulmonary edema: a preliminary case series</TI>
<SO>Prehospital Emergency Care</SO>
<YR>2001</YR>
<VL>5</VL>
<NO>2</NO>
<PG>190-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kramer-1995" MODIFIED="2013-04-16 14:14:12 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Kramer 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-04-16 14:14:12 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kramer N, Thomaas JM, Meharg J, Cece RD, Hill NS</AU>
<TI>Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1995</YR>
<VL>151</VL>
<PG>1799-806</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-L_x0027_Her-1998" NAME="L'Her 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>L'Her E, Duquesne F, Paris A, Mouline J,Renault A, Garo B, Boles JM</AU>
<TI>Spontaneous positive end-expiratory pressure ventilation in elderly patients with cardiogenic pulmonary edema</TI>
<SO>Presse Medicale</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>22</NO>
<PG>1089-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-L_x0027_Her-E-1998" MODIFIED="2008-05-09 13:11:29 +0100" MODIFIED_BY="[Empty name]" NAME="L'Her E 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-05-09 13:11:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>L'Her E, Moriconi M, Texier F, Bouquin V, Kaba L, Renault A, Garo B, Boles JM</AU>
<TI>Non-invasive continuous positive airway pressure in acute hypoxaemic respiratory failure--experience of an emergency department</TI>
<SO>European Journal of Emergency Medicine</SO>
<YR>1998</YR>
<VL>5</VL>
<NO>3</NO>
<PG>313-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lal-1969" NAME="Lal 1969" YEAR="1969">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lal S, Savidge RS, Chhabra GP</AU>
<TI>Oxygen administration after myocardial infarction</TI>
<SO>Lancet</SO>
<YR>1969</YR>
<VL>1</VL>
<PG>381-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lapinsky-1994" NAME="Lapinsky 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lapinsky SE, Mount DB, Mackey D, Grossman RF</AU>
<TI>Management of acute respiratory failure due to pulmonary edema with nasal positive pressure support</TI>
<SO>Chest</SO>
<YR>1994</YR>
<VL>105</VL>
<PG>229-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leman-2005" MODIFIED="2013-04-16 14:14:24 +0100" MODIFIED_BY="[Empty name]" NAME="Leman 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-04-16 14:14:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leman P, Greene S, Whelan K, Legassick T</AU>
<TI>Simple lightweight disposable continuous positive airways pressure mask to effectively treat acute pulmonary oedema: randomized controlled trial</TI>
<SO>Emergency Medicine Australasia</SO>
<YR>2005</YR>
<VL>17</VL>
<NO>3</NO>
<PG>224-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lenique-1997" MODIFIED="2013-04-16 14:14:33 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Lenique 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-04-16 14:14:33 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lenique F, Habis M, Lofaso F, Dubois-Randé J, Harf A, Brochard L</AU>
<TI>Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1997</YR>
<VL>155</VL>
<PG>500-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004" MODIFIED="2013-04-16 14:14:39 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-04-16 14:14:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li XK, Zhao WH</AU>
<TI>The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation</TI>
<SO>Chongqing Medical Journal</SO>
<YR>2004</YR>
<VL>34</VL>
<NO>4</NO>
<PG>575-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liesching-T-2003" NAME="Liesching T 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liesching T. Kwok H. Hill NS</AU>
<TI>Acute applications of noninvasive positive pressure ventilation</TI>
<SO>Chest</SO>
<YR>2003</YR>
<VL>124</VL>
<NO>2</NO>
<PG>699-713</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lo-Coco-1997" MODIFIED="2013-04-16 14:15:00 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Lo Coco 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-04-16 14:15:00 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lo Coco A, Vitali G, Marchese S, Bozzo P, Pesco C, Arena A</AU>
<TI>Treatment of acute respiratory failure secondary to pulmonary oedema with bi-level positive airway pressure by nasal mask</TI>
<SO>Monaldi Archives For Chest Disease</SO>
<YR>1997</YR>
<VL>52</VL>
<NO>5</NO>
<PG>444-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mackay-CA-2000" MODIFIED="2008-05-09 13:12:18 +0100" MODIFIED_BY="[Empty name]" NAME="Mackay CA 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-05-09 13:12:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mackay CA, Mackay TW, Barr J, Newby D, McDonagh T, Douglas NJ</AU>
<TI>Randomized controlled trial of CPAP vs conventional therapy in acute pulmonary edema</TI>
<SO>American Journal Respiratory Critical Care Medicine</SO>
<YR>2000</YR>
<VL>161</VL>
<PG>A416</PG>
<CY>Toronto</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Masip-2008" MODIFIED="2013-04-16 14:15:06 +0100" MODIFIED_BY="[Empty name]" NAME="Masip 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-16 14:15:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Masip J, Mebazaa A, Filippatos GS</AU>
<TI>Noninvasive ventilation in acute cardiogenic pulmonary edema</TI>
<SO>New England Journal of Medicine</SO>
<YR>2008</YR>
<VL>359</VL>
<NO>19</NO>
<PG>2068-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Massaria-1976" NAME="Massaria 1976" YEAR="1976">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Massaria E, De Liguori S, Castelli P, Cattani C, Merli M, Pratelli EM</AU>
<TI>Use of artificial respiration in complicated acute myocarial infarct. Critical evaluation</TI>
<SO>Minerva Anestesiologica</SO>
<YR>1976</YR>
<VL>42</VL>
<NO>5</NO>
<PG>391-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meduri-1991" NAME="Meduri 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meduri GU</AU>
<TI>Nonivasive face mask mechanical ventilation in patients with acute hipercapnic respiratory failure</TI>
<SO>Chest</SO>
<YR>1991</YR>
<VL>100</VL>
<PG>445-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehta-2000" MODIFIED="2013-04-16 14:15:17 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Mehta 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-04-16 14:15:17 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehta S, Liu PP, Fitzgerald FS, Allidina YK, Douglas Bradley T</AU>
<TI>Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2000</YR>
<VL>161</VL>
<NO>1</NO>
<PG>128-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehta-2004" NAME="Mehta 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehta S</AU>
<TI>Continuous versus bilevel positive airway pressure in acute cardiogenic pulmonary oedema? A good question!</TI>
<SO>Critical Care Medicine</SO>
<YR>2004</YR>
<VL>32</VL>
<NO>12</NO>
<PG>2546-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehta-2005" NAME="Mehta 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehta S, Nava S</AU>
<TI>Mask ventilation and cardiogenic pulmonary edema: "another brick in the wall"</TI>
<SO>Intensive Care Med</SO>
<YR>2005</YR>
<VL>31</VL>
<PG>757-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Minuto-2003" MODIFIED="2008-05-09 13:12:57 +0100" MODIFIED_BY="[Empty name]" NAME="Minuto 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 13:12:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Minuto A, Giacomini M, Giamundo B, Tartufari A, Denkewitz T, Marzorati S, et al</AU>
<TI>Non-invasive mechanical ventilation in patients with acute cardiogenic pulmonary edema</TI>
<SO>Minerva Anestesiologica</SO>
<YR>2003</YR>
<VL>69</VL>
<NO>11</NO>
<PG>835-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mollica-2001" MODIFIED="2008-05-09 13:41:04 +0100" MODIFIED_BY="[Empty name]" NAME="Mollica 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-05-09 13:41:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mollica C, Brunetti G, Buscajoni M, Cecchini L, Maialetti E, Marazzi M, et al</AU>
<TI>Non-invasive pressure support ventilation in acute hypoxemic (non hypercapnic) respiratory failure. Observations in Respiratory Intermediate Intensive Care Unit</TI>
<SO>Minerva Anestesiologica</SO>
<YR>2001</YR>
<VL>67</VL>
<NO>3</NO>
<PG>107-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moritz-2003" MODIFIED="2008-05-09 13:40:50 +0100" MODIFIED_BY="[Empty name]" NAME="Moritz 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 13:40:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moritz F, Benichou J, Vanhest M, Richard JC, Line S, Hellot MF, et al</AU>
<TI>Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study</TI>
<SO>European Journal of Emergency Medicine</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>3</NO>
<PG>204-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murray-2002" NAME="Murray 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray S</AU>
<TI>Bi-level positive airway pressure (BiPAP) and acute cardiogenic pulmonary oedema (ACPO) in the emergency department</TI>
<SO>Australian Critical Care</SO>
<YR>2002</YR>
<VL>15</VL>
<NO>2</NO>
<PG>51-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murray-2003" NAME="Murray 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray S</AU>
<TI>Bi-level positive airway pressure (BiPAP) and acute cardiogenic pulmonary oedema (ACPO) in emergency department</TI>
<SO>Australian Emergency Nursing Journal</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>1</NO>
<PG>19-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nadar-2005" MODIFIED="2013-04-16 14:15:28 +0100" MODIFIED_BY="[Empty name]" NAME="Nadar 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-04-16 14:15:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nadar S, Prasad N, Taylor RS, Lip GYH</AU>
<TI>Positive pressure ventilation in the management of acute and chronic cardiac failure: A systematic review and meta-analysis</TI>
<SO>International Journal of Cardiology</SO>
<YR>2005</YR>
<VL>99</VL>
<NO>2</NO>
<PG>171-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nava-2002" NAME="Nava 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nava S, Carlucci A</AU>
<TI>Non-invasive pressure support ventilation in acute hypoxemic respiratory failure: Common strategy for differnet pathologies?</TI>
<SO>Intensive Care Medicine</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>9</NO>
<PG>1205-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newberry-1995" MODIFIED="2013-04-16 14:15:36 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Newberry 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-04-16 14:15:36 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newberry DL</AU>
<TI>Noninvasive bilevel positive pressure ventilation in severe acute pulmonary edema</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>1995</YR>
<VL>13</VL>
<PG>479-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newby-2007" MODIFIED="2012-01-17 16:53:58 +0000" MODIFIED_BY="[Empty name]" NAME="Newby 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-01-17 16:53:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newby D</AU>
<TI>3CPO</TI>
<SO>ACC Cardiosource Review Journal</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>10</NO>
<PG>38-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nikki-1982" NAME="Nikki 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nikki P, Rasanen J, Tahvanainen J, Makelainen A</AU>
<TI>Ventilatory pattern in respiratory failure arising from acute myocardial infarction. I. Respiratory and hemodynamic effects of IMV4 vs IPPV12 and PEEP0 vs PEEP10</TI>
<SO>Critical Care Medicine</SO>
<YR>1982</YR>
<VL>10</VL>
<NO>2</NO>
<PG>75-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niranjan-1998" NAME="Niranjan 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Niranjan V, Bach J, Agusti AGN, Barbe F, Tagores B, Hilberg RE, Johnson DC</AU>
<TI>Noninvasive ventilation</TI>
<SO>New England Journal of Medicine</SO>
<YR>1998</YR>
<VL>338</VL>
<NO>19</NO>
<PG>1388-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Panacek-2002" NAME="Panacek 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Panacek EA, Kirk JD</AU>
<TI>Role of noninvasive ventilation in the managemnet of acutely descompensated heart failure</TI>
<SO>Reviews i Cardiovascular Medicine</SO>
<YR>2002</YR>
<VL>3</VL>
<NO>Suppl 4</NO>
<PG>S35-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pang-1998" NAME="Pang 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pang D, Keena SP, Cook DJ, Sibald WJ</AU>
<TI>The effect of positive pressure airway support on mortality and the need for intubation i cardiogenic pulmonary edema: A systematic review</TI>
<SO>Chest</SO>
<YR>1998</YR>
<VL>114</VL>
<NO>4</NO>
<PG>1185-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-2005" MODIFIED="2013-04-16 14:15:42 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Park 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-04-16 14:15:42 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park M</AU>
<TI>Noninvasive ventilation in threatment of the acute pulmonary oedema. Where are we really?</TI>
<SO>Jornal do médico - Hospital Sírio Libanês</SO>
<YR>2005</YR>
<VL>38</VL>
<PG>10-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-2006" MODIFIED="2010-08-23 20:45:43 +0100" MODIFIED_BY="[Empty name]" NAME="Park 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-08-23 20:45:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lorenzi-Filho, Geraldo DB</AU>
<TI>Noninvasive mechanical ventilation in the treatment of acute cardiogenic pulmonary edema</TI>
<SO>Clinics</SO>
<YR>2006</YR>
<VL>61</VL>
<NO>3</NO>
<PG>247-252</PG>
<IDENTIFIERS MODIFIED="2010-08-23 20:45:43 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perel-1983" MODIFIED="2013-04-16 14:16:15 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Perel 1983" YEAR="1983">
<REFERENCE MODIFIED="2013-04-16 14:16:15 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perel A, Willianson DC</AU>
<TI>Effectiveness of CPAP by mask for pulmonary edema associated with hypercarbia</TI>
<SO>Intensive Care Medicine</SO>
<YR>1983</YR>
<VL>9</VL>
<PG>17-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perkins-2006" MODIFIED="2013-04-16 14:16:22 +0100" MODIFIED_BY="[Empty name]" NAME="Perkins 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-04-16 14:16:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perkins GD, McAuley DF, Thickett DR, Gao F</AU>
<TI>From the authors</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2006</YR>
<VL>173</VL>
<NO>11</NO>
<PG>1291-Transcatheter valve implantation versus aortic valve replacement for aortic stenosis in high-risk patients2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Philip_x002d_joet-1999" NAME="Philip-joet 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philip-Joet FF, Paganelli FFF, Dutau HL</AU>
<TI>Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure</TI>
<SO>Respiration</SO>
<YR>1999</YR>
<VL>66</VL>
<PG>136-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Plaisance-2007" MODIFIED="2013-04-16 14:16:30 +0100" MODIFIED_BY="[Empty name]" NAME="Plaisance 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-04-16 14:16:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Plaisance P, Pirracchio R, Berton C, Vicaut E, Payen D</AU>
<TI>A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema</TI>
<SO>European Heart Journal</SO>
<YR>2007</YR>
<VL>28</VL>
<NO>23</NO>
<PG>2895-901</PG>
<IDENTIFIERS MODIFIED="2010-05-14 22:21:56 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pollack-1996" MODIFIED="2008-05-09 13:42:35 +0100" MODIFIED_BY="[Empty name]" NAME="Pollack 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-05-09 13:42:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pollack CV Jr, Torres MT, Alexander L</AU>
<TI>Feasibility study of the use of bilevel positive airway pressure for respiratory support in the emergency department</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>1996</YR>
<VL>27</VL>
<NO>2</NO>
<PG>189-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poponick-1999" MODIFIED="2008-05-09 13:42:54 +0100" MODIFIED_BY="[Empty name]" NAME="Poponick 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-05-09 13:42:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poponick JM, Renston JP, Bennett RP, Emerman CL</AU>
<TI>Use of a ventilatory support system (BIPAP) for acute respiratory failure in the emergency department</TI>
<SO>Chest</SO>
<YR>1999</YR>
<VL>116</VL>
<NO>1</NO>
<PG>166-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Popova-2010" MODIFIED="2013-04-16 14:18:18 +0100" MODIFIED_BY="[Empty name]" NAME="Popova 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-04-16 14:18:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Popova X, Avdeev S, Nekludova G, Chuchalin A</AU>
<TI>Effect of noninvasive ventilation (NIV) on exercise tolerance in patients with acute decompensated heart failure [Abstract]</TI>
<SO>Europe Respiratory Society Conference</SO>
<YR>2010</YR>
<PG>E3918</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poulton-1936" MODIFIED="2008-05-09 13:43:09 +0100" MODIFIED_BY="[Empty name]" NAME="Poulton 1936" YEAR="1936">
<REFERENCE MODIFIED="2008-05-09 13:43:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poulton PE</AU>
<TI>Left-side heart failure with pulmonary edema: its treatment with the "pulmonary plus pressure machine"</TI>
<SO>Lancet</SO>
<YR>1936</YR>
<VL>2</VL>
<PG>981-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rabatin-1999" NAME="Rabatin 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rabatin JT, Gay PC</AU>
<TI>Noinvasive ventilation</TI>
<SO>Mayo Clinic Proceedings</SO>
<YR>1999</YR>
<VL>74</VL>
<NO>8</NO>
<PG>817-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rasanen-J-1985" NAME="Rasanen J 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Räsänen J, Väisanen IT, Heikkilä J, Nikki P</AU>
<TI>Acute myocardial infarction complicated by left ventricular dysfunction and respiratory failure</TI>
<SO>Chest</SO>
<YR>1985</YR>
<VL>87</VL>
<NO>2</NO>
<PG>158-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rizk-1982" MODIFIED="2013-04-16 14:18:27 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Rizk 1982" YEAR="1982">
<REFERENCE MODIFIED="2013-04-16 14:18:27 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rizk NW, Murray JF</AU>
<TI>PEEP and pulmonary edema</TI>
<SO>American Journal of Medicine</SO>
<YR>1982</YR>
<VL>72</VL>
<PG>381-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roche-2003" MODIFIED="2008-05-09 13:44:12 +0100" MODIFIED_BY="[Empty name]" NAME="Roche 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 13:44:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roche F, Xuong ANT, Court-Fortune I, Costes F, Pichot V, Duverney D, et al</AU>
<TI>Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance</TI>
<SO>Pacing and Clinical Electrophysiology</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>3</NO>
<PG>669-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rusterholtz-1999" MODIFIED="2013-04-16 14:18:34 +0100" MODIFIED_BY="[Empty name]" NAME="Rusterholtz 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-04-16 14:18:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rusterholtz T, Kempf J, Berton C, Gayol S, Tournoud C, Zaehringer M, et al</AU>
<TI>Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema</TI>
<SO>Intensive Care Medicine</SO>
<YR>1999</YR>
<VL>25</VL>
<NO>1</NO>
<PG>21-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rutherholtz-2008" MODIFIED="2013-04-16 14:18:46 +0100" MODIFIED_BY="[Empty name]" NAME="Rutherholtz 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-16 14:18:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rusterholtz T, Bollaert PE, Feissel M, Romano-Girard F, Harlay ML, Zaehringer M</AU>
<TI>Continuous positive airway pressure vs. proportional assist ventilation for noninvasive ventilation in acute cardiogenic pulmonary edema</TI>
<SO>Intensive Care Medicine</SO>
<YR>2008</YR>
<VL>34</VL>
<NO>5</NO>
<PG>840-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacchetti-2001" NAME="Sacchetti 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sachetti A</AU>
<TI>Effectiveness of BiPAP for congestive heart failure</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>2001</YR>
<VL>37</VL>
<NO>6</NO>
<PG>1754-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sachetti-1995" MODIFIED="2013-04-16 14:19:11 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Sachetti 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-04-16 14:19:11 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sachetti AD, Harris RH, Paston C</AU>
<TI>Bi-level positive airway pressure support system use in acut congestive failure:Preliminary case series</TI>
<SO>Academic Emergency Medicine</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>714-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salvucci-A-2001" NAME="Salvucci A 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salvucci A Jr</AU>
<TI>CPAP for cardiogenic pulmonary edema</TI>
<SO>Emergency Medical Services</SO>
<YR>2001</YR>
<VL>30</VL>
<NO>7</NO>
<PG>84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sarullo-2004" MODIFIED="2008-05-09 13:45:10 +0100" MODIFIED_BY="[Empty name]" NAME="Sarullo 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-05-09 13:45:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sarullo FM, D'Alfonso G, Brusca I, De Michele P, Taomina A, Di Pasquale P, et al</AU>
<TI>Efficacy and safety of non-invasive positive pressure ventilation therapy in acute pulmonary edema</TI>
<SO>Monaldi Archives for Chest Disease</SO>
<YR>2004</YR>
<VL>62</VL>
<NO>1</NO>
<PG>7-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schettino-2008" MODIFIED="2013-04-16 14:19:23 +0100" MODIFIED_BY="[Empty name]" NAME="Schettino 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-16 14:19:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schettino G, Altobelli N, Kacmarek RM</AU>
<TI>Noninvasive positive-pressure ventilation in acute respiratory failure outside clinical trials: experience at the Massachusetts General Hospital</TI>
<SO>Critical Care Medicine</SO>
<YR>2008</YR>
<VL>36</VL>
<NO>2</NO>
<PG>441-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Severinghaus-2002" NAME="Severinghaus 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Severinghaus JW</AU>
<TI>Sightings</TI>
<SO>High Altitude Medicine &amp; Biology</SO>
<YR>2002</YR>
<VL>3</VL>
<NO>1</NO>
<PG>9-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simonds-2000" MODIFIED="2008-05-09 13:46:12 +0100" MODIFIED_BY="[Empty name]" NAME="Simonds 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-05-09 13:46:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simonds AK</AU>
<TI>Nasal ventilation: Where are we?</TI>
<SO>Monaldi Archives for Chest Disease</SO>
<YR>2000</YR>
<VL>55</VL>
<NO>1</NO>
<PG>45-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sinuff-2000" MODIFIED="2008-05-09 13:46:28 +0100" MODIFIED_BY="[Empty name]" NAME="Sinuff 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-05-09 13:46:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sinuff T, Cook DJ, Randall J, Allen C</AU>
<TI>Noninvasive positive-pressure ventilation: A utilization review of use in a teaching hospital</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>2000</YR>
<VL>163</VL>
<NO>8</NO>
<PG>969-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Somauroo-2000" MODIFIED="2008-05-09 13:46:58 +0100" MODIFIED_BY="[Empty name]" NAME="Somauroo 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-05-09 13:46:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Somauroo J, Wilkinson M, White V, Rodrigues E, Connolly D, Calverley P, et al</AU>
<TI>Acute hemodynamic changes of nasal bilevel and continuous positive airway pressure ventilation in patients with congestive heart failure</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2000</YR>
<VL>161</VL>
<NO>3</NO>
<PG>A548</PG>
<PB>American Thoracic Society 2000 International Conference</PB>
<CY>Toronto</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sutton-2002" NAME="Sutton 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sutton AGC, Cooper N, Jacob B</AU>
<TI>Biphasic positive pressure ventilation in acute cardiogenic pulmonary oedema</TI>
<SO>British Journal of Cardiology</SO>
<YR>2002</YR>
<VL>9</VL>
<NO>3</NO>
<PG>141-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trevisan-2008" MODIFIED="2012-01-17 17:27:02 +0000" MODIFIED_BY="[Empty name]" NAME="Trevisan 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-17 17:27:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trevisan CE, Vieira SR</AU>
<TI>Noninvasive mechanical ventilation may be useful in treating patients who fail weaning from invasive mechanical ventilation: A randomized clinical trial</TI>
<SO>Critical Care</SO>
<YR>2008</YR>
<VL>12</VL>
<PG>2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uy-2003" MODIFIED="2008-05-09 13:47:24 +0100" MODIFIED_BY="[Empty name]" NAME="Uy 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 13:47:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uy CA, Limpin MEB, Guzman AV, De Guia TS</AU>
<TI>Continuous positive airway pressure (CPAP) among patients with cardiogenic pulmonary edema</TI>
<SO>European Respiratory Journal</SO>
<YR>2003</YR>
<VL>22</VL>
<NO>Suppl 45</NO>
<PG>P553</PG>
<PB>European Respiratory Society 13th Annual Congress</PB>
<CY>Vienna</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uy-2004" MODIFIED="2013-02-20 16:57:00 +0000" MODIFIED_BY="[Empty name]" NAME="Uy 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-20 16:57:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uy CA, Limpin MB, Guzman AV, De Guia TS</AU>
<TI>Continuous positive airway pressure amoung patients with cadiogenic pulmonary edema [Abstract]</TI>
<SO>American Thoracic Society 100th International Conference</SO>
<YR>2004</YR>
<VL>1</VL>
<PG>C23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vaisanen-1987" NAME="Vaisanen 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vaisanen IT, Rasane J</AU>
<TI>Continuous positive airway pressure and supplemental oxygen in the treatment of cardiogenic pulmonary edema</TI>
<SO>Chest</SO>
<YR>1987</YR>
<VL>92</VL>
<NO>3</NO>
<PG>481-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valipour-2004" NAME="Valipour 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valipour A, Cozzarini W, Burghuber OC</AU>
<TI>Non-invasive pressure support ventilation in patients with respiratory failure due to severe acute cardiogenic pulmonary edema</TI>
<SO>Respiration</SO>
<YR>2004</YR>
<VL>71</VL>
<NO>2</NO>
<PG>144-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Werdan-1999" NAME="Werdan 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Werdan K</AU>
<TI>Emergency treatment of acute heart failure</TI>
<SO>Deutsche Medizinische Wochenschrift</SO>
<YR>1999</YR>
<VL>124</VL>
<NO>Suppl 2</NO>
<PG>S54-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Widger-2001" MODIFIED="2008-05-09 13:47:59 +0100" MODIFIED_BY="[Empty name]" NAME="Widger 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-05-09 13:47:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Widger HN, Hoffman P, Mazzolini D, Stone A, Scholly S, Clark J</AU>
<TI>Pressure upport noninvasive positive pressure ventilation treatment of acute cardiogenic pulmonary edema</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>2001</YR>
<VL>19</VL>
<NO>3</NO>
<PG>179-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wood-1998" NAME="Wood 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wood KA, Lewis L, Harz BV, Kollef MH</AU>
<TI>The use of noninvasive positive pressure ventilation in the emergency department</TI>
<SO>Chest</SO>
<YR>1998</YR>
<VL>113</VL>
<PG>1339-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wright-2001" MODIFIED="2008-05-09 13:48:22 +0100" MODIFIED_BY="[Empty name]" NAME="Wright 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-05-09 13:48:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wright J, Louis J, Younge P, Crane SD, Gray AJ, Elliott MW</AU>
<TI>The role of non-invasive ventilation in the emergency department</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>5</NO>
<PG>413-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wysocki-1995" NAME="Wysocki 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wysocki M, Tric L, Wolff MA, Millet H, Herman B</AU>
<TI>Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy</TI>
<SO>Chest</SO>
<YR>1995</YR>
<VL>107</VL>
<NO>3</NO>
<PG>761-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wysocki-1999" MODIFIED="2013-04-16 14:19:37 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Wysocki 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-04-16 14:19:37 +0100" MODIFIED_BY="Joey SW Kwong" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wysocki M</AU>
<TI>Noninvasive ventilation in acute cardiogenic pulmonary edema: Better than CPAP?</TI>
<SO>Intensive Care Medicine</SO>
<YR>1999</YR>
<VL>25</VL>
<PG>1-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2008" MODIFIED="2013-04-16 14:19:43 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-16 14:19:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang H-Y, Li C-S</AU>
<TI>Changes of plasma B-type natriuretic peptide level during non-invasive ventilation in treating acute left heart failure</TI>
<SO>Academiae Medicinae Sinicae</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>2</NO>
<PG>140-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2011-04-29 21:04:56 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2013-04-10 02:38:01 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-NCT00554580" MODIFIED="2013-04-10 02:37:03 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00554580" YEAR="2010">
<IDENTIFIERS MODIFIED="2013-04-06 13:38:50 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-06 13:38:50 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00554580"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00912158" MODIFIED="2013-04-10 02:38:01 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00912158" YEAR="">
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-04-16 14:42:40 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-04-16 14:42:40 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AHA-2012" MODIFIED="2013-04-16 14:20:02 +0100" MODIFIED_BY="[Empty name]" NAME="AHA 2012" TYPE="OTHER">
<AU>American Heart Association</AU>
<TI>Heart and Stroke Statistics 2012</TI>
<SO>http://circ.ahajournals.org/content/early/2011/12/15/CIR.0b013e31823ac046</SO>
<YR>(accessed in 14 August 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Allison-1991" MODIFIED="2013-04-16 14:20:11 +0100" MODIFIED_BY="[Empty name]" NAME="Allison 1991" TYPE="JOURNAL_ARTICLE">
<AU>Allison RC</AU>
<TI>Initial tratment of pulmonary edema: a physiological approach</TI>
<SO>American Journal of the Medical Sciences</SO>
<YR>1991</YR>
<VL>302</VL>
<NO>6</NO>
<PG>385-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bach-1997" MODIFIED="2013-04-16 14:20:19 +0100" MODIFIED_BY="[Empty name]" NAME="Bach 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bach JR, Brougher P, Hess DR, Hill NS, Kacmarek RM, Kreimer D, et al</AU>
<TI>Consensus statement noninvasive positive pressure ventilation</TI>
<SO>Respiratory Care</SO>
<YR>1997</YR>
<VL>2</VL>
<NO>4</NO>
<PG>365-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Castro-1999" MODIFIED="2013-04-16 14:20:26 +0100" MODIFIED_BY="[Empty name]" NAME="Castro 1999" TYPE="JOURNAL_ARTICLE">
<AU>Castro AA, Clark OAC, Atallah NA</AU>
<TI>Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS database): Update</TI>
<SO>Revista Paulista de Medicina</SO>
<YR>1999</YR>
<VL>117</VL>
<NO>3</NO>
<PG>138-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Collins-2006" MODIFIED="2013-04-16 14:20:36 +0100" MODIFIED_BY="[Empty name]" NAME="Collins 2006" TYPE="JOURNAL_ARTICLE">
<AU>Collins SP, Mielniczuk LM, Whittingham HA, Boseley ME, Schramm DR, Storrow AB</AU>
<TI>The Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic Review</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>2006</YR>
<VL>48</VL>
<NO>3</NO>
<PG>260-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Confalonieri-1999" MODIFIED="2013-04-16 14:21:35 +0100" MODIFIED_BY="[Empty name]" NAME="Confalonieri 1999" TYPE="JOURNAL_ARTICLE">
<AU>Confalonieri M, Potena A, Carbone G, Della Porta R, Tolley E, Meduri GU</AU>
<TI>Acute respiratory failure inpatients with severe community acquired pneumonia. A prospective randomized evaluation of non-invasive ventilation</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1999</YR>
<VL>160</VL>
<PG>1585-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Covelli-1982" MODIFIED="2008-05-09 11:28:58 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Covelli 1982" TYPE="JOURNAL_ARTICLE">
<AU>Covelli HD, Weled BJ, Beekman JF</AU>
<TI>Efficacy of continuous positive airway pressure administrated by facemask</TI>
<SO>Chest</SO>
<YR>1982</YR>
<VL>81</VL>
<PG>147-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" MODIFIED="2008-05-09 11:28:59 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Dickersin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Lefebvre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<PG>1286-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickstein-2008" MODIFIED="2013-04-16 14:21:48 +0100" MODIFIED_BY="[Empty name]" NAME="Dickstein 2008" TYPE="JOURNAL_ARTICLE">
<AU>Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al</AU>
<TI>ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)</TI>
<SO>European Heart Journal</SO>
<YR>2008</YR>
<VL>29</VL>
<NO>19</NO>
<PG>2388-442</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2013-04-16 14:21:56 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Smith GD, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by simple, graph test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gay-2009" MODIFIED="2013-04-16 14:22:04 +0100" MODIFIED_BY="[Empty name]" NAME="Gay 2009" TYPE="JOURNAL_ARTICLE">
<AU>Gay PC</AU>
<TI>Complications of Noninvasive Ventilation in Acute Care</TI>
<SO>Respiratory Care</SO>
<YR>2009</YR>
<VL>54</VL>
<NO>2</NO>
<PG>246&#8211;57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gibelin-2002" MODIFIED="2013-04-16 14:22:14 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Gibelin 2002" TYPE="JOURNAL_ARTICLE">
<AU>Gibelin P</AU>
<TI>Acute cardiogenic pulmonary edema and its treatment</TI>
<SO>La Revue du Praticien</SO>
<YR>2002</YR>
<VL>52</VL>
<NO>15</NO>
<PG>1655-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guimar_x00e3_es-2004" MODIFIED="2013-04-16 14:22:28 +0100" MODIFIED_BY="[Empty name]" NAME="Guimarães 2004" TYPE="OTHER">
<AU>Guimarães JI</AU>
<TI>Latin-American guideline for the evaluation and management of descompensed heart failure. 2004</TI>
<TO>I Diretriz Latino-Americana para Avaliação e Conduta na Insuficiência Cardíaca Descompensada</TO>
<SO>Available online at http://publicacoes.cardiol.br/consenso/2004/I_Dir_Latino_Americ_Ins_Cardiaca.asp</SO>
<YR>(accessed 13 February 2005)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2008" MODIFIED="2013-04-16 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2008" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al; for the GRADE Working Group.</AU>
<TI>Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>336</VL>
<PG>924-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-04-16 14:36:17 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>
<I>Cochrane Handbook for Systematic Reviews of Interventions</I> Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS MODIFIED="2010-12-29 20:03:48 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Ho-2006" MODIFIED="2011-11-03 18:28:19 +0000" MODIFIED_BY="[Empty name]" NAME="Ho 2006" TYPE="JOURNAL_ARTICLE">
<AU>Ho KM, Wong K</AU>
<TI>A comparison of continuous and bi-level positive airway pressure non-invasive ventilation in patients with acute cardiogenic pulmonary oedema: a meta-analysis</TI>
<SO>Critical care</SO>
<YR>2006</YR>
<VL>10</VL>
<NO>2</NO>
<PG>R49</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-2000" MODIFIED="2013-04-16 14:39:08 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Jadad 2000" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al</AU>
<TI>Systematic reviews and meta-analyses on treatment of asthma: critical evaluation</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>320</VL>
<PG>537-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keenan-1997" MODIFIED="2013-04-16 14:39:15 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Keenan 1997" TYPE="JOURNAL_ARTICLE">
<AU>Keenan SP, Kernerman PD, Cook DJ, Martin CM, McCormack D, Sibbald WJ</AU>
<TI>Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis</TI>
<SO>Critical Care Medicine</SO>
<YR>1997</YR>
<VL>25</VL>
<NO>10</NO>
<PG>1685-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kelly-1997" MODIFIED="2013-04-16 14:39:23 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Kelly 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kelly AM, Georgakas C, Bau S</AU>
<TI>Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema</TI>
<SO>Australian &amp; New Zealand Journal of Medicine</SO>
<YR>1997</YR>
<VL>27</VL>
<NO>3</NO>
<PG>319-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-1996" MODIFIED="2008-05-09 11:28:59 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Lefebvre 1996" TYPE="CONFERENCE_PROC">
<AU>Lefebvre C, McDonald S</AU>
<TI>Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE</TI>
<SO>Fourth International Cochrane Colloquium</SO>
<YR>1996</YR>
<CY>Adelaide</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2013-04-16 14:39:48 +0100" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). <I>Cochrane Handbook for Systematic Reviews of Interventions</I> Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mart_x00ed_nez-1995" MODIFIED="2013-04-16 14:40:52 +0100" MODIFIED_BY="[Empty name]" NAME="Martínez 1995" TYPE="JOURNAL_ARTICLE">
<AU>Martínez AS, Muñoz VD, Lisboa CB, Jalil JM, Godoy IJ, Moreno RB, et al</AU>
<TI>Non invasive intermittent mechanical ventilation in the treatment of chronic severe cardiac failure</TI>
<SO>Revista Médica de Chile</SO>
<YR>1995</YR>
<VL>123</VL>
<PG>1467-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Masip-2005" MODIFIED="2013-04-16 14:40:57 +0100" MODIFIED_BY="[Empty name]" NAME="Masip 2005" TYPE="JOURNAL_ARTICLE">
<AU>Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA</AU>
<TI>Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis</TI>
<SO>JAMA</SO>
<YR>2005</YR>
<VL>294</VL>
<NO>24</NO>
<PG>3124-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McKibbon-2004" MODIFIED="2013-04-16 14:41:08 +0100" MODIFIED_BY="Liz Bickerdike" NAME="McKibbon 2004" TYPE="JOURNAL_ARTICLE">
<AU>McKibbon KA, Wilczynski NL, Haynes RB</AU>
<TI>What do evidence-based secondary journals tell us about the publication of clinically important article in primary healthcare journals?</TI>
<SO>BMC Medicine</SO>
<YR>2004</YR>
<VL>2</VL>
<PG>33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meyer-1998" MODIFIED="2013-04-16 14:41:16 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Meyer 1998" TYPE="JOURNAL_ARTICLE">
<AU>Meyer EC, Lorenzi Filho G, Schttino PP, Carvalho RR</AU>
<TI>Noninvasive ventilation in the severe congestive heart failure patient</TI>
<SO>Revista da Sociedade de Cardiologia do Estado de São Paulo</SO>
<YR>1998</YR>
<VL>8</VL>
<NO>3</NO>
<PG>420-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MIX-2006" MODIFIED="2012-09-02 19:03:26 +0100" MODIFIED_BY="[Empty name]" NAME="MIX 2006" TYPE="COMPUTER_PROGRAM">
<AU>Bax L</AU>
<TI>The MIX program</TI>
<YR>2006</YR>
<EN>Version 1.2</EN>
<PB>MIX</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nieminen-2005" MODIFIED="2008-05-09 13:55:48 +0100" MODIFIED_BY="[Empty name]" NAME="Nieminen 2005" TYPE="JOURNAL_ARTICLE">
<AU>Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al</AU>
<TI>Executive summary of the guidelline on the diagnosis and treatment of acute heart failure</TI>
<SO>European Heart Journal</SO>
<YR>2005</YR>
<VL>26</VL>
<PG>384-416</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peter-2006" MODIFIED="2013-04-16 14:41:24 +0100" MODIFIED_BY="[Empty name]" NAME="Peter 2006" TYPE="JOURNAL_ARTICLE">
<AU>Peter J, V, Moran JL, Phillips-Hughes J, Graham P, Bersten AD</AU>
<TI>Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis</TI>
<SO>Lancet</SO>
<YR>2006</YR>
<VL>367</VL>
<PG>1155-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Potts-2009" MODIFIED="2013-04-16 14:41:44 +0100" MODIFIED_BY="[Empty name]" NAME="Potts 2009" TYPE="JOURNAL_ARTICLE">
<AU>Potts JM</AU>
<TI>Noninvasive positive pressure ventilation: effect on mortality in acute cardiogenic pulmonary edema: a pragmatic meta-analysis</TI>
<SO>Polskie Archiwum Medycyny Wewn&#281;trznej</SO>
<YR>2009</YR>
<VL>119</VL>
<NO>6</NO>
<PG>349-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ram-2004" MODIFIED="2008-05-09 14:20:43 +0100" MODIFIED_BY="[Empty name]" NAME="Ram 2004" TYPE="COCHRANE_REVIEW">
<AU>Ram FSF, Picot J, Lightowler J, Wedzicha JA</AU>
<TI>Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-05-09 12:50:12 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-05-09 12:50:12 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004104.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Remme-1997" MODIFIED="2013-04-16 14:41:55 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Remme 1997" TYPE="JOURNAL_ARTICLE">
<AU>Remme WJ, Cleland JGF, Dargie H, Erdmann R, Ferrari J, Kjekshus M, et al</AU>
<TI>The treatment of heart failure. The task force of the Working Group on heart failure of the European Society of Cardiology</TI>
<SO>European Heart Journal</SO>
<YR>1997</YR>
<VL>18</VL>
<PG>736-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Review-Manager-2013" MODIFIED="2013-04-16 14:42:11 +0100" MODIFIED_BY="Joey SW Kwong" NAME="Review Manager 2013" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2013</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2008-05-09 11:28:59 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman D</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-V_x00e4_is_x00e4_nen-1987" MODIFIED="2008-05-09 11:28:59 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Väisänen 1987" TYPE="JOURNAL_ARTICLE">
<AU>Väisänen IT, Räsänen J</AU>
<TI>Continuous positive airway pressure and supplemental oxygen in threatment of cardiogenic pulmonary edema</TI>
<SO>Chest</SO>
<YR>1987</YR>
<VL>92</VL>
<NO>3</NO>
<PG>481-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weng-201O" MODIFIED="2013-04-16 14:42:19 +0100" MODIFIED_BY="[Empty name]" NAME="Weng 201O" TYPE="JOURNAL_ARTICLE">
<AU>Weng CL, Zhao YT, Liu QH, Fu CJ, Sun F, Ma YL, et al</AU>
<TI>Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2010</YR>
<VL>152</VL>
<NO>9</NO>
<PG>590-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williams-1995" MODIFIED="2013-04-16 14:42:32 +0100" MODIFIED_BY="Liz Bickerdike" NAME="Williams 1995" TYPE="JOURNAL_ARTICLE">
<AU>Williams JF, Bristow MR, Fowler MB, Francis GS, Garson A, Gersh BJ, et al</AU>
<TI>Guidelines for the evaluation and management of heart failure</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>1995</YR>
<VL>26</VL>
<NO>5</NO>
<PG>1376-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Winck-2006" MODIFIED="2013-04-16 14:42:40 +0100" MODIFIED_BY="[Empty name]" NAME="Winck 2006" TYPE="JOURNAL_ARTICLE">
<AU>Winck JC, Azevedo LF, Costa-Pereira A, Antonelli M, Wyatt JC</AU>
<TI>Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema - a systematic review and meta-analysis</TI>
<SO>Critical care</SO>
<YR>2006</YR>
<VL>10</VL>
<NO>2</NO>
<PG>R69</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-02-20 16:52:44 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Vital-2008" MODIFIED="2013-02-20 16:52:44 +0000" MODIFIED_BY="[Empty name]" NAME="Vital 2008" TYPE="COCHRANE_REVIEW">
<AU>Vital FMR, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B, Burns KEA, Atallah ÁN</AU>
<TI>Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-02-20 16:52:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-20 16:52:44 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005351.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2012-09-02 16:31:51 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Agostoni-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Agostoni 2010" NOTES="&lt;p&gt;Agostoni P&lt;br&gt;Caldara G&lt;br&gt;Bussotti M&lt;br&gt;Revera M&lt;br&gt;Valentini M&lt;br&gt;Gregorini F&lt;br&gt;Faini A&lt;br&gt;Lombardi C&lt;br&gt;Bilo G&lt;br&gt;Giuliano A&lt;br&gt;Veglia F&lt;br&gt;Savia G&lt;br&gt;Modesti PA&lt;br&gt;Mancia G&lt;br&gt;Parati G&lt;br&gt;HIGHCARE Investigators&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Agostoni Piergiuseppe, Caldara Gianluca, Bussotti Maurizio, Revera Miriam, Valentini Mariaconsuelo, Gregorini Francesca, et al</AU>
<TI>Continuous positive airway pressure increases haemoglobin O2 saturation after acute but not prolonged altitude exposure</TI>
<YR>2010</YR>
<VL>31</VL>
<PG>457-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Al_x002d_aqeedi-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Al-aqeedi 2009" NOTES="&lt;p&gt;Al-aqeedi RF&lt;br&gt;Kamha A&lt;br&gt;Al-aani FK&lt;br&gt;Al-ani AA&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Al-aqeedi Rafid Fayadh, Kamha Ahmed, Al-aani Fuad K, Al-ani Ahmed A</AU>
<TI>Salmonella myocarditis in a young adult patient presenting with acute pulmonary edema, rhabdomyolysis, and multi-organ failure</TI>
<YR>2009</YR>
<VL>54</VL>
<PG>475-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beck_x002d_Schimmer-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Beck-Schimmer 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Beck-Schimmer B, Schimmer R C</AU>
<TI>Perioperative tidal volume and intra-operative open lung strategy in healthy lungs: Where are we going?</TI>
<YR>2010</YR>
<VL>24</VL>
<PG>199-210</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belyavskiy-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Belyavskiy 2010" NOTES="&lt;p&gt;Acetazolamide improves severity of chronic heart failure in patients with obstructive sleep apnea syndrome.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Congress Berlin Germany. Conference Start: 20100529 Conference End: 20100601. Conference: Heart Failure 2010 Congress Berlin Germany. Conference Start: 20100529 Conference End: 20100601. Conference Publication: (var.pagings). ( 2010. Date of Publication: May 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Belyavskiy E, Kalinkin A, Mareev V</AU>
<TI>Acetazolamide improves severity of chronic heart failure in patients with obstructive sleep apnea syndrome</TI>
<YR>2010</YR>
<VL>9</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belyavskiy-2010a" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Belyavskiy 2010a" NOTES="&lt;p&gt;Effects of acetazolamide in patients with obstructive sleep apnea syndrome and chronic heart failure.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Stockholm Sweden. Conference Start: 20100828 Conference End: 20100901. Conference: European Society of Cardiology, ESC Congress 2010 Stockholm Sweden. Conference Start: 20100828 Conference End: 20100901. Conference Publication: (var.pagings). ( 2010. Date of Publication: September 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Belyavskiy E, Litvin A, Mareev V</AU>
<TI>Effects of acetazolamide in patients with obstructive sleep apnea syndrome and chronic heart failure</TI>
<YR>2010</YR>
<VL>31</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bitter-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Bitter 2010" NOTES="&lt;p&gt;Schlafbezogene atmungsstorungen bei diastolischer herzinsuffizienz.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: December 2010&lt;br&gt;English, German&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Bitter T, Horstkotte D, Oldenburg O</AU>
<TI>Sleep-disordered breathing in heart failure with preserved ejection fraction. [German]</TI>
<YR>2010</YR>
<VL>36</VL>
<PG>500-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bonnemains-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Bonnemains 2010" NOTES="&lt;p&gt;Bonnemains L&lt;br&gt;Lambert V&lt;br&gt;Moulin-Zinch A&lt;br&gt;Youssef D&lt;br&gt;Serraf A&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Bonnemains Laurent, Lambert Virginie, Moulin-Zinch Anne, Youssef Dany, Serraf Alain</AU>
<TI>Very early correction of anomalous left coronary artery from the pulmonary artery improves intensive care management</TI>
<YR>2010</YR>
<VL>103</VL>
<PG>579-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boskabadi-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Boskabadi 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: February 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Boskabadi H, Afshari J T, Ghayour-Mobarhan M, Maamouri G, Shakeri M T, Sahebkar A, et al</AU>
<TI>Association between serum interleukin-6 levels and severity of perinatal asphyxia</TI>
<YR>2010</YR>
<VL>4</VL>
<PG>79-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boyle-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Boyle 2010" NOTES="&lt;p&gt;Accession Number: 2010804856. Language: English. Entry Date: 20101015. Revision Date: 20101112. Publication Type: journal article; abstract; commentary. Journal Subset: Biomedical; Online/Print; Peer Reviewed; USA. NLM UID: 9880022&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Boyle A J</AU>
<TI>No Role for Elective IABP in High-risk PCI</TI>
<YR>2010</YR>
<VL>29</VL>
<PG>75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bravata-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Bravata 2010" NOTES="&lt;p&gt;Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Bravata D M, Concato J, Fried T, Ranjbar N, Sadarangani T, McClain V, et al</AU>
<TI>Auto-titrating continuous positive airway pressure for patients with acute transient ischemic attack: a randomized feasibility trial</TI>
<YR>2010</YR>
<PG>1464-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Budhiraja-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Budhiraja 2010" NOTES="&lt;p&gt;Budhiraja R&lt;br&gt;Budhiraja P&lt;br&gt;Quan SF&lt;br&gt;HL068060 (United States NHLBI NIH HHS)&lt;br&gt;HL53938 (United States NHLBI NIH HHS)&lt;br&gt;U01 HL053938-14 (United States NHLBI NIH HHS)&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Budhiraja Rohit, Budhiraja Pooja, Quan Stuart F</AU>
<TI>Sleep-disordered breathing and cardiovascular disorders</TI>
<YR>2010</YR>
<VL>55</VL>
<PG>1322-32; discussion 1330-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cabello-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Cabello 2010" NOTES="&lt;p&gt;Cabello B&lt;br&gt;Thille AW&lt;br&gt;Roche-Campo F&lt;br&gt;Brochard L&lt;br&gt;Gomez FJ&lt;br&gt;Mancebo J&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Cabello Belen, Thille Arnaud W, Roche-Campo Ferran, Brochard Laurent, Gomez Francisco J, Mancebo Jordi</AU>
<TI>Physiological comparison of three spontaneous breathing trials in difficult-to-wean patients</TI>
<YR>2010</YR>
<VL>36</VL>
<PG>1171-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Caldara-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Caldara 2009" NOTES="&lt;p&gt;Positive pressure ventilation increases arterial haemoglobin oxygen saturation after acute but not after prolonged exposure to high altitude hypoxia. Evidence from the HIGHCARE study.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Barcelona Spain. Conference Start: 20090829 Conference End: 20090902. Conference: European Society of Cardiology, ESC Congress 2009 Barcelona Spain. Conference Start: 20090829 Conference End: 20090902. Conference Publication: (var.pagings). ( 2009. Date of Publication: September 2009&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Caldara G, Agostoni P, Valentini M, Bussotti M, Gregorini F, Faini A, et al</AU>
<TI>Positive pressure ventilation increases arterial haemoglobin oxygen saturation after acute but not after prolonged exposure to high altitude hypoxia. Evidence from the HIGHCARE study</TI>
<YR>2009</YR>
<VL>30</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Calhoun-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Calhoun 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: June 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Calhoun D A</AU>
<TI>Obstructive sleep apnea and hypertension</TI>
<YR>2010</YR>
<VL>12</VL>
<PG>189-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cereda-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Cereda 2010" NOTES="&lt;p&gt;Sleep-disordered breathing in TIA/ischaemic stroke: Effects on short- and long-term outcome and CPAP treatment efficacy: An open, observational, clinical, multicentre trial with a randomized arm (SAS CARE study).&lt;br&gt;Using Smart Source Parsing&lt;br&gt;20100914 Conference End: 20100918. Conference: 20th Congress of the European Sleep Research Society Lisbon Portugal. Conference Start: 20100914 Conference End: 20100918. Conference Publication: (var.pagings). ( Date of Publication: September 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Cereda C W, Azzola A, Baumann C, Bornatico F, Ciccon A, Dell'acqua M L, et al</AU>
<TI>Sleep-disordered breathing in TIA/ischaemic stroke: Effects on short- and long-term outcome and CPAP treatment efficacy: An open, observational, clinical, multicentre trial with a randomized arm (SAS CARE study)</TI>
<YR>2010</YR>
<VL>19</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chaiwat-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Chaiwat 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: August 2010&lt;br&gt;English, Thai&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Chaiwat O, Sarima N, Niyompanitpattana K, Komoltri C, Udomphorn Y, Kongsayreepong S</AU>
<TI>Protocol-directed vs. physician-directed weaning fromventilator in intra-abdominal surgical patients</TI>
<YR>2010</YR>
<VL>93</VL>
<PG>930-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chaudhry-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Chaudhry 2010" NOTES="&lt;p&gt;Evaluation of non-invasive ventilation in management of acute severe asthma.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;London United Kingdom. Conference Start: 20101201 Conference End: 20101203. Conference: British Thoracic Society Winter Meeting 2010 London United Kingdom. Conference Start: 20101201 Conference End: 20101203. Conference Publication: (var.pagings). ( 2010. Date of Publication: December 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Chaudhry D, Indora M, Sangwan V, Sehgal I P S, Chaudhry A</AU>
<TI>Evaluation of non-invasive ventilation in management of acute severe asthma</TI>
<YR>2010</YR>
<VL>65</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cheng-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Cheng 2009" TYPE="OTHER">
<AU>Cheng J M, den Uil C A, Hoeks S E, van der Ent M, Jewbali L S, van Domburg R T, et al</AU>
<TI>Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials (Structured abstract)</TI>
<YR>2009</YR>
<PG>2102-8</PG>
<PB>Centre for Reviews and Dissemination</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chermont-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Chermont 2009" NOTES="&lt;p&gt;CPAP acutely improves chronotropic responses, rate pressure product and mild correlated pulse pressure with six minute walk distance in patients with chronic heart failure.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Nice France. Conference Start: 20090530 Conference End: 20090602. Conference: Heart Failure 2009 Nice France. Conference Start: 20090530 Conference End: 20090602. Conference Publication: (var.pagings). ( 2009. Date of Publication: May 2009&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Chermont S, Quintao M M P, Velloso M M, Rocha N N R, Martins W, Mesquita E T, et al</AU>
<TI>CPAP acutely improves chronotropic responses, rate pressure product and mild correlated pulse pressure with six minute walk distance in patients with chronic heart failure</TI>
<YR>2009</YR>
<VL>8</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conti-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Conti 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: December 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Conti C R</AU>
<TI>The effects of hyperoxic ventilation in the treatment of myocardial infarction</TI>
<YR>2010</YR>
<VL>11</VL>
<PG>143-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cordero_x002d_Guevara-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Cordero-Guevara 2011" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: 2011&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Cordero-Guevara J, Teran-Santos J, Alonso-Alvarez M L, Castrodeza-Sanz J, Ordax-Carbajo E, Masa-Jimenez F</AU>
<TI>Effectiveness of nasal continuous positive airway pressure (CPAP) therapy on cardiovascular outcomes in obstructive sleep apnea-hypopnea syndrome (OSAHS)</TI>
<YR>2011</YR>
<VL>7</VL>
<PG>121-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Edwin-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Edwin 2010" NOTES="&lt;p&gt;Edwin F&lt;br&gt;Mamorare H&lt;br&gt;Brink J&lt;br&gt;Kinsley R&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Edwin Frank, Mamorare Hendrick, Brink Johann, Kinsley Robin</AU>
<TI>Primary arterial switch operation for transposition of the great arteries with intact ventricular septum--is it safe after three weeks of age?</TI>
<YR>2010</YR>
<VL>11</VL>
<PG>641-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gangopadhyay-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Gangopadhyay 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: November - 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Gangopadhyay S, Acharjee A, Nayak S K, Dawn S, Piplai G, Gupta K</AU>
<TI>Immediate extubation versus standard postoperative ventilation: Our experience in on pump open heart surgery</TI>
<YR>2010</YR>
<VL>54</VL>
<PG>525-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gray-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Gray 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: January 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Gray A, Goodacre S, Nicholl J, Masson M, Sampson F, Elliott M, et al</AU>
<TI>The development of a simple risk score to predict early outcome in severe acute acidotic cardiogenic pulmonary edema the 3CPO score</TI>
<YR>2010</YR>
<VL>3</VL>
<PG>111-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haneya-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Haneya 2011" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: 2011&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Haneya A, Haake N, Diez C, Puehler T, Cremer J, Schmid C, et al</AU>
<TI>Impact of the eurotransplant high-urgency heart allocation system on the outcome of transplant candidates in Germany</TI>
<YR>2011</YR>
<VL>59</VL>
<PG>93-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hastings-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Hastings 2010" TYPE="OTHER">
<AU>Hastings P C, Vazir A, Meadows G E, Dayer M, Poole-Wilson P A, McIntyre H F, et al</AU>
<TI>Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study</TI>
<YR>2010</YR>
<PG>17-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heeley-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Heeley 2010" NOTES="&lt;p&gt;The sleep apnea cardiovascular endpoints (SAVE) study.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;20100901 Conference End: 20100903. Conference: 21st Annual Scientific Meeting of the Stroke Society of Australasia Melbourne, VIC Australia. Conference Start: 20100901 Conference End: 20100903. Conference Publication: (var.pagings). ( Date of Publication: September 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Heeley E, Antic N, Anderson C, Huang Y, Huang S, Wang J, et al</AU>
<TI>The sleep apnea cardiovascular endpoints (SAVE) study</TI>
<YR>2010</YR>
<VL>5</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hill-2010a" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Hill 2010a" NOTES="&lt;p&gt;Selection of patients for noninvasive ventilation.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;20101122 Conference End: 20101125. Conference: 15th Congress of the Asian Pacific Society of Respirology Manila Philippines. Conference Start: 20101122 Conference End: 20101125. Conference Publication: (var.pagings). ( Date of Publication: November 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Hill N S</AU>
<TI>Selection of patients for noninvasive ventilation</TI>
<YR>2010</YR>
<VL>15</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Karpman-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Karpman 2010" NOTES="&lt;p&gt;Prediction of prolonged mechanical ventilation.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Annual Meeting Vancouver, BC Canada. Conference Start: 20101030 Conference End: 20101104. Conference: CHEST 2010 Annual Meeting Vancouver, BC Canada. Conference Start: 20101030 Conference End: 20101104. Conference Publication: (var.pagings). ( 2010. Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Karpman C, Afessa B</AU>
<TI>Prediction of prolonged mechanical ventilation</TI>
<YR>2010</YR>
<VL>138</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kasai-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Kasai 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: January 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, et al</AU>
<TI>Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration</TI>
<YR>2010</YR>
<VL>3</VL>
<PG>140-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kasai-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Kasai 2011" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: 11 Jan 2011&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Kasai T, Bradley T D</AU>
<TI>Obstructive sleep apnea and heart failure: Pathophysiologic and therapeutic implications</TI>
<YR>2011</YR>
<VL>57</VL>
<PG>119-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kaya-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Kaya 2010" NOTES="&lt;p&gt;Journal Article; Randomized Controlled Trial UNIT: NEW&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Kaya D, Barutcu I, Esen A M, Celik A, Onrat E</AU>
<TI>Acute effects of moxonidine on cardiac autonomic modulation</TI>
<YR>2010</YR>
<PG>929-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Koyama-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Koyama 2010" NOTES="&lt;p&gt;Koyama T&lt;br&gt;Watanabe H&lt;br&gt;Kobukai Y&lt;br&gt;Makabe S&lt;br&gt;Munehisa Y&lt;br&gt;Iino K&lt;br&gt;Kosaka T&lt;br&gt;Ito H&lt;br&gt;Comment in: Circ J. 2010 Oct;74(10):2056-7; PMID: 20838005&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Koyama Takashi, Watanabe Hiroyuki, Kobukai Yusuke, Makabe Shin, Munehisa Yoshiko, Iino Kenji, et al</AU>
<TI>Beneficial effects of adaptive servo ventilation in patients with chronic heart failure</TI>
<YR>2010</YR>
<VL>74</VL>
<PG>2118-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kuss-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Kuss 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp e13), Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Kuss O, Von Salviati B, Borgermann J</AU>
<TI>Off-pump versus on-pump coronary artery bypass grafting: A systematic review and meta-analysis of propensity score analyses</TI>
<YR>2010</YR>
<VL>140</VL>
<PG>829-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-LaPar-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="LaPar 2011" NOTES="&lt;p&gt;LaPar DJ&lt;br&gt;Bhamidipati CM&lt;br&gt;Reece TB&lt;br&gt;Cleveland JC&lt;br&gt;Kron IL&lt;br&gt;Ailawadi G&lt;br&gt;2T32HL007849-11A1 (United States NHLBI NIH HHS)&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>LaPar Damien J, Bhamidipati Castigliano M, Reece T Brett, Cleveland Joseph C, Kron Irving L, Ailawadi Gorav</AU>
<TI>Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians?</TI>
<YR>2011</YR>
<VL>141</VL>
<PG>81-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lari-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Lari 2009" TYPE="OTHER">
<AU>Lari F Bragagni G</AU>
<TI>Comparison between two CPAP devices in acute respiratory failure due to acute cardiogenic pulmonary edema [Abstract]</TI>
<YR>2009</YR>
<PG>[P810]</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Logan-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Logan 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: June 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Logan A G, Bradley T D</AU>
<TI>Sleep apnea and cardiovascular disease</TI>
<YR>2010</YR>
<VL>12</VL>
<PG>182-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lomivorotov-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Lomivorotov 2010" NOTES="&lt;p&gt;Levosimendan versus intraaortic balloon pump in high risk cardiac patients operated under cardiopulmonary bypass: Preliminary report.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;20101009 Conference End: 20101013. Conference: 23rd Annual Congress of the European Society of Intensive Care Medicine, ESICM Barcelona Spain. Conference Start: 20101009 Conference End: 20101013. Conference Publication: (var.pagings). ( Date of Publication: September 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Lomivorotov V V, Boboshko V A, Kornilov I A, Kniazkova L G, Deryagin M N, Cherniavsky A M</AU>
<TI>Levosimendan versus intraaortic balloon pump in high risk cardiac patients operated under cardiopulmonary bypass: Preliminary report</TI>
<YR>2010</YR>
<VL>36</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marin-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Marin 2010" NOTES="&lt;p&gt;Accession Number: 2010733127. Language: English. Entry Date: 20101008. Revision Date: 20101008. Publication Type: journal article; research. Journal Subset: Biomedical; Peer Reviewed; USA. Special Interest: Critical Care. Instrumentation: Apnea-Hypopnea Index (AHI). NLM UID: 9421642&lt;br&gt;PMID: 20378728&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Marin J M, Soriano J B, Carrizo S J, Boldova A, Celli B R</AU>
<TI>Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome</TI>
<YR>2010</YR>
<VL>182</VL>
<PG>325-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matsuda-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Matsuda 2010" NOTES="&lt;p&gt;Comparative Study; Controlled Clinical Trial; Journal Article&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Matsuda K, Moriguchi T, Oda S, Hirasawa H</AU>
<TI>Efficacy of continuous hemodiafiltration with a cytokine-adsorbing hemofilter in the treatment of acute respiratory distress syndrome</TI>
<YR>2010</YR>
<PG>83-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matthys-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Matthys 2011" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: February 2011&lt;br&gt;English, Italian&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Matthys H</AU>
<TI>Fit for high altitude: Are hypoxic challenge tests useful?</TI>
<YR>2011</YR>
<VL>6</VL>
<PG>38-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McEvoy-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="McEvoy 2010" NOTES="&lt;p&gt;Sleep apnea cardiovascular endpoints (SAVEx) trial.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Biodiversity of Sleep Christchurch New Zealand. Conference Start: 20101021 Conference End: 20101023. Conference: 22nd Annual Scientific Meeting of the Australian Sleep Association and Australian Sleep Technologists Association: Sleep Down Under 2010 - Biodiversity of Sleep Christchurch New Zealand. Conference Start: 20101021 Conference End: 20101023. Conference Publication: (var.pagings). ( 2010. Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>McEvoy D, Antic N, Heeley E, Huang Y, Huang S, Wang J, et al</AU>
<TI>Sleep apnea cardiovascular endpoints (SAVEx) trial</TI>
<YR>2010</YR>
<VL>8</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miller-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Miller 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: 2010 May-Jun&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Miller N E</AU>
<TI>Techniques of early respiratory management of very low and extremely low birth weight infants</TI>
<YR>2010</YR>
<VL>29</VL>
<PG>153-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miwa-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Miwa 2010" NOTES="&lt;p&gt;Miwa Y&lt;br&gt;Muramatsu M&lt;br&gt;Takahashi R&lt;br&gt;Wakabayashi K&lt;br&gt;Odai T&lt;br&gt;Isozaki T&lt;br&gt;Yajima N&lt;br&gt;Kasama T&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Miwa Yusuke, Muramatsu Mizuho, Takahashi Ryo, Wakabayashi Kuninobu, Odai Tsuyoshi, Isozaki Takeo, et al</AU>
<TI>Dermatomyositis complicated with hemorrhagic shock of the iliopsoas muscle on both sides and the thigh muscle</TI>
<YR>2010</YR>
<VL>20</VL>
<PG>420-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murphy-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Murphy 2010" NOTES="&lt;p&gt;Transfusion associated circulatory overload (TACO): Risk factors and mortality.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;20101009 Conference End: 20101012. Conference: AABB Annual Meeting and CTTXPO Baltimore, MD United States. Conference Start: 20101009 Conference End: 20101012. Conference Publication: (var.pagings). ( Date of Publication: September 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Murphy E L, Kwaan N, Looney M, Gajic O, Hubmayr R, Gropper M A, et al</AU>
<TI>Transfusion associated circulatory overload (TACO): Risk factors and mortality</TI>
<YR>2010</YR>
<VL>50</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Myers-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Myers 2010" NOTES="&lt;p&gt;Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Validation Studies&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Myers J, Goldsmith R L, Keteyian S J, Brawner C A, Brazil D A, Aldred H, et al</AU>
<TI>The ventilatory anaerobic threshold in heart failure: a multicenter evaluation of reliability</TI>
<YR>2010</YR>
<PG>76-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Natarajan-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Natarajan 2010" NOTES="&lt;p&gt;Natarajan D&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Natarajan Deepak</AU>
<TI>Primary PCI for acute anterior wall MI with pulmonary edema and left anterior descending artery ostial stenosis</TI>
<YR>2010</YR>
<VL>62</VL>
<PG>90-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ng-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Ng 2009" NOTES="&lt;p&gt;The efficacy and safety of tight blood glucose control during heart surgery: A systematic review and meta-analysis.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;20090619 Conference End: 20090619. Conference: Meeting of the Association of Cardiothoracic Anaesthetists Cambridge United Kingdom. Conference Start: 20090619 Conference End: 20090619. Conference Publication: (var.pagings). ( (pp ), 2009. Date of Publication: December 2009&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Ng K, Grounds R, Haga K, Carter G, Clarke S, Loveless R, et al</AU>
<TI>The efficacy and safety of tight blood glucose control during heart surgery: A systematic review and meta-analysis</TI>
<YR>2009</YR>
<VL>64</VL>
<PG>1389</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olson-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Olson 2010" NOTES="&lt;p&gt;Olson TP&lt;br&gt;Joyner MJ&lt;br&gt;Dietz NM&lt;br&gt;Eisenach JH&lt;br&gt;Curry TB&lt;br&gt;Johnson BD&lt;br&gt;Comment in: J Physiol. 2010 Aug 1;588(Pt 15):2683; PMID: 20675813&lt;br&gt;1KL2RR024151 (United States NCRR NIH HHS)&lt;br&gt;1UL1RR024150 (United States NCRR NIH HHS)&lt;br&gt;HL46493 (United States NHLBI NIH HHS)&lt;br&gt;HL71478 (United States NHLBI NIH HHS)&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Olson Thomas P, Joyner Michael J, Dietz Niki M, Eisenach John H, Curry Timothy B, Johnson Bruce D</AU>
<TI>Effects of respiratory muscle work on blood flow distribution during exercise in heart failure</TI>
<YR>2010</YR>
<VL>588</VL>
<PG>2487-501</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ouanes_x002d_Besbes-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Ouanes-Besbes 2011" NOTES="&lt;p&gt;Ouanes-Besbes L&lt;br&gt;Ouanes I&lt;br&gt;Dachraoui F&lt;br&gt;Dimassi S&lt;br&gt;Mebazaa A&lt;br&gt;Abroug F&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Ouanes-Besbes Lamia, Ouanes Islem, Dachraoui Fahmi, Dimassi Saoussen, Mebazaa Alexandre, Abroug Fekri</AU>
<TI>Weaning difficult-to-wean chronic obstructive pulmonary disease patients: a pilot study comparing initial hemodynamic effects of levosimendan and dobutamine</TI>
<YR>2011</YR>
<VL>26</VL>
<PG>15-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parissis-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Parissis 2010" NOTES="&lt;p&gt;Accession Number: 2010794591. Language: English. Entry Date: 20101105. Revision Date: 20101231. Publication Type: journal article; review; tables/charts. Journal Subset: Biomedical; Expert Peer Reviewed; Online/Print; Peer Reviewed; USA. Special Interest: Critical Care. No. of Refs: 84 ref. NLM UID: 9504454&lt;br&gt;PMID: 20711077&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Parissis J T, Rafouli-Stergiou P, Stasinos V, Psarogiannakopoulos P, Mebazaa A</AU>
<TI>Inotropes in cardiac patients: update 2011</TI>
<YR>2010</YR>
<VL>16</VL>
<PG>432-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rahman-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Rahman 2010" NOTES="&lt;p&gt;Acute lung injury in minimally invasive mitral valve repair surgery: Identifying patients at high risk for acute respiratory failure following the surgery.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Annual Meeting Vancouver, BC Canada. Conference Start: 20101030 Conference End: 20101104. Conference: CHEST 2010 Annual Meeting Vancouver, BC Canada. Conference Start: 20101030 Conference End: 20101104. Conference Publication: (var.pagings). ( 2010. Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Rahman K Y, Barber L, Huizar I, Shaw R</AU>
<TI>Acute lung injury in minimally invasive mitral valve repair surgery: Identifying patients at high risk for acute respiratory failure following the surgery</TI>
<YR>2010</YR>
<VL>138</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Randerath-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Randerath 2010" NOTES="&lt;p&gt;Randerath WJ&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Randerath Winfried J</AU>
<TI>Treatment options in Cheyne-Stokes respiration</TI>
<YR>2010</YR>
<VL>4</VL>
<PG>341-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reis-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Reis 2010" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Reis M S, Sampaio L M M, Lacerda D, De Oliveira L V F, Pereira G B, Pantoni C B F, et al</AU>
<TI>Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease</TI>
<YR>2010</YR>
<VL>6</VL>
<PG>719-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Routsi-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Routsi 2010" NOTES="&lt;p&gt;Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al</AU>
<TI>Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial</TI>
<YR>2010</YR>
<PG>R74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ryan-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Ryan 2010" NOTES="&lt;p&gt;Journal Article; Multicenter Study; Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Ryan C M, Floras J S, Logan A G, Kimoff R J, Series F, Morrison D, et al</AU>
<TI>Shift in sleep apnoea type in heart failure patients in the CANPAP trial</TI>
<YR>2010</YR>
<PG>592-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Santiago-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Santiago 2010" NOTES="&lt;p&gt;Accession Number: 2010839402. Language: English. Entry Date: 20101119. Revision Date: 20101119. Publication Type: journal article; research. Journal Subset: Biomedical; Peer Reviewed; USA. Special Interest: Critical Care. NLM UID: 0355501&lt;br&gt;PMID: 20818231&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Santiago V R, Rzezinski A F, Nardelli L M, Silva J D, Garcia C S, Maron-Gutierrez T, et al</AU>
<TI>Recruitment maneuver in experimental acute lung injury: the role of alveolar collapse and edema</TI>
<YR>2010</YR>
<VL>38</VL>
<PG>2207-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sato-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Sato 2010" NOTES="&lt;p&gt;Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Sato N, Kajimoto K, Asai K, Mizuno M, Minami Y, Nagashima M, et al</AU>
<TI>Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data</TI>
<YR>2010</YR>
<PG>949-955.e1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sheikh-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Sheikh 2010" NOTES="&lt;p&gt;Noninvasive positive pressure ventilation use at New York hospital medical center queens: A quality-improvement project.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Annual Meeting Vancouver, BC Canada. Conference Start: 20101030 Conference End: 20101104. Conference: CHEST 2010 Annual Meeting Vancouver, BC Canada. Conference Start: 20101030 Conference End: 20101104. Conference Publication: (var.pagings). ( 2010. Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Sheikh M, Mehta U, Shaikh Z, D'Orazi F, Roy M D, Zhu Q M, et al</AU>
<TI>Noninvasive positive pressure ventilation use at New York hospital medical center queens: A quality-improvement project</TI>
<YR>2010</YR>
<VL>138</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shirakabe-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Shirakabe 2011" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: January 2011&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Shirakabe A, Hata N, Yokoyama S, Shinada T, Kobayashi N, Tomita K, et al</AU>
<TI>Predicting the success of noninvasive positive pressure ventilation in emergency room for patients with acute heart failure</TI>
<YR>2011</YR>
<VL>57</VL>
<PG>107-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sivaraman-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Sivaraman 2010" NOTES="&lt;p&gt;Yoga breathing exercise to reduce postoperative pulmonary complications in patients undergoing elective valve replacement for valvular heart disease: A randomized clinical trial.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;20101020 Conference End: 20101023. Conference: 20th World Congress of the World Society of Cardio-Thoracic Surgeons, WSCTS Chennai India. Conference Start: 20101020 Conference End: 20101023. Conference Publication: (var.pagings). ( Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Sivaraman A, Vanithamani, Manoharan T S</AU>
<TI>Yoga breathing exercise to reduce postoperative pulmonary complications in patients undergoing elective valve replacement for valvular heart disease: A randomized clinical trial</TI>
<YR>2010</YR>
<VL>13</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Suborov-1089" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Suborov 1089" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp 2010. Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Suborov E V, Kuzkov V V, Sobhkhez M, Kirov M Y, Bjertnaes L J</AU>
<TI>The effects of methylene blue on ovine post-pneumonectomy pulmonary oedema</TI>
<YR>1089</YR>
<VL>54</VL>
<PG>1089-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tack-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Tack 2010" NOTES="&lt;p&gt;The role of clinical, metabolic and cardiac biomarkers in predicting outcome from copd exacerbations requiring hospital admission: A prospective observational study.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;London United Kingdom. Conference Start: 20101201 Conference End: 20101203. Conference: British Thoracic Society Winter Meeting 2010 London United Kingdom. Conference Start: 20101201 Conference End: 20101203. Conference Publication: (var.pagings). ( 2010. Date of Publication: December 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Tack G, Osman-Hicks V, Hicks A, Perry Y, Angus R M, Calverley P M A, et al</AU>
<TI>The role of clinical, metabolic and cardiac biomarkers in predicting outcome from copd exacerbations requiring hospital admission: A prospective observational study</TI>
<YR>2010</YR>
<VL>65</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tanaka-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Tanaka 2009" NOTES="&lt;p&gt;Can N-acetylcysteine reduce contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction?.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;TCT Asia Pacific Seoul South Korea. Conference Start: 20090422 Conference End: 20090424. Conference: 14th Annual Symposium - Angioplasty Summit 2009 TCT Asia Pacific Seoul South Korea. Conference Start: 20090422 Conference End: 20090424. Conference Publication: (var.pagings). ( (pp 92B), 2009. Date of Publication: 22 Apr 2009&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Tanaka A, Suzuki Y, Kawase H, Yanagisawa S, Morishita Y, Fujita M, et al</AU>
<TI>Can N-acetylcysteine reduce contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction?</TI>
<YR>2009</YR>
<VL>103</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tissier-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Tissier 2009" NOTES="&lt;p&gt;Comparison of ultra-fast cooling induced by total liquid ventilation and conventional external cooling during prolonged myocardial ischemia in rabbits.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Nice France. Conference Start: 20090530 Conference End: 20090602. Conference: Heart Failure 2009 Nice France. Conference Start: 20090530 Conference End: 20090602. Conference Publication: (var.pagings). ( 2009. Date of Publication: May 2009&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Tissier R, Chenoune M, Lidouren F, Couvreur N, Bize A, Dubois-Rande J L, et al</AU>
<TI>Comparison of ultra-fast cooling induced by total liquid ventilation and conventional external cooling during prolonged myocardial ischemia in rabbits</TI>
<YR>2009</YR>
<VL>8</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vazir-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Vazir 2009" NOTES="&lt;p&gt;Central sleep apnoea predicts mortality even in patients with mild chronic heart failure.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Nice France. Conference Start: 20090530 Conference End: 20090602. Conference: Heart Failure 2009 Nice France. Conference Start: 20090530 Conference End: 20090602. Conference Publication: (var.pagings). ( 2009. Date of Publication: May 2009&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Vazir A, Morrell M J, Hastings P C, McIntyre H F, Simonds A K, Cowie M R</AU>
<TI>Central sleep apnoea predicts mortality even in patients with mild chronic heart failure</TI>
<YR>2009</YR>
<VL>8</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vignon-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Vignon 2011" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: April 2011&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Vignon P, Mucke F, Bellec F, Marin B, Croce J, Brouqui T, et al</AU>
<TI>Basic critical care echocardiography: Validation of a curriculum dedicated to noncardiologist residents</TI>
<YR>2011</YR>
<VL>39</VL>
<PG>636-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Voga-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Voga 2010" NOTES="&lt;p&gt;Voga G&lt;br&gt;Comment on: Crit Care. 2010;14(3):R120; PMID: 20569504&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Voga Gorazd</AU>
<TI>Hemodynamic changes during weaning: can we assess and predict cardiac-related weaning failure by transthoracic echocardiography?</TI>
<YR>2010</YR>
<VL>14</VL>
<PG>174</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vukovic-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Vukovic 2011" NOTES="&lt;p&gt;Vukovic PM&lt;br&gt;Maravic-Stojkovic VR&lt;br&gt;Peric MS&lt;br&gt;Jovic MDj&lt;br&gt;Cirkovic MV&lt;br&gt;Gradinac SDj&lt;br&gt;Djukanovic BP&lt;br&gt;Milojevic PS&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Vukovic Petar M, Maravic-Stojkovic Vera R, Peric Miodrag S, Jovic Miomir Dj, Cirkovic Milan V, Gradinac Sinisa Dj, et al</AU>
<TI>Steroids and statins: an old and a new anti-inflammatory strategy compared</TI>
<YR>2011</YR>
<VL>26</VL>
<PG>31-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wakabayashi-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Wakabayashi 2010" NOTES="&lt;p&gt;Comparison of high-stretch versus atelectasis in the pathophysiology of ventilator-induced lung injury using the mouse isolated perfused lung.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;London United Kingdom. Conference Start: 20101201 Conference End: 20101203. Conference: British Thoracic Society Winter Meeting 2010 London United Kingdom. Conference Start: 20101201 Conference End: 20101203. Conference Publication: (var.pagings). ( 2010. Date of Publication: December 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Wakabayashi K, Wilson M R, O'Dea K P, Takata M</AU>
<TI>Comparison of high-stretch versus atelectasis in the pathophysiology of ventilator-induced lung injury using the mouse isolated perfused lung</TI>
<YR>2010</YR>
<VL>65</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Watanabe-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Watanabe 2010" NOTES="&lt;p&gt;Renal effect of carperitide vs nicorandil in the treatment of acute heart failure syndromes.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Stockholm Sweden. Conference Start: 20100828 Conference End: 20100901. Conference: European Society of Cardiology, ESC Congress 2010 Stockholm Sweden. Conference Start: 20100828 Conference End: 20100901. Conference Publication: (var.pagings). ( 2010. Date of Publication: September 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Watanabe K, Kawamura A, Omura A, Sakabe S, Seko T, Kasai A</AU>
<TI>Renal effect of carperitide vs nicorandil in the treatment of acute heart failure syndromes</TI>
<YR>2010</YR>
<VL>31</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Watanabe-2010a" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Watanabe 2010a" NOTES="&lt;p&gt;Renal effect of carperitide vs nicorandil in the treatment of acute heart failure syndromes.&lt;br&gt;Using Smart Source Parsing&lt;br&gt;Copenhagen Denmark. Conference Start: 20101016 Conference End: 20101019. Conference: 4th Official Congress of the Working Group on Acute Cardiac Care, Acute Cardiac Care 2010 Copenhagen Denmark. Conference Start: 20101016 Conference End: 20101019. Conference Publication: (var.pagings). ( 2010. Date of Publication: October 2010&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Watanabe K, Kawamura A, Seko T, Omura A, Sakabe S, Kasai A</AU>
<TI>Renal effect of carperitide vs nicorandil in the treatment of acute heart failure syndromes</TI>
<YR>2010</YR>
<VL>12</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weng-2009" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Weng 2009" TYPE="OTHER">
<AU>Weng C L, Chen Q, Ma Y L, He Q Y</AU>
<TI>A meta-analysis of the effects of atrial overdrive pacing on sleep apnea syndrome (Structured abstract)</TI>
<YR>2009</YR>
<PG>1434-43</PG>
<PB>Centre for Reviews and Dissemination</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weng-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Weng 2010" NOTES="&lt;p&gt;Accession Number: 2010776102. Language: English. Entry Date: 20100924. Publication Type: journal article; meta analysis; research. Journal Subset: Biomedical; Expert Peer Reviewed; Peer Reviewed; USA. Special Interest: Evidence-Based Practice. NLM UID: 0372351&lt;br&gt;PMID: 20439577&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Weng C L, Zhao Y T, Liu Q H, Fu C J, Sun F, Ma Y L, et al</AU>
<TI>Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema</TI>
<YR>2010</YR>
<VL>152</VL>
<PG>590-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yang-2011" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2011" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: 01 Mar 2011&lt;br&gt;English&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Yang M, Ahn H J, Kim K, Kim J A, Yi C A, Kim M J, et al</AU>
<TI>Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: A randomized controlled trial</TI>
<YR>2011</YR>
<VL>139</VL>
<PG>530-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zeng-2010" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Zeng 2010" NOTES="&lt;p&gt;Zeng Z&lt;br&gt;Jiang Z&lt;br&gt;Wang CS&lt;br&gt;Luo H&lt;br&gt;Huang YF&lt;br&gt;Jin XH&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Zeng Z, Jiang Z, Wang C S, Luo H, Huang Y F, Jin X H</AU>
<TI>Preoperative evaluation improves the outcome in heart transplant recipients with pulmonary hypertension--retrospective analysis of 106 cases</TI>
<YR>2010</YR>
<VL>42</VL>
<PG>3708-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zhang-2008" MODIFIED="2011-04-28 00:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2008" NOTES="&lt;p&gt;English Abstract; Journal Article; Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2011-04-28 00:31:02 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Zhang H Y, Li C S</AU>
<TI>[Changes of plasma B-type natriuretic peptide level during non-invasive ventilation in treating acute left heart failure]</TI>
<YR>2008</YR>
<PG>140-3</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-04-16 13:30:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Agmy-2008">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:24 +0100" MODIFIED_BY="[Empty name]">
<P>Single centre randomised controlled trial, parallel design, unblinded, using ITT approach. No patients were lost to follow up. Setting: RICU or CCU.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-10-06 21:00:37 +0100" MODIFIED_BY="[Empty name]">
<P>129 participants. Causes: systolic, diastolic or valvular heart failure. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-09 02:47:51 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group. N=44.<BR/>BILEVEL group. N=44.<BR/>Control group: standard medical care+O<SUB>2</SUB> mask (High flow facemask - 60%). N= 41.<BR/>Co-intervention: morphine, diuretics, ACE and nitrates.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:30:25 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Mortality</LI>
<LI>Need for tracheal intubation</LI>
<LI>Arterial blood gases (PaO<SUB>2</SUB>, PaCO<SUB>2</SUB>, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
<LI>Intrapulmonary shunt</LI>
<LI>A-aoxygengradient</LI>
<LI>Cardiac output</LI>
<LI>Intolerance</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-10-06 21:00:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:30:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bautin-2005">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:25 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial, parallel design, unblinded, using ITT approach. No patients were lost to follow up. Setting: ICU.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:30:27 +0100" MODIFIED_BY="[Empty name]">
<P>22 participants, with age 63.4±4.6 years in BILEVEL group and 64.3±5.6 in standard medical care group. All patients underwent cardiosurgery procedure (6 - CABG, 16 - valves replacement). Causes: HF, Mitral valve dysfunction and arrhythmias.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:30:29 +0100" MODIFIED_BY="[Empty name]">
<P>BILEVEL group: EPAP=5.1±0.3 cm H<SUB>2</SUB>O; e IPAP= 9.8±1.1 cmH<SUB>2</SUB>O. N=11.<BR/>Control group: standard medical care + O<SUB>2</SUB> mask. N= 11.<BR/>Co-intervention: not related.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:30:29 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Mortality</LI>
<LI>Need tracheal intubation</LI>
<LI>Arterial blood gases (PaO<SUB>2</SUB>, PaCO<SUB>2</SUB>) and pH</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Droupouts/ withdrawal</LI>
<LI>Side effects</LI>
<LI>Treatment failure</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-06 19:16:01 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: full face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:30:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bellone-2004">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:30 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (used a computer-generated random number sequence in closed envelopes with identification numbers that were stored in emergency room), parallel design, unblinded, using ITT approach. No patients were lost to follow up. Written consent was obtained from the patients' relatives at the start of the protocol. Setting: emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:30:33 +0100" MODIFIED_BY="[Empty name]">
<P>46 participants (23 males and 23 females), with age 77.3±7.3 years in BILEVEL group and 76.8±7 in CPAP group. Diagnosis criteria: bilateral rales , and typical findings of congestion on chest radiograph, without a history suggesting pulmonary aspiration or pneumonia, SaO2&lt;90% with O2 mask&gt;5l/min via reservoir face mask, dyspnoea, BR&gt;30b/min, use accessory muscles or paradoxical abdominal motion in association with tachycardia, HR&gt;100b/min, cardiac gallops. History: heart failure, coronary artery disease, diabetes, hypertension, COPD, chronic atrial fibrillation and chronic kidney failure. Causes: respiratory infections, hypertension, tachyarrhythmia, other. Excluded patients: patients required endotracheal intubation immediately or already intubated, presenting a respiratory or cardiac arrest, cardiogenic shock (SBP&lt;90mmHg), or at the time of admission had an acute coronary syndrome, patients unresponsive, with diagnosis of pneumonia, agitated, and unable to cooperate or if they had any condition that precluded application of a face mask.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:30:35 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP=10 cmH<SUB>2</SUB>O. N=22, TIME=103±45 minutes.<BR/>BILEVEL group: EPAP=5 cm H<SUB>2</SUB>O; e IPAP= 15 cm H<SUB>2</SUB>O initially, and then adjusted to obtain a tidal volume of more than 400ml, without leakage. N=24, time= 98±39 minutes.<BR/>Co-intervention: morphine sulfate, furosemide, sodium nitroprusside, glyceryl trinitrate,digoxin, oxygen therapy to obtain SaO2&gt;90%.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:30:36 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases (PaCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Droupouts/ withdrawal</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:30:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bellone-2005">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:37 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (used a computer-generated random number sequence in closed envelopes with identification numbers that were stored in emergency room), parallel design, unblinded, using ITT approach. No losses to follow up. Written consent was obtained from the patients' relatives at the start of the protocol. Setting: Niguarda Hospital Emergency Department - Milan - Italy.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:30:42 +0100" MODIFIED_BY="[Empty name]">
<P>36 participants (12 males and 24 females), with age 76.8±6.6 years in BILEVEL group and 76.8±6.9 in CPAP group. Diagnosis criteria: typical findings of congestion on chest radiograph and widespread rales without a history suggesting pulmonary aspiration or pneumonia, SaO<SUB>2</SUB>&lt;90% with O<SUB>2</SUB> mask &gt;5l/min, dyspnoea, BR &gt;30b/min, use accessory muscles or paradoxical abdominal motion in association with tachycardia, HR&gt;100b/min, cardiac gallop. History: heart failure, acute myocardial infarction, diabetes, hypertension. Causes : respiratory infections, hypertension, tachyarrhythmia, myocardial infarction, others. Excluded patients: patients with PaCO<SUB>2 </SUB>&lt;45mmHg, required endotracheal intubation or already intubated, presenting a respiratory or cardiac arrest, cardiogenic shock (SBP&lt;90mmHg), severe renal failure, presenting clinical and history findings of chronic obstructive pulmonary disease or previously enrolled in other studies.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:30:43 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP=10 cmH<SUB>2</SUB>O. N=18, TIME=220±82 minutes.<BR/>BILEVEL group: EPAP=5 cm H<SUB>2</SUB>O; e IPAP= 15 cm H<SUB>2</SUB>O initially, and then adjusted to obtain a tidal volume of more than 400ml, without leakage. N=18, time= 205±68 minutes.<BR/>Co-intervention: morphine, furosemide, sodium nitroprusside, glyceryl trinitrate,digoxin, oxygen therapy to obtain SaO2&gt;90%.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-08 17:11:34 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases (PCO2, pH)</LI>
<LI>Vital signs (BR)</LI>
<LI>Droupouts/ withdrawals</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:30:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bersten-1991">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:45 +0100" MODIFIED_BY="[Empty name]">
<P>Single centre randomised controlled trial (random selection of a coloured cap), parallel design, unblinded, lack of intention-to-treat analysis confirmed on study assessment. Loss to follow up: no patients in standard medical care group and one patient in CPAP group. Patients or next-of-kin were aware through informed consent. Setting: emergency department or ward to the intensive care unit (ICU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:30:47 +0100" MODIFIED_BY="Liz Bickerdike">
<P>40 participants (13 males and 27 females), with age 75±6 years in standard medical care group and 76±6 in CPAP group. Diagnosis criteria: dyspnoea of sudden onset with typical finds on chest radiographs and widespread rales without a history suggesting pulmonary aspiration or infection, jugular venous pressure elevated and third heart sound. Causes: acute myocardial infarction, myocardial ischaemia, congestive heart failure. Excluded patients: acute myocardial infarction with shock, SBP&lt;90mmHg, severe stenotic valvular disease, chronic airflow obstruction with known carbon dioxide retention.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:30:49 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 10 cmH<SUB>2</SUB>O. N=19, TIME=9.3±4.9 hours.<BR/>Control group: O2 mask + standard medical care. N= 20.<BR/>Co-intervention: furosemide, morphine, diazepam, nitroglycerin.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:30:49 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality,</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases ( PaO<SUB>2</SUB>, PaCO<SUB>2</SUB>, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Treatment failure</LI>
<LI>Side-effects</LI>
<LI>Droupouts/ withdrawals</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:30:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Crane-2004">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:50 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Multicenter randomised controlled trial (2 university hospitals). Randomization procedure: random numbers produced by Microsoft Excel, assignments were concealed in an opaque envelope. Parallel design, unblinded, using ITT approach. No reported loss to follow up. Patients or next-of-kin were aware through informed consent, but in 17 cases, the patient gave verbal consent. Setting: emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:30:55 +0100" MODIFIED_BY="Liz Bickerdike">
<P>60 participants (23 males and 37 females), with age 74.6±11.1 years in standard medical care group, 74.9±12.2 in CPAP group and 76±8.4 in BILEVEL group. Diagnosis criteria: BR &gt;23 bpm, Rx consistent with pulmonary oedema, pH &lt;7,35, widespread pulmonary crepitations and diaphoresis. History: heart failure, ischaemic heart disease, DM, Hypertension, COPD. Excluded patients: Hypotension (SBP&lt;90mmHg), T&gt;38oC, patients requiring thrombolysis for myocardial infarction or dialysis for renal impairment, patients with impaired consciousness or with dementia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:30:55 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP=10 cm H<SUB>2</SUB>O. N=20.<BR/>BILEVEL group: EPAP=5 cm H<SUB>2</SUB>O; e IPAP= 15 cmH<SUB>2</SUB>O. N=20.<BR/>Control group: standard medical care+O2 mask (To maintain SaO<SUB>2</SUB> &gt;90%). N= 20.<BR/>Co-intervention: furosemide, nitrates and diamorphine (without restriction)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:30:56 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases ( PaO2, PCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Compliance of patient</LI>
<LI>Treatment failure</LI>
<LI>Side-effects</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: full face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:30:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Delclaux-2000">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:57 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter randomised controlled trial (6 centres). Randomization procedure: randomisation computer-generated; sealed envelopes were used to randomly assign patients to their treatment group. Parallel design, using ITT approach. Blindness only of the investigators. No patient were lost to follow-up. Informed consent was obtained of the all patients. Setting: intensive care unit (ICU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:30:58 +0100" MODIFIED_BY="Liz Bickerdike">
<P>123 participants, but only a subgroup with 42 participants had CPO. Diagnosis criteria: acute respiratory insufficiency (PaO2/FiO2&lt;300 with O2 =10l/min, bilateral lung infiltrates on a posteroanterior chest radiograph, randomisation within 3 hours after the criteria were first fulfilled. Because a cardiogenic mechanism contributing to the pulmonary oedema might have had a substantial influence on the study results, the randomisation was stratified based on whether there was an underlying cardiac disease. Causes: ischaemia, arrhythmias, fluid overload, hypertension, valvular disease, pneumonia, aspiration, systemic inflammatory response syndrome (SIRS), shock, other. Excluded patients: younger than 18 years, intubation was refused or contraindicated, history of COPD, acute respiratory acidosis (defined as a pH&lt;7,30 and PaCO2 &gt; 50 mmHg, systolic blood pressure less than 90 mmHg under optimal therapy (fluid repletion), ventricular arrhythmias, coma or seizures, life-threatening hypoxaemia, use of epinephrine or norepinephrine, and the inability to clear copious airway secretions.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-09 10:02:24 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 7,5 cmH2O with increase or decrease 2,5 cmH2O. N=22, TIME=6 hours or more.<BR/>Control group: standard medical care+O2 mask. N= 20.<BR/>Co-intervention: diuretics, antibiotics.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-09 10:02:41 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: full face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ferrari-2007">
<CHAR_METHODS MODIFIED="2013-04-16 13:30:59 +0100" MODIFIED_BY="[Empty name]">
<P>Single centre randomised controlled trial (according to a random sequence previously generated from a table of random numbers, the assignments were placed in closed boxes, with identification numbers, stored in the HDU), parallel design, unblinded, lack of intention-to-treat analysis. Two patients were lost (Two patients refused) to follow up. Written consent was obtained from the patients. Setting: High Dependency Unit (HDU) of the Emergency Department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:00 +0100" MODIFIED_BY="[Empty name]">
<P>52 participants (23 males and 29 females), with age 74.2±9.7 years in BILEVEL group and 76.7±9.2 in CPAP group. Diagnosis criteria: rapid onset of symptoms,severe dyspnoea at rest, respiratory rate 30 breaths/min, use of accessory respiratory muscles, oxygen saturation by pulse oximetry (Spo2) 90% with a fraction of inspired oxygen (Fio2) of 60% via a Venturi mask, radiologic findings of ACPE. Causes : hypertensive crisis, tachyarrhythmia, chronic Ischaemic cardiomyopathy, dilated cardiomyopathy and valvular heart disease. Excluded patients: acute coronary syndrome on hospital admission,18 haemodynamic instability (systolic BP 90 mm Hg with dopamine or dobutamine infusion 5 g/kg/min) or life-threatening arrhythmias, need for immediate endotracheal intubation (respiratory arrest, bradypnoea, or gasping for air), inability to protect the airways, impaired sensorium (unconsciousness or agitation), inability to clear secretions, respiratory tract infection, recent oesophageal/gastric surgery, GI bleeding, facial deformities, hematologic malignancy or cancer with an Eastern Cooperative Oncology Group performance status 2, chronic respiratory failure necessitating long-term oxygen therapy, diagnosis of myocardial infarction, pulmonary embolism, pneumonia, exacerbation of COPD, pneumothorax in the previous 3 months, and denial or refusal of intubation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:05 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP = 8.8±1.9 cmH2O. N = 27, TIME= 8.1±8.3 hours.<BR/>BILEVEL group: EPAP = 7±1.2 cm H2O e IPAP= 15±3.1 cmH2O . N=25, TIME= 6.0±4.7 hours.<BR/>Co-intervention:</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:06 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Rate of acute myocardial infarction</LI>
<LI>Mortality</LI>
<LI>ETI</LI>
<LI>Duration of ventilatory assistance</LI>
<LI>HDU length of stay</LI>
<LI>Hospital length of stay</LI>
<LI>Arterial blood gases (PaCO2, pH, PaO2/FiO2, SaO2)</LI>
<LI>Vital signs (BR, HR)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-04-07 19:37:40 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ferrari-2010">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:06 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter (3 - Italy) randomised controlled trial (according to a random sequence previously generated from a table of random numbers, the assignments were placed in closed boxes, each with an identification number and were stored in the ED), parallel design, unblinded, using intention-to-treat analysis. Written consent was obtained from patients&#8217; next of kin if patients were unable to give informed consent due to the severity of their disease. Setting: Emergency Department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:07 +0100" MODIFIED_BY="[Empty name]">
<P>80 adults participants with age 76.55±9.48 years in BILEVEL group and 77.25±9,17 in CPAP group, with acute respiratory failure due to severe ACPE. Diagnosis criteria: severe dyspnoea at rest, respiratory rate &gt; 30 breaths/min, use of accessory respiratory muscles, PaO2/FiO2 &lt; 200 despite oxygen via Venturi mask with a FiO2 of 60%, radiologic findings of ACPE. Causes : hypertensive crisis, dysrhythmias, UA/NSTEMI, respiratory infections. Exclusion criteria: STEMI (patients with unstable angina/Non-ST elevation MI were included in the study protocol),haemodynamic instability (systolic arterial pressure 90 mmHg), need for immediate ETI (respiratory arrest, bradypnoea), Inability to protect the airways, impaired sensorium (severe agitation or unconsciousness), COPD, exacerbation, pulmonary embolism, pneumonia, recent oesophageal-gastric surgery, gastrointestinal bleeding, facial deformities, hematological malignancy or cancer with ECOG performance status <U>&gt;</U> 2.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:10 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP = 8.88±1.77 cmH2O. N = 40, TIME = 8.46±7.14 hours.<BR/>BILEVEL group: EPAP = 6.75±1.44 cmH2O e IPAP= 14±3.11 cmH2O . N=40, TIME = 5.91±4.01 hours.<BR/>Co-intervention: furosemide, glycerol trinitrate, sodium nitroprusside, morphine hydrochloride.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-30 21:54:56 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>M<B>ortality</B>
</LI>
<LI>
<B>Tracheal intubation rate</B>
</LI>
<LI>
<B>Duration of ventilatory assistance</B>
</LI>
<LI>H<B>ospital length of stay</B>
</LI>
<LI>Arterial blood gases (PaCO2, PaO2/FiO2, SaO2) and pH</LI>
<LI>Vital signs (BP, BR, HR)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-16 21:33:46 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ferrer-2003">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:11 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter (3 - Spain), prospective, randomised (randomly allocated within 24-hours, using a computer-generated table for each centre), controlled trial, parallel-group, using intention-to-treat analysis. No patient were lost to follow-up. Informed consent was obtained in all cases. Setting: ICU.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:12 +0100" MODIFIED_BY="[Empty name]">
<P>Group of patients with acute hypoxaemic respiratory failure whose sub-group contained 30 patients with pulmonary oedema cardiogenic (10 males and 20 females), with age 76±9 years in standard medical care group and 71±13 in BILEVEL group. Diagnosis criteria: dyspnoea of sudden onset with physical findings consistent with pulmonary oedema, such as widespread rales with or without third heart sound, and typical findings of congestion on a chest x-ray. Exclusion criteria: hypercapnia (PaCO2 of more than 45 mm Hg) on admission; need for emergency intubation; recent oesophageal, facial, or cranial trauma or surgery; severely decreased consciousness (a Glasgow coma score of 11 or less); severe haemodynamic instability despite fluid repletion and use of vasoactive agents; a lack of cooperation; tracheotomy or other upper airway disorders; severe ventricular arrhythmia or myocardial ischaemia; active upper gastrointestinal bleeding; an inability to clear respiratory secretions; and more than one severe organ dysfunction in addition to respiratory failure.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-09-30 22:19:47 +0100" MODIFIED_BY="[Empty name]">
<P>BILEVEL group. N=15.<BR/>Control group: standard medical care + O2 mask (To maintain SaO2 &gt;92%). N= 15.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-10 02:53:46 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Tracheal intubation rate</LI>
<LI>Mortality</LI>
<LI>ICU length of stay</LI>
<LI>Hospital length of stay</LI>
<LI>Droupouts/ withdrawals</LI>
<LI>Side-effects</LI>
<LI>Treatment failure</LI>
<LI>Arterial blood gases (PaCO2, pH, PaO2/FiO2, SaO2)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-10 21:48:52 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: face mask or nasal mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fontanella-2010">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:12 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Losses to follow up not reported. Informed consent not described. Setting: Cardiac Care Unit (CCU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:14 +0100" MODIFIED_BY="[Empty name]">
<P>40 participants with age 80±7 in CPAP group and 76±9 in BILEVEL group.Diagnosis criteria: patients with acute cardiogenic pulmonary oedema.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:15 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP = 8±2 cmH2O. N = 21.<BR/>BILEVEL group: EPAP = 10±2 cmH2O e IPAP= 18±3 cmH2O . N=19.<BR/>Co-intervention: ?</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-06 20:04:42 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Tracheal intubation rate</LI>
<LI>Mortality</LI>
<LI>ICU length of stay</LI>
<LI>Arterial blood gases (PaO2, pH, PaO2/FiO2, SaO2)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-04-29 20:59:16 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frontin-2010">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:18 +0100" MODIFIED_BY="[Empty name]">
<P>Single centre (France) randomised controlled trial (by balanced blocks of random numbers was provided by telephone using sealed opaque envelopes), parallel design, unblinded, not using ITT approach by Cochrane - All patients after randomisation. Two patients (in the CPAP group) refused the ongoing use of their data once their condition stabilised and were not analysed. Informed consent was obtained from patients or their surrogates. Setting: out-of-hospital medical emergencies is the responsibility of the "Service d'Aide Médicale Urgente" (SAMU) and continued on ICU.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:21 +0100" MODIFIED_BY="[Empty name]">
<P>124 participants randomised, 122 analysed (52 males and 70 females), with age 79.3±10.5 years in standard medical care group and 79.4±10.7 in CPAP group. Inclusion criteria: 18 years or older with clinical symptoms of ACPE such as orthopnoea, diffuse crackles without evidence of pulmonary aspiration or infection, pulse oximetry (SpO2) less than 90% and a respiratory rate greater than 25 breaths per minute. Excluded patients: cardiovascular collapse or an impaired level of consciousness, acute myocardial infarction, or if they had an immediate need for intubation. Patient with a history of gastric surgery (b8 days) and patients vomiting were also excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:22 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP= 10 cmH2O. N=60.<BR/>Control group: standard medical care+O2 mask. N= 62.<BR/>Co-intervention: furosemide - 1mg/Kg, morphine pre-hospital, isosorbide dinitrate injections was 4 (range, 3-5) in both groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-06 13:59:35 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Mortality 30 days</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases (PaO2, PaCO2)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Side-effects</LI>
<LI>Intensive care unit (ICU) length of stay</LI>
<LI>Length of hospital stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-09 20:36:22 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gray-2008">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:22 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter, open, prospective, randomised, controlled trial, parallel-group trial with three treatment groups:<BR/>standard oxygen therapy, CPAP, and bilevel NIPPV. Patients were randomly assigned to one of the three treatments at a 1:1:1 ratio with the use of a 24 hour telephone randomisation service. The randomisation sequence was stratified according to centre, with variable block length. Lack of intention-to-treat analysis. Eighty-seven patients were excluded after randomisation because of ineligibility or previous recruitment into the trial. Informed written or witnessed oral consent from the patient or relative was obtained. Setting: emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>1156 participants, 56.9% were women, with age 79±9 years in standard medical care group and 78±10 in CPAP group and 77±10 in BILEVEL group. Diagnosis criteria: age of more than 16 years, a clinical diagnosis of acute cardiogenic pulmonary oedema, pulmonary oedema shown by a chest radiograph, a respiratory rate of more than 20 breaths per minute, and an arterial hydrogen ion concentration of greater than 45 nmol per litre (pH &lt;7.35). Excluded patients: patients requirement for a lifesaving or emergency intervention, such as primary percutaneous coronary intervention; inability to give consent; or previous recruitment into the trial.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP= 10±4 cmH2O. N=346. Time = 2.2±1.5hours.<BR/>Bilevel NPPV group: EPAP= 7±3 cm H2O e IPAP= 14±5 cmH2O. N=356. Time= 2.0±1.3 hours.<BR/>Control group: standard medical care + O2 mask with a reservoir. N= 367.<BR/>Co-intervention: nitrates, diuretics and opioids.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>7-day mortality</LI>
<LI>7-day tracheal intubation rate</LI>
<LI>30-day mortality</LI>
<LI>Admission to the critical care unit</LI>
<LI>Arterial blood gases ( PaO2, PaCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction</LI>
<LI>Compliance of patients with NPPV</LI>
<LI>Side-effects and complications</LI>
<LI>Length of hospital stay</LI>
<LI>PEEP levels, PS levels and bilevel NPPV vs CPAP.</LI>
<LI>Duration of therapy.</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Although the study reports that held ITT, analyses submitted have not included all randomised patients (follow-up bias), as well as, it was not described as the total distribution of randomisation by group. Results were presented in the format completely different from other studies included, making impossible their inclusion in meta-analyses (variables dicotômicas acute myocardial infarction and Intolerance to the allocated treatment not possessed N total to perform ITT or were analysed in times different from those envisaged in this review - mortality and intubation in 7 or 30 days). Continuous variables were presented just as mean value of the difference between 0 and 1 hour after the intervention and not as mean and standard deviation. However the author, although asked, did not send the data in the format required to include in Meta-analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kelly-2002">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (by balanced blocks using sealed envelopes), parallel design, unblinded, using ITT approach. No patients were lost to follow up. Informed consent was obtained of the patients. Setting: emergency department and continued in the high dependency unit.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>58 participants (26 males and 32 females), with age 78±2 years in standard medical care group and 77±2 in CPAP group. Diagnosis criteria: acute onset of breathlessness, BR&gt;20bpm, bilateral basal crackles or chest auscultation, Rx typical of pulmonary oedema. Causes: left ventricular systolic dysfunction and hypertensive crisis; the CPAP group had more severe disease with a slightly greater acidosis and hypercapnia. Excluded patients: patients with radiograph consistent with pneumonia or pneumothorax, or if they had received pre-hospital treatment with intervention other than oxygen, diuretics or opiates.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 7.5 cmH2O. N=27, TIME= minimum of 6 hours.<BR/>Control group: standard medical care+O2 mask. N= 31. (FiO2=60%).<BR/>Co-intervention: furosemide, morphine sulfate, nitrate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases ( PaO2, PaCO2)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Treatment failure</LI>
<LI>Side-effects</LI>
<LI>Droupouts/ withdrawals</LI>
<LI>Length of hospital stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: full face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-L_x0027_Her-2004">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter randomised controlled trial, in three teaching hospitals in France. The randomisation protocol was computer generated and equalised in groups of 10 patients, parallel design, unblinded, using ITT approach. No patients were lost to follow up. Patients or their next of kin gave written informed consent. Setting: emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>89 participants (37 males and 51 females), with age 84±6 years in standard medical care group and 84±6 in CPAP group. Diagnosis criteria: Age similar or more than 75 year, acute hypoxaemic respiratory failure (PaO2/ FiO2&lt;300 despite O2&gt; 8l/min for 15 minutes), BR&gt; 25bpm, contraction of accessory muscles, clinical examination: systolic and/or diastolic hypertension, widespread crackles or wheezing; medical record : previous cardiomyopathy, and/or acute dyspnoea with progressive orthopnoea; electrocardiographic tracing (Q waves and/or abnormalities in the T wave and ST segment; left ventricular hypertrophy, bundle branch block, atrial fibrillation); and chest radiography ( cardiac enlargement with a cardiothoracic ratio&gt;50%, and/or pulmonary congestion with Kerley B lines, alveolar filing, pleural effusions) compatible with a diagnosis of cardiogenic pulmonary oedema. Causes: Tachyarrythymia, acute Ischaemic heart disease, hypertensive crises, respiratory tract infection, undiagnosed. Exclusion criteria: Glasgow Coma Scale less or similar 7, SpO2 similar or less 85% despite oxygen, haemodynamic instability, chronic respiratory insufficiency.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 7.5 cmH2O. N=43, TIME=8±6 hours.<BR/>Control group: standard medical care+O2 mask. N= 46.<BR/>Co-intervention: furosemide, nitroglycerin, glyceryl-trinitrate, morphine, isosorbide dinitrate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-09 10:06:59 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases ( PCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Treatment failure</LI>
<LI>Side-effects</LI>
<LI>Droupouts/ withdrawals</LI>
<LI>Length of hospital stay</LI>
<LI>Compliance of patient</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike" STUDY_ID="STD-Levitt-2001">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (from a previously computer-generated list), parallel design, unblinded, lack of intention-to-treat analysis confirmed on study assessment. Four patients were lost to follow up. Informed consent was obtained of the patients. Setting: emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>42 patients were randomised, but 4 patients did not meet inclusion criteria following randomisation. Therefore, study entry 38 participants (13 males and 25 females), with age 68.5±15 years in standard medical care group and 67.4±15 in BILEVEL group. Diagnosis criteria: tachypnoea, BR&gt;30bpm, diaphoresis or accessory muscle use, pulmonary rales, distended neck veins, peripheral oedema, history CHF (congestive heart failure) and radiograph findings of the pulmonary oedema. Causes: acute congestive heart failure. Excluded patients: patients with radiograph were found not to have CHF or required immediate intubation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-09 10:08:46 +0100" MODIFIED_BY="Liz Bickerdike">
<P>BILEVEL group: EPAP= cm H2O e IPAP= cmH2O. N=21, time= 2 hours.<BR/>Control group: standard medical care+O2 mask. N= 17.<BR/>Co-intervention: morphine,furosemide, nitroglycerin.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Treatment failure</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Length of hospital stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask:nasal or face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liesching-2003">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial, parallel design, unblinded, using ITT approach. Losses to follow up not reported. Informed consent not described.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>27 participants. Diagnosis criteria: patients with acute cardiogenic pulmonary oedema. Patients with myocardial infarction at presentation were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-10-01 22:32:34 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP=10 cmH2O. N=14.<BR/>BILEVEL group: EPAP=4 cm H2O e IPAP= 12cmH2O. N=13.<BR/>Co-intervention: medical treatment..</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Tracheal intubation rate</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-1991">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial, parallel design, unblinded, lack of intention-to-treat analysis confirmed on study assessment. 15 patients in CPAP group and 10 patients in O2 group were lost to follow up. Infomed consent was obtained of the patients. Setting: intensive care unit. Wash out of 30 minutes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>80 patients were randomised, but 25 patients did not meet inclusion criteria following randomisation. Therefore, study entry 55 patients (50 males and 5 females), with age 74.1±8.8 years in standard medical care group and 73.4±8.2 in CPAP group. Diagnosis criteria: Radiologic evidence of acute interstitial or alveolar oedema of cardiac origin, tachypnoea, BR&gt;22bpm, intercostal or suprasternal retractions, PaO2/FiO2 &gt; 200, P(A-a)O2&gt;200. Causes: CHF, dilated cardiomyopathy, Ischaemic heart disease, hypertensive cardiovascular disease, acute myocardial infarction. Excluded patients: patients unresponsive to speech or unable to maintain a patent airway and who had cardiogenic shock, signs of lung infection, evidence pulmonary embolism, chronic lung disease with CO2 retention at rest.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP=3.75±1.76 cmH2O in first hour (pressure was applied by connecting a serial CPAP valve -2,5 cm, 5 cm, 7,5 cm, 10 cm, 12,5 cm - to the face mask at each 30 min interval. N=25, TIME=6 hours.<BR/>Control group: standard medical care+O2 mask. N= 30.<BR/>Co-intervention: medical treatment of pulmonary oedema was not restricted.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-09 10:13:02 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases ( PaO2, PCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Droupouts/ withdrawals</LI>
<LI>Treatment failure</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.<BR/>FiO2=100% full time.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike" STUDY_ID="STD-Lin-1995">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial, parallel design, unblinded, using ITT approach. No losses to follow up were reported. Informed consent not reported. Setting: emergency department or the patient was recruited during hospitalisation. Wash out of 30 minutes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>100 participants (90 males and 10 females), with age 73±9 years in standard medical care group and 72±8 in CPAP group. Diagnosis criteria: dyspnoea and tachypnoea, BR&gt;22bpm, use of accessory respiratory muscles, PaO2/FiO2 between 200 and 400, P(A-a)O2&lt; 250. Rx bilateral diffuse interstitial or alveolar oedema and most rales, and without history aspiration or infection. Causes: CHF, dilated cardiomyopathy, Ischaemic heart disease, hypertensive crisis, acute myocardial infarction. Excluded patients: patients unresponsive, unable to maintain a patent airway and who had cardiogenic shock, ventricular septal rupture, any severe stenotic valvular disease or chronic lung disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP=3.75±1.7 cmH2O in first hour (pressure was applied by connecting a serial CPAP valve -2,5 cm, 5 cm, 7,5 cm, 10 cm, 12,5 cm - to the face mask at each 30 min interval. N=41, TIME=6 hours.<BR/>Control group: standard medical care+O2 mask. N= 33.<BR/>Co-intervention: Isosorbide dinitrate, morphine, furosemide, nitroprusside, nitroglycerin, dopamine.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-09 10:15:46 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases (PaO2, PCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Droupouts/ withdrawals</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
<LI>Treatment failure</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martin_x002d_Bermudez-2002">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Losses to follow up not reported. Informed consent not described.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>84 consecutive patients with respiratory failure due to severe cardiogenic pulmonary oedema were randomly assigned to receive either pressure support ventilation plus positive end expiratory pressure or continuous positive airway pressure. Lack of intention-to-treat analysis confirmed on study assessment. 3 patients in CPAP group and 1 patients in BILEVEL group were lost after randomisation (a case of respiratory failure by aspiration pneumonia, a re-acute CPE and two declined to continue participating in the study).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: time= 107±57 min. N=42.<BR/>BILEVEL group: time= 76±50 min . N=42.<BR/>Co-intervention: ?</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Mortality</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
<LI>Arterial blood gases (pH, PaCO<SUB>2</SUB>, PaO<SUB>2</SUB>/FiO<SUB>2</SUB>,)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Dyspnea score</LI>
<LI>Tidal volume</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-06 20:40:16 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: face mask</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Masip-2000">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (the randomisation sequence was generated by a table of random numbers, the assignments were placed in closed envelopes with identification numbers that were stored in the intensive-care unit), parallel design, unblinded, lack of intention-to-treat analysis confirmed on study assessment. Two patients in standard medical care group and one patient in BILEVEL group were lost to follow up. Patients or next-of-kin were aware through informed consent. Setting: emergency department or ward to the intensive care unit (ICU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>40 participants went randomised, but 3 patients were excluded from the analysis. Therefore, study entry 37 patients (19 males and 18 females), with age 78.5±5 years in standard medical care group, 75.3±11 in BILEVEL group. Diagnosis criteria: dyspnoea of sudden onset with physical findings consistent with pulmonary oedema (widespread rales with or without third heart sound) and typical findings of congestion on a chest radiograph. History: heart failure, acute myocardial infarction, Hypertension, diabetes mellitus, chronic obstructive pulmonary disease. Causes: acute myocardial infarction, hypertensive crisis, hypervolaemia,unstable angina, tachyarrhythmia, respiratory-tract infection, treatment non-compliance. Excluded patients: cardiogenic shock (SBP &lt; 90mmHg), severe acute or chronic airflow obstruction without evidence of cardiogenic pulmonary oedema, severe chronic renal failure, neurological impairment, acute myocardial infarction necessitating thrombolysis, evidence of pneumonia, immediate need for intubation, and absence of pulmonary oedema on a first chest radiograph.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>BILEVEL group: EPAP= 5 cm H2O e IPAP= 15.2±2.4 cmH2O. N=19, time= 254±90 min.<BR/>Control group: standard medical care+O2 mask (FiO2 &gt; or = 50%). N= 26<BR/>Co-intervention: morphine, furosemide, glyceryl trinitrate, digoxin.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases (pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Dropouts/ withdrawals</LI>
<LI>Side-effects</LI>
<LI>Length of hospital</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mehta-1997">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (computer random number sequence), parallel design, double-blind, lack of intention-to-treat analysis confirmed on study assessment. 4 patients in CPAP group and 5 patients in BILEVEL group were lost to follow up. Patients or next-of-kin were aware through informed consent. Single blind. Setting: emergency department and ICU.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>36 participants (11 males and 25 females), with age 76±7 years in CPAP group and 77±12 in BILEVEL group. Diagnosis criteria: moderate-to-severe dyspnoea, BR&gt;30bpm, use of accessory respiratory muscles or paradoxical abdominal motion in combination with tachycardia (heart rate of &gt;100 bpm), cardiac gallops, bilateral rales, and typical findings of congestion on a chest radiograph, without a history suggesting pulmonary aspiration or infection. Causes: acute myocardial infarction, left bundle-branch block, coronary artery disease. Excluded patients: already intubated, suffering a respiratory or cardiac arrest, had an unstable cardiac rhythm, or a systolic blood pressure (BP)&lt;90mmHg, patients unresponsive, agitated, and unable to cooperate, or if they had any condition that precluded application of a face mask.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP=10 cmH2O. N=13, TIME= 6.4±5.8 hours.<BR/>BILEVEL group: EPAP=5 cm H2O and IPAP= 15cmH2O. N=14, TIME = 7.1±4.7 hours.<BR/>Co-intervention: morphine, furosemide, isosorbide dinitrate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Dropouts/ withdrawals</LI>
<LI>Side-effects</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: nasal mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moritz-2007">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter randomised controlled trial (3 centres), randomisation procedure: allocation to treatment was stratified for centre and based on block randomisation of 10 consecutive study numbers. Parallel design, single blind. Lack of intention-to-treat analysis confirmed on study assessment, eleven patients were withdrawn because no informed consent was obtained (n7) or because they were lost to follow-up. Patients or next-of-kin gave written informed consent. Setting: emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>109 participants (57 males and 52 females), with age 77.6±9.4 years in CPAP group and 77.7±9.2 in BILEVEL group. Diagnosis criteria: association of sudden onset of dyspnoea; presence of bilateral rales on auscultation, with no medical history suggesting pulmonary aspiration or infection; or congestion found on chest radiograph. Furthermore, patients had to present 2 of the following severity criteria of respiratory failure: respiratory frequency greater than 30 breaths/min; pulse oxymetry saturation (SpO2) below 90%, with oxygen at greater than 5 L per minute through reservoir facemask; and use of accessory muscles (Patrick scale 3). Causes: acute myocardial infarction, treatment noncompliance, respiratory tract infection, myocardial ischaemia, hypertensive emergency, previous pulmonary oedema. Excluded patients: out-of-hospital use CPAP or BILEVEL, temperature above 39°C, altered mental state, severe acute or chronic airflow obstruction, with no evidence of pulmonary oedema, chronic renal failure, evidence of pneumonia, acute myocardial infarction necessitating thrombolysis or primary angioplasty, immediate indication for tracheal intubation, respiratory or cardiac arrest, SpO2 &lt; 85% with 100% FiO2, decreased alertness or major agitation requiring sedation, clinical signs of exhaustion: active contraction of the respiratory accessory muscles, with paradoxic abdominal or thoracic motion.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>CPAP group: PEEP=7.7±2.1 cmH2O. N=59, TIME= 2.3 hours.<BR/>BILEVEL group: EPAP=4.9±0.9 cm H2O and IPAP= 12±3.2cmH2O. N=50, time= 2.8 hours.<BR/>Co-intervention: morphine sulfate, furosemide, nitroprusside, sublingual or topical or intravenous nitroglycerin.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Hospital mortality</LI>
<LI>ETI</LI>
<LI>Incidence of acute myocardial infarction</LI>
<LI>Vital signs (pulse rate, systolic and diastolic blood pressure, BR)</LI>
<LI>Arterial blood gases (PaO2, PCO2, pH)</LI>
<LI>Acessory muscle use evaluated with Patrick Scale</LI>
<LI>SpO2</LI>
<LI>Duration of the ventilation period</LI>
<LI>Length of hospital stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-04-08 18:38:41 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: full face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nava-2003">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Multicenter randomised controlled trial (5 centres), randomisation procedure: the randomisation schedule had a block design for each centre and was generated by an independent statistician who used random numbers (because the level of PaCO2 might have a substantial influence on the study results, the randomisation was balanced according to whether the patients had an admission PaCO2&lt; or &gt;45mmHg), parallel design, unblinded, using ITT approach. No patients were lost to follow up. Patients or next-of-kin were aware through informed consent. Setting: emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>130 participants (101 males and 29 females), with age 73.1±8.3 years in standard medical care group and 72.1±9.1 in BILEVEL group. Diagnosis criteria: dyspnoea of sudden onset with BR&gt;30bpm, PaO2/FiO2&lt;250, typical finds on chest radiographs (congestion) and physical signs of pulmonary oedema (widespread rales) without a history suggesting pulmonary aspiration or infection. Causes: acute acute myocardial infarction, hypertension, hyperthermia (but not showing any signs of pulmonary infection), arrhythmia, aortic stenosis, mitral regurgitation. Excluded patients: immediate need for endotracheal intubation, severe sensorial impairment, shock, ventricular arrhythmias, life threatening hypoxia (SaO2&lt;80%), acute myocardial infarction necessitating thrombolysis, severe chronic renal failure and pneumothorax.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>BILEVEL group: EPAP=6.1±3.2 cm H2O e IPAP= 14.5±21,1cmH2O. N=65, time= 11.4±3.6 hours.<BR/>Control group: standard medical care+O2 mask (to maintain an SpO2&gt;90%). N= 65<BR/>Co-intervention: morphine sulfate, furosemide, glyceryl trinitrate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases (PaO2, PCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Compliance of patient</LI>
<LI>Side-effects</LI>
<LI>Length of hospital stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-05-09 14:32:14 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: full face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Park-2001">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (computer random number sequence in closed envelopes), parallel design, unblinded, not using ITT approach. Loss to follow up not reported. Patients or guardians were aware through informed consent. Setting: in hospital.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>26 participants (10 males and 16 females), with mean age 69±7 years. Diagnosis criteria: dyspnoea of acute onset or worsening, respiration rate more or similar 25 bpm, Rx compatible with pulmonary congestion. Causes: acute myocardial infarction, hypertensive emergencies, acute ischaemic heart disease, infectious endocarditis or undetermined. Excluded patients: SBP less than 90mmHg, arrhythmias requiring electric cardioversion, decreased consciousness level, bradypnoea, lack of cooperation or agitation, repetitive vomiting, upper digestive haemorrhage, facial deformities or any other decompensated respiratory disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 7.5 cmH2O. N=9, TIME=170±90min.<BR/>BILEVEL group: EPAP=4 cm H2O e IPAP= 12cmH2O. N=7, time= 155±38min.<BR/>Control group: standard medical care+O2 mask (15l/min). N= 10.<BR/>Co-intervention: Isosorbide dinitrate (5mg) + standard medication</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality,</LI>
<LI>Traqueal intubation rate,</LI>
<LI>Arterial blood gases ( PaO2, PaCO2, pH),</LI>
<LI>Vital signs (BR, BP, HR),</LI>
<LI>Incidence of acute myocardial infarction (follow-up),</LI>
<LI>Compliance of patient,</LI>
<LI>Dropouts/ withdrawals.</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-05-09 10:29:18 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Outcome 6 was poorly reported as a brief comment: BILEVEL group more cooperated and related less dyspnoea.<BR/>Mask: CPAP: closed face mask, BILEVEL: nasal mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike" STUDY_ID="STD-Park-2004">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (the patients were randomised with sealed envelopes - nine per envelope - using a 3:3:3 assignment scheme), parallel design, lack of intention-to-treat analysis confirmed on study assessment. Two patients in BILEVEL group and one patients in O2 group were lost to follow up. Patients or guardians were aware through informed consent. Setting: in emergency department. Wash out of 6 minutes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>83 participants went randomised, but 3 patients did not meet inclusion criteria for study entry. Therefore, study entry 80 patients (34 males and 46 females), with age 65±15 years in standard medical care group, 61±17 in CPAP group and 66+/-14 in BILEVEL group. Diagnosis criteria: More than 16 years, acute onset of severe respiratory distress (BR&gt;25rpm), associated tachycardia and diaphoresis and findings of pulmonary congestion on physical examination and chest Rx 2 hours after randomisation. Causes: acute myocardial infarction, myocardial ischaemia, crisis hypertensive, progressive heart failure, hypervolaemia (20%with CPO severe). Excluded patients: SBP &lt; 90mmHg, decrease consciousness level, intractable vomiting, acute myocardial infarction with persistent ST segment elevation, pulmonary embolism, COPD, pneumonia or pneumothorax .</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP=11±2 cmH2O. N=27, TIME=102±41min.<BR/>BILEVEL group: EPAP=11±2 cm H2O e IPAP= 17±2cmH2O. N=7, time= 124±62min.<BR/>Control group: standard medical care+O2 mask (FiO2 &gt; or = 50%). N=26<BR/>Co-intervention: Isosorbide dinitrate, morphine, furosemide, nitroprusside, nitroglycerin</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Compliance of patient</LI>
<LI>Dropouts/ withdrawals</LI>
<LI>Treatment failure</LI>
<LI>Side-effects</LI>
<LI>Length of hospital stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask. CPAP or BILEVEL with FiO2=50%.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial. The patients were randomly assigned to 1 of 2 group by opening 1 of 40 sealed envelopes. Parallel design, unblinded, using ITT approach. Loss to follow up not reported. Informed consent not described. Wash out of 10 minutes. Setting: intensive care unit (ICU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>40 participants (13 males and 17 females), with age 73±9 years in standard medical care group and 74±9 in CPAP group. Diagnosis criteria: respiratory failure and clinical and radiologic evidence of acute alveolar pulmonary oedema of cardiac origin, dyspnoea, signs increase respiratory work (intercostal and suprasternal retractions or use of accessory respiration muscles), respiratory rate of more than 25 bpm. PaO2/FiO2&lt;200. Causes: severe heart failure primarily after acute myocardial infarction, acute exacerbation of chronic left ventricular dysfunction, ventricular arrhythmia or acute valve incompetence. Excluded patients: patients unresponsive to speech or unable to maintain patent airway, with lung infection, pulmonary embolism, chronic lung disease with CO2 retention at rest or after treatment PaO2&lt;50mmHg, PaCO2&gt;55mmHg, BR&gt;35bpm.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-09 10:33:46 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 10 cmH2O. N=20, TIME=180min.<BR/>Control group: standard medical care+O2 mask (FiO2=28-30%). N= 20.<BR/>Co-intervention: furosemide, morphine, diazepam, chlorpromazine, nitroglycerin, nitroprusside, digitalis, dopamine and dobutamine.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Arterial blood gases ( PaO2, PCO2, pH)</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Treatment failure</LI>
<LI>Side-effects</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike" STUDY_ID="STD-Sharon-2000">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (according to their numerical order on list that had been predetermined by lot), parallel design, unblinded, using ITT approach. No losses to follow up. Informed consent was obtained. Setting: mobile intensive care unit teams in the patient's home or during delivery to the emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>40 patients went randomised (19 males and 21 females), with age 73±7 years in standard medical care group and 72+/-6 in BILEVEL group. Diagnosis criteria: symptoms and signs of pulmonary oedema accompanied by oxygen saturation of &lt; 90% measured by pulse oximetry, prior to oxygen administration. Echocardiographics findings: moderate aortic stenosis, moderate mitral regurgitation, ejection fraction. Excluded patients: previous treatment with nitrates above 40 mg/d, or mononitrate or long-acting trinitrates administered more than twice daily or short acting trinitrates administered more than three times a day; previous treatment with furosemide&gt; 80 mg/d; hypotension (blood pressure &lt;110/70 mmHg); previous adverse effect of nitrates; ST elevations consistent with acute myocardial infarction on baseline ECG; and absence of pulmonary oedema on chest radiograph obtained on arrival to the emergency department.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>BILEVEL group: EPAP= 4.2±3,.cm H2O, e IPAP=9.3±2.3 cmH2O + ISDN = 3.5±2.5mg. N=20, time=at least 50 minutes.<BR/>Control group: O2 mask + high dose IV ISDN =10.8±5.7mg . N= 20.<BR/>Co-intervention: IV ISDN (Isorsobide-dinitrate), furosemide and morphine</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike" STUDY_ID="STD-Takeda-1997">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial, parallel design, unblinded, using ITT approach. Loss to follow up not reported. Patients or guardians were aware through informed consent. Setting: intensive care unit (ICU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>30 participants (22 males and 8 females), with age 64±9 years in standard medical care group and 69+/-10 in CPAP group. Diagnosis criteria: dyspnoea of sudden onset, PaO2&lt;80mmHg with FiO2&gt;ou= 50%, typical finds on chest radiographs, and widespread rales without a history suggesting pulmonary aspiration or infection. Causes: acute myocardial infarction, prior myocardial infarction, cardiomyopathy, mitral valve regurgitation. Exclusion criteria: complicated with aspiration and/or pneumonia, immediate need for endotracheal intubation, shock, and life-threatening hypoxia at study entry.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 7±3 cmH2O. N=15, TIME=11.9±8.4hours.<BR/>Control group: standard medical care+O2 mask. N=15.<BR/>Co-intervention: furosemide, morphine, nitroglycerin, digitalis, dopamine, dobutamine, norepinephrine.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-09 10:37:38 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Length of ICU stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: nasal mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Takeda-1998">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Single centre randomised controlled trial (by envelope method), parallel design, unblinded, using ITT approach. No patients were lost after randomisation. Patient's next of kin were aware through informed consent. Setting: coronary care unit (CCU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>22 participants (17 males and 5 females), with age 75±10 years in standard medical care group and 74±11 in CPAP group. Diagnosis criteria: dyspnoea of sudden onset, PaO2&lt;80mmHg with FiO2= 50%, typical finds on chest radiographs and widespread rales without a history suggesting pulmonary aspiration or infection, typical chest pain 30 minutes creatine kinase twice a least the normal, ECG changes consistent with acute myocardial infarction. Causes: Acute myocardial infarction. Exclusion criteria: complicated with aspiration and/or pneumonia, immediate need for endotracheal intubation, shock, and life-threatening hypoxia at study entry.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>CPAP group: PEEP= 7±3 cmH2O. N=11, TIME=48hours.<BR/>Control group: standard medical care+O2 mask. N= 11.<BR/>Co-intervention: furosemide, morphine, nitroglycerin, dopamine, dobutamine, norepinephrine, epinephrine.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-09 10:38:35 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: nasal mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike" STUDY_ID="STD-Thys-2002">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>Single centre randomised controlled trial (through opaque and sealed envelopes by batches of 20 envelopes), parallel design with placebo, single blind, using ITT approach. None patient went lost. Informed consent was obtained of the patients. Setting: emergency department and intensive care unit (ICU).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Joey SW Kwong">
<P>8 participants (5 males and 3 females), with age 77.5±8.38 years. Diagnosis criteria: orthopnoea, bibasilar crackles, bilateral perihilar infiltrates on chest radiograph with cardiomegaly and a compatible clinical history; age more than 18 years, acute onset of moderate-to-severe dyspnoea, BR&gt;30 or &lt; 10bpm, hypoxaemia (PaO2 &lt;55mmHg) or need for O2 supplementation, pH&lt;7,33. Excluded patients: immediate indication for endotracheal intubation, major unrest, haemodynamic instability, facial or thoracic trauma, lack of cooperation, difficult adaptation of a facial mask, pulmonary embolism, retrosternal pain suggestive of a acute myocardial infarction.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<P>BILEVEL group: EPAP= 6.1±1.5 cmH<SUB>2</SUB>O e IPAP= 16.5±1.5 cmH<SUB>2</SUB>O. N=3, time= 77.33±16.25 minutes.<BR/>Control group: standard medical care+O2 with similar mask (placebo). N= 5.<BR/>Co-intervention: furosemide, isosorbide dinitrate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Liz Bickerdike">
<OL>
<LI>Mortality</LI>
<LI>Tracheal intubation rate</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Side-effects</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mask: face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weitz-2007">
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Single centre randomised controlled trial, parallel design, unblinded, not using ITT approach. Three patients allocated to the standard group were not followed up because it was obvious on admission that these patients did not suffer from an acute cardiogenic pulmonary oedema. Informed consent was obtained. Setting: mobile intensive care unit teams in the patient's home or during delivery to the emergency department.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-06 13:13:57 +0100" MODIFIED_BY="[Empty name]">
<P>23 participants (12 males and 11 females), with age 72-92 years in standard medical care group and 54-86 in BILEVEL group. Diagnosis criteria: severe dyspnoea and consecutively showed additional clinical signs of ACPE (SaO2&lt; 90% and basal rales). Excluded patients: severe uncontrolled agitation, angina, obvious ST elevation in the ECG, emesis and aspiration, cardiogenic shock, life threatening arrhythmias, coma or any obvious need for intubation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>BILEVEL group: EPAP= 5 cm H2O e IPAP= 12.5±1.2 cmH2O. N=10.<BR/>Control group: standard medical care+O2 with similar mask (placebo). N= 5.<BR/>Co-intervention: furosemide, isosorbide dinitrate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>SaO2 at the time of the hospital admission</LI>
<LI>Measure the brain natriuretic peptide (BNP)</LI>
<LI>Mortality</LI>
<LI>Length of hospital stay</LI>
<LI>Length of ICU stay</LI>
<LI>Vital signs (BR, BP, HR)</LI>
<LI>Dyspnea scale</LI>
<LI>Tracheal intubation rate</LI>
<LI>Incidence of acute myocardial infarction (follow-up)</LI>
<LI>Side-effects</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-03 23:43:11 +0100" MODIFIED_BY="[Empty name]">
<P>Mask: Face mask.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ITT - intention to treat; SaO<SUB>2</SUB> - arterial saturation of oxygen; O<SUB>2</SUB> - oxygen; l/min - litre per minute;<BR/>BR - breath rate; b/min - breaths per minute; HR - heart rate; b/min - beats per minute; Rx - radiograph;<BR/>CHF - congestive heart failure; CPO - cardiogenic pulmonary oedema; ISDN - isosorbide dinitrate; FiO2 - fraction of inspired oxygen; P(A-a)O<SUB>2</SUB> - alveolar-arterial oxygen gradient; PaCO<SUB>2</SUB> - carbon dioxide tension of arterial blood; PaO<SUB>2</SUB> - partial pressure of oxygen in arterial blood; CO<SUB>2</SUB> - carbon dioxide; pH - potential of hydrogen; BP - blood pressure; ICU - intensive care unit; SBP - systolic blood pressure; N - number; IPAP - inspiratory positive airway pressure; EPAP - expiratory positive airway pressure; BILEVEL - bilevel positive airway pressure; PEEP - positive expiratory end pressure; CPAP - continuous positive airway pressure; SMC - standard medical care; STEMI - ST segment elevation myocardial infarction.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-02-11 15:24:45 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Acosta-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Albert-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 20:30:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alper-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 20:30:15 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:02:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alper-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:02:28 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Andrade-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Antonelli-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:02:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aronow-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:02:42 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barach-1938">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Baratz-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:02:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bavry-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:02:58 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bellone-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>The outcomes did not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Blomqvist-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study with dogs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bollaert-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study involve other kind of ventilatory support (PAV)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bouquin--1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bradley--2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brezins-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study involve other kind of ventilatory support (invasive mechanical ventilation).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brijker-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brochard-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter commenting the L'Her's article.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chadda-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>The outcomes did not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-29 21:38:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-29 21:38:41 +0000" MODIFIED_BY="[Empty name]">
<P>Compare NPPV vs. mechanical ventilation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Crane-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Craven-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cross-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-11-03 19:09:11 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cross-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-11-03 19:09:11 +0000" MODIFIED_BY="[Empty name]">
<P>This is study is in patients with acute respiratory failure and include a subgroup with pulmonary edema (inclusion criteria not clear for cardiogenic pulmonary edema). However, although the author have been contected, he is not replay.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cydulka-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter commenting the Nava's article.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Domenighetti-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Du-Cailar-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eaton-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Evans-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fromm-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Giacomini-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Girou-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-30 21:47:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gorbunova-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-30 21:47:28 +0100" MODIFIED_BY="[Empty name]">
<P>The end point doesn't similar commended in protocol.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-23 21:02:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gray-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-23 21:02:24 +0100" MODIFIED_BY="[Empty name]">
<P>It is the same study published in New England in 2008 by Gray et al.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guerra-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guntupalli-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gust-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter to the editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hao-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hess-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hilberg-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hipona-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter to the editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hoffman-B-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hoffmann-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Holt-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hotchkiss-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:13:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hubble-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:13:11 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hughes-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter to the editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Iapichino-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jackson-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jackson-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jackson-R-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kallio-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Keenan-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kelly-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter to the editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kiely-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>The outcomes did not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kindgen_x002d_Milles-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kosowsky-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kosowsky-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kramer-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is study is in acute respiratory failure and include only two patients with cardiogenic pulmonary edema that received NPPV and nobody received CPAP or SMC.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-L_x0027_Her-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-L_x0027_Her-E-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lal-1969">
<CHAR_REASON_FOR_EXCLUSION>
<P>The study test only different oxygen masks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lapinsky-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:16:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leman-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:16:20 +0100" MODIFIED_BY="[Empty name]">
<P>It is a RCT, but only compared two different brands of CPAP equipment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lenique-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-14 22:26:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-14 22:26:03 +0100" MODIFIED_BY="[Empty name]">
<P>It is a RCT, it is Chinese paper  whose data was translated by Cochrane, but dichotomous variables advocated not were analyzed and the continuous variables analysis happened in different period of advocated - 2hs and 24hs after the start of the intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liesching-T-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lo-Coco-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mackay-CA-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a Poster of Congress. Did not assess relevant outcomes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:17:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Masip-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:17:04 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Massaria-1976">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 20:21:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meduri-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 20:21:37 +0100" MODIFIED_BY="[Empty name]">
<P>The clinical situation is different. It was conducted in patients with COPD or asthma.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mehta-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>The outcomes did not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mehta-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mehta-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Minuto-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mollica-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Moritz-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>The outcomes did not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Murray-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Murray-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nadar-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nava-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Newberry-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:19:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Newby-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:19:42 +0100" MODIFIED_BY="[Empty name]">
<P>It is a brief presentation of RCT published in The New England in 2008 by Gray et al.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nikki-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>The study compares CPAP vs. mechanical ventilation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Niranjan-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter to the editor with comment about noninvasive ventilation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Panacek-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pang-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Park-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-23 20:46:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Park-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-23 20:46:49 +0100" MODIFIED_BY="[Empty name]">
<P>It is an article of review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Perel-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:21:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perkins-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:21:36 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Philip_x002d_joet-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-14 22:26:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Plaisance-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-14 22:26:27 +0100" MODIFIED_BY="[Empty name]">
<P>It is a RCT, but this study cross-over, the groups were compared in different times were different from those described in this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pollack-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Poponick-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-04-29 20:21:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Popova-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-04-29 20:21:34 +0100" MODIFIED_BY="[Empty name]">
<P>The outcomes did not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Poulton-1936">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rabatin-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rasanen-J-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rizk-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roche-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>The clinical situation is different.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rusterholtz-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:23:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rutherholtz-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:23:46 +0100" MODIFIED_BY="[Empty name]">
<P>It is a RCT, but compared CPAP vs.PAV.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sacchetti-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter to the editor .</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sachetti-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Salvucci-A-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sarullo-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:24:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schettino-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:24:53 +0100" MODIFIED_BY="[Empty name]">
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Severinghaus-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Simonds-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sinuff-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 20:22:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Somauroo-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 20:22:16 +0100" MODIFIED_BY="[Empty name]">
<P>The clinical situation is different. It was conducted in patients with chronic congestive heart failure.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sutton-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is a letter to the editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:28:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trevisan-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:28:06 +0100" MODIFIED_BY="[Empty name]">
<P>It is a RCT, but compared It is a RCT, but compared NPPV as a method of weaning.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Uy-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>The study compares CPAP vs. mechanical ventilation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:28:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Uy-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:28:09 +0100" MODIFIED_BY="[Empty name]">
<P>It is a RCT, but compared It is a RCT, but compared CPAP vs.invasive mechanical ventilation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vaisanen-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>The outcomes did not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Valipour-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Werdan-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Widger-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wood-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is study is in acute respiratory failure and include a subgroup with cardiogenic pulmonary oedema. However, although the author have been contected, he is not replay.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wright-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>
<BR/>It is a letter to the editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wysocki-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is study is in acute respiratory failure and include a subgroup with cardiogenic pulmonary oedema. However, although the author have been contected, he is not replay.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wysocki-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>It is not a RCT or QRCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-07 21:29:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-07 21:29:00 +0100" MODIFIED_BY="[Empty name]">
<P>The end point doesn&#8217;t similar commended in protocol.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>108 excluded.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2011-04-29 21:04:56 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00554580">
<CHAR_STUDY_NAME MODIFIED="2012-01-16 19:18:13 +0000" MODIFIED_BY="[Empty name]">
<P>Effect of Continuous Positive Airway Pressure on Short Term Inhospital Prognosis for Acute Pulmonary Edema</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomised<BR/>Endpoint classification: Efficacy Study<BR/>Intervention model: Parallel Assignment<BR/>Masking: Open label<BR/>Primary purpose: Treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Adults with acute cardiogenic pulmonary oedema</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>A: Active comparator</LI>
<UL>
<LI>usual care of pulmonary acute oedema</LI>
<LI>Intervention: usual care of acute pulmonary oedema</LI>
</UL>
<LI>B: Experimental</LI>
<UL>
<LI>CPAP + usual care of pulmonary acute oedema</LI>
<LI>Intervention: continuous positive airway pressure (CPAP)</LI>
</UL>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-01-16 19:30:43 +0000" MODIFIED_BY="[Empty name]">
<P>Death, tracheal intubation and mechanical ventilation rates, persistence of inclusion criteria for respiratory distress and shock until H2, reappearance of inclusion criteria after H2. [ Time Frame: 48 hours ]</P>
<P>Brain natriuretic factor value curves from H0, H6 and H24; composite criteria without intubation rate; clinical and biological parameters evolution during the first 48 hours, myocardial infarction rate, CPAP non tol [ Time Frame: H0, H6, H24, H48 ]</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-01-16 19:31:06 +0000" MODIFIED_BY="[Empty name]">
<P>November 6, 2007</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<A HREF="http://clinicaltrials.gov/ct2/show/NCT00554580">http://clinicaltrials.gov/ct2/show/NCT00554580</A>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00912158">
<CHAR_STUDY_NAME MODIFIED="2012-01-16 19:04:46 +0000" MODIFIED_BY="[Empty name]">
<P>Noninvasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomised<BR/>Endpoint classification: Safety/efficacy study<BR/>Intervention model: Parallel assignment<BR/>Masking: Open label<BR/>Primary purpose: Treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Adults with acute cardiogenic pulmonary oedema<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-01-16 19:08:54 +0000" MODIFIED_BY="[Empty name]">
<P>Other: standard therapy (ST)<BR/>Device: CPAP and BIPAP<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Number of patients who were intubated, arterial blood gases, respiratory rate, blood pressure, cardiac output, intrapulmonary shunt, A-a oxygen gradient, heart rate, and dyspnoea duration of hospital and ICU stay and mortality [ Time Frame: Hospital stay ]</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-01-16 19:10:06 +0000" MODIFIED_BY="[Empty name]">
<P>April 8, 2009</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-01-16 19:10:36 +0000" MODIFIED_BY="[Empty name]">
<P>
<A HREF="mailto:mahaghanem%40hotmail.com?subject=NCT00912158, RICU, Assiut University 1, Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema">mahaghanem@hotmail.com</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<A HREF="http://clinicaltrials.gov/ct2/show/NCT00912158">http://clinicaltrials.gov/ct2/show/NCT00912158</A>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-03-22 22:24:57 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:14:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agmy-2008">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:17:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bautin-2005">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:28:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:29:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:30:26 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bersten-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:31:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crane-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:32:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delclaux-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:33:03 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrari-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:33:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrari-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-06 20:05:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrer-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:45:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fontanella-2010">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-09 20:36:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frontin-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:36:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gray-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:53:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kelly-2002">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:38:43 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x0027_Her-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:39:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levitt-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:55:08 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liesching-2003">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:56:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1991">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:56:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1995">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 20:23:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x002d_Bermudez-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:42:11 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masip-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:42:43 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mehta-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:43:26 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moritz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:43:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nava-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:44:11 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:44:40 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:08:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:46:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sharon-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:13:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Takeda-1997">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:20:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Takeda-1998">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:24:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thys-2002">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:52:28 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weitz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:14:47 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agmy-2008">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:17:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bautin-2005">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:21:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:21:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:22:06 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bersten-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:22:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crane-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:22:25 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delclaux-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:21:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrari-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:23:04 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrari-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:36:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ferrer-2003">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:45:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fontanella-2010">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-09 20:36:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frontin-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:54:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gray-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:53:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kelly-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:54:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x0027_Her-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:54:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Levitt-2001">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:55:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liesching-2003">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:56:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1991">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:56:41 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1995">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 20:27:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x002d_Bermudez-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:01:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masip-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:02:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehta-1997">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:02:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moritz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:02:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nava-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:03:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:08:03 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:08:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:12:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharon-2000">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:13:12 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Takeda-1997">
<DESCRIPTION>
<P>The method used was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:21:03 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Takeda-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:25:03 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thys-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weitz-2007">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="GROUP" NO="9">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" NO="10">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-03-22 22:07:45 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:25:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agmy-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:27:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bautin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:28:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:29:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:30:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bersten-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:31:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crane-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:32:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delclaux-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:33:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrari-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-22 19:48:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ferrari-2010">
<DESCRIPTION>
<P>Not reported if there were drop-outs over the monitoring of patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-22 19:49:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrer-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-22 19:49:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fontanella-2010">
<DESCRIPTION>
<P>Not reported if there were drop-outs over the monitoring of patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-09 20:40:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frontin-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:37:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gray-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:38:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kelly-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:38:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x0027_Her-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:39:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levitt-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-22 19:55:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liesching-2003">
<DESCRIPTION>
<P>Not reported if there were drop-outs over the monitoring of patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:40:34 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lin-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:41:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-08-09 20:27:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x002d_Bermudez-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:42:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masip-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:42:54 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mehta-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:43:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moritz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:43:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nava-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-22 22:07:45 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-2001">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:44:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:45:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:46:49 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sharon-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:49:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Takeda-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:50:07 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Takeda-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:50:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thys-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-10 17:52:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weitz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-03-22 22:27:20 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:25:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agmy-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:27:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bautin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:28:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:29:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:30:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bersten-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:31:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crane-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:32:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delclaux-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:33:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrari-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:33:41 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ferrari-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:20:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ferrer-2003">
<DESCRIPTION>
<P>Not submitted multiple planning outcomes reported on results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-06 20:06:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fontanella-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-09 20:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frontin-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:37:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gray-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:38:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kelly-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:38:52 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-L_x0027_Her-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:39:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levitt-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:40:03 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liesching-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:41:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 20:08:23 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1995">
<DESCRIPTION>
<P>Not submitted multiple planning outcomes reported on results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:01:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Martin_x002d_Bermudez-2002">
<DESCRIPTION>
<P>Not submitted multiple planning outcomes reported on results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:01:43 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masip-2000">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:42:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mehta-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:43:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moritz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:43:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nava-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:44:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:44:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:12:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985">
<DESCRIPTION>
<P>Not submitted multiple planning outcomes reported on results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:46:53 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sharon-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:17:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Takeda-1997">
<DESCRIPTION>
<P>Not submitted multiple planning outcomes reported on results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:24:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Takeda-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:50:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thys-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:27:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weitz-2007">
<DESCRIPTION>
<P>Not submitted multiple planning outcomes reported on results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-10-26 19:18:31 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2012-03-22 22:28:05 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Detection bias</NAME>
<DESCRIPTION>
<P>Are outcome assessors were independent from the individuals administering/supervising the assigned treatments?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:15:42 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agmy-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:17:53 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bautin-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:18:11 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellone-2004">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:18:47 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellone-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:19:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bersten-1991">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:20:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Crane-2004">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:32:40 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delclaux-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:21:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ferrari-2007">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:23:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ferrari-2010">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:36:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ferrer-2003">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:45:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fontanella-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:53:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frontin-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-22 18:11:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gray-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:53:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kelly-2002">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:54:14 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-L_x0027_Her-2004">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:39:39 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Levitt-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:55:47 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liesching-2003">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:56:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1991">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:56:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1995">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 20:27:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x002d_Bermudez-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:28:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masip-2000">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:02:21 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehta-1997">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:43:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moritz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:02:52 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nava-2003">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:03:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-2001">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:08:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-2004">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:08:42 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:12:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharon-2000">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:13:21 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Takeda-1997">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:20:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Takeda-1998">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:25:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thys-2002">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 22:25:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weitz-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2012-03-22 19:52:12 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Adherence to the intention-to-treat principle</NAME>
<DESCRIPTION>
<P>There is specifically reported by authors that intention-to-treat analysis was undertaken and this was confirmed on study assessment?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:25:50 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agmy-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:27:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bautin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:29:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:29:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bellone-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:30:54 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bersten-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:31:25 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crane-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:32:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delclaux-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:33:20 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ferrari-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:33:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrari-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:36:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ferrer-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-22 19:52:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fontanella-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-09 20:40:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Frontin-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:37:50 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gray-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:38:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kelly-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:39:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x0027_Her-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:39:43 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Levitt-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:40:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liesching-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:41:20 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lin-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:41:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 20:27:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Martin_x002d_Bermudez-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:42:32 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Masip-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:43:07 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mehta-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:43:38 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moritz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:44:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nava-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:44:27 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Park-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:44:50 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Park-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:45:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:47:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sharon-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:49:50 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Takeda-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:50:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Takeda-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:50:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thys-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-10 17:52:47 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weitz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2013-04-06 14:15:15 +0100" MODIFIED_BY="Grade Profiler">Non-invasive positive pressure ventilation (CPAP and bilevel NPPV) for cardiogenic pulmonary edema</TITLE>
<TABLE COLS="7" ROWS="29">
<TR>
<TD COLSPAN="7">
<P>
<B>Non-invasive positive pressure ventilation (CPAP and bilevel NPPV) for cardiogenic pulmonary oedema</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with cardiogenic pulmonary oedema<BR/>
<B>Settings:</B> Emergency Department or Intensive Care Unit<BR/>
<B>Intervention:</B> Non-invasive positive pressure ventilation (CPAP and bilevel NPPV)<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Non-invasive positive pressure ventilation (CPAP and bilevel NPPV)</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Hospital mortalityY</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.66 </B>
<BR/>(0.48 to 0.89)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1107<BR/>(20 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>204 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>135 per 1000</B>
<BR/>(98 to 182)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>132 per 1000</B>
<BR/>(96 to 178)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Endotracheal intubation rate</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.52 </B>
<BR/>(0.36 to 0.75)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1261<BR/>(22 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>249 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>130 per 1000</B>
<BR/>(90 to 187)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>300 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>156 per 1000</B>
<BR/>(108 to 225)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Incidence of acute myocardial infarction (During intervention)</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.24 </B>
<BR/>(0.79 to 1.95)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>461<BR/>(8 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>5,6</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>153 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>190 per 1000</B>
<BR/>(121 to 299)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>169 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>210 per 1000</B>
<BR/>(134 to 330)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Incidence of acute myocardial infarction (After intervention)</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.7 </B>
<BR/>(0.11 to 4.26)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>154<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>5,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>26 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>18 per 1000</B>
<BR/>(3 to 111)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>13 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>9 per 1000</B>
<BR/>(1 to 55)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Intolerance to allocated treatment</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.47 </B>
<BR/>(0.29 to 0.77)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1848<BR/>(13 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>8,9,10</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>234 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>110 per 1000</B>
<BR/>(68 to 180)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>350 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>165 per 1000</B>
<BR/>(101 to 269)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Hospital length of stay</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean hospital length of stay in the intervention groups was<BR/>
<B>0.8 lower</B>
<BR/>(2.1 lower to 0.51 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>542<BR/>(10 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>11,12</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Intensive care unit length of stay (Copy)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean intensive care unit length of stay (copy) in the intervention groups was<BR/>
<B>0.89 lower</B>
<BR/>(1.33 to 0.45 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>222<BR/>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>5,13</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> The most studies have mixed populations (with different levels of severity and co-morbidities).<BR/>
<SUP>2</SUP> Was included only two quasi-randomised trials, but sensitivity analysis with quasi-randomised studies exclusion (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>), showed the results to remain statistically significant. <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK> was interrupted early due to a greater number in deaths and complications in the control group.<BR/>
<SUP>3</SUP> Although there is less 300 events in meta-analysis, when add Gray's study that analysed the mortality in 30 days, our meta-analysis of hospital mortality show that these study reinforce the favourable use of NPPV in ACPE with more 300 events.<BR/>
<SUP>4</SUP> Was included only two quasi-randomised trials, but sensitivity analysis with quasi-randomised studies exclusion (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>), showed the results to remain statistically significant. <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK> was interrupted early due to a difference in the frequency of intubations. <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK> lost 35 of the 80 (44%) randomised patients for having fulfilled the criteria of exclusion or having presented failures on the received intervention.<BR/>
<SUP>5</SUP> There is less 300 events in meta-analysis.<BR/>
<SUP>6</SUP> Although two studies (<LINK REF="STD-Sharon-2000" TYPE="STUDY">Sharon 2000</LINK>; <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK>) were interrupted early due to the incidence of acute myocardial infarction and the second due to a batch of failures of treatment and clinical decline.<BR/>
<SUP>7</SUP> Was included one quasi-randomised trial (<LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK> lost 35 of the 80 (44%) randomised patients for having fulfilled the criteria of exclusion or having presented failures on the received intervention.<BR/>
<SUP>8</SUP> Was included two quasi-randomised trials (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK> was interrupted early due to a greater number in deaths and complications in the control group and not present the results in relation to autonomy for the activities of daily living, patient comfort and some planned adverse effects to be observed. <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK> lost 35 of the 80 (44%) randomised patients for having fulfilled the criteria of exclusion or having presented failures on the received intervention. <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK> was interrupted early due to a batch of failures of treatment and clinical decline.<BR/>
<SUP>9</SUP> The grouping of the studies demonstrated relevant heterogeneity which was eliminated with the exclusion of Gray 2008 study, but we have not found plausible justification for this result<BR/>
<SUP>10</SUP> RR &lt; 0.5<BR/>
<SUP>11</SUP> Was included two quasi-randomised trials (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK> and <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK> were interrupted early, the first due to a greater number in deaths and in the control group and the second due to a batch of failures of treatment and clinical decline. <LINK REF="STD-L_x0027_Her-2004" TYPE="STUDY">L'Her 2004</LINK> did not present the results in relation to autonomy for the activities of daily living, patient comfort and some planned adverse effects to be observed. <LINK REF="STD-Lin-1991" TYPE="STUDY">Lin 1991</LINK> lost 35 of the 80 (44%) randomised patients for having fulfilled the criteria of exclusion or having presented failures on the received intervention.<BR/>
<SUP>12</SUP> The grouping of the studies demonstrated relevant heterogeneity.<BR/>
<SUP>13</SUP> Was included two quasi-randomised trials (<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>; <LINK REF="STD-Weitz-2007" TYPE="STUDY">Weitz 2007</LINK>). <LINK REF="STD-Thys-2002" TYPE="STUDY">Thys 2002</LINK> was interrupted early due to a batch of failures of treatment and clinical decline.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-04-06 12:35:06 +0100" MODIFIED_BY="Joey SW Kwong">IPAP Level and EPAP Level and time of intervention</TITLE>
<TABLE COLS="6" ROWS="26">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>IPAP level</P>
<P>(cmH<SUB>2</SUB>O)</P>
</TH>
<TH>
<P>EPAP in bievel NPPV</P>
<P>(cmH<SUB>2</SUB>O)</P>
</TH>
<TH>
<P>PEEP in CPAP (cmH<SUB>2</SUB>O)</P>
</TH>
<TH>
<P>Time of bilevel NPPV</P>
<P>(hours)</P>
</TH>
<TH>
<P>Time of CPAP</P>
<P>(hours)</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bautin-2005" TYPE="STUDY">Bautin 2005</LINK>
</P>
</TD>
<TD>
<P>5.1 (SD 0.3)</P>
</TD>
<TD>
<P>9.8 (SD 1.1)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bellone-2004" TYPE="STUDY">Bellone 2004</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>1.6 (SD 0.6)</P>
</TD>
<TD>
<P>1.7 (SD 0.7)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bellone-2005" TYPE="STUDY">Bellone 2005</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>3.41 (SD 1.1)</P>
</TD>
<TD>
<P>3.6 (SD 1.3)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bersten-1991" TYPE="STUDY">Bersten 1991</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>9.3 (SD 4.9)</P>
</TD>
</TR>
<TR>
<TD>
<P>Crane 2004</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Ferrari 2007</P>
</TD>
<TD>
<P>15 (SD 3.1)</P>
</TD>
<TD>
<P>7 (SD 1.2)</P>
</TD>
<TD>
<P>8.8 (SD 1.9)</P>
</TD>
<TD>
<P>6.0 (SD 4.7)</P>
</TD>
<TD>
<P>8.1 (SD 8.3)</P>
</TD>
</TR>
<TR>
<TD>
<P>Ferrari 2009</P>
</TD>
<TD>
<P>14 (SD 3.1)</P>
</TD>
<TD>
<P>6.7 (SD 1.4)</P>
</TD>
<TD>
<P>8.8 (SD 1.7)</P>
</TD>
<TD>
<P>5.9 (SD 4.0)</P>
</TD>
<TD>
<P>8.4 (SD 7.1)</P>
</TD>
</TR>
<TR>
<TD>
<P>Fontanella 2010</P>
</TD>
<TD>
<P>18 (SD 3)</P>
</TD>
<TD>
<P>10 (SD 2)</P>
</TD>
<TD>
<P>8 (SD 2)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Frontin 2010</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Gray 2009</P>
</TD>
<TD>
<P>14 (SD 5)</P>
</TD>
<TD>
<P>7 (SD 3)</P>
</TD>
<TD>
<P>10 (SD 4)</P>
</TD>
<TD>
<P>2.0 (SD 1.3)</P>
</TD>
<TD>
<P>2.2 (SD 1.5)</P>
</TD>
</TR>
<TR>
<TD>
<P>Kelly 2002</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>7.5</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>L'Her 2004</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>7.5</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>8 (SD 6)</P>
</TD>
</TR>
<TR>
<TD>
<P>Liesching 2003</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Martin-Bermudez 2002</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>1.3 (SD 0.8)</P>
</TD>
<TD>
<P>1.8 (SD 1)</P>
</TD>
</TR>
<TR>
<TD>
<P>Masip 2000</P>
</TD>
<TD>
<P>15.2 (SD 2.4)</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>4.2 (SD 1.5)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Mehta 1997</P>
</TD>
<TD>
<P>14.35 (SD 1.73)</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>10.08 (SD 1.24)</P>
</TD>
<TD>
<P>7.1 (SD 4.7)</P>
</TD>
<TD>
<P>6.4 (SD 5.8)</P>
</TD>
</TR>
<TR>
<TD>
<P>Moritz 2007</P>
</TD>
<TD>
<P>12 (SD 3.2)</P>
</TD>
<TD>
<P>4.9 (SD 0.9)</P>
</TD>
<TD>
<P>7.7 (SD 2.1)</P>
</TD>
<TD>
<P>2.8</P>
</TD>
<TD>
<P>2.3</P>
</TD>
</TR>
<TR>
<TD>
<P>Nava 2003</P>
</TD>
<TD>
<P>14.5 (SD 21.1)</P>
</TD>
<TD>
<P>6.1 (SD 3.2)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>11.4 (SD 3.6)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Park 2001</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>7.5</P>
</TD>
<TD>
<P>2.5 (SD 0.6)</P>
</TD>
<TD>
<P>2.8 (SD 1.5)</P>
</TD>
</TR>
<TR>
<TD>
<P>Park 2004</P>
</TD>
<TD>
<P>17 (SD 2)</P>
</TD>
<TD>
<P>11 (SD 2)</P>
</TD>
<TD>
<P>11 (SD 2)</P>
</TD>
<TD>
<P>2.0 (SD 1.0)</P>
</TD>
<TD>
<P>1.7 (SD 0.6)</P>
</TD>
</TR>
<TR>
<TD>
<P>Rasanen 1985</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Sharon 2000</P>
</TD>
<TD>
<P>9.3 (SD 2.3)</P>
</TD>
<TD>
<P>4.2 (SD 3.1)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Takeda 1997</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>11.9 (SD 8.4)</P>
</TD>
</TR>
<TR>
<TD>
<P>Thys 2002</P>
</TD>
<TD>
<P>16.5 (SD 3.3)</P>
</TD>
<TD>
<P>6.1 (SD 1.5)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>1.2 (SD 0.2)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Weitz 2007</P>
</TD>
<TD>
<P>12.5 (SD 1.2)</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CPAP - continuous positive airway pressure; EPAP - expiratory positive airway pressure; IPAP - inspiratory positive airway pressure; PEEP - positive expiratory end pressure; SD - standard deviation; * statistically significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-05-09 10:45:43 +0100" MODIFIED_BY="Liz Bickerdike">Summary of adverse events</TITLE>
<TABLE COLS="6" ROWS="20">
<TR>
<TH>
<P>Adverse events</P>
</TH>
<TH>
<P>Number of events (CPAP)</P>
</TH>
<TH>
<P>Total number CPAP</P>
</TH>
<TH>
<P>Number of event (bilevel NPPV)</P>
</TH>
<TH>
<P>Total number (bilevel NPPV)</P>
</TH>
<TH>
<P>RR (95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Skin damage</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>472</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>458</P>
</TD>
<TD>
<P>0.06 (0.01, 0.43)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumonia</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>76</P>
</TD>
<TD>
<P>0.63 (0.03, 15.03)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pulmonary aspiration</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>476</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>383</P>
</TD>
<TD>
<P>0.27 (0.01, 6.57)</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastric distention</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>178</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD>
<P>0.18 (0.06, 0.52)*</P>
</TD>
</TR>
<TR>
<TD>
<P>GI bleeding</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>85</P>
</TD>
<TD>
<P>1.02 (0.06, 18.63)</P>
</TD>
</TR>
<TR>
<TD>
<P>Vomitting</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>381</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>419</P>
</TD>
<TD>
<P>0.86 (0.32, 2.27)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumothorax</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>440</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>430</P>
</TD>
<TD>
<P>0.33 (0.01, 7.97)</P>
</TD>
</TR>
<TR>
<TD>
<P>Asphyxia/claustrophobia</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>65</P>
</TD>
<TD>
<P>1.05 (0.04, 24.76)</P>
</TD>
</TR>
<TR>
<TD>
<P>Mask discomfort</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>364</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>440</P>
</TD>
<TD>
<P>0.82 (0.43, 1.57)</P>
</TD>
</TR>
<TR>
<TD>
<P>Sinusitis</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>65</P>
</TD>
<TD>
<P>0.50 (0.02, 12.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Conjunctivitis</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>70</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Eye irritation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cardiac arrest</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>333</P>
</TD>
<TD>
<P>13</P>
</TD>
<TD>
<P>410</P>
</TD>
<TD>
<P>0.57 (0.22, 1.48)</P>
</TD>
</TR>
<TR>
<TD>
<P>Stroke</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>65</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Seizure</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>65</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hypotension</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD>
<P>332</P>
</TD>
<TD>
<P>37</P>
</TD>
<TD>
<P>346</P>
</TD>
<TD>
<P>1.01 (0.66, 1.56)</P>
</TD>
</TR>
<TR>
<TD>
<P>Arrhythmia requiring treatment</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>332</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>345</P>
</TD>
<TD>
<P>0.50 (0.25, 0.98)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Progressive respiratory distress</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>333</P>
</TD>
<TD>
<P>21</P>
</TD>
<TD>
<P>346</P>
</TD>
<TD>
<P>0.84 (0.45, 1.57)</P>
</TD>
</TR>
<TR>
<TD>
<P>Increase breathing discomfort</P>
</TD>
<TD>
<P>16</P>
</TD>
<TD>
<P>287</P>
</TD>
<TD>
<P>19</P>
</TD>
<TD>
<P>291</P>
</TD>
<TD>
<P>0.85 (0.45, 1.63)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI - confidence interval; CPAP - continuous positive airway pressure; RR - relative risk; SD - standard deviation; * statistically significant..</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2013-04-06 14:17:07 +0100" MODIFIED_BY="[Empty name]">Adverse events by NPPV versus SMC</TITLE>
<TABLE COLS="5" ROWS="20">
<TR>
<TH>
<P>Adverse events</P>
</TH>
<TH>
<P>Studies</P>
</TH>
<TH>
<P>NPPV group</P>
</TH>
<TH>
<P>SMC group</P>
</TH>
<TH>
<P>RR (95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Skin damage</P>
</TD>
<TD>
<P>11 studies (Rasanen 1985, Bersten 1991, Takeda 1998, Masip 2000, Kelly 2002, Thys 2002, Nava 2003, Crane 2004, L'Her 2004, Park 2004, Bautin 2005)</P>
</TD>
<TD>
<P>17/318</P>
</TD>
<TD>
<P>0/276</P>
</TD>
<TD>
<P>6.62 (1.20, 36.55)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumonia</P>
</TD>
<TD>
<P>3 study (Lin 1991, Nava 2003, Bautin 2005)</P>
</TD>
<TD>
<P>1/116</P>
</TD>
<TD>
<P>4/116</P>
</TD>
<TD>
<P>0.35 (0.05, 2.20)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pulmonary aspiration</P>
</TD>
<TD>
<P>5 studies (Rasanen 1985, Bersten 1991, Lin 1991, Kelly 2002, Gray 2008)</P>
</TD>
<TD>
<P>1/787</P>
</TD>
<TD>
<P>0/468</P>
</TD>
<TD>
<P>1.58 (0.06, 38,61)</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastrointestinal<BR/>bleeding<BR/>
</P>
</TD>
<TD>
<P>3 study (Takeda 1998, Masip 2000, Nava 2003)</P>
</TD>
<TD>
<P>3/96</P>
</TD>
<TD>
<P>2/96</P>
</TD>
<TD>
<P>1,37 (0.27, 6.89)</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastric distension</P>
</TD>
<TD>
<P>8 studies (Rasanen 1985, Bersten 1991, Lin 1991, Takeda 1998, Thys 2002, Park 2004, L'Her 2004, Frotin 2010)</P>
</TD>
<TD>
<P>13/253</P>
</TD>
<TD>
<P>0/231</P>
</TD>
<TD>
<P>13.26 ( 0.82, 215.12)</P>
</TD>
</TR>
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>5 studies (Masip 2000, Thys 2002, Crane 2004, Park 2004, Gray 2008)</P>
</TD>
<TD>
<P>16/800</P>
</TD>
<TD>
<P>8/429</P>
</TD>
<TD>
<P>1.06 (0.46, 2.47)</P>
</TD>
</TR>
<TR>
<TD>
<P>Asphyxia</P>
</TD>
<TD>
<P>2 study (Bersten 1991, Nava 2003)</P>
</TD>
<TD>
<P>1/85</P>
</TD>
<TD>
<P>0/85</P>
</TD>
<TD>
<P>3.00 (0.12, 72.31)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumothorax</P>
</TD>
<TD>
<P>6 studies (Bersten 1991, Kelly 2002, Nava 2003, L'Her 2004, Gray 2008, Frotin 2010)</P>
</TD>
<TD>
<P>1/894</P>
</TD>
<TD>
<P>1/580</P>
</TD>
<TD>
<P>0.72 (0.08, 6.89)</P>
</TD>
</TR>
<TR>
<TD>
<P>Conjunctivitis</P>
</TD>
<TD>
<P>2 studies (Kelly 2002, L'Her 2004)</P>
</TD>
<TD>
<P>0/70</P>
</TD>
<TD>
<P>0/77</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Sinusitis</P>
</TD>
<TD>
<P>2 study (Nava 2003, L'Her 2004)</P>
</TD>
<TD>
<P>1/108</P>
</TD>
<TD>
<P>0/111</P>
</TD>
<TD>
<P>3.00 (0.12, 72.31)</P>
</TD>
</TR>
<TR>
<TD>
<P>Mask discomfort</P>
</TD>
<TD>
<P>7 study (Masip 2000, Nava 2003, L'Her 2004, Park 2004, Bautin 2005, Weitz 2007, Frotin 2010)</P>
</TD>
<TD>
<P>7/265</P>
</TD>
<TD>
<P>0/247</P>
</TD>
<TD>
<P>5.39 (0.97, 30.09)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypotension</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>73/678</P>
</TD>
<TD>
<P>46/352</P>
</TD>
<TD>
<P>0.82 (0.58, 1.16)</P>
</TD>
</TR>
<TR>
<TD>
<P>Arrhythmia</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>37/677</P>
</TD>
<TD>
<P>23/350</P>
</TD>
<TD>
<P>0.83 (0.50, 1.38)</P>
</TD>
</TR>
<TR>
<TD>
<P>Progressive respiratory distress</P>
</TD>
<TD>
<P>2 studies (L'Her 2004, Gray 2008)</P>
</TD>
<TD>
<P>39/722</P>
</TD>
<TD>
<P>36/400</P>
</TD>
<TD>
<P>0.58 (0.37, 0.89)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Neurological failure (coma)</P>
</TD>
<TD>
<P>1 study (L'Her 2004)</P>
</TD>
<TD>
<P>1/44</P>
</TD>
<TD>
<P>11/46</P>
</TD>
<TD>
<P>0,10 (0.01, 0,71)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Cardiorespiratory arrest</P>
</TD>
<TD>
<P>3 studies (Nava 2003, L'Her 2004, Gray 2008)</P>
</TD>
<TD>
<P>21/786</P>
</TD>
<TD>
<P>22/466</P>
</TD>
<TD>
<P>0.60 (0.29, 1.26)</P>
</TD>
</TR>
<TR>
<TD>
<P>Eye irritation</P>
</TD>
<TD>
<P>1 study (Masip 2000)</P>
</TD>
<TD>
<P>0/20</P>
</TD>
<TD>
<P>0/20</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Stroke</P>
</TD>
<TD>
<P>1 study (Nava 2003)</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Seizure</P>
</TD>
<TD>
<P>1 study (Nava 2003)</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>1/65</P>
</TD>
<TD>
<P>0.33 (0.01, 8.03)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI - confidence interval; NPPV - noninvasive positive pressure ventilation; RR - relative risk; SMC - standard medical care; * statistically significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE>Adverse events by CPAP versus SMC</TITLE>
<TABLE COLS="5" ROWS="17">
<TR>
<TH>
<P>Adverse Events</P>
</TH>
<TH>
<P>Studies</P>
</TH>
<TH>
<P>CPAP group</P>
</TH>
<TH>
<P>SMC group</P>
</TH>
<TH>
<P>RR (95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Skin damage</P>
</TD>
<TD>
<P>7 studies (Rasanen 1985, Bersten 1991, Takeda 1998,</P>
<P>Kelly 2002, Crane 2004, L'Her 2004, and Park 2004)</P>
</TD>
<TD>
<P>1/168</P>
</TD>
<TD>
<P>0/175</P>
</TD>
<TD>
<P>3.00 (0.13, 69.52)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumonia</P>
</TD>
<TD>
<P>1 study (Lin 1991)</P>
</TD>
<TD>
<P>0/40</P>
</TD>
<TD>
<P>0/40</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Pulmonary aspiration</P>
</TD>
<TD>
<P>5 studies (Rasanen 1985, Bersten 1991, Lin 1991,</P>
<P>Kelly 2002, Gray 2008)</P>
</TD>
<TD>
<P>0/440</P>
</TD>
<TD>
<P>0/468</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastrointestinal<BR/>bleeding<BR/>
</P>
</TD>
<TD>
<P>1 study (Takeda 1998)</P>
</TD>
<TD>
<P>0/11</P>
</TD>
<TD>
<P>1/11</P>
</TD>
<TD>
<P>0.33 (0.02,7.39)</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastric distension</P>
</TD>
<TD>
<P>7 studies (Rasanen 1985, Bersten 1991, Lin 1991,</P>
<P>Takeda 1998, Park 2004, L'Her 2004, Frotin 2010)</P>
</TD>
<TD>
<P>5/221</P>
</TD>
<TD>
<P>0/226</P>
</TD>
<TD>
<P>11.00 ( 0.64, 189.65)</P>
</TD>
</TR>
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>3 studies (Crane 2004, Park 2004, Gray 2008)</P>
</TD>
<TD>
<P>7/381</P>
</TD>
<TD>
<P>8/404</P>
</TD>
<TD>
<P>0.93 (0.34, 2.54)</P>
</TD>
</TR>
<TR>
<TD>
<P>Asphyxia</P>
</TD>
<TD>
<P>1 study (Bersten 1991)</P>
</TD>
<TD>
<P>0/20</P>
</TD>
<TD>
<P>0/20</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumothorax</P>
</TD>
<TD>
<P>5 studies (Bersten 1991, Kelly 2002, L'Her 2004,</P>
<P>Gray 2008, Frotin 2010)</P>
</TD>
<TD>
<P>0/483</P>
</TD>
<TD>
<P>0/515</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Conjunctivitis</P>
</TD>
<TD>
<P>2 studies (Kelly 2002, L'Her 2004)</P>
</TD>
<TD>
<P>0/70</P>
</TD>
<TD>
<P>0/77</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Sinusitis</P>
</TD>
<TD>
<P>1 study (L'Her 2004)</P>
</TD>
<TD>
<P>0/43</P>
</TD>
<TD>
<P>0/46</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Mask discomfort</P>
</TD>
<TD>
<P>3 studies (L'Her 2004, Park 2004, Frotin 2010)</P>
</TD>
<TD>
<P>0/130</P>
</TD>
<TD>
<P>0/135</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypotension</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>36/332</P>
</TD>
<TD>
<P>46/352</P>
</TD>
<TD>
<P>0.83 (0.55, 1.25)</P>
</TD>
</TR>
<TR>
<TD>
<P>Arrhythmia</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>12/332</P>
</TD>
<TD>
<P>23/350</P>
</TD>
<TD>
<P>0.55 (0.28, 1.09)</P>
</TD>
</TR>
<TR>
<TD>
<P>Progressive respiratory distress</P>
</TD>
<TD>
<P>2 studies (L'Her 2004, Gray 2008)</P>
</TD>
<TD>
<P>18/376</P>
</TD>
<TD>
<P>36/400</P>
</TD>
<TD>
<P>0.53 (0.31, 0.92)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Neurological failure (coma)</P>
</TD>
<TD>
<P>1 study (L'Her 2004)</P>
</TD>
<TD>
<P>1/44</P>
</TD>
<TD>
<P>11/46</P>
</TD>
<TD>
<P>0,10 (0.01, 0,71)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Cardiorespiratory arrest</P>
</TD>
<TD>
<P>2 studies (L'Her 2004, Gray 2008)</P>
</TD>
<TD>
<P>8/376</P>
</TD>
<TD>
<P>21/401</P>
</TD>
<TD>
<P>0.41 (0.18, 0.91)*</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI - confidence interval; CPAP - continuous positive airway pressure; RR - relative risk; SMC - standard medical care; * statistically significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2013-04-06 14:17:22 +0100" MODIFIED_BY="[Empty name]">Adverse events by bilevel NPPV versus SMC</TITLE>
<TABLE COLS="5" ROWS="18">
<TR>
<TH>
<P>Adverse Events</P>
</TH>
<TH>
<P>Studies</P>
</TH>
<TH>
<P>Bilevel NPPV Group</P>
</TH>
<TH>
<P>SMC Group</P>
</TH>
<TH>
<P>RR (95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Skin damage</P>
</TD>
<TD>
<P>6 studies (Masip 2000, Thys 2002, Nava 2003, Crane 2004, Park 2004, Bautin 2005)</P>
</TD>
<TD>
<P>16/148</P>
</TD>
<TD>
<P>0/148</P>
</TD>
<TD>
<P>7.16 (1.27, 40.50)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumonia</P>
</TD>
<TD>
<P>2 study (Nava 2003, Bautin 2005)</P>
</TD>
<TD>
<P>1/76</P>
</TD>
<TD>
<P>4/76</P>
</TD>
<TD>
<P>0.35 (0.05, 2.20)</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastrointestinal<BR/>bleeding<BR/>
</P>
</TD>
<TD>
<P>2 studies (Nava 2003, Masip 2000)</P>
</TD>
<TD>
<P>3/85</P>
</TD>
<TD>
<P>1/85</P>
</TD>
<TD>
<P>2.32 (0.35, 15.42)</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastric distension</P>
</TD>
<TD>
<P>2 studies (Thys 2002, Park 2004)</P>
</TD>
<TD>
<P>8/32</P>
</TD>
<TD>
<P>0/32</P>
</TD>
<TD>
<P>15.87 (0.96, 262.30)</P>
</TD>
</TR>
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>5 studies (Masip 2000, Thys 2002, Crane 2004, Park 2004, Gray 2008)</P>
</TD>
<TD>
<P>9/419</P>
</TD>
<TD>
<P>8/429</P>
</TD>
<TD>
<P>1.21 (0.47, 3.11)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumothorax</P>
</TD>
<TD>
<P>2 study (Nava 2003, Gray 2008)</P>
</TD>
<TD>
<P>1/411</P>
</TD>
<TD>
<P>1/421</P>
</TD>
<TD>
<P>1.01 (0.11, 9.63)</P>
</TD>
</TR>
<TR>
<TD>
<P>Eye irritation</P>
</TD>
<TD>
<P>1 study (Masip 2000)</P>
</TD>
<TD>
<P>0/20</P>
</TD>
<TD>
<P>0/20</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Sinusitis</P>
</TD>
<TD>
<P>1 study (Nava 2003)</P>
</TD>
<TD>
<P>1/65</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>3.00 (0.12, 72.31)</P>
</TD>
</TR>
<TR>
<TD>
<P>Mask discomfort</P>
</TD>
<TD>
<P>5 studies (Masip 2000, Nava 2003, Park 2004, Bautin 2005, Weitz 2007)</P>
</TD>
<TD>
<P>7/135</P>
</TD>
<TD>
<P>0/139</P>
</TD>
<TD>
<P>5.39 (0.97, 30.09)</P>
</TD>
</TR>
<TR>
<TD>
<P>Claustrophobia</P>
</TD>
<TD>
<P>1 study (Nava 2003)</P>
</TD>
<TD>
<P>1/65</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>3.00 (0.12, 72.31)</P>
</TD>
</TR>
<TR>
<TD>
<P>Cardiac arrest</P>
</TD>
<TD>
<P>2 study (Nava 2003, Gray 2008)</P>
</TD>
<TD>
<P>13/410</P>
</TD>
<TD>
<P>17/420</P>
</TD>
<TD>
<P>0.96 (0.25, 3.61)</P>
</TD>
</TR>
<TR>
<TD>
<P>Stroke</P>
</TD>
<TD>
<P>1 study (Nava 2003)</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>inestimable</P>
</TD>
</TR>
<TR>
<TD>
<P>Seizure</P>
</TD>
<TD>
<P>1 study (Nava 2003)</P>
</TD>
<TD>
<P>0/65</P>
</TD>
<TD>
<P>1/65</P>
</TD>
<TD>
<P>0.33 (0.01, 8.03)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pulmonary aspiration</P>
</TD>
<TD>
<P>1 studies (Gray 2008)</P>
</TD>
<TD>
<P>1/347</P>
</TD>
<TD>
<P>0/357</P>
</TD>
<TD>
<P>3.09 (0.13, 75.50)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypotension</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>37/346</P>
</TD>
<TD>
<P>46/352</P>
</TD>
<TD>
<P>0.82 (0.54, 1.23)</P>
</TD>
</TR>
<TR>
<TD>
<P>Arrhythmia</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>25/345</P>
</TD>
<TD>
<P>23/350</P>
</TD>
<TD>
<P>1.10 (0.64, 1.90)</P>
</TD>
</TR>
<TR>
<TD>
<P>Progressive respiratory distress</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>21/346</P>
</TD>
<TD>
<P>35/354</P>
</TD>
<TD>
<P>0.61 (0.36, 1.03)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI - confidence interval; NPPV - noninvasive positive pressure ventilation; RR - relative risk; SMC - standard medical care; * statistically significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2013-04-06 14:17:46 +0100" MODIFIED_BY="[Empty name]">Adverse events by bilevel NPPV versus CPAP</TITLE>
<TABLE COLS="5" ROWS="14">
<TR>
<TH>
<P>Adverse events</P>
</TH>
<TH>
<P>Sstudies</P>
</TH>
<TH>
<P>Bilevel NPPV group</P>
</TH>
<TH>
<P>CPAP group</P>
</TH>
<TH>
<P>RR (95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Skin damage</P>
</TD>
<TD>
<P>5 studies (Mehta 1997, Martin-Bermudez 2002, Crane 2004, Park 2004, Gray 2008)</P>
</TD>
<TD>
<P>4/400</P>
</TD>
<TD>
<P>6/390</P>
</TD>
<TD>
<P>0.64 (0.19, 2.16)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pulmonary aspiration</P>
</TD>
<TD>
<P>3 studies (Mehta 1997, Martin-Bermudez 2002, Gray 2008)</P>
</TD>
<TD>
<P>1/407</P>
</TD>
<TD>
<P>0/389</P>
</TD>
<TD>
<P>2.88 (0.12, 70.43)</P>
</TD>
</TR>
<TR>
<TD>
<P>Gastric distension</P>
</TD>
<TD>
<P>3 studies (Mehta 1997, Martin-Bermudez 2002, Park 2004)</P>
</TD>
<TD>
<P>8/89</P>
</TD>
<TD>
<P>5/83</P>
</TD>
<TD>
<P>1.49 (0.56, 4.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>4 studies (Martin-Bermudez 2002, Crane 2004, Park 2004, Gray 2008)</P>
</TD>
<TD>
<P>11/437</P>
</TD>
<TD>
<P>11/420</P>
</TD>
<TD>
<P>0.97 (0.43, 2.19)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pneumothorax</P>
</TD>
<TD>
<P>2 studies (Mehta 1997, Gray 2008)</P>
</TD>
<TD>
<P>1/365</P>
</TD>
<TD>
<P>0/350</P>
</TD>
<TD>
<P>2.89 (0.12, 70.63)</P>
</TD>
</TR>
<TR>
<TD>
<P>Mask discomfort</P>
</TD>
<TD>
<P>4 studies (Mehta 1997, Martin-Bermudez 2002, Park 2004, Gray 2008)</P>
</TD>
<TD>
<P>17/375</P>
</TD>
<TD>
<P>16/360</P>
</TD>
<TD>
<P>1.03 (0.53, 2.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Increased breathing discomfort</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>16/291</P>
</TD>
<TD>
<P>11/285</P>
</TD>
<TD>
<P>1.42 (0.67, 3.02)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypotension</P>
</TD>
<TD>
<P>2 studies (Martin-Bermudez 2002, Gray 2008)</P>
</TD>
<TD>
<P>41/387</P>
</TD>
<TD>
<P>40/371</P>
</TD>
<TD>
<P>0.98 (0.65, 1.48)</P>
</TD>
</TR>
<TR>
<TD>
<P>Arrhythmia</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>25/345</P>
</TD>
<TD>
<P>12/332</P>
</TD>
<TD>
<P>2.00 (1.02, 3.92)*</P>
</TD>
</TR>
<TR>
<TD>
<P>Progressive respiratory distress</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>21/346</P>
</TD>
<TD>
<P>17/333</P>
</TD>
<TD>
<P>1.19 (0.64, 2.21)</P>
</TD>
</TR>
<TR>
<TD>
<P>Cardiorespiratory arrest</P>
</TD>
<TD>
<P>1 study (Gray 2008)</P>
</TD>
<TD>
<P>10/345</P>
</TD>
<TD>
<P>6/333</P>
</TD>
<TD>
<P>1.61 (0.59, 4.38)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pharyngeal damage</P>
</TD>
<TD>
<P>1 study (Martin-Bermudez 2002)</P>
</TD>
<TD>
<P>1/41</P>
</TD>
<TD>
<P>1/39</P>
</TD>
<TD>
<P>0.95 (0.06, 14.69)</P>
</TD>
</TR>
<TR>
<TD>
<P>Cough</P>
</TD>
<TD>
<P>1 study (Martin-Bermudez 2002)</P>
</TD>
<TD>
<P>1/41</P>
</TD>
<TD>
<P>1/39</P>
</TD>
<TD>
<P>0.32 (0.01, 7.57)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI - confidence interval; CPAP - continuous positive airway pressure; NPPV - noninvasive positive pressure ventilation; RR - relative risk; SMC - standard medical care; * statistically significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-04-16 14:44:45 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-04-06 12:54:47 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Hospital mortality</NAME>
<DICH_OUTCOME CHI2="21.424825562455077" CI_END="0.8929776233130114" CI_START="0.4830668237097138" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6567860109180659" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="104" I2="11.317831061851665" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.04915942374688647" LOG_CI_START="-0.3159927881697818" LOG_EFFECT_SIZE="-0.18257610595833412" METHOD="MH" MODIFIED="2013-02-11 18:04:12 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3138086954122743" P_Q="1.0" P_Z="0.007315222888286735" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="20" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.05248299784043459" TOTALS="YES" TOTAL_1="598" TOTAL_2="509" WEIGHT="99.99999999999996" Z="2.682142788926282">
<NAME>NPPV (CPAP and BILEVEL) x SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7270985884096945" CI_START="0.14475143554497316" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.23731712921785653" LOG_CI_START="-0.8393771205458188" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13025" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="5.429417059547512"/>
<DICH_DATA CI_END="2.115709729958969" CI_START="0.6969244292065352" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3254560833421525" LOG_CI_START="-0.1568143119420807" LOG_EFFECT_SIZE="0.08432088570003587" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13019" O_E="0.0" SE="0.28328801746691673" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.08025210084033613" WEIGHT="18.50843470978607"/>
<DICH_DATA CI_END="2.427899066052217" CI_START="0.1029696841584531" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.38523062805078434" LOG_CI_START="-0.9872906193787466" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13013" O_E="0.0" SE="0.8062257748298549" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.6499999999999999" WEIGHT="3.497193405651772"/>
<DICH_DATA CI_END="2.2198220326012796" CI_START="0.2002162506350232" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34631815762298346" LOG_CI_START="-0.6985006757343459" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13020" O_E="0.0" SE="0.6137317546507323" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.3766666666666666" WEIGHT="5.724620361644029"/>
<DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13027" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="1.961478847909311"/>
<DICH_DATA CI_END="0.9757912475554729" CI_START="0.02091447665310805" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.010643081648438522" LOG_CI_START="-1.6795529983800752" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13028" O_E="0.0" SE="0.9803259463254868" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.961038961038961" WEIGHT="2.4239424573951376"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13026" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="1.0421992661508777"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13021" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="1.0421992661508777"/>
<DICH_DATA CI_END="2.1374255087371723" CI_START="0.3866550097832482" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3298909880981643" LOG_CI_START="-0.41267635841461436" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13015" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.19025974025974024" WEIGHT="10.120669013036423"/>
<DICH_DATA CI_END="43.49940689111513" CI_START="0.08662568892945194" EFFECT_SIZE="1.9411764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.638483335444938" LOG_CI_START="-1.062353298445711" LOG_EFFECT_SIZE="0.2880650184996135" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13023" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="2.516934046345811" WEIGHT="0.9561386358780528"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13018" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="3.9376075531159374"/>
<DICH_DATA CI_END="9.457412222749872" CI_START="0.026434292395400003" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9757723191583028" LOG_CI_START="-1.5778323104862653" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13029" O_E="0.0" SE="1.5" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="2.25" WEIGHT="1.0669867746838015"/>
<DICH_DATA CI_END="1.2498387186188826" CI_START="0.021525131079781504" EFFECT_SIZE="0.164021164021164" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.09685397450170918" LOG_CI_START="-1.667054195179652" LOG_EFFECT_SIZE="-0.7851001103389715" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13016" O_E="0.0" SE="1.0361283903570913" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="1.0735620413039768" WEIGHT="2.1817234854981584"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13022" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="8.20296582619337"/>
<DICH_DATA CI_END="1.7553147303648262" CI_START="0.47899411270804515" EFFECT_SIZE="0.9169435215946844" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.24435499738647806" LOG_CI_START="-0.3196698244437294" LOG_EFFECT_SIZE="-0.037657413528625644" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13017" O_E="0.0" SE="0.33131097231096013" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.1097669603736338" WEIGHT="15.14156881562166"/>
<DICH_DATA CI_END="0.8913237996836371" CI_START="0.06520125872785698" EFFECT_SIZE="0.24107142857142858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="-0.04996449700715811" LOG_CI_START="-1.1857440200152305" LOG_EFFECT_SIZE="-0.6178542585111942" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13024" O_E="0.0" SE="0.6671625140142543" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.4451058201058201" WEIGHT="4.937247018069866"/>
<DICH_DATA CI_END="1.2008537868107867" CI_START="0.14457306378005058" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.07949013192673515" LOG_CI_START="-0.8399126153499471" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="13014" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="0.2916666666666667" WEIGHT="7.138518967172676"/>
<DICH_DATA CI_END="4.745176453876752" CI_START="0.05268507977100682" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6762523667148672" LOG_CI_START="-1.2783123580428297" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="451" O_E="0.0" SE="1.148120994574099" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.3181818181818183" WEIGHT="1.7923557086404194"/>
<DICH_DATA CI_END="22.801387382009104" CI_START="0.11227386987951042" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3579612730539414" LOG_CI_START="-0.9497213077420916" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="414" O_E="0.0" SE="1.355544171172596" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="1.8375" WEIGHT="1.2998629672527184"/>
<DICH_DATA CI_END="0.7366979722073639" CI_START="0.03273937506443277" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.13271052555758273" LOG_CI_START="-1.4849296147426083" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 17:50:20 +0000" MODIFIED_BY="[Empty name]" ORDER="1414" O_E="0.0" SE="0.7943001865797283" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.6309127864005912" WEIGHT="3.5948698606013036"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="20.319677417157866" CI_END="0.9144150014463429" CI_START="0.460188529315299" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6486935291024873" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="98" I2="21.258592488827333" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.03885665773096619" LOG_CI_START="-0.33706421078070714" LOG_EFFECT_SIZE="-0.18796043425583667" METHOD="MH" MODIFIED="2013-02-11 18:04:27 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2061664728577116" P_Q="1.0" P_Z="0.013483629570227298" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0993334439913989" TOTALS="YES" TOTAL_1="550" TOTAL_2="473" WEIGHT="100.0" Z="2.4707334062628536">
<NAME>NPPV (CPAP and BILEVEL) X SMC - sensitivity analysis</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7366979722073639" CI_START="0.03273937506443277" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.13271052555758273" LOG_CI_START="-1.4849296147426083" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="1817" O_E="0.0" SE="0.7943001865797283" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.6309127864005912" WEIGHT="4.20187528958279"/>
<DICH_DATA CI_END="4.745176453876752" CI_START="0.05268507977100682" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6762523667148672" LOG_CI_START="-1.2783123580428297" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="1008" O_E="0.0" SE="1.148120994574099" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.3181818181818183" WEIGHT="2.1646353112917183"/>
<DICH_DATA CI_END="1.2008537868107867" CI_START="0.14457306378005058" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.07949013192673515" LOG_CI_START="-0.8399126153499471" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13257" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="0.2916666666666667" WEIGHT="7.847577295133915"/>
<DICH_DATA CI_END="2.1374255087371723" CI_START="0.3866550097832482" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3298909880981643" LOG_CI_START="-0.41267635841461436" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13258" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.19025974025974024" WEIGHT="10.595565633665338"/>
<DICH_DATA CI_END="1.2498387186188826" CI_START="0.021525131079781504" EFFECT_SIZE="0.164021164021164" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.09685397450170918" LOG_CI_START="-1.667054195179652" LOG_EFFECT_SIZE="-0.7851001103389715" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13259" O_E="0.0" SE="1.0361283903570913" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="1.0735620413039768" WEIGHT="2.6160929334827765"/>
<DICH_DATA CI_END="1.7553147303648262" CI_START="0.47899411270804515" EFFECT_SIZE="0.9169435215946844" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.24435499738647806" LOG_CI_START="-0.3196698244437294" LOG_EFFECT_SIZE="-0.037657413528625644" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13260" O_E="0.0" SE="0.33131097231096013" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.1097669603736338" WEIGHT="14.674307302813636"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13261" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="4.574504101687881"/>
<DICH_DATA CI_END="2.115709729958969" CI_START="0.6969244292065352" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3254560833421525" LOG_CI_START="-0.1568143119420807" LOG_EFFECT_SIZE="0.08432088570003587" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13262" O_E="0.0" SE="0.28328801746691673" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.08025210084033613" WEIGHT="17.086027684856617"/>
<DICH_DATA CI_END="2.2198220326012796" CI_START="0.2002162506350232" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34631815762298346" LOG_CI_START="-0.6985006757343459" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13263" O_E="0.0" SE="0.6137317546507323" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.3766666666666666" WEIGHT="6.446224532496529"/>
<DICH_DATA CI_END="22.67918836256158" CI_START="0.08642284585613896" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="1.355627508070598" LOG_CI_START="-1.063371436714122" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13264" O_E="0.0" SE="1.4209319544044392" STUDY_ID="STD-Masip-2000" TOTAL_1="2" TOTAL_2="20" VAR="2.019047619047619" WEIGHT="1.4484663049211595"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13265" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="8.859461660817106"/>
<DICH_DATA CI_END="43.49940689111513" CI_START="0.08662568892945194" EFFECT_SIZE="1.9411764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.638483335444938" LOG_CI_START="-1.062353298445711" LOG_EFFECT_SIZE="0.2880650184996135" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13266" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="2.516934046345811" WEIGHT="1.1728172299383646"/>
<DICH_DATA CI_END="0.8913237996836371" CI_START="0.06520125872785698" EFFECT_SIZE="0.24107142857142858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="-0.04996449700715811" LOG_CI_START="-1.1857440200152305" LOG_EFFECT_SIZE="-0.6178542585111942" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13267" O_E="0.0" SE="0.6671625140142543" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.4451058201058201" WEIGHT="5.63589695516003"/>
<DICH_DATA CI_END="1.7270985884096945" CI_START="0.14475143554497316" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.23731712921785653" LOG_CI_START="-0.8393771205458188" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13268" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="6.144999153807806"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="528" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="1.2763235835826028"/>
<DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13269" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="2.361521290000287"/>
<DICH_DATA CI_END="0.9757912475554729" CI_START="0.02091447665310805" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.010643081648438522" LOG_CI_START="-1.6795529983800752" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13270" O_E="0.0" SE="0.9803259463254868" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.961038961038961" WEIGHT="2.8937037367614553"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 17:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13271" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.611397355660268" CI_END="0.8587149899030238" CI_START="0.35514567344550063" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5522399056450518" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="58" I2="16.765484726435705" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.0661509559025517" LOG_CI_START="-0.4495934717428486" LOG_EFFECT_SIZE="-0.25787221382270015" METHOD="MH" MODIFIED="2013-02-11 18:03:14 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.29336659124040143" P_Q="1.0" P_Z="0.008383427879750667" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.07544941586247532" TOTALS="YES" TOTAL_1="400" TOTAL_2="317" WEIGHT="99.99999999999999" Z="2.6362243665051004">
<NAME>NPPV (CPAP and BILEVEL) X SMC- ED place</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7366979722073639" CI_START="0.03273937506443277" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.13271052555758273" LOG_CI_START="-1.4849296147426083" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="1818" O_E="0.0" SE="0.7943001865797283" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.6309127864005912" WEIGHT="7.182047665143572"/>
<DICH_DATA CI_END="1.2008537868107867" CI_START="0.14457306378005058" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.07949013192673515" LOG_CI_START="-0.8399126153499471" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="13272" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="0.2916666666666667" WEIGHT="13.818863424776328"/>
<DICH_DATA CI_END="1.2498387186188826" CI_START="0.021525131079781504" EFFECT_SIZE="0.164021164021164" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.09685397450170918" LOG_CI_START="-1.667054195179652" LOG_EFFECT_SIZE="-0.7851001103389715" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="13273" O_E="0.0" SE="1.0361283903570913" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="1.0735620413039768" WEIGHT="4.415210112891161"/>
<DICH_DATA CI_END="1.7553147303648262" CI_START="0.47899411270804515" EFFECT_SIZE="0.9169435215946844" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.24435499738647806" LOG_CI_START="-0.3196698244437294" LOG_EFFECT_SIZE="-0.037657413528625644" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="13274" O_E="0.0" SE="0.33131097231096013" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.1097669603736338" WEIGHT="27.390272440283766"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="13275" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="7.842478960760495"/>
<DICH_DATA CI_END="2.2198220326012796" CI_START="0.2002162506350232" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34631815762298346" LOG_CI_START="-0.6985006757343459" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="13276" O_E="0.0" SE="0.6137317546507323" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.3766666666666666" WEIGHT="11.220850576980155"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="13277" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="15.732677091737045"/>
<DICH_DATA CI_END="0.8913237996836371" CI_START="0.06520125872785698" EFFECT_SIZE="0.24107142857142858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="-0.04996449700715811" LOG_CI_START="-1.1857440200152305" LOG_EFFECT_SIZE="-0.6178542585111942" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="13278" O_E="0.0" SE="0.6671625140142543" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.4451058201058201" WEIGHT="9.745607487882628"/>
<DICH_DATA CI_END="22.801387382009104" CI_START="0.11227386987951042" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3579612730539414" LOG_CI_START="-0.9497213077420916" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2013-02-11 18:01:36 +0000" MODIFIED_BY="[Empty name]" ORDER="1012" O_E="0.0" SE="1.355544171172596" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="1.8375" WEIGHT="2.651992239544845"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.0566284631426415" CI_END="0.8312155295612842" CI_START="0.28239659340138695" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.48449193381359457" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="35" I2="0.9349832747253957" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-0.08028635147136862" LOG_CI_START="-0.5491405465575682" LOG_EFFECT_SIZE="-0.3147134490144684" METHOD="MH" MODIFIED="2013-02-11 18:05:09 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.4168766777066023" P_Q="1.0" P_Z="0.008508133587629597" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.005466515778450091" TOTALS="YES" TOTAL_1="207" TOTAL_2="158" WEIGHT="100.00000000000001" Z="2.6312104359238426">
<NAME>NPPV (CPAP and BILEVEL) X SMC - ICU place</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7366979722073639" CI_START="0.03273937506443277" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.13271052555758273" LOG_CI_START="-1.4849296147426083" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:03:33 +0000" MODIFIED_BY="[Empty name]" ORDER="600" O_E="0.0" SE="0.7943001865797283" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.6309127864005912" WEIGHT="11.918861423664845"/>
<DICH_DATA CI_END="4.745176453876752" CI_START="0.05268507977100682" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6762523667148672" LOG_CI_START="-1.2783123580428297" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:03:33 +0000" MODIFIED_BY="[Empty name]" ORDER="599" O_E="0.0" SE="1.148120994574099" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.3181818181818183" WEIGHT="5.730311081091274"/>
<DICH_DATA CI_END="2.1374255087371723" CI_START="0.3866550097832482" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3298909880981643" LOG_CI_START="-0.41267635841461436" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 18:03:33 +0000" MODIFIED_BY="[Empty name]" ORDER="13279" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.19025974025974024" WEIGHT="38.75267871102869"/>
<DICH_DATA CI_END="2.577129902321556" CI_START="0.0970071395216797" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.41113631006800627" LOG_CI_START="-1.0131963013959688" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:03:33 +0000" MODIFIED_BY="[Empty name]" ORDER="13280" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.7" WEIGHT="10.751632495542218"/>
<DICH_DATA CI_END="1.7270985884096945" CI_START="0.14475143554497316" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.23731712921785653" LOG_CI_START="-0.8393771205458188" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:03:33 +0000" MODIFIED_BY="[Empty name]" ORDER="13281" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="18.70664141278927"/>
<DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 18:03:33 +0000" MODIFIED_BY="[Empty name]" ORDER="13282" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="6.29210070647416"/>
<DICH_DATA CI_END="0.9757912475554729" CI_START="0.02091447665310805" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.010643081648438522" LOG_CI_START="-1.6795529983800752" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-02-11 18:03:33 +0000" MODIFIED_BY="[Empty name]" ORDER="13283" O_E="0.0" SE="0.9803259463254868" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.961038961038961" WEIGHT="7.84777416940954"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.845947260808303" CI_END="0.8832967625386542" CI_START="0.4010485848729509" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5951847752076546" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="51" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.0538933613373208" LOG_CI_START="-0.3968030117586438" LOG_EFFECT_SIZE="-0.22534818654798228" METHOD="MH" MODIFIED="2013-02-11 18:06:26 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.44866167193135353" P_Q="1.0" P_Z="0.009993935109312116" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="338" TOTAL_2="265" WEIGHT="100.0" Z="2.5760390766068357">
<NAME>NPPV (CPAP and BILEVEL) X SMC - in patients hypercanics - baseline</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7366979722073639" CI_START="0.03273937506443277" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.13271052555758273" LOG_CI_START="-1.4849296147426083" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="601" O_E="0.0" SE="0.7943001865797283" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.6309127864005912" WEIGHT="6.430804247795875"/>
<DICH_DATA CI_END="2.427899066052217" CI_START="0.1029696841584531" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.38523062805078434" LOG_CI_START="-0.9872906193787466" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="13284" O_E="0.0" SE="0.8062257748298549" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.6499999999999999" WEIGHT="6.241964041190237"/>
<DICH_DATA CI_END="1.2008537868107867" CI_START="0.14457306378005058" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.07949013192673515" LOG_CI_START="-0.8399126153499471" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="13285" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="0.2916666666666667" WEIGHT="13.91066272036681"/>
<DICH_DATA CI_END="1.7553147303648262" CI_START="0.47899411270804515" EFFECT_SIZE="0.9169435215946844" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.24435499738647806" LOG_CI_START="-0.3196698244437294" LOG_EFFECT_SIZE="-0.037657413528625644" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="13286" O_E="0.0" SE="0.33131097231096013" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.1097669603736338" WEIGHT="36.962639877820806"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="602" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="7.100234096853893"/>
<DICH_DATA CI_END="22.67918836256158" CI_START="0.08642284585613896" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="1.355627508070598" LOG_CI_START="-1.063371436714122" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="13287" O_E="0.0" SE="1.4209319544044392" STUDY_ID="STD-Masip-2000" TOTAL_1="2" TOTAL_2="20" VAR="2.019047619047619" WEIGHT="2.0095002160907245"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="13288" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="16.425652779671882"/>
<DICH_DATA CI_END="0.8913237996836371" CI_START="0.06520125872785698" EFFECT_SIZE="0.24107142857142858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="-0.04996449700715811" LOG_CI_START="-1.1857440200152305" LOG_EFFECT_SIZE="-0.6178542585111942" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="13289" O_E="0.0" SE="0.6671625140142543" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.4451058201058201" WEIGHT="9.11530796386592"/>
<DICH_DATA CI_END="9.457412222749872" CI_START="0.026434292395400003" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9757723191583028" LOG_CI_START="-1.5778323104862653" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="603" O_E="0.0" SE="1.5" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="2.25" WEIGHT="1.8032340563438458"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.92129604657362" CI_END="0.9361374575872956" CI_START="0.3892187805146045" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6036242868176939" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="86" I2="33.04055706230976" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-0.028660377021895934" LOG_CI_START="-0.40980621239885695" LOG_EFFECT_SIZE="-0.21923329471037642" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.11810131053579442" P_Q="1.0" P_Z="0.024150648167680915" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.18165803114768203" TOTALS="YES" TOTAL_1="348" TOTAL_2="351" WEIGHT="99.99999999999999" Z="2.254724160474806">
<NAME>CPAP x SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="1417" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="3.8522202525046225"/>
<DICH_DATA CI_END="2.427899066052217" CI_START="0.1029696841584531" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.38523062805078434" LOG_CI_START="-0.9872906193787466" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13095" O_E="0.0" SE="0.8062257748298549" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.6499999999999999" WEIGHT="6.02716076600216"/>
<DICH_DATA CI_END="1.2804065064867485" CI_START="0.004621313413620057" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.10734787237939857" LOG_CI_START="-2.3352345769930722" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13096" O_E="0.0" SE="1.4347850217395144" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.058608058608059" WEIGHT="2.2374737889330074"/>
<DICH_DATA CI_END="2.1374255087371723" CI_START="0.3866550097832482" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3298909880981643" LOG_CI_START="-0.41267635841461436" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13097" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.19025974025974024" WEIGHT="13.47754004089485"/>
<DICH_DATA CI_END="1.4473642164370495" CI_START="0.07435016546998537" EFFECT_SIZE="0.328042328042328" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.16057783124703495" LOG_CI_START="-1.1287180605970155" LOG_EFFECT_SIZE="-0.4840701146749903" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13098" O_E="0.0" SE="0.7573387889867894" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.5735620413039768" WEIGHT="6.637186747158074"/>
<DICH_DATA CI_END="1.7553147303648262" CI_START="0.47899411270804515" EFFECT_SIZE="0.9169435215946844" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.24435499738647806" LOG_CI_START="-0.3196698244437294" LOG_EFFECT_SIZE="-0.037657413528625644" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13099" O_E="0.0" SE="0.33131097231096013" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.1097669603736338" WEIGHT="17.20009196842432"/>
<DICH_DATA CI_END="2.115709729958969" CI_START="0.6969244292065352" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3254560833421525" LOG_CI_START="-0.1568143119420807" LOG_EFFECT_SIZE="0.08432088570003587" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13100" O_E="0.0" SE="0.28328801746691673" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.08025210084033613" WEIGHT="19.13838391060497"/>
<DICH_DATA CI_END="2.2198220326012796" CI_START="0.2002162506350232" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34631815762298346" LOG_CI_START="-0.6985006757343459" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13101" O_E="0.0" SE="0.6137317546507323" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.3766666666666666" WEIGHT="8.977816449256657"/>
<DICH_DATA CI_END="72.08425860083103" CI_START="0.15107320532078622" EFFECT_SIZE="3.3" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8578404360205125" LOG_CI_START="-0.8208125562647377" LOG_EFFECT_SIZE="0.5185139398778874" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13102" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" VAR="2.4757575757575756" WEIGHT="1.8862449076610013"/>
<DICH_DATA CI_END="1.2929612153521088" CI_START="0.02148384456390142" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.11158549764822756" LOG_CI_START="-1.6678879984155148" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13103" O_E="0.0" SE="1.04527154012371" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="1.0925925925925928" WEIGHT="3.9337133234832105"/>
<DICH_DATA CI_END="1.7270985884096945" CI_START="0.14475143554497316" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.23731712921785653" LOG_CI_START="-0.8393771205458188" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13104" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="8.617669468387751"/>
<DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13105" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="3.627914102522329"/>
<DICH_DATA CI_END="0.9757912475554729" CI_START="0.02091447665310805" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.010643081648438522" LOG_CI_START="-1.6795529983800752" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-02-11 17:52:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13106" O_E="0.0" SE="0.9803259463254868" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.961038961038961" WEIGHT="4.386584274167045"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="20.0805101274903" CI_END="-0.0398069762994088" CI_START="-0.19119451117440406" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RD" EFFECT_SIZE="-0.11550074373690643" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="82" I2="45.22051516539435" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="NaN" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.044248742588372525" P_Q="1.0" P_Z="0.0027833942363438106" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.007486755794209465" TOTALS="YES" TOTAL_1="328" TOTAL_2="331" WEIGHT="100.0" Z="2.9906993082204907">
<NAME>CPAP X SMC - sensitivity analysis</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="-0.006806972846497186" CI_START="-0.24042140852822563" EFFECT_SIZE="-0.1236141906873614" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="1822" O_E="0.0" SE="0.05959661440833844" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="0.003551756448936173" WEIGHT="13.511809616609993"/>
<DICH_DATA CI_END="-0.09180164482399125" CI_START="-0.5081983551760088" EFFECT_SIZE="-0.3" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13333" O_E="0.0" SE="0.10622560252037833" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.011283878630817408" WEIGHT="7.945936855556701"/>
<DICH_DATA CI_END="0.25379912419033773" CI_START="-0.31743548782670133" EFFECT_SIZE="-0.0318181818181818" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13334" O_E="0.0" SE="0.14572579305611347" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.02123600676183321" WEIGHT="5.1927552438240046"/>
<DICH_DATA CI_END="-0.025253625045550038" CI_START="-0.35228520410618236" EFFECT_SIZE="-0.18876941457586618" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13335" O_E="0.0" SE="0.08342795623802673" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.006960223882054105" WEIGHT="10.323976306622535"/>
<DICH_DATA CI_END="0.16354539383390543" CI_START="-0.2141015111240976" EFFECT_SIZE="-0.02527805864509608" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13336" O_E="0.0" SE="0.09634026643775948" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.009281446937298484" WEIGHT="8.894827804040357"/>
<DICH_DATA CI_END="0.287878391400762" CI_START="-0.137878391400762" EFFECT_SIZE="0.07500000000000001" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13337" O_E="0.0" SE="0.1086134199811423" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.011796875" WEIGHT="7.734553594792407"/>
<DICH_DATA CI_END="0.07733621952904292" CI_START="-0.15733621952904292" EFFECT_SIZE="-0.039999999999999994" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13338" O_E="0.0" SE="0.05986651818838307" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.0035840000000000004" WEIGHT="13.472456501842005"/>
<DICH_DATA CI_END="0.36435182767603785" CI_START="-0.14212960545381564" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13339" O_E="0.0" SE="0.12920682143266773" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" VAR="0.016694402704733283" WEIGHT="6.168036816206451"/>
<DICH_DATA CI_END="-0.012949063093849827" CI_START="-0.35742130727652055" EFFECT_SIZE="-0.18518518518518517" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13340" O_E="0.0" SE="0.08787718725951696" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="0.00772240004064421" WEIGHT="9.80661106372557"/>
<DICH_DATA CI_END="0.10460679016713872" CI_START="-0.40460679016713874" EFFECT_SIZE="-0.15" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13341" O_E="0.0" SE="0.1299038105676658" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.016875" WEIGHT="6.1223122479314"/>
<DICH_DATA CI_END="0.10522588582895429" CI_START="-0.37189255249562103" EFFECT_SIZE="-0.13333333333333336" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13342" O_E="0.0" SE="0.12171612389003691" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="0.014814814814814815" WEIGHT="6.687882144930592"/>
<DICH_DATA CI_END="-0.21428464189509777" CI_START="-0.8766244490139931" EFFECT_SIZE="-0.5454545454545454" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:19:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13343" O_E="0.0" SE="0.16896734132447003" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.028549962434259956" WEIGHT="4.138841803917981"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.2561023741339605" CI_END="1.0864404387882192" CI_START="0.3852119196838561" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.64692333939021" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="35" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.03600592226754508" LOG_CI_START="-0.41430028288490484" LOG_EFFECT_SIZE="-0.1891471803086799" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6185686782400921" P_Q="1.0" P_Z="0.0996543935630712" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="250" TOTAL_2="256" WEIGHT="99.99999999999997" Z="1.6465314354565004">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="1420" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="6.249537847253035"/>
<DICH_DATA CI_END="4.745176453876752" CI_START="0.05268507977100682" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6762523667148672" LOG_CI_START="-1.2783123580428297" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="464" O_E="0.0" SE="1.148120994574099" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.3181818181818183" WEIGHT="5.307814664494834"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13170" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="26.237492943809684"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13171" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="12.244163373777855"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13172" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="3.0357429852341786"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13173" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="28.325597918576545"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13174" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.4077010501059621" CI_START="0.0684192939987241" EFFECT_SIZE="0.3103448275862069" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.14851043458276453" LOG_CI_START="-1.164821411502027" LOG_EFFECT_SIZE="-0.5081554884596312" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13175" O_E="0.0" SE="0.771457627487693" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.59514687100894" WEIGHT="11.756198555080392"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13176" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="3.0357429852341786"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="13177" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="22.801387382009104" CI_START="0.11227386987951042" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3579612730539414" LOG_CI_START="-0.9497213077420916" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2013-02-11 17:55:53 +0000" MODIFIED_BY="[Empty name]" ORDER="403" O_E="0.0" SE="1.355544171172596" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="1.8375" WEIGHT="3.807708726539275"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.754285923891884" CI_END="1.0891435902209057" CI_START="0.36705915227703045" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6322816800560073" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.03708513992995715" LOG_CI_START="-0.43526394273036634" LOG_EFFECT_SIZE="-0.19908940140020456" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.4512704540888376" P_Q="1.0" P_Z="0.09849337291775352" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="229" TOTAL_2="229" WEIGHT="100.00000000000001" Z="1.6522020292718396">
<NAME>BILEVEL X SMC - sensitivity analysis</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="1824" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="6.876353454883088"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="13366" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="28.86905874663014"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="13367" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="13.47222741509407"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="13368" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="3.3402216731638186"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="13369" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="31.16659629393981"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="13370" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.4077010501059621" CI_START="0.0684192939987241" EFFECT_SIZE="0.3103448275862069" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.14851043458276453" LOG_CI_START="-1.164821411502027" LOG_EFFECT_SIZE="-0.5081554884596312" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="13371" O_E="0.0" SE="0.771457627487693" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.59514687100894" WEIGHT="12.935320743125267"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="529" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="3.3402216731638186"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:20:48 +0000" MODIFIED_BY="[Empty name]" ORDER="13372" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.934541105863378" CI_END="1.023522493541195" CI_START="0.3385760721768202" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.588676673266236" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.01009739141813949" LOG_CI_START="-0.4703437375701544" LOG_EFFECT_SIZE="-0.2301231730760074" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.5588785427647323" P_Q="1.0" P_Z="0.06043875570909515" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="202" TOTAL_2="199" WEIGHT="100.0" Z="1.8775791830596655">
<NAME>BILEVEL X SMC - in patients hypercanics - baseline</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:22:04 +0000" MODIFIED_BY="[Empty name]" ORDER="607" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="7.113976023855589"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 18:22:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13373" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="29.8666717908405"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:22:04 +0000" MODIFIED_BY="[Empty name]" ORDER="608" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="13.937780169058902"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 18:22:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13374" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="3.455647975799727"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:22:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13375" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="32.24360414789701"/>
<DICH_DATA CI_END="1.4077010501059621" CI_START="0.0684192939987241" EFFECT_SIZE="0.3103448275862069" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.14851043458276453" LOG_CI_START="-1.164821411502027" LOG_EFFECT_SIZE="-0.5081554884596312" MODIFIED="2013-02-11 18:22:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13376" O_E="0.0" SE="0.771457627487693" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.59514687100894" WEIGHT="13.382319892548276"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:22:04 +0000" MODIFIED_BY="[Empty name]" ORDER="609" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.003168296221746183" CI_END="0.8625430660220513" CI_START="0.044534882950930506" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.19599299601115538" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-0.06421921176911606" LOG_CI_START="-1.3512996847838146" LOG_EFFECT_SIZE="-0.7077594482764654" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.9551127106294358" P_Q="1.0" P_Z="0.031118835986543202" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="55" TOTAL_2="49" WEIGHT="100.0" Z="2.1555498003798395">
<NAME>BILEVEL X SMC - in patients hypercanics</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6718635249956648" CI_START="0.02502527410263055" EFFECT_SIZE="0.20454545454545456" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.22320082288746676" LOG_CI_START="-1.6016211569811916" LOG_EFFECT_SIZE="-0.6892101670468626" MODIFIED="2013-02-11 18:25:30 +0000" MODIFIED_BY="[Empty name]" ORDER="625" O_E="0.0" SE="1.071909463989333" STUDY_ID="STD-Agmy-2008" TOTAL_1="22" TOTAL_2="18" VAR="1.148989898989899" WEIGHT="49.7474009733435"/>
<DICH_DATA CI_END="1.5194654936458305" CI_START="0.023230826288859585" EFFECT_SIZE="0.18787878787878787" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.18169084190239357" LOG_CI_START="-1.6339353426616607" LOG_EFFECT_SIZE="-0.7261222503796336" MODIFIED="2013-02-11 18:25:30 +0000" MODIFIED_BY="[Empty name]" ORDER="623" O_E="0.0" SE="1.0665078083074875" STUDY_ID="STD-Nava-2003" TOTAL_1="33" TOTAL_2="31" VAR="1.1374389051808407" WEIGHT="50.252599026656505"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.17735386230732" CI_END="1.9685704708142753" CI_START="0.614517463333644" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="1.099873143648078" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="26" I2="1.586724948428088" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.29415096626263065" LOG_CI_START="-0.2114657708382724" LOG_EFFECT_SIZE="0.041342597712179116" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.42852711063459004" P_Q="1.0" P_Z="0.7485745790920946" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.017544352367279043" TOTALS="YES" TOTAL_1="347" TOTAL_2="347" WEIGHT="100.0" Z="0.32051946305340945">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.4889800508606" CI_START="0.06456203034133534" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.190022820414652" LOG_CI_START="-1.1900228204146521" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="1.3980505908390635" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="44" VAR="1.9545454545454546" WEIGHT="4.472922763376168"/>
<DICH_DATA CI_END="107.33008636188617" CI_START="0.275196480362374" EFFECT_SIZE="5.434782608695652" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0307214788105274" LOG_CI_START="-0.5603571248296005" LOG_EFFECT_SIZE="0.7351821769904635" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13219" O_E="0.0" SE="1.522012397824155" STUDY_ID="STD-Bellone-2004" TOTAL_1="22" TOTAL_2="24" VAR="2.3165217391304345" WEIGHT="3.7792440500696602"/>
<DICH_DATA CI_END="69.09028858730679" CI_START="0.1302643277951726" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8394170067179525" LOG_CI_START="-0.8851744972786274" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13220" O_E="0.0" SE="1.6004385363930504" STUDY_ID="STD-Bellone-2005" TOTAL_1="18" TOTAL_2="18" VAR="2.5614035087719293" WEIGHT="3.420389191143067"/>
<DICH_DATA CI_END="1.5422965811171738" CI_START="0.005358543169388946" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.1881678958663492" LOG_CI_START="-2.2709532661827994" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13221" O_E="0.0" SE="1.444499943433743" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.0865800865800868" WEIGHT="4.1922451094075885"/>
<DICH_DATA CI_END="3.3941805428002123" CI_START="0.11226258323174593" EFFECT_SIZE="0.6172839506172839" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5307349395304163" LOG_CI_START="-0.9497649686156782" LOG_EFFECT_SIZE="-0.20951501454263097" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="394" O_E="0.0" SE="0.8696529746377553" STUDY_ID="STD-Ferrari-2007" TOTAL_1="27" TOTAL_2="25" VAR="0.7562962962962962" WEIGHT="11.398994617297474"/>
<DICH_DATA CI_END="1.2922110638903557" CI_START="0.06317284795214462" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.11133345514244113" LOG_CI_START="-1.1994695438429925" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="469" O_E="0.0" SE="0.7699721701835351" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.5928571428571427" WEIGHT="14.451152983363722"/>
<DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="583" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Fontanella-2010" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="4.6007584910222885"/>
<DICH_DATA CI_END="12.174646810603075" CI_START="0.5133619149063762" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0854563710833007" LOG_CI_START="-0.2895763537392256" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="586" O_E="0.0" SE="0.8077010290825141" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="42" TOTAL_2="42" VAR="0.6523809523809523" WEIGHT="13.16714763010356"/>
<DICH_DATA CI_END="22.509252726006434" CI_START="0.22197715105018606" EFFECT_SIZE="2.235294117647059" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3523610773035457" LOG_CI_START="-0.6536917268264734" LOG_EFFECT_SIZE="0.34933467523853623" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13222" O_E="0.0" SE="1.1783653472675046" STUDY_ID="STD-Mehta-1997" TOTAL_1="17" TOTAL_2="19" VAR="1.388544891640867" WEIGHT="6.273432092843017"/>
<DICH_DATA CI_END="6.288926694015676" CI_START="0.6360385793344134" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7985765324658621" LOG_CI_START="-0.1965165411378997" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="399" O_E="0.0" SE="0.5845225972250061" STUDY_ID="STD-Moritz-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.3416666666666667" WEIGHT="24.556611354754928"/>
<DICH_DATA CI_END="51.3197562011779" CI_START="0.11223747785200497" EFFECT_SIZE="2.4" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.710284584555295" LOG_CI_START="-0.9498621011320829" LOG_EFFECT_SIZE="0.38021124171160603" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13223" O_E="0.0" SE="1.5625833311112296" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" VAR="2.4416666666666664" WEIGHT="3.5869249610906695"/>
<DICH_DATA CI_END="5.589232695646902" CI_START="0.051600782227968996" EFFECT_SIZE="0.5370370370370371" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7473521909062447" LOG_CI_START="-1.2873437147542695" LOG_EFFECT_SIZE="-0.26999576192401237" MODIFIED="2013-02-11 17:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13224" O_E="0.0" SE="1.1951904468921568" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="29" VAR="1.4284802043422733" WEIGHT="6.100176755527854"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.478298209284253" CI_END="2.143725407798751" CI_START="0.4476414245941084" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9796021108009204" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="18" I2="15.596662783158893" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.33116915531404784" LOG_CI_START="-0.3490697308117073" LOG_EFFECT_SIZE="-0.00895028774882974" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.3035659446397395" P_Q="1.0" P_Z="0.958865977924926" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.22245057691390102" TOTALS="YES" TOTAL_1="261" TOTAL_2="257" WEIGHT="100.00000000000001" Z="0.051576709290722146">
<NAME>CPAP X BILEVEL - in patients hypercanics - baseline</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.4889800508606" CI_START="0.06456203034133534" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.190022820414652" LOG_CI_START="-1.1900228204146521" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="613" O_E="0.0" SE="1.3980505908390635" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="44" VAR="1.9545454545454546" WEIGHT="7.333992753789696"/>
<DICH_DATA CI_END="3.6337674038680188" CI_START="0.009317052039148534" EFFECT_SIZE="0.184" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5603571248296005" LOG_CI_START="-2.0307214788105274" LOG_EFFECT_SIZE="-0.7351821769904635" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="13394" O_E="0.0" SE="1.522012397824155" STUDY_ID="STD-Bellone-2004" TOTAL_1="24" TOTAL_2="22" VAR="2.3165217391304345" WEIGHT="6.288399845425113"/>
<DICH_DATA CI_END="7.676698731922972" CI_START="0.014473814199463616" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8851744972786274" LOG_CI_START="-1.8394170067179525" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="13395" O_E="0.0" SE="1.6004385363930504" STUDY_ID="STD-Bellone-2005" TOTAL_1="18" TOTAL_2="18" VAR="2.5614035087719293" WEIGHT="5.735240651385806"/>
<DICH_DATA CI_END="186.617886315178" CI_START="0.6483837234960623" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2709532661827994" LOG_CI_START="-0.18816789586634924" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="13396" O_E="0.0" SE="1.444499943433743" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.0865800865800868" WEIGHT="6.914621521566213"/>
<DICH_DATA CI_END="3.3941805428002123" CI_START="0.11226258323174593" EFFECT_SIZE="0.6172839506172839" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5307349395304163" LOG_CI_START="-0.9497649686156782" LOG_EFFECT_SIZE="-0.20951501454263097" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="614" O_E="0.0" SE="0.8696529746377553" STUDY_ID="STD-Ferrari-2007" TOTAL_1="27" TOTAL_2="25" VAR="0.7562962962962962" WEIGHT="16.312770499470027"/>
<DICH_DATA CI_END="1.2922110638903557" CI_START="0.06317284795214462" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.11133345514244113" LOG_CI_START="-1.1994695438429925" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="615" O_E="0.0" SE="0.7699721701835351" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.5928571428571427" WEIGHT="19.5828798533092"/>
<DICH_DATA CI_END="12.174646810603075" CI_START="0.5133619149063762" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0854563710833007" LOG_CI_START="-0.2895763537392256" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="616" O_E="0.0" SE="0.8077010290825141" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="42" TOTAL_2="42" VAR="0.6523809523809523" WEIGHT="18.25045461338263"/>
<DICH_DATA CI_END="22.509252726006434" CI_START="0.22197715105018606" EFFECT_SIZE="2.235294117647059" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3523610773035457" LOG_CI_START="-0.6536917268264734" LOG_EFFECT_SIZE="0.34933467523853623" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="617" O_E="0.0" SE="1.1783653472675046" STUDY_ID="STD-Mehta-1997" TOTAL_1="17" TOTAL_2="19" VAR="1.388544891640867" WEIGHT="9.910687789876333"/>
<DICH_DATA CI_END="19.379551177772136" CI_START="0.17891543516855837" EFFECT_SIZE="1.8620689655172413" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2873437147542695" LOG_CI_START="-0.7473521909062447" LOG_EFFECT_SIZE="0.2699957619240124" MODIFIED="2013-02-11 18:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="13397" O_E="0.0" SE="1.1951904468921568" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="1.4284802043422733" WEIGHT="9.670952471794994"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.005341284190628781" CI_END="3.3741158496767327" CI_START="0.3312636021643548" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.057223614229155" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.5281599899340736" LOG_CI_START="-0.47982627992717347" LOG_EFFECT_SIZE="0.024166855003450043" METHOD="MH" MODIFIED="2013-02-11 19:41:40 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.9417392023352819" P_Q="1.0" P_Z="0.9251236403762363" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="47" TOTAL_2="51" WEIGHT="100.0" Z="0.09398176709864077">
<NAME>CPAP X BILEVEL - in patients hypercanics</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<DICH_DATA CI_END="17.280655904606014" CI_START="0.07758503085807585" EFFECT_SIZE="1.1578947368421053" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.237560222537839" LOG_CI_START="-1.1102220627990844" LOG_EFFECT_SIZE="0.0636690798693773" MODIFIED="2013-02-11 18:27:27 +0000" MODIFIED_BY="[Empty name]" ORDER="638" O_E="0.0" SE="1.3790989361166537" STUDY_ID="STD-Agmy-2008" TOTAL_1="19" TOTAL_2="22" VAR="1.9019138755980862" WEIGHT="18.432896735243652"/>
<DICH_DATA CI_END="3.743537969164376" CI_START="0.2865482039900612" EFFECT_SIZE="1.0357142857142858" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5732822423565237" LOG_CI_START="-0.54280230924305" LOG_EFFECT_SIZE="0.015239966556736905" MODIFIED="2013-02-11 18:27:27 +0000" MODIFIED_BY="[Empty name]" ORDER="656" O_E="0.0" SE="0.6555935903172213" STUDY_ID="STD-Moritz-2007" TOTAL_1="28" TOTAL_2="29" VAR="0.42980295566502463" WEIGHT="81.56710326475635"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-04-16 14:43:05 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>EETI rate</NAME>
<DICH_OUTCOME CHI2="35.658239426748835" CI_END="0.7500688939927105" CI_START="0.35666774774772936" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5172285598031208" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="146" I2="46.71638222904731" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.1248988447326517" LOG_CI_START="-0.44773616066016736" LOG_EFFECT_SIZE="-0.2863175026964095" METHOD="MH" MODIFIED="2013-02-11 18:12:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.011622787692734171" P_Q="1.0" P_Z="5.080038880458007E-4" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.2863270896869677" TOTALS="YES" TOTAL_1="675" TOTAL_2="586" WEIGHT="100.0" Z="3.4765001797648973">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8743483718723556" CI_START="0.15889046552143893" EFFECT_SIZE="0.37272727272727274" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="-0.05831549432563452" LOG_CI_START="-0.7989021625513445" LOG_EFFECT_SIZE="-0.4286088284384895" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="1415" O_E="0.0" SE="0.43502427487891365" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.18924611973392463" WEIGHT="7.56180159866116"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="452" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="2.654977190912422"/>
<DICH_DATA CI_END="1.0942083056670993" CI_START="0.004061790082771148" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.039100006997564246" LOG_CI_START="-2.391282525108927" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13030" O_E="0.0" SE="1.4276187299469136" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="2.0380952380952384" WEIGHT="1.547132899343014"/>
<DICH_DATA CI_END="50.95043024524692" CI_START="0.12872503808498176" EFFECT_SIZE="2.5609756097560976" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.707147855709426" LOG_CI_START="-0.8903369710090208" LOG_EFFECT_SIZE="0.4084054423502026" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13031" O_E="0.0" SE="1.5257754449716752" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="2.3279907084785134" WEIGHT="1.375575019151398"/>
<DICH_DATA CI_END="2.364625144143514" CI_START="0.3495041415078417" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.3737623033261822" LOG_CI_START="-0.4565476736426324" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13032" O_E="0.0" SE="0.4877281905721545" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.23787878787878786" WEIGHT="6.860263131689556"/>
<DICH_DATA CI_END="4.943824870337866" CI_START="0.05056813430021737" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6940630779397805" LOG_CI_START="-1.296123069267743" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="473" O_E="0.0" SE="1.1690451944500122" STUDY_ID="STD-Ferrer-2003" TOTAL_1="15" TOTAL_2="15" VAR="1.3666666666666667" WEIGHT="2.1755619109005084"/>
<DICH_DATA CI_END="3.8526364229800345" CI_START="0.11536111785515027" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5857580261570842" LOG_CI_START="-0.9379405442684468" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="593" O_E="0.0" SE="0.8950280826975231" STUDY_ID="STD-Frontin-2010" TOTAL_1="62" TOTAL_2="62" VAR="0.8010752688172043" WEIGHT="3.307138546421982"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13033" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.773110492974689" CI_START="0.1031695619921994" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4429671741336449" LOG_CI_START="-0.9864484132576323" LOG_EFFECT_SIZE="-0.2717406195619937" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13034" O_E="0.0" SE="0.8396457917549096" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.705005055611729" WEIGHT="3.6276340602228325"/>
<DICH_DATA CI_END="1.8942671028263436" CI_START="0.26934115092396554" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.27744121706681374" LOG_CI_START="-0.5696972884232897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13035" O_E="0.0" SE="0.4976133515281193" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.24761904761904763" WEIGHT="6.735118027866307"/>
<DICH_DATA CI_END="0.8834048901615281" CI_START="0.19192804443201444" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.053840200997608285" LOG_CI_START="-0.7168615617304259" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13036" O_E="0.0" SE="0.38946202930312424" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.15168067226890758" WEIGHT="8.210334536586593"/>
<DICH_DATA CI_END="0.9267001555176237" CI_START="0.21315509986851866" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.033060764096141525" LOG_CI_START="-0.6713042721265834" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13037" O_E="0.0" SE="0.3749073959733998" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.14055555555555557" WEIGHT="8.424306528639109"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13038" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="2.6579503699789284"/>
<DICH_DATA CI_END="1.550251766402913" CI_START="0.4258380892103588" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.19040223486730365" LOG_CI_START="-0.37075549556547965" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13039" O_E="0.0" SE="0.32962682863178194" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.10865384615384616" WEIGHT="9.104718554640995"/>
<DICH_DATA CI_END="1.6715906045340252" CI_START="0.13144759362969213" EFFECT_SIZE="0.46875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.2231299214507131" LOG_CI_START="-0.8812473599791626" LOG_EFFECT_SIZE="-0.32905871926422475" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13040" O_E="0.0" SE="0.6487166818676188" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="0.4208333333333333" WEIGHT="5.085395248676244"/>
<DICH_DATA CI_END="0.5001136511201912" CI_START="0.06146351276125322" EFFECT_SIZE="0.17532467532467533" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.3009312907727554" LOG_CI_START="-1.2113826225821962" LOG_EFFECT_SIZE="-0.7561569566774757" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13041" O_E="0.0" SE="0.5348036191116428" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.28601491101491106" WEIGHT="6.283289101392551"/>
<DICH_DATA CI_END="1.0681664778949462" CI_START="0.23404591435286307" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.02863894444973777" LOG_CI_START="-0.6306989357777002" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13042" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.15000000000000002" WEIGHT="8.241959622216722"/>
<DICH_DATA CI_END="9.872894922206104" CI_START="1.6205986315131156" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="4" LOG_CI_END="0.9944445148172463" LOG_CI_START="0.20967546783867852" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13043" O_E="0.0" SE="0.4609772228646444" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.21250000000000002" WEIGHT="7.20929221694047"/>
<DICH_DATA CI_END="1.2221392528015427" CI_START="0.022728815651818755" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.0871206930405403" LOG_CI_START="-1.6434231938078274" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13044" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.0333333333333334" WEIGHT="2.7250876002242586"/>
<DICH_DATA CI_END="0.9217243669784655" CI_START="0.06780768984645952" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="-0.03539893122073283" LOG_CI_START="-1.1687210514351918" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13045" O_E="0.0" SE="0.6657190234489458" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.4431818181818181" WEIGHT="4.929604308445479"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13046" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 18:10:16 +0000" MODIFIED_BY="[Empty name]" ORDER="415" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="1.2828595270894776"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="33.364542552051105" CI_END="0.7790949977892198" CI_START="0.36659593659663614" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5344277878369473" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="138" I2="49.04770543915365" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.10840958404727828" LOG_CI_START="-0.4358123531311366" LOG_EFFECT_SIZE="-0.2721109685892074" METHOD="MH" MODIFIED="2013-02-11 18:37:50 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.010130533889539106" P_Q="1.0" P_Z="0.0011222797391637147" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.28598318268156536" TOTALS="YES" TOTAL_1="645" TOTAL_2="550" WEIGHT="100.00000000000001" Z="3.257930284007796">
<NAME>NPPV (CPAP and BILEVEL) X SMC - sensitivity analysis</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8743483718723556" CI_START="0.15889046552143893" EFFECT_SIZE="0.37272727272727274" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="-0.05831549432563452" LOG_CI_START="-0.7989021625513445" LOG_EFFECT_SIZE="-0.4286088284384895" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="1819" O_E="0.0" SE="0.43502427487891365" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.18924611973392463" WEIGHT="7.782814678474375"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="1013" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="2.731293149743391"/>
<DICH_DATA CI_END="50.95043024524692" CI_START="0.12872503808498176" EFFECT_SIZE="2.5609756097560976" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.707147855709426" LOG_CI_START="-0.8903369710090208" LOG_EFFECT_SIZE="0.4084054423502026" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13295" O_E="0.0" SE="1.5257754449716752" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="2.3279907084785134" WEIGHT="1.414942055461376"/>
<DICH_DATA CI_END="2.364625144143514" CI_START="0.3495041415078417" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.3737623033261822" LOG_CI_START="-0.4565476736426324" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13296" O_E="0.0" SE="0.4877281905721545" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.23787878787878786" WEIGHT="7.06029793787885"/>
<DICH_DATA CI_END="4.943824870337866" CI_START="0.05056813430021737" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6940630779397805" LOG_CI_START="-1.296123069267743" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="1015" O_E="0.0" SE="1.1690451944500122" STUDY_ID="STD-Ferrer-2003" TOTAL_1="15" TOTAL_2="15" VAR="1.3666666666666667" WEIGHT="2.237994691942196"/>
<DICH_DATA CI_END="3.8526364229800345" CI_START="0.11536111785515027" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5857580261570842" LOG_CI_START="-0.9379405442684468" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="598" O_E="0.0" SE="0.8950280826975231" STUDY_ID="STD-Frontin-2010" TOTAL_1="62" TOTAL_2="62" VAR="0.8010752688172043" WEIGHT="3.40241280069253"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13297" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.773110492974689" CI_START="0.1031695619921994" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4429671741336449" LOG_CI_START="-0.9864484132576323" LOG_EFFECT_SIZE="-0.2717406195619937" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13298" O_E="0.0" SE="0.8396457917549096" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.705005055611729" WEIGHT="3.732255790290987"/>
<DICH_DATA CI_END="1.8942671028263436" CI_START="0.26934115092396554" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.27744121706681374" LOG_CI_START="-0.5696972884232897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13299" O_E="0.0" SE="0.4976133515281193" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.24761904761904763" WEIGHT="6.9314207858478"/>
<DICH_DATA CI_END="0.8834048901615281" CI_START="0.19192804443201444" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.053840200997608285" LOG_CI_START="-0.7168615617304259" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13300" O_E="0.0" SE="0.38946202930312424" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.15168067226890758" WEIGHT="8.450827155692256"/>
<DICH_DATA CI_END="0.9267001555176237" CI_START="0.21315509986851866" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.033060764096141525" LOG_CI_START="-0.6713042721265834" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13301" O_E="0.0" SE="0.3749073959733998" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.14055555555555557" WEIGHT="8.671244271427183"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13302" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="2.7343525689686627"/>
<DICH_DATA CI_END="1.550251766402913" CI_START="0.4258380892103588" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.19040223486730365" LOG_CI_START="-0.37075549556547965" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13303" O_E="0.0" SE="0.32962682863178194" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.10865384615384616" WEIGHT="9.372211222538295"/>
<DICH_DATA CI_END="1.6715906045340252" CI_START="0.13144759362969213" EFFECT_SIZE="0.46875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.2231299214507131" LOG_CI_START="-0.8812473599791626" LOG_EFFECT_SIZE="-0.32905871926422475" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13304" O_E="0.0" SE="0.6487166818676188" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="0.4208333333333333" WEIGHT="5.23278885917042"/>
<DICH_DATA CI_END="0.5001136511201912" CI_START="0.06146351276125322" EFFECT_SIZE="0.17532467532467533" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.3009312907727554" LOG_CI_START="-1.2113826225821962" LOG_EFFECT_SIZE="-0.7561569566774757" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13305" O_E="0.0" SE="0.5348036191116428" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.28601491101491106" WEIGHT="6.466143211384617"/>
<DICH_DATA CI_END="1.0681664778949462" CI_START="0.23404591435286307" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.02863894444973777" LOG_CI_START="-0.6306989357777002" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13306" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.15000000000000002" WEIGHT="8.483404262824106"/>
<DICH_DATA CI_END="9.872894922206104" CI_START="1.6205986315131156" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="4" LOG_CI_END="0.9944445148172463" LOG_CI_START="0.20967546783867852" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="530" O_E="0.0" SE="0.4609772228646444" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.21250000000000002" WEIGHT="7.419751997617778"/>
<DICH_DATA CI_END="1.2221392528015427" CI_START="0.022728815651818755" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.0871206930405403" LOG_CI_START="-1.6434231938078274" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13307" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.0333333333333334" WEIGHT="2.8034376478908913"/>
<DICH_DATA CI_END="0.9217243669784655" CI_START="0.06780768984645952" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="-0.03539893122073283" LOG_CI_START="-1.1687210514351918" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13308" O_E="0.0" SE="0.6657190234489458" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.4431818181818181" WEIGHT="5.072406912154287"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13309" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.473124394301195" CI_END="0.7712023027192921" CI_START="0.24969676843837324" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4388242504707771" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="61" I2="38.98784882453673" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-0.11283168235109063" LOG_CI_START="-0.6025870782272028" LOG_EFFECT_SIZE="-0.3577093802891467" METHOD="MH" MODIFIED="2013-02-11 18:38:13 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.11927178897418478" P_Q="1.0" P_Z="0.0041958213277834425" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.22836363365178192" TOTALS="YES" TOTAL_1="356" TOTAL_2="265" WEIGHT="99.99999999999999" Z="2.863051671108972">
<NAME>NPPV (CPAP and BILEVEL) X SMC - in patients hypercapnics - baseline</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8743483718723556" CI_START="0.15889046552143893" EFFECT_SIZE="0.37272727272727274" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="-0.05831549432563452" LOG_CI_START="-0.7989021625513445" LOG_EFFECT_SIZE="-0.4286088284384895" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="604" O_E="0.0" SE="0.43502427487891365" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.18924611973392463" WEIGHT="19.818146291418124"/>
<DICH_DATA CI_END="1.0942083056670993" CI_START="0.004061790082771148" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.039100006997564246" LOG_CI_START="-2.391282525108927" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13310" O_E="0.0" SE="1.4276187299469136" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="2.0380952380952384" WEIGHT="3.651622047278325"/>
<DICH_DATA CI_END="50.95043024524692" CI_START="0.12872503808498176" EFFECT_SIZE="2.5609756097560976" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.707147855709426" LOG_CI_START="-0.8903369710090208" LOG_EFFECT_SIZE="0.4084054423502026" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13311" O_E="0.0" SE="1.5257754449716752" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="2.3279907084785134" WEIGHT="3.2375211248782123"/>
<DICH_DATA CI_END="2.773110492974689" CI_START="0.1031695619921994" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4429671741336449" LOG_CI_START="-0.9864484132576323" LOG_EFFECT_SIZE="-0.2717406195619937" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13312" O_E="0.0" SE="0.8396457917549096" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.705005055611729" WEIGHT="8.867076087426376"/>
<DICH_DATA CI_END="1.8942671028263436" CI_START="0.26934115092396554" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.27744121706681374" LOG_CI_START="-0.5696972884232897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="605" O_E="0.0" SE="0.4976133515281193" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.24761904761904763" WEIGHT="17.387714954720945"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13313" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="6.390778025259983"/>
<DICH_DATA CI_END="1.550251766402913" CI_START="0.4258380892103588" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.19040223486730365" LOG_CI_START="-0.37075549556547965" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13314" O_E="0.0" SE="0.32962682863178194" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.10865384615384616" WEIGHT="24.557335097557058"/>
<DICH_DATA CI_END="0.5001136511201912" CI_START="0.06146351276125322" EFFECT_SIZE="0.17532467532467533" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.3009312907727554" LOG_CI_START="-1.2113826225821962" LOG_EFFECT_SIZE="-0.7561569566774757" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13315" O_E="0.0" SE="0.5348036191116428" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.28601491101491106" WEIGHT="16.089806371460966"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="606" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.465483522868993" CI_END="0.6654261557537738" CI_START="0.3267473177621692" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.46628983643366817" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="101" I2="10.883259560491098" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="-0.17690013241777885" LOG_CI_START="-0.4857879688151159" LOG_EFFECT_SIZE="-0.3313440506164474" METHOD="MH" MODIFIED="2013-02-11 18:38:13 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.3361340976004067" P_Q="1.0" P_Z="2.6118883735344316E-5" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.045847397888421404" TOTALS="YES" TOTAL_1="410" TOTAL_2="415" WEIGHT="99.99999999999999" Z="4.2049076018938525">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="1418" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="2.8249000745397765"/>
<DICH_DATA CI_END="1.0942083056670993" CI_START="0.004061790082771148" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.039100006997564246" LOG_CI_START="-2.391282525108927" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13107" O_E="0.0" SE="1.4276187299469136" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="2.0380952380952384" WEIGHT="1.5797597967704364"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13108" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.257845498028208"/>
<DICH_DATA CI_END="2.624838988613523" CI_START="0.38097574911755405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4191026683129021" LOG_CI_START="-0.41910266831290216" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13109" O_E="0.0" SE="0.4923659639173309" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.24242424242424238" WEIGHT="11.420231249706358"/>
<DICH_DATA CI_END="8.668431951705076" CI_START="0.2595625151740882" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9379405442684465" LOG_CI_START="-0.5857580261570842" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="589" O_E="0.0" SE="0.8950280826975231" STUDY_ID="STD-Frontin-2010" TOTAL_1="62" TOTAL_2="62" VAR="0.8010752688172043" WEIGHT="3.8871657643885875"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13110" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.773110492974689" CI_START="0.1031695619921994" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4429671741336449" LOG_CI_START="-0.9864484132576323" LOG_EFFECT_SIZE="-0.2717406195619937" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13111" O_E="0.0" SE="0.8396457917549096" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.705005055611729" WEIGHT="4.384521592433119"/>
<DICH_DATA CI_END="0.8834048901615281" CI_START="0.19192804443201444" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.053840200997608285" LOG_CI_START="-0.7168615617304259" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13112" O_E="0.0" SE="0.38946202930312424" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.15168067226890758" WEIGHT="16.666637771941218"/>
<DICH_DATA CI_END="0.9267001555176237" CI_START="0.21315509986851866" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.033060764096141525" LOG_CI_START="-0.6713042721265834" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13113" O_E="0.0" SE="0.3749073959733998" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.14055555555555557" WEIGHT="17.661355328751466"/>
<DICH_DATA CI_END="2.755097441814039" CI_START="0.2520580339210077" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4401369635122246" LOG_CI_START="-0.5984994556074743" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13114" O_E="0.0" SE="0.6101001739241041" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" VAR="0.3722222222222221" WEIGHT="7.874594652994688"/>
<DICH_DATA CI_END="0.7440063492545441" CI_START="0.04443221657018341" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.1284233582250261" LOG_CI_START="-1.3523020207634615" LOG_EFFECT_SIZE="-0.7403626894942439" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13115" O_E="0.0" SE="0.7189123846721636" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="0.5168350168350169" WEIGHT="5.850776048725274"/>
<DICH_DATA CI_END="1.0681664778949462" CI_START="0.23404591435286307" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.02863894444973777" LOG_CI_START="-0.6306989357777002" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13116" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.15000000000000002" WEIGHT="16.80966318979838"/>
<DICH_DATA CI_END="1.2221392528015427" CI_START="0.022728815651818755" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.0871206930405403" LOG_CI_START="-1.6434231938078274" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13117" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.0333333333333334" WEIGHT="3.050581519719808"/>
<DICH_DATA CI_END="0.9217243669784655" CI_START="0.06780768984645952" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="-0.03539893122073283" LOG_CI_START="-1.1687210514351918" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13118" O_E="0.0" SE="0.6657190234489458" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.4431818181818181" WEIGHT="6.731967512202674"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.337958294001918" CI_END="0.6723911503947472" CI_START="0.3449845358427883" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4816269811002394" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="94" I2="2.9807685408466114" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-0.17237801111599915" LOG_CI_START="-0.46220037202431014" LOG_EFFECT_SIZE="-0.3172891915701546" METHOD="MH" MODIFIED="2013-02-11 18:38:10 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.41539996528803935" P_Q="1.0" P_Z="1.7753057571496633E-5" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.010757796377109911" TOTALS="YES" TOTAL_1="390" TOTAL_2="395" WEIGHT="100.00000000000001" Z="4.291424486449968">
<NAME>CPAP X SMC - sensitivity analysis</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="1823" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="2.564145039937119"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13344" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.122409670498346"/>
<DICH_DATA CI_END="2.624838988613523" CI_START="0.38097574911755405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4191026683129021" LOG_CI_START="-0.41910266831290216" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13345" O_E="0.0" SE="0.4923659639173309" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="22" VAR="0.24242424242424238" WEIGHT="11.447379774550642"/>
<DICH_DATA CI_END="8.668431951705076" CI_START="0.2595625151740882" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9379405442684465" LOG_CI_START="-0.5857580261570842" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="596" O_E="0.0" SE="0.8950280826975231" STUDY_ID="STD-Frontin-2010" TOTAL_1="62" TOTAL_2="62" VAR="0.8010752688172043" WEIGHT="3.570033144142001"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13346" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.773110492974689" CI_START="0.1031695619921994" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4429671741336449" LOG_CI_START="-0.9864484132576323" LOG_EFFECT_SIZE="-0.2717406195619937" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13347" O_E="0.0" SE="0.8396457917549096" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.705005055611729" WEIGHT="4.049205602387548"/>
<DICH_DATA CI_END="0.8834048901615281" CI_START="0.19192804443201444" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.053840200997608285" LOG_CI_START="-0.7168615617304259" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13348" O_E="0.0" SE="0.38946202930312424" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.15168067226890758" WEIGHT="17.842269595448766"/>
<DICH_DATA CI_END="0.9267001555176237" CI_START="0.21315509986851866" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.033060764096141525" LOG_CI_START="-0.6713042721265834" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13349" O_E="0.0" SE="0.3749073959733998" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.14055555555555557" WEIGHT="19.154099180512684"/>
<DICH_DATA CI_END="2.755097441814039" CI_START="0.2520580339210077" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4401369635122246" LOG_CI_START="-0.5984994556074743" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13350" O_E="0.0" SE="0.6101001739241041" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" VAR="0.3722222222222221" WEIGHT="7.56768188808885"/>
<DICH_DATA CI_END="0.7440063492545441" CI_START="0.04443221657018341" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.1284233582250261" LOG_CI_START="-1.3523020207634615" LOG_EFFECT_SIZE="-0.7403626894942439" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13351" O_E="0.0" SE="0.7189123846721636" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="0.5168350168350169" WEIGHT="5.4933859553708535"/>
<DICH_DATA CI_END="1.0681664778949462" CI_START="0.23404591435286307" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.02863894444973777" LOG_CI_START="-0.6306989357777002" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13352" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.15000000000000002" WEIGHT="18.028804920013048"/>
<DICH_DATA CI_END="1.2221392528015427" CI_START="0.022728815651818755" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.0871206930405403" LOG_CI_START="-1.6434231938078274" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13353" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.0333333333333334" WEIGHT="2.7758792961471377"/>
<DICH_DATA CI_END="0.9217243669784655" CI_START="0.06780768984645952" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="-0.03539893122073283" LOG_CI_START="-1.1687210514351918" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:32:50 +0000" MODIFIED_BY="[Empty name]" ORDER="13354" O_E="0.0" SE="0.6657190234489458" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.4431818181818181" WEIGHT="6.384705932903015"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="25.548591466120925" CI_END="1.1675031937637157" CI_START="0.25948067069399355" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5504039532517808" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="61" I2="60.858898960200435" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.06725807727417639" LOG_CI_START="-0.585894988195472" LOG_EFFECT_SIZE="-0.2593184554606478" METHOD="MH" MODIFIED="2013-02-11 18:38:07 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0043971784824923255" P_Q="1.0" P_Z="0.11963402379483361" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.8029972944881494" TOTALS="YES" TOTAL_1="265" TOTAL_2="271" WEIGHT="100.00000000000001" Z="1.5563115603352924">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1421" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="7.656465021438719"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="465" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="7.8666491651855495"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13178" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="4.362196767537792"/>
<DICH_DATA CI_END="4.943824870337866" CI_START="0.05056813430021737" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6940630779397805" LOG_CI_START="-1.296123069267743" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="474" O_E="0.0" SE="1.1690451944500122" STUDY_ID="STD-Ferrer-2003" TOTAL_1="15" TOTAL_2="15" VAR="1.3666666666666667" WEIGHT="6.784419093527775"/>
<DICH_DATA CI_END="1.8942671028263436" CI_START="0.26934115092396554" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.27744121706681374" LOG_CI_START="-0.5696972884232897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13179" O_E="0.0" SE="0.4976133515281193" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.24761904761904763" WEIGHT="14.010737330693384"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13180" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="7.8730241960196645"/>
<DICH_DATA CI_END="1.550251766402913" CI_START="0.4258380892103588" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.19040223486730365" LOG_CI_START="-0.37075549556547965" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13181" O_E="0.0" SE="0.32962682863178194" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.10865384615384616" WEIGHT="16.14642811090205"/>
<DICH_DATA CI_END="2.453236202902516" CI_START="0.009514391380292033" EFFECT_SIZE="0.1527777777777778" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.389739365034198" LOG_CI_START="-2.021618987580285" LOG_EFFECT_SIZE="-0.8159398112730434" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13182" O_E="0.0" SE="1.4164438327421005" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" VAR="2.0063131313131315" WEIGHT="5.239687814278971"/>
<DICH_DATA CI_END="0.6951086510889302" CI_START="0.041224316133599045" EFFECT_SIZE="0.16927899686520376" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.1579473063733935" LOG_CI_START="-1.3848465400950318" LOG_EFFECT_SIZE="-0.7713969232342126" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13183" O_E="0.0" SE="0.7206866831372454" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.5193892952513643" WEIGHT="11.131320991010195"/>
<DICH_DATA CI_END="9.872894922206104" CI_START="1.6205986315131156" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="4" LOG_CI_END="0.9944445148172463" LOG_CI_START="0.20967546783867852" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13184" O_E="0.0" SE="0.4609772228646444" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.21250000000000002" WEIGHT="14.49527210411452"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13185" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 18:14:04 +0000" MODIFIED_BY="[Empty name]" ORDER="406" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="4.433799405291382"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.074746137521242" CI_END="0.804042102353766" CI_START="0.25746472453284724" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4549862397867915" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="56" I2="20.593532672692294" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="-0.09472120953366318" LOG_CI_START="-0.5892822656137895" LOG_EFFECT_SIZE="-0.34200173757372637" METHOD="MH" MODIFIED="2013-02-11 18:38:04 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.25981896661769566" P_Q="1.0" P_Z="0.006713498882265828" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.14799363070067442" TOTALS="YES" TOTAL_1="235" TOTAL_2="235" WEIGHT="100.00000000000003" Z="2.7107313851498334">
<NAME>BILEVEL X SMC - sensitivity analysis</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="1825" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="6.658132110305402"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="490" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="6.93935015492196"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13377" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="3.1034045699145567"/>
<DICH_DATA CI_END="4.943824870337866" CI_START="0.05056813430021737" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6940630779397805" LOG_CI_START="-1.296123069267743" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="491" O_E="0.0" SE="1.1690451944500122" STUDY_ID="STD-Ferrer-2003" TOTAL_1="15" TOTAL_2="15" VAR="1.3666666666666667" WEIGHT="5.571854827306032"/>
<DICH_DATA CI_END="1.8942671028263436" CI_START="0.26934115092396554" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.27744121706681374" LOG_CI_START="-0.5696972884232897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13378" O_E="0.0" SE="0.4976133515281193" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.24761904761904763" WEIGHT="21.332651232159176"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13379" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="6.948006210383875"/>
<DICH_DATA CI_END="1.550251766402913" CI_START="0.4258380892103588" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.19040223486730365" LOG_CI_START="-0.37075549556547965" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13380" O_E="0.0" SE="0.32962682863178194" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.10865384615384616" WEIGHT="32.883499939486576"/>
<DICH_DATA CI_END="2.453236202902516" CI_START="0.009514391380292033" EFFECT_SIZE="0.1527777777777778" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.389739365034198" LOG_CI_START="-2.021618987580285" LOG_EFFECT_SIZE="-0.8159398112730434" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13381" O_E="0.0" SE="1.4164438327421005" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" VAR="2.0063131313131315" WEIGHT="3.91748632944268"/>
<DICH_DATA CI_END="0.6951086510889302" CI_START="0.041224316133599045" EFFECT_SIZE="0.16927899686520376" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.1579473063733935" LOG_CI_START="-1.3848465400950318" LOG_EFFECT_SIZE="-0.7713969232342126" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13382" O_E="0.0" SE="0.7206866831372454" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.5193892952513643" WEIGHT="12.645614626079764"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:34:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13383" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.576719622060358" CI_END="0.9719414705303759" CI_START="0.22260864948797612" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.46514790995566613" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="46" I2="41.70265299171729" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="-0.012359887122107003" LOG_CI_START="-0.6524579651049934" LOG_EFFECT_SIZE="-0.3324089261135503" METHOD="MH" MODIFIED="2013-02-11 18:38:01 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.12718593339838213" P_Q="1.0" P_Z="0.04178498035658117" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3176813223519278" TOTALS="YES" TOTAL_1="202" TOTAL_2="199" WEIGHT="100.0" Z="2.0356553026225868">
<NAME>BILEVEL X SMC - in patients hypercapnics - baseline</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:35:11 +0000" MODIFIED_BY="[Empty name]" ORDER="610" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="9.8365280268708"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 18:35:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13384" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="4.893326437031715"/>
<DICH_DATA CI_END="1.8942671028263436" CI_START="0.26934115092396554" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.27744121706681374" LOG_CI_START="-0.5696972884232897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-02-11 18:35:11 +0000" MODIFIED_BY="[Empty name]" ORDER="611" O_E="0.0" SE="0.4976133515281193" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.24761904761904763" WEIGHT="25.00857698616378"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 18:35:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13385" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="10.212286170002963"/>
<DICH_DATA CI_END="1.550251766402913" CI_START="0.4258380892103588" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.19040223486730365" LOG_CI_START="-0.37075549556547965" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2013-02-11 18:35:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13386" O_E="0.0" SE="0.32962682863178194" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.10865384615384616" WEIGHT="33.16019617212165"/>
<DICH_DATA CI_END="0.6951086510889302" CI_START="0.041224316133599045" EFFECT_SIZE="0.16927899686520376" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.1579473063733935" LOG_CI_START="-1.3848465400950318" LOG_EFFECT_SIZE="-0.7713969232342126" MODIFIED="2013-02-11 18:35:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13387" O_E="0.0" SE="0.7206866831372454" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.5193892952513643" WEIGHT="16.889086207809097"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:35:11 +0000" MODIFIED_BY="[Empty name]" ORDER="612" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7958019318862027" CI_END="0.6921759846940384" CI_START="0.11630470693536338" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.28373107874805803" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="-0.1597834727907927" LOG_CI_START="-0.9344027087050049" LOG_EFFECT_SIZE="-0.5470930907478988" METHOD="MH" MODIFIED="2013-02-11 18:37:58 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.6717287697905161" P_Q="1.0" P_Z="0.00563078124898343" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="58" WEIGHT="100.0" Z="2.7685415087609284">
<NAME>BILEVEL X SMC - in patients hypercapnics</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4108693296773402" CI_START="0.11861861930126438" EFFECT_SIZE="0.4090909090909091" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.14948679261474837" LOG_CI_START="-0.925847135380511" LOG_EFFECT_SIZE="-0.38818017138288136" MODIFIED="2013-02-11 18:36:23 +0000" MODIFIED_BY="[Empty name]" ORDER="636" O_E="0.0" SE="0.631656472293207" STUDY_ID="STD-Agmy-2008" TOTAL_1="22" TOTAL_2="18" VAR="0.398989898989899" WEIGHT="51.890739272642726"/>
<DICH_DATA CI_END="2.216215668397938" CI_START="0.008704082247886375" EFFECT_SIZE="0.1388888888888889" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.34561202096506394" LOG_CI_START="-2.0602770138276005" LOG_EFFECT_SIZE="-0.8573324964312684" MODIFIED="2013-02-11 18:36:23 +0000" MODIFIED_BY="[Empty name]" ORDER="631" O_E="0.0" SE="1.413231128380005" STUDY_ID="STD-Masip-2000" TOTAL_1="7" TOTAL_2="9" VAR="1.9972222222222222" WEIGHT="10.366338102260148"/>
<DICH_DATA CI_END="0.8913956986901371" CI_START="0.048887738337342224" EFFECT_SIZE="0.20875420875420875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.04992946587430438" LOG_CI_START="-1.3108000537636124" LOG_EFFECT_SIZE="-0.6803647598189585" MODIFIED="2013-02-11 18:36:23 +0000" MODIFIED_BY="[Empty name]" ORDER="635" O_E="0.0" SE="0.7406416247362498" STUDY_ID="STD-Nava-2003" TOTAL_1="33" TOTAL_2="31" VAR="0.5485500162919519" WEIGHT="37.74292262509712"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.816420987069258" CI_END="1.9681875906133135" CI_START="0.5546719674037263" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="1.044843760140762" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="0.2940664892607741" LOG_CI_START="-0.25596378239863216" LOG_EFFECT_SIZE="0.01905135343107098" METHOD="MH" MODIFIED="2013-02-11 18:37:55 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.8853279631143021" P_Q="1.0" P_Z="0.891999768846758" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="359" TOTAL_2="362" WEIGHT="100.0" Z="0.13577422373132447">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>CPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.7486937606574395" CI_START="0.2667595871647359" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5738799633639553" LOG_CI_START="-0.5738799633639553" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="1827" O_E="0.0" SE="0.6741998624632421" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="44" VAR="0.4545454545454546" WEIGHT="22.965244268378594"/>
<DICH_DATA CI_END="18.837295742088415" CI_START="0.17842853651234752" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.275018556175252" LOG_CI_START="-0.7485356866260893" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13225" O_E="0.0" SE="1.1886457789765579" STUDY_ID="STD-Bellone-2004" TOTAL_1="24" TOTAL_2="22" VAR="1.4128787878787878" WEIGHT="7.388282338352363"/>
<DICH_DATA CI_END="20.145619854387196" CI_START="0.19855432738789142" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3041806346034457" LOG_CI_START="-0.7021206432754833" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13226" O_E="0.0" SE="1.1785113019775793" STUDY_ID="STD-Bellone-2005" TOTAL_1="18" TOTAL_2="18" VAR="1.3888888888888888" WEIGHT="7.515898124196631"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13227" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="5.494077576167128"/>
<DICH_DATA CI_END="75.8304681762221" CI_START="0.13764744005310217" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8798437373227375" LOG_CI_START="-0.8612318611406102" LOG_EFFECT_SIZE="0.5093059380910637" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="395" O_E="0.0" SE="1.6101213750804138" STUDY_ID="STD-Ferrari-2007" TOTAL_1="25" TOTAL_2="27" VAR="2.5924908424908426" WEIGHT="4.026532022264767"/>
<DICH_DATA CI_END="131.2766945785389" CI_START="0.3732574175280195" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1181876330635214" LOG_CI_START="-0.42799155303500774" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="470" O_E="0.0" SE="1.4956382577045184" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" VAR="2.2369337979094075" WEIGHT="4.666542838448497"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="584" O_E="0.0" SE="0.0" STUDY_ID="STD-Fontanella-2010" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.021859875081781" CI_START="0.013784114918081134" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8464521586403041" LOG_CI_START="-1.8606211148345155" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13228" O_E="0.0" SE="1.5901482410679288" STUDY_ID="STD-Liesching-2003" TOTAL_1="14" TOTAL_2="13" VAR="2.528571428571428" WEIGHT="4.128318178701854"/>
<DICH_DATA CI_END="2.5843209551150403" CI_START="0.09673721040925096" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4123464490983779" LOG_CI_START="-1.0144064404263402" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="590" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="42" TOTAL_2="42" VAR="0.7023809523809523" WEIGHT="14.861945443326674"/>
<DICH_DATA CI_END="16.522005898291937" CI_START="0.07560431558894572" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2180627728678457" LOG_CI_START="-1.1214534137187355" LOG_EFFECT_SIZE="0.048304679574555046" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13229" O_E="0.0" SE="1.3742433887928538" STUDY_ID="STD-Mehta-1997" TOTAL_1="17" TOTAL_2="19" VAR="1.888544891640867" WEIGHT="5.527402309006174"/>
<DICH_DATA CI_END="21.472680254365798" CI_START="0.18628321907726103" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3318862571530974" LOG_CI_START="-0.7298262658251348" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="400" O_E="0.0" SE="1.2110601416389968" STUDY_ID="STD-Moritz-2007" TOTAL_1="60" TOTAL_2="60" VAR="1.4666666666666668" WEIGHT="7.117327769125597"/>
<DICH_DATA CI_END="2.9766502489416946" CI_START="0.010712630788040368" EFFECT_SIZE="0.17857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.47372780882273935" LOG_CI_START="-1.9701038628351402" LOG_EFFECT_SIZE="-0.7481880270062004" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13230" O_E="0.0" SE="1.4355188210937138" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="9" VAR="2.0607142857142855" WEIGHT="5.065596656015447"/>
<DICH_DATA CI_END="6.154089464619752" CI_START="0.14085352724705172" EFFECT_SIZE="0.9310344827586207" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7891638054811934" LOG_CI_START="-0.8512322729611309" LOG_EFFECT_SIZE="-0.03103423373996879" MODIFIED="2013-02-11 18:14:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13231" O_E="0.0" SE="0.9635767765685687" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.9284802043422733" WEIGHT="11.24283247601628"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.377922225876833" CI_END="2.3339320392536305" CI_START="0.5845760974426075" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="1.168058595791818" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-002.11" LOG_CI_END="0.36808820586237323" LOG_CI_START="-0.23315894635286172" LOG_EFFECT_SIZE="0.06746462975475567" METHOD="MH" MODIFIED="2013-02-11 18:39:10 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.9084548899968597" P_Q="1.0" P_Z="0.6600482473346194" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="259" TOTAL_2="259" WEIGHT="99.99999999999999" Z="0.43984655582140814">
<NAME>CPAP X BILEVEL - in patients hypercapnics - baseline</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.7486937606574395" CI_START="0.2667595871647359" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5738799633639553" LOG_CI_START="-0.5738799633639553" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="618" O_E="0.0" SE="0.6741998624632421" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="44" VAR="0.4545454545454546" WEIGHT="27.441253739338148"/>
<DICH_DATA CI_END="18.837295742088415" CI_START="0.17842853651234752" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.275018556175252" LOG_CI_START="-0.7485356866260893" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="13398" O_E="0.0" SE="1.1886457789765579" STUDY_ID="STD-Bellone-2004" TOTAL_1="24" TOTAL_2="22" VAR="1.4128787878787878" WEIGHT="8.828285385309862"/>
<DICH_DATA CI_END="20.145619854387196" CI_START="0.19855432738789142" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3041806346034457" LOG_CI_START="-0.7021206432754833" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="13399" O_E="0.0" SE="1.1785113019775793" STUDY_ID="STD-Bellone-2005" TOTAL_1="18" TOTAL_2="18" VAR="1.3888888888888888" WEIGHT="8.980773951056122"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="13400" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="6.564893239076112"/>
<DICH_DATA CI_END="75.8304681762221" CI_START="0.13764744005310217" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8798437373227375" LOG_CI_START="-0.8612318611406102" LOG_EFFECT_SIZE="0.5093059380910637" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="619" O_E="0.0" SE="1.6101213750804138" STUDY_ID="STD-Ferrari-2007" TOTAL_1="25" TOTAL_2="27" VAR="2.5924908424908426" WEIGHT="4.8113177295779295"/>
<DICH_DATA CI_END="131.2766945785389" CI_START="0.3732574175280195" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1181876330635214" LOG_CI_START="-0.42799155303500774" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="620" O_E="0.0" SE="1.4956382577045184" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" VAR="2.2369337979094075" WEIGHT="5.5760689770532785"/>
<DICH_DATA CI_END="2.5843209551150403" CI_START="0.09673721040925096" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4123464490983779" LOG_CI_START="-1.0144064404263402" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="621" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="42" TOTAL_2="42" VAR="0.7023809523809523" WEIGHT="17.758592558585555"/>
<DICH_DATA CI_END="16.522005898291937" CI_START="0.07560431558894572" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2180627728678457" LOG_CI_START="-1.1214534137187355" LOG_EFFECT_SIZE="0.048304679574555046" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="622" O_E="0.0" SE="1.3742433887928538" STUDY_ID="STD-Mehta-1997" TOTAL_1="17" TOTAL_2="19" VAR="1.888544891640867" WEIGHT="6.604713083313131"/>
<DICH_DATA CI_END="6.154089464619752" CI_START="0.14085352724705172" EFFECT_SIZE="0.9310344827586207" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7891638054811934" LOG_CI_START="-0.8512322729611309" LOG_EFFECT_SIZE="-0.03103423373996879" MODIFIED="2013-02-11 18:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="13401" O_E="0.0" SE="0.9635767765685687" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.9284802043422733" WEIGHT="13.434101336689865"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3263577159862586" CI_END="3.2147702208871296" CI_START="0.2638346595043644" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9209602633189589" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-002.12" LOG_CI_END="0.5071499367106129" LOG_CI_START="-0.5786681525245221" LOG_EFFECT_SIZE="-0.03575910790695457" METHOD="MH" MODIFIED="2013-02-11 18:39:49 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.5678118503392511" P_Q="1.0" P_Z="0.8972828857059855" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="47" TOTAL_2="51" WEIGHT="100.0" Z="0.12909448518449787">
<NAME>CPAP X BILEVEL - in patients hypercapnics</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.075881489904784" CI_START="0.2641354460842225" EFFECT_SIZE="1.1578947368421053" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.7055114737691546" LOG_CI_START="-0.5781733140304001" LOG_EFFECT_SIZE="0.0636690798693773" MODIFIED="2013-02-11 18:39:30 +0000" MODIFIED_BY="[Empty name]" ORDER="650" O_E="0.0" SE="0.7540427986956395" STUDY_ID="STD-Agmy-2008" TOTAL_1="19" TOTAL_2="22" VAR="0.5685805422647527" WEIGHT="71.54797650932501"/>
<DICH_DATA CI_END="5.395464497942404" CI_START="0.049703972755345535" EFFECT_SIZE="0.5178571428571429" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7320288392338558" LOG_CI_START="-1.3036088974483442" LOG_EFFECT_SIZE="-0.28579002910724427" MODIFIED="2013-02-11 18:39:30 +0000" MODIFIED_BY="[Empty name]" ORDER="657" O_E="0.0" SE="1.1957436830964336" STUDY_ID="STD-Moritz-2007" TOTAL_1="28" TOTAL_2="29" VAR="1.4298029556650245" WEIGHT="28.45202349067499"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-04-16 14:43:15 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Incidence of acute myocardial infarction (during intervention)</NAME>
<DICH_OUTCOME CHI2="6.143107690310827" CI_END="1.9546957760354016" CI_START="0.7884299208047013" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2414268548315184" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="32" I2="18.607970882779497" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.29107917448370924" LOG_CI_START="-0.10323690266529331" LOG_EFFECT_SIZE="0.09392113590920796" METHOD="MH" MODIFIED="2013-02-11 18:57:08 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.29254204789162697" P_Q="1.0" P_Z="0.35047023549911893" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.05999330316110475" TOTALS="YES" TOTAL_1="252" TOTAL_2="209" WEIGHT="99.99999999999999" Z="0.933677597424358">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2702994966838874" CI_START="0.4404705200616262" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.3560831528659938" LOG_CI_START="-0.35608315286599374" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13047" O_E="0.0" SE="0.4183300132670378" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="0.175" WEIGHT="22.830145918798607"/>
<DICH_DATA CI_END="2.876124507846021" CI_START="0.5800871183519357" EFFECT_SIZE="1.2916666666666667" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.45880768278874773" LOG_CI_START="-0.23650677854341443" LOG_EFFECT_SIZE="0.11115045212266668" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13048" O_E="0.0" SE="0.4084311564486052" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.16681600955794504" WEIGHT="23.653929094851915"/>
<DICH_DATA CI_END="2.5708795860891116" CI_START="0.2489420365944033" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4100817357942751" LOG_CI_START="-0.6039017618103879" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13049" O_E="0.0" SE="0.5956189257922424" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.3547619047619048" WEIGHT="12.935175492972673"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13050" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="16.423596083527194"/>
<DICH_DATA CI_END="4.184565039561249" CI_START="0.46838798811106686" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6216503223685584" LOG_CI_START="-0.3293942510120824" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13051" O_E="0.0" SE="0.5586482901503522" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.3120879120879121" WEIGHT="14.418710704107966"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13052" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="21.71482040802469" CI_START="1.3930578025329257" EFFECT_SIZE="5.5" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="2" LOG_CI_END="1.3367562418895258" LOG_CI_START="0.14396913709896197" LOG_EFFECT_SIZE="0.7403626894942439" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13053" O_E="0.0" SE="0.7006490497453707" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.4909090909090909" WEIGHT="9.738442705741631"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="13054" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6028260524586777" CI_END="2.238881890669507" CI_START="0.368029336981325" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.907730256079742" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" I2="37.6101980332778" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.3500311835372924" LOG_CI_START="-0.4341175607251782" LOG_EFFECT_SIZE="-0.04204318859394292" METHOD="MH" MODIFIED="2013-02-11 18:57:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2055032295774354" P_Q="1.0" P_Z="0.8335332721494555" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.17084572875609805" TOTALS="YES" TOTAL_1="74" TOTAL_2="78" WEIGHT="100.0" Z="0.2101722053176464">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7270985884096945" CI_START="0.14475143554497316" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.23731712921785653" LOG_CI_START="-0.8393771205458188" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:57:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13119" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="37.16664425477683"/>
<DICH_DATA CI_END="2.876124507846021" CI_START="0.5800871183519357" EFFECT_SIZE="1.2916666666666667" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.45880768278874773" LOG_CI_START="-0.23650677854341443" LOG_EFFECT_SIZE="0.11115045212266668" MODIFIED="2013-02-11 18:57:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13120" O_E="0.0" SE="0.4084311564486052" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.16681600955794504" WEIGHT="62.833355745223166"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:57:04 +0000" MODIFIED_BY="[Empty name]" ORDER="13121" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.863490025879457" CI_END="2.4909808722134303" CI_START="0.7835641335906531" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3970838446302376" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="24" I2="31.78124321273924" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.39637039268140717" LOG_CI_START="-0.10592545136560694" LOG_EFFECT_SIZE="0.14522247065790012" METHOD="MH" MODIFIED="2013-02-11 18:57:58 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.20957759519128616" P_Q="1.0" P_Z="0.25708016660496524" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.1377188224997143" TOTALS="YES" TOTAL_1="178" TOTAL_2="178" WEIGHT="100.0" Z="1.133319399747086">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4275937504674845" CI_START="0.6564371870771225" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5349893423102398" LOG_CI_START="-0.18280682419887723" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-02-11 18:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13186" O_E="0.0" SE="0.42163702135578396" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.1777777777777778" WEIGHT="27.59304886257254"/>
<DICH_DATA CI_END="2.5708795860891116" CI_START="0.2489420365944033" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4100817357942751" LOG_CI_START="-0.6039017618103879" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-02-11 18:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13187" O_E="0.0" SE="0.5956189257922424" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.3547619047619048" WEIGHT="17.67686048515713"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 18:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13188" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="21.52775839058495"/>
<DICH_DATA CI_END="4.184565039561249" CI_START="0.46838798811106686" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6216503223685584" LOG_CI_START="-0.3293942510120824" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-02-11 18:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13189" O_E="0.0" SE="0.5586482901503522" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.3120879120879121" WEIGHT="19.353896769494558"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13190" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="21.71482040802469" CI_START="1.3930578025329257" EFFECT_SIZE="5.5" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="2" LOG_CI_END="1.3367562418895258" LOG_CI_START="0.14396913709896197" LOG_EFFECT_SIZE="0.7403626894942439" MODIFIED="2013-02-11 18:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13191" O_E="0.0" SE="0.7006490497453707" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.4909090909090909" WEIGHT="13.848435492190823"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13192" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.65582560662332" CI_END="1.1032023431666256" CI_START="0.39098994957557215" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6567655811066624" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.042655175596414595" LOG_CI_START="-0.40783440603116294" LOG_EFFECT_SIZE="-0.18258961521737418" METHOD="MH" MODIFIED="2013-02-11 18:58:33 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.45930900579648015" P_Q="1.0" P_Z="0.11210540675968914" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="202" TOTAL_2="207" WEIGHT="100.0" Z="1.5888006487703086">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.895658519253885" CI_START="0.301010424873842" EFFECT_SIZE="1.6363636363636365" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9491781031442141" LOG_CI_START="-0.521418463254052" LOG_EFFECT_SIZE="0.21387981994508107" MODIFIED="2013-02-11 18:58:18 +0000" MODIFIED_BY="[Empty name]" ORDER="13232" O_E="0.0" SE="0.8638357026727486" STUDY_ID="STD-Bellone-2004" TOTAL_1="22" TOTAL_2="24" VAR="0.7462121212121212" WEIGHT="9.383879189803775"/>
<DICH_DATA CI_END="1.0530372514691644" CI_START="0.10551489128812148" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.022443734738520807" LOG_CI_START="-0.9766862441778457" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 18:58:18 +0000" MODIFIED_BY="[Empty name]" ORDER="13233" O_E="0.0" SE="0.5868938953886337" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.34444444444444444" WEIGHT="20.32944501896639"/>
<DICH_DATA CI_END="63.19673887573602" CI_START="0.12405703426273017" EFFECT_SIZE="2.8" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8006946680796287" LOG_CI_START="-0.9063786053951907" LOG_EFFECT_SIZE="0.4471580313422192" MODIFIED="2013-02-11 18:58:18 +0000" MODIFIED_BY="[Empty name]" ORDER="13234" O_E="0.0" SE="1.5901482410679288" STUDY_ID="STD-Liesching-2003" TOTAL_1="14" TOTAL_2="13" VAR="2.528571428571428" WEIGHT="2.7692966535566272"/>
<DICH_DATA CI_END="2.602218883342218" CI_START="0.38428742731880705" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4153438240586409" LOG_CI_START="-0.41534382405864095" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:58:18 +0000" MODIFIED_BY="[Empty name]" ORDER="587" O_E="0.0" SE="0.48795003647426655" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="42" TOTAL_2="42" VAR="0.23809523809523805" WEIGHT="29.40993046077138"/>
<DICH_DATA CI_END="1.1643954713840445" CI_START="0.17164408193544303" EFFECT_SIZE="0.4470588235294118" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.06610050769364993" LOG_CI_START="-0.765371165888615" LOG_EFFECT_SIZE="-0.3496353290974826" MODIFIED="2013-02-11 18:58:18 +0000" MODIFIED_BY="[Empty name]" ORDER="13235" O_E="0.0" SE="0.4884105769133863" STUDY_ID="STD-Mehta-1997" TOTAL_1="17" TOTAL_2="19" VAR="0.23854489164086684" WEIGHT="29.354493182624623"/>
<DICH_DATA CI_END="3.8481017433944946" CI_START="0.11549706168953583" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5852465462167757" LOG_CI_START="-0.9374290643281383" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:58:18 +0000" MODIFIED_BY="[Empty name]" ORDER="477" O_E="0.0" SE="0.8944271909999157" STUDY_ID="STD-Moritz-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.7999999999999998" WEIGHT="8.752955494277197"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:58:18 +0000" MODIFIED_BY="[Empty name]" ORDER="13236" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="29" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.281019634160454" CI_END="1.882052074733532" CI_START="0.6930925509457537" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1421192028373448" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="0.2746316358056576" LOG_CI_START="-0.1592087687341198" LOG_EFFECT_SIZE="0.057711433535768866" METHOD="MH" MODIFIED="2013-02-11 19:00:26 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.7336451180561385" P_Q="1.0" P_Z="0.6020556041285663" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="158" TOTAL_2="158" WEIGHT="99.99999999999999" Z="0.5214467349866823">
<NAME>BILEVEL X SMC - heterogeneity analysis</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4275937504674845" CI_START="0.6564371870771225" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5349893423102398" LOG_CI_START="-0.18280682419887723" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-02-11 18:59:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13388" O_E="0.0" SE="0.42163702135578396" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.1777777777777778" WEIGHT="36.530677235806664"/>
<DICH_DATA CI_END="2.5708795860891116" CI_START="0.2489420365944033" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4100817357942751" LOG_CI_START="-0.6039017618103879" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-02-11 18:59:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13389" O_E="0.0" SE="0.5956189257922424" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.3547619047619048" WEIGHT="18.306200672976946"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-02-11 18:59:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13390" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="24.35378482387111"/>
<DICH_DATA CI_END="4.184565039561249" CI_START="0.46838798811106686" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6216503223685584" LOG_CI_START="-0.3293942510120824" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-02-11 18:59:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13391" O_E="0.0" SE="0.5586482901503522" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.3120879120879121" WEIGHT="20.80933726734527"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:59:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13392" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:59:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13393" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-04-16 14:43:22 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incidence of acute myocardial infarction (after intervention)</NAME>
<DICH_OUTCOME CHI2="0.6610070822143801" CI_END="4.2640830630975675" CI_START="0.11491515536131316" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7000055483132982" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.6298256560310784" LOG_CI_START="-0.9396226914531367" LOG_EFFECT_SIZE="-0.15489851771102905" METHOD="MH" MODIFIED="2013-02-11 19:08:55 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7185618809541771" P_Q="1.0" P_Z="0.6988437021109764" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="77" TOTAL_2="77" WEIGHT="100.0" Z="0.3868818192824407">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:01:18 +0000" MODIFIED_BY="[Empty name]" ORDER="454" O_E="0.0" SE="0.0" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:01:18 +0000" MODIFIED_BY="[Empty name]" ORDER="13055" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="32.4652310453118"/>
<DICH_DATA CI_END="43.49940689111513" CI_START="0.08662568892945194" EFFECT_SIZE="1.9411764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.638483335444938" LOG_CI_START="-1.062353298445711" LOG_EFFECT_SIZE="0.2880650184996135" MODIFIED="2013-02-11 19:01:18 +0000" MODIFIED_BY="[Empty name]" ORDER="13056" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="2.516934046345811" WEIGHT="33.7673844773441"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 19:01:18 +0000" MODIFIED_BY="[Empty name]" ORDER="416" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="33.7673844773441"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.032652246689568" CI_END="10.230340677046637" CI_START="0.11439459023080109" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0818020288723098" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="3.161978952182903" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="1.0098900962437294" LOG_CI_START="-0.941594513029563" LOG_EFFECT_SIZE="0.034147791607083096" METHOD="MH" MODIFIED="2013-02-11 19:02:48 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.30953686234934197" P_Q="1.0" P_Z="0.9453141213680599" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.08315945621230444" TOTALS="YES" TOTAL_1="49" TOTAL_2="50" WEIGHT="100.0" Z="0.06859233363504243">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:02:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13122" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="48.648958062053254"/>
<DICH_DATA CI_END="72.08425860083103" CI_START="0.15107320532078622" EFFECT_SIZE="3.3" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8578404360205125" LOG_CI_START="-0.8208125562647377" LOG_EFFECT_SIZE="0.5185139398778874" MODIFIED="2013-02-11 19:02:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13123" O_E="0.0" SE="1.573454027214515" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" VAR="2.4757575757575756" WEIGHT="51.35104193794675"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="11.543919735107691" CI_START="0.02298881919248082" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" METHOD="MH" MODIFIED="2013-02-11 19:03:18 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6758809558774361" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="28" TOTAL_2="37" WEIGHT="100.0" Z="0.41809049416793886">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:02:45 +0000" MODIFIED_BY="[Empty name]" ORDER="466" O_E="0.0" SE="0.0" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:02:45 +0000" MODIFIED_BY="[Empty name]" ORDER="13193" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 19:02:45 +0000" MODIFIED_BY="[Empty name]" ORDER="411" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8202781571532433" CI_END="4.32306741785596" CI_START="0.5734648639872385" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.574524457983562" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.6357920083706909" LOG_CI_START="-0.24149318603458356" LOG_EFFECT_SIZE="0.19714941116805365" METHOD="MH" MODIFIED="2013-02-11 19:03:45 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.3650989138700057" P_Q="1.0" P_Z="0.37836519252794854" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.00000000000001" Z="0.8809124967043687">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>CPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.398125495850566" CI_START="0.6352863200092719" EFFECT_SIZE="1.8518518518518519" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7322429768344036" LOG_CI_START="-0.19703049648034077" LOG_EFFECT_SIZE="0.2676062401770315" MODIFIED="2013-02-11 19:03:13 +0000" MODIFIED_BY="[Empty name]" ORDER="475" O_E="0.0" SE="0.5458598382029612" STUDY_ID="STD-Ferrari-2007" TOTAL_1="27" TOTAL_2="25" VAR="0.297962962962963" WEIGHT="89.12396917669327"/>
<DICH_DATA CI_END="8.909679896037831" CI_START="0.01948567323819531" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9498621011320829" LOG_CI_START="-1.7102845845552948" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-02-11 19:03:13 +0000" MODIFIED_BY="[Empty name]" ORDER="13237" O_E="0.0" SE="1.5625833311112296" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="9" VAR="2.4416666666666664" WEIGHT="10.876030823306749"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-04-16 14:43:28 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Intolerance to allocated treatment</NAME>
<DICH_OUTCOME CHI2="28.955805656374253" CI_END="0.7653290531315313" CI_START="0.28911617310946647" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.47039239684637746" ESTIMABLE="YES" EVENTS_1="179" EVENTS_2="166" I2="58.557533703579224" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-0.11615179983504449" LOG_CI_START="-0.5389276132904796" LOG_EFFECT_SIZE="-0.32753970656276205" METHOD="MH" MODIFIED="2013-02-11 19:05:14 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.003999960604425423" P_Q="1.0" P_Z="0.0023901688181924034" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3094838884584901" TOTALS="YES" TOTAL_1="1138" TOTAL_2="710" WEIGHT="100.00000000000001" Z="3.036909907986025">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.984732675103974" CI_START="0.0869612790066911" EFFECT_SIZE="0.9318181818181818" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.9993364418375307" LOG_CI_START="-1.0606740813704347" LOG_EFFECT_SIZE="-0.03066881976645196" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="1416" O_E="0.0" SE="1.2100603785489072" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="1.4642461197339245" WEIGHT="3.4770261597765906"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="455" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="4.476634359946349"/>
<DICH_DATA CI_END="1.0942083056670993" CI_START="0.004061790082771148" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.039100006997564246" LOG_CI_START="-2.391282525108927" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13057" O_E="0.0" SE="1.4276187299469136" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="2.0380952380952384" WEIGHT="2.6270917001717606"/>
<DICH_DATA CI_END="19.98828732790042" CI_START="0.31268311774145907" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.3007755837175556" LOG_CI_START="-0.5048955663734803" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13058" O_E="0.0" SE="1.0606601717798212" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="1.125" WEIGHT="4.2993202562164825"/>
<DICH_DATA CI_END="1.4332416965936874" CI_START="0.8390379381975044" EFFECT_SIZE="1.0966057441253263" ESTIMABLE="YES" EVENTS_1="140" EVENTS_2="65" LOG_CI_END="0.1563194343929969" LOG_CI_START="-0.07621840153444151" LOG_EFFECT_SIZE="0.04005051642927769" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="532" O_E="0.0" SE="0.13659387590462954" STUDY_ID="STD-Gray-2008" TOTAL_1="766" TOTAL_2="390" VAR="0.018657886934649336" WEIGHT="18.794637261521668"/>
<DICH_DATA CI_END="4.562163562529396" CI_START="0.011451780990118114" EFFECT_SIZE="0.22857142857142856" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6591708515304123" LOG_CI_START="-1.9411269662470765" LOG_EFFECT_SIZE="-0.640978057358332" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13059" O_E="0.0" SE="1.5274278098442866" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="2.3330357142857143" WEIGHT="2.3338731839344335"/>
<DICH_DATA CI_END="0.6465079423718663" CI_START="0.08741377183068344" EFFECT_SIZE="0.23772609819121446" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="18" LOG_CI_END="-0.18942613542846404" LOG_CI_START="-1.0584201399182482" LOG_EFFECT_SIZE="-0.6239231376733562" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13060" O_E="0.0" SE="0.5104513798269965" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.26056061116728463" WEIGHT="10.818989820820148"/>
<DICH_DATA CI_END="0.827457231587009" CI_START="0.182770253407752" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" LOG_CI_END="-0.08225444415740223" LOG_CI_START="-0.7380944860206963" LOG_EFFECT_SIZE="-0.41017446508904926" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13061" O_E="0.0" SE="0.3852436870510644" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.1484126984126984" WEIGHT="13.468773988919697"/>
<DICH_DATA CI_END="0.8452048051431108" CI_START="0.27259665183870846" EFFECT_SIZE="0.48" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="-0.07303804256955183" LOG_CI_START="-0.5644794826792737" LOG_EFFECT_SIZE="-0.3187587626244128" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13062" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.08333333333333331" WEIGHT="15.700191582064045"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13063" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="4.481563166106396"/>
<DICH_DATA CI_END="1.061083118875249" CI_START="0.27324987387388167" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.025749405253812693" LOG_CI_START="-0.5634400298389727" LOG_EFFECT_SIZE="-0.26884531229257996" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13064" O_E="0.0" SE="0.3460927907082431" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.11978021978021978" WEIGHT="14.367158866765045"/>
<DICH_DATA CI_END="1.8433019091517913" CI_START="0.010087897826173621" EFFECT_SIZE="0.13636363636363635" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2655964728969871" LOG_CI_START="-1.9961993251020749" LOG_EFFECT_SIZE="-0.8653014261025438" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="13065" O_E="0.0" SE="1.328590047814417" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="1.765151515151515" WEIGHT="2.972717822193839"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 19:04:22 +0000" MODIFIED_BY="[Empty name]" ORDER="413" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="2.1820218315635582"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.177872025306543" CI_END="0.5820995929270529" CI_START="0.30356770946036304" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4203648892363338" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="101" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-0.2350027044251288" LOG_CI_START="-0.5177444262844686" LOG_EFFECT_SIZE="-0.3763735653547987" METHOD="MH" MODIFIED="2013-02-11 19:07:47 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6054780848484997" P_Q="1.0" P_Z="1.80827622520363E-7" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="372" TOTAL_2="320" WEIGHT="99.99999999999999" Z="5.218038766810106">
<NAME>NPPV (CPAP and BILEVEL) X SMC - heterogeneity analysis</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.984732675103974" CI_START="0.0869612790066911" EFFECT_SIZE="0.9318181818181818" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.9993364418375307" LOG_CI_START="-1.0606740813704347" LOG_EFFECT_SIZE="-0.03066881976645196" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="537" O_E="0.0" SE="1.2100603785489072" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="1.4642461197339245" WEIGHT="1.8838265749190983"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="538" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="2.5823185768805383"/>
<DICH_DATA CI_END="1.0942083056670993" CI_START="0.004061790082771148" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.039100006997564246" LOG_CI_START="-2.391282525108927" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="539" O_E="0.0" SE="1.4276187299469136" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="2.0380952380952384" WEIGHT="1.3534135701896195"/>
<DICH_DATA CI_END="19.98828732790042" CI_START="0.31268311774145907" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.3007755837175556" LOG_CI_START="-0.5048955663734803" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="540" O_E="0.0" SE="1.0606601717798212" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="1.125" WEIGHT="2.451898446735057"/>
<DICH_DATA CI_END="4.562163562529396" CI_START="0.011451780990118114" EFFECT_SIZE="0.22857142857142856" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6591708515304123" LOG_CI_START="-1.9411269662470765" LOG_EFFECT_SIZE="-0.640978057358332" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="541" O_E="0.0" SE="1.5274278098442866" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="2.3330357142857143" WEIGHT="1.182316128161566"/>
<DICH_DATA CI_END="0.6465079423718663" CI_START="0.08741377183068344" EFFECT_SIZE="0.23772609819121446" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="18" LOG_CI_END="-0.18942613542846404" LOG_CI_START="-1.0584201399182482" LOG_EFFECT_SIZE="-0.6239231376733562" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="542" O_E="0.0" SE="0.5104513798269965" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.26056061116728463" WEIGHT="10.58634971809306"/>
<DICH_DATA CI_END="0.827457231587009" CI_START="0.182770253407752" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" LOG_CI_END="-0.08225444415740223" LOG_CI_START="-0.7380944860206963" LOG_EFFECT_SIZE="-0.41017446508904926" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="543" O_E="0.0" SE="0.3852436870510644" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.1484126984126984" WEIGHT="18.585914696507718"/>
<DICH_DATA CI_END="0.8452048051431108" CI_START="0.27259665183870846" EFFECT_SIZE="0.48" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="-0.07303804256955183" LOG_CI_START="-0.5644794826792737" LOG_EFFECT_SIZE="-0.3187587626244128" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="544" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.08333333333333331" WEIGHT="33.10062903092328"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="545" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="2.58598664304088"/>
<DICH_DATA CI_END="1.061083118875249" CI_START="0.27324987387388167" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.025749405253812693" LOG_CI_START="-0.5634400298389727" LOG_EFFECT_SIZE="-0.26884531229257996" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="546" O_E="0.0" SE="0.3460927907082431" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.11978021978021978" WEIGHT="23.028725090321235"/>
<DICH_DATA CI_END="1.8433019091517913" CI_START="0.010087897826173621" EFFECT_SIZE="0.13636363636363635" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2655964728969871" LOG_CI_START="-1.9961993251020749" LOG_EFFECT_SIZE="-0.8653014261025438" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="547" O_E="0.0" SE="1.328590047814417" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="1.765151515151515" WEIGHT="1.5626906409448758"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 19:06:58 +0000" MODIFIED_BY="[Empty name]" ORDER="548" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="1.0959308832830472"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.406469519635621" CI_END="0.8480616809305843" CI_START="0.35860746763298357" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5514718957436436" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="142" I2="44.46939280233633" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-0.0715725596376124" LOG_CI_START="-0.4453806709421858" LOG_EFFECT_SIZE="-0.25847661528989907" METHOD="MH" MODIFIED="2013-02-11 19:07:08 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0717670749932775" P_Q="1.0" P_Z="0.006718031599442769" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.14867655499057356" TOTALS="YES" TOTAL_1="646" TOTAL_2="658" WEIGHT="100.00000000000001" Z="2.71050756521034">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="14.4160952743426" CI_START="0.060230257045560294" EFFECT_SIZE="0.9318181818181818" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1588476438475661" LOG_CI_START="-1.22018528338047" LOG_EFFECT_SIZE="-0.03066881976645196" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="1419" O_E="0.0" SE="1.3974557178566656" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.9528824833702882" WEIGHT="2.294198814106638"/>
<DICH_DATA CI_END="1.0942083056670993" CI_START="0.004061790082771148" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.039100006997564246" LOG_CI_START="-2.391282525108927" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13124" O_E="0.0" SE="1.4276187299469136" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="2.0380952380952384" WEIGHT="2.204799910455667"/>
<DICH_DATA CI_END="32.72441962136761" CI_START="0.48893151307571864" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.514871952931805" LOG_CI_START="-0.31075197027588036" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13125" O_E="0.0" SE="1.0723805294763609" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="1.15" WEIGHT="3.712544309092862"/>
<DICH_DATA CI_END="1.2018728819337317" CI_START="0.6209299636566195" EFFECT_SIZE="0.8638743455497382" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="65" LOG_CI_END="0.07985853622400849" LOG_CI_START="-0.206957382291651" LOG_EFFECT_SIZE="-0.06354942303382127" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="533" O_E="0.0" SE="0.16847709029779268" STUDY_ID="STD-Gray-2008" TOTAL_1="382" TOTAL_2="390" VAR="0.028384529955210583" WEIGHT="27.230118097711195"/>
<DICH_DATA CI_END="4.562163562529396" CI_START="0.011451780990118114" EFFECT_SIZE="0.22857142857142856" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6591708515304123" LOG_CI_START="-1.9411269662470765" LOG_EFFECT_SIZE="-0.640978057358332" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13126" O_E="0.0" SE="1.5274278098442866" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="2.3330357142857143" WEIGHT="1.9427692377040073"/>
<DICH_DATA CI_END="0.6465079423718663" CI_START="0.08741377183068344" EFFECT_SIZE="0.23772609819121446" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="18" LOG_CI_END="-0.18942613542846404" LOG_CI_START="-1.0584201399182482" LOG_EFFECT_SIZE="-0.6239231376733562" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13127" O_E="0.0" SE="0.5104513798269965" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.26056061116728463" WEIGHT="11.781418337069567"/>
<DICH_DATA CI_END="1.3322041307764492" CI_START="0.18765892870658823" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.12457077594344682" LOG_CI_START="-0.7266307672714092" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13128" O_E="0.0" SE="0.5" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.25" WEIGHT="12.093498333998033"/>
<DICH_DATA CI_END="0.8452048051431108" CI_START="0.27259665183870846" EFFECT_SIZE="0.48" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="-0.07303804256955183" LOG_CI_START="-0.5644794826792737" LOG_EFFECT_SIZE="-0.3187587626244128" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13129" O_E="0.0" SE="0.28867513459481287" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.08333333333333331" WEIGHT="20.780986053712812"/>
<DICH_DATA CI_END="1.061083118875249" CI_START="0.27324987387388167" EFFECT_SIZE="0.5384615384615384" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.025749405253812693" LOG_CI_START="-0.5634400298389727" LOG_EFFECT_SIZE="-0.26884531229257996" MODIFIED="2013-02-11 19:05:34 +0000" MODIFIED_BY="[Empty name]" ORDER="13130" O_E="0.0" SE="0.3460927907082431" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.11978021978021978" WEIGHT="17.959666906149234"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.684893679402089" CI_END="1.4191778709692948" CI_START="0.2369835020035064" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5799325321347164" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="83" I2="38.04784855035788" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="0.15203683065080478" LOG_CI_START="-0.625281887062618" LOG_EFFECT_SIZE="-0.2366225282059066" METHOD="MH" MODIFIED="2013-02-15 16:57:53 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.13856453802370317" P_Q="1.0" P_Z="0.23276761789570666" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.4985445115009769" TOTALS="YES" TOTAL_1="492" TOTAL_2="503" WEIGHT="100.0" Z="1.1932599142308846">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="14.4160952743426" CI_START="0.060230257045560294" EFFECT_SIZE="0.9318181818181818" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1588476438475661" LOG_CI_START="-1.22018528338047" LOG_EFFECT_SIZE="-0.03066881976645196" MODIFIED="2013-02-11 19:05:57 +0000" MODIFIED_BY="[Empty name]" ORDER="1422" O_E="0.0" SE="1.3974557178566656" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="41" VAR="1.9528824833702882" WEIGHT="8.504611727782375"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 19:05:57 +0000" MODIFIED_BY="[Empty name]" ORDER="467" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="13.307004787878626"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:05:57 +0000" MODIFIED_BY="[Empty name]" ORDER="13194" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="8.69211918745581"/>
<DICH_DATA CI_END="1.775980376070444" CI_START="0.9932069291935884" EFFECT_SIZE="1.328125" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="65" LOG_CI_END="0.2494381626748993" LOG_CI_START="-0.0029602592140881667" LOG_EFFECT_SIZE="0.12323895173040557" MODIFIED="2013-02-11 19:05:57 +0000" MODIFIED_BY="[Empty name]" ORDER="534" O_E="0.0" SE="0.14826008240992952" STUDY_ID="STD-Gray-2008" TOTAL_1="384" TOTAL_2="390" VAR="0.021981052036199093" WEIGHT="40.052662598761046"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 19:05:57 +0000" MODIFIED_BY="[Empty name]" ORDER="13195" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="13.319886198865028"/>
<DICH_DATA CI_END="1.8433019091517913" CI_START="0.010087897826173621" EFFECT_SIZE="0.13636363636363635" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2655964728969871" LOG_CI_START="-1.9961993251020749" LOG_EFFECT_SIZE="-0.8653014261025438" MODIFIED="2013-02-11 19:05:57 +0000" MODIFIED_BY="[Empty name]" ORDER="13196" O_E="0.0" SE="1.328590047814417" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="1.765151515151515" WEIGHT="9.209909159585667"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 19:05:57 +0000" MODIFIED_BY="[Empty name]" ORDER="412" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="6.913806339671456"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.9036549347792477" CI_END="2.527850425176429" CI_START="0.3459594253279381" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9351650551688837" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="87" I2="31.12129213273576" I2_Q="0.0" ID="CMP-005.05" LOG_CI_END="0.40275137283727674" LOG_CI_START="-0.4609748329687016" LOG_EFFECT_SIZE="-0.029111730065712462" METHOD="MH" MODIFIED="2013-02-15 16:57:53 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.23414205819660516" P_Q="1.0" P_Z="0.8948890301968262" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3356266861277899" TOTALS="YES" TOTAL_1="446" TOTAL_2="448" WEIGHT="100.0" Z="0.13212043833544504">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.4889800508606" CI_START="0.06456203034133534" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.190022820414652" LOG_CI_START="-1.1900228204146521" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:06:21 +0000" MODIFIED_BY="[Empty name]" ORDER="1816" O_E="0.0" SE="1.3980505908390635" STUDY_ID="STD-Agmy-2008" TOTAL_1="44" TOTAL_2="44" VAR="1.9545454545454546" WEIGHT="11.239817758657196"/>
<DICH_DATA CI_END="32.72441962136761" CI_START="0.48893151307571864" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.514871952931805" LOG_CI_START="-0.31075197027588036" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-02-11 19:06:21 +0000" MODIFIED_BY="[Empty name]" ORDER="13238" O_E="0.0" SE="1.0723805294763609" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="1.15" WEIGHT="17.326773769939482"/>
<DICH_DATA CI_END="0.8852275701637335" CI_START="0.47793443128106156" EFFECT_SIZE="0.6504465660609794" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="85" LOG_CI_END="-0.052945068554635086" LOG_CI_START="-0.32063168097381856" LOG_EFFECT_SIZE="-0.1867883747642268" MODIFIED="2013-02-11 19:06:21 +0000" MODIFIED_BY="[Empty name]" ORDER="535" O_E="0.0" SE="0.15724044120513028" STUDY_ID="STD-Gray-2008" TOTAL_1="382" TOTAL_2="384" VAR="0.024724556350384036" WEIGHT="71.43340847140333"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2013-04-16 14:43:35 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Hospital length of stay</NAME>
<CONT_OUTCOME CHI2="31.13842542730118" CI_END="0.5060721329396332" CI_START="-2.098399309708795" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.796163588384581" ESTIMABLE="YES" I2="71.09680442573347" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2013-02-11 19:09:23 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.80272699284545E-4" P_Q="1.0" P_Z="0.23080538035597387" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="2.471940496073502" TOTALS="YES" TOTAL_1="268" TOTAL_2="274" UNITS="" WEIGHT="100.0" Z="1.1982868642623032">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.09250416527522987" CI_START="-4.107495834724766" EFFECT_SIZE="-2.099999999999998" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="19.4" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="456" SD_1="2.3" SD_2="2.5" SE="1.0242513895967675" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="12.537562981390282"/>
<CONT_DATA CI_END="4.942109015279237" CI_START="-3.342109015279239" EFFECT_SIZE="0.7999999999999989" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="7.9" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13066" SD_1="8.3" SD_2="4.1" SE="2.113359759644394" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="20" WEIGHT="6.362595819700613"/>
<CONT_DATA CI_END="-0.061142348961210846" CI_START="-2.5388576510387906" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="15.0" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13067" SD_1="2.0" SD_2="2.7" SE="0.6320818447740575" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="29" WEIGHT="15.37372302257393"/>
<CONT_DATA CI_END="6.8602687979871115" CI_START="-0.8602687979871115" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="9.0" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13068" SD_1="11.0" SD_2="7.0" SE="1.9695610880793826" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="6.950776075232856"/>
<CONT_DATA CI_END="3.778532423037456" CI_START="-5.378532423037456" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="8.1" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13069" SD_1="8.0" SD_2="6.4" SE="2.3360288551995523" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="17" WEIGHT="5.567576333003376"/>
<CONT_DATA CI_END="1.2639675860860489" CI_START="-2.263967586086049" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="9.0" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13070" SD_1="4.5" SD_2="4.5" SE="0.9" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" WEIGHT="13.450930342739905"/>
<CONT_DATA CI_END="2.8101857574216647" CI_START="-3.0101857574216675" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.3" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13071" SD_1="5.0" SD_2="4.0" SE="1.4848159355870005" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="9.439544751456909"/>
<CONT_DATA CI_END="1.2189831047891941" CI_START="-0.6189831047891927" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="5.1" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13072" SD_1="3.0" SD_2="2.3" SE="0.46887754674984583" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="16.399944996762493"/>
<CONT_DATA CI_END="41.28930238906365" CI_START="-3.28930238906365" EFFECT_SIZE="19.0" ESTIMABLE="YES" MEAN_1="29.0" MEAN_2="10.0" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="13073" SD_1="18.52" SD_2="8.66" SE="11.372302024363112" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" WEIGHT="0.3349374290102407"/>
<CONT_DATA CI_END="-2.570970950794316" CI_START="-6.029029049205685" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="12.5" MODIFIED="2013-02-11 19:08:23 +0000" MODIFIED_BY="[Empty name]" ORDER="417" SD_1="2.3" SD_2="1.8" SE="0.8821738883183797" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="13" WEIGHT="13.58240824812941"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="13.277307691914679" CI_END="0.5790330546436977" CI_START="-1.3463582875444433" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.38366261645037286" ESTIMABLE="YES" I2="39.74682077397616" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2013-02-11 19:11:33 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.10265787726476616" P_Q="1.0" P_Z="0.43474165942113396" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.7040007530975647" TOTALS="YES" TOTAL_1="258" TOTAL_2="261" UNITS="" WEIGHT="99.99999999999999" Z="0.7811034504835294">
<NAME>NPPV (CPAP and BILEVEL) X SMC - heterogeneity analysis</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.09250416527522987" CI_START="-4.107495834724766" EFFECT_SIZE="-2.099999999999998" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="19.4" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1022" SD_1="2.3" SD_2="2.5" SE="1.0242513895967675" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="13.761863048484898"/>
<CONT_DATA CI_END="4.942109015279237" CI_START="-3.342109015279239" EFFECT_SIZE="0.7999999999999989" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="7.9" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1023" SD_1="8.3" SD_2="4.1" SE="2.113359759644394" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="20" WEIGHT="4.666238510462793"/>
<CONT_DATA CI_END="-0.061142348961210846" CI_START="-2.5388576510387906" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="15.0" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1024" SD_1="2.0" SD_2="2.7" SE="0.6320818447740575" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="29" WEIGHT="21.86242917315675"/>
<CONT_DATA CI_END="6.8602687979871115" CI_START="-0.8602687979871115" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="9.0" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1025" SD_1="11.0" SD_2="7.0" SE="1.9695610880793826" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="5.263998230822565"/>
<CONT_DATA CI_END="3.778532423037456" CI_START="-5.378532423037456" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="8.1" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1026" SD_1="8.0" SD_2="6.4" SE="2.3360288551995523" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="17" WEIGHT="3.9158714105409866"/>
<CONT_DATA CI_END="1.2639675860860489" CI_START="-2.263967586086049" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="9.0" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1027" SD_1="4.5" SD_2="4.5" SE="0.9" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" WEIGHT="15.935135644495826"/>
<CONT_DATA CI_END="2.8101857574216647" CI_START="-3.0101857574216675" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.3" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1021" SD_1="5.0" SD_2="4.0" SE="1.4848159355870005" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="8.294420390513155"/>
<CONT_DATA CI_END="1.2189831047891941" CI_START="-0.6189831047891927" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="5.1" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1020" SD_1="3.0" SD_2="2.3" SE="0.46887754674984583" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="26.11450791808333"/>
<CONT_DATA CI_END="41.28930238906365" CI_START="-3.28930238906365" EFFECT_SIZE="19.0" ESTIMABLE="YES" MEAN_1="29.0" MEAN_2="10.0" MODIFIED="2013-02-11 19:10:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1019" SD_1="18.52" SD_2="8.66" SE="11.372302024363112" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" WEIGHT="0.18553567343967653"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.001783692986108" CI_END="0.6696763604673623" CI_START="-1.6923874473676441" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5113555434501409" ESTIMABLE="YES" I2="20.02852891041425" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2013-02-11 19:10:58 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.2871145955672145" P_Q="1.0" P_Z="0.39609695203547846" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.38084813890274355" TOTALS="YES" TOTAL_1="166" TOTAL_2="171" UNITS="" WEIGHT="99.99999999999999" Z="0.8486125100708464">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.942109015279237" CI_START="-3.342109015279239" EFFECT_SIZE="0.7999999999999989" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="7.9" MODIFIED="2013-02-11 19:09:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13131" SD_1="8.3" SD_2="4.1" SE="2.113359759644394" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="20" WEIGHT="7.491033297145899"/>
<CONT_DATA CI_END="-0.061142348961210846" CI_START="-2.5388576510387906" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="15.0" MODIFIED="2013-02-11 19:09:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13132" SD_1="2.0" SD_2="2.7" SE="0.6320818447740575" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="29" WEIGHT="46.52896550444637"/>
<CONT_DATA CI_END="6.8602687979871115" CI_START="-0.8602687979871115" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="9.0" MODIFIED="2013-02-11 19:09:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13133" SD_1="11.0" SD_2="7.0" SE="1.9695610880793826" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="8.523452382108708"/>
<CONT_DATA CI_END="1.2639675860860489" CI_START="-2.263967586086049" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="9.0" MODIFIED="2013-02-11 19:09:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13134" SD_1="4.5" SD_2="4.5" SE="0.9" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" WEIGHT="30.490931686044807"/>
<CONT_DATA CI_END="3.3083150770488023" CI_START="-5.308315077048802" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="12.0" MODIFIED="2013-02-11 19:09:19 +0000" MODIFIED_BY="[Empty name]" ORDER="13135" SD_1="8.0" SD_2="8.0" SE="2.1981603289816762" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="26" WEIGHT="6.96561713025421"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="26.40744840709489" CI_END="0.6209563991524853" CI_START="-3.3761618825440007" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.3776027416957577" ESTIMABLE="YES" I2="77.27913766031261" I2_Q="0.0" ID="CMP-006.04" MODIFIED="2013-02-15 16:57:50 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.8690413937072492E-4" P_Q="1.0" P_Z="0.17669569565324877" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="4.442494189865211" TOTALS="YES" TOTAL_1="156" TOTAL_2="155" UNITS="" WEIGHT="100.0" Z="1.3509991791292923">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.09250416527522987" CI_START="-4.107495834724766" EFFECT_SIZE="-2.099999999999998" ESTIMABLE="YES" MEAN_1="17.3" MEAN_2="19.4" MODIFIED="2013-02-11 19:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="468" SD_1="2.3" SD_2="2.5" SE="1.0242513895967675" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="18.933901291458767"/>
<CONT_DATA CI_END="3.778532423037456" CI_START="-5.378532423037456" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="8.1" MODIFIED="2013-02-11 19:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="13197" SD_1="8.0" SD_2="6.4" SE="2.3360288551995523" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="17" WEIGHT="10.503244365186957"/>
<CONT_DATA CI_END="2.8101857574216647" CI_START="-3.0101857574216675" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.3" MODIFIED="2013-02-11 19:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="13198" SD_1="5.0" SD_2="4.0" SE="1.4848159355870005" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="15.642309474746552"/>
<CONT_DATA CI_END="1.2189831047891941" CI_START="-0.6189831047891927" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="5.1" MODIFIED="2013-02-11 19:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="13199" SD_1="3.0" SD_2="2.3" SE="0.46887754674984583" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="22.301488637037604"/>
<CONT_DATA CI_END="2.053077227718652" CI_START="-6.053077227718652" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="12.0" MODIFIED="2013-02-11 19:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="13200" SD_1="7.0" SD_2="8.0" SE="2.0679345435369263" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="26" WEIGHT="11.92555903749256"/>
<CONT_DATA CI_END="41.28930238906365" CI_START="-3.28930238906365" EFFECT_SIZE="19.0" ESTIMABLE="YES" MEAN_1="29.0" MEAN_2="10.0" MODIFIED="2013-02-11 19:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="13201" SD_1="18.52" SD_2="8.66" SE="11.372302024363112" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" WEIGHT="0.7772727210523238"/>
<CONT_DATA CI_END="-2.570970950794316" CI_START="-6.029029049205685" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="12.5" MODIFIED="2013-02-11 19:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="404" SD_1="2.3" SD_2="1.8" SE="0.8821738883183797" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="13" WEIGHT="19.916224473025228"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.539142719326695" CI_END="1.071806174547579" CI_START="-1.9851721132489888" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.45668296935070485" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.05" MODIFIED="2013-02-15 16:57:50 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.8196860708481535" P_Q="1.0" P_Z="0.5581448220389101" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="205" TOTAL_2="197" UNITS="" WEIGHT="100.0" Z="0.5855992997093579">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.398376441387196" CI_START="-6.398376441387196" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="9.9" MODIFIED="2013-02-11 19:10:14 +0000" MODIFIED_BY="[Empty name]" ORDER="397" SD_1="23.7" SD_2="7.4" SE="4.795178133639388" STUDY_ID="STD-Ferrari-2007" TOTAL_1="27" TOTAL_2="25" WEIGHT="2.644959610370085"/>
<CONT_DATA CI_END="5.839380628609202" CI_START="-4.959380628609203" EFFECT_SIZE="0.4399999999999995" ESTIMABLE="YES" MEAN_1="10.5" MEAN_2="10.06" MODIFIED="2013-02-11 19:10:14 +0000" MODIFIED_BY="[Empty name]" ORDER="471" SD_1="15.41" SD_2="8.13" SE="2.7548366557747124" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="8.013769170792017"/>
<CONT_DATA CI_END="0.8794787307201435" CI_START="-3.0794787307201448" EFFECT_SIZE="-1.1000000000000005" ESTIMABLE="YES" MEAN_1="6.8" MEAN_2="7.9" MODIFIED="2013-02-11 19:10:14 +0000" MODIFIED_BY="[Empty name]" ORDER="589" SD_1="4.0" SD_2="5.0" SE="1.0099566861095508" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="39" TOTAL_2="41" WEIGHT="59.62426489104897"/>
<CONT_DATA CI_END="3.522377158927985" CI_START="-4.322377158927986" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="9.6" MODIFIED="2013-02-11 19:10:14 +0000" MODIFIED_BY="[Empty name]" ORDER="13239" SD_1="3.9" SD_2="6.3" SE="2.00124960961895" STUDY_ID="STD-Mehta-1997" TOTAL_1="13" TOTAL_2="14" WEIGHT="15.185392249260168"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="11.1" MEAN_2="13.6" MODIFIED="2013-02-11 19:10:14 +0000" MODIFIED_BY="[Empty name]" ORDER="402" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Moritz-2007" TOTAL_1="59" TOTAL_2="50" WEIGHT="0.0"/>
<CONT_DATA CI_END="5.009640450946694" CI_START="-3.0096404509466943" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="10.0" MODIFIED="2013-02-11 19:10:14 +0000" MODIFIED_BY="[Empty name]" ORDER="13240" SD_1="8.0" SD_2="7.0" SE="2.045772515502441" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" WEIGHT="14.531614078528747"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2013-04-16 14:43:42 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>ICU length of stay</NAME>
<CONT_OUTCOME CHI2="6.155904216389069" CI_END="-0.4526369702910525" CI_START="-1.3254520873661277" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8890445288285901" ESTIMABLE="YES" I2="18.77716377249124" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2013-02-11 19:12:34 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2913431220765722" P_Q="1.0" P_Z="6.529312343587109E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.057502068426536684" TOTALS="YES" TOTAL_1="108" TOTAL_2="114" UNITS="" WEIGHT="100.00000000000001" Z="3.992816400787746">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.022206504585875475" CI_START="-5.022206504585876" EFFECT_SIZE="-2.5000000000000004" ESTIMABLE="YES" MEAN_1="2.94" MEAN_2="5.44" MODIFIED="2013-02-11 19:11:58 +0000" MODIFIED_BY="[Empty name]" ORDER="458" SD_1="2.11" SD_2="3.71" SE="1.2868636997826077" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="2.8933375577417833"/>
<CONT_DATA CI_END="-0.6052146117364604" CI_START="-2.39478538826354" EFFECT_SIZE="-1.5000000000000002" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="2.7" MODIFIED="2013-02-11 19:11:58 +0000" MODIFIED_BY="[Empty name]" ORDER="13074" SD_1="0.4" SD_2="2.0" SE="0.4565315461516093" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="20" WEIGHT="18.64370603149115"/>
<CONT_DATA CI_END="0.777740192212409" CI_START="-1.777740192212409" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.5" MODIFIED="2013-02-11 19:11:58 +0000" MODIFIED_BY="[Empty name]" ORDER="13075" SD_1="3.0" SD_2="3.5" SE="0.6519202405202649" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" WEIGHT="10.27517355967354"/>
<CONT_DATA CI_END="-0.21275457676445064" CI_START="-1.7872454232355492" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="2.9" MEAN_2="3.9" MODIFIED="2013-02-11 19:11:58 +0000" MODIFIED_BY="[Empty name]" ORDER="13076" SD_1="1.1" SD_2="1.1" SE="0.40166320883712187" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" WEIGHT="22.655349436670992"/>
<CONT_DATA CI_END="7.914098358295745" CI_START="-3.914098358295745" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="3.0" MODIFIED="2013-02-11 19:11:58 +0000" MODIFIED_BY="[Empty name]" ORDER="13077" SD_1="4.35" SD_2="3.74" SE="3.0174525679784927" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" WEIGHT="0.5410947399590312"/>
<CONT_DATA CI_END="-0.1500940874278885" CI_START="-1.0499059125721113" EFFECT_SIZE="-0.5999999999999999" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="2.3" MODIFIED="2013-02-11 19:11:58 +0000" MODIFIED_BY="[Empty name]" ORDER="418" SD_1="0.5" SD_2="0.6" SE="0.22954805094425806" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="13" WEIGHT="44.99133867446351"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.6757725350700858" CI_END="-0.5551417122995994" CI_START="-1.6280172898652092" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0915795010824043" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.02" MODIFIED="2013-02-11 19:13:02 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4326242737355286" P_Q="1.0" P_Z="6.655805500134336E-5" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="84" TOTAL_2="85" UNITS="" WEIGHT="99.99999999999999" Z="3.988265840179178">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.6052146117364604" CI_START="-2.39478538826354" EFFECT_SIZE="-1.5000000000000002" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="2.7" MODIFIED="2013-02-11 19:12:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13136" SD_1="0.4" SD_2="2.0" SE="0.4565315461516093" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="20" WEIGHT="35.941894106460026"/>
<CONT_DATA CI_END="0.777740192212409" CI_START="-1.777740192212409" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.5" MODIFIED="2013-02-11 19:12:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13137" SD_1="3.0" SD_2="3.5" SE="0.6519202405202649" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" WEIGHT="17.625993889979163"/>
<CONT_DATA CI_END="-0.21275457676445064" CI_START="-1.7872454232355492" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="2.9" MEAN_2="3.9" MODIFIED="2013-02-11 19:12:30 +0000" MODIFIED_BY="[Empty name]" ORDER="13138" SD_1="1.1" SD_2="1.1" SE="0.40166320883712187" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" WEIGHT="46.4321120035608"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.922700042158566" CI_END="0.0630014227007979" CI_START="-1.3661518778667916" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6515752275829969" ESTIMABLE="YES" I2="31.57012450299566" I2_Q="0.0" ID="CMP-007.03" MODIFIED="2013-02-11 19:13:28 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.2319230140853511" P_Q="1.0" P_Z="0.0739113670250481" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.1277097857521668" TOTALS="YES" TOTAL_1="24" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.7871616414753773">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.07829186160066992" CI_START="-1.6721241117079342" EFFECT_SIZE="-0.7969161250536322" ESTIMABLE="YES" MEAN_1="2.94" MEAN_2="5.44" MODIFIED="2013-02-11 19:12:59 +0000" MODIFIED_BY="[Empty name]" ORDER="469" SD_1="2.11" SD_2="3.71" SE="0.44654289239895784" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="40.635647729845886"/>
<CONT_DATA CI_END="1.90284250998866" CI_START="-1.0231173634634279" EFFECT_SIZE="0.43986257326261596" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="3.0" MODIFIED="2013-02-11 19:12:59 +0000" MODIFIED_BY="[Empty name]" ORDER="13202" SD_1="4.35" SD_2="3.74" SE="0.7464320509284063" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" WEIGHT="19.40854332616905"/>
<CONT_DATA CI_END="-0.14658914118094468" CI_START="-1.92126595838816" EFFECT_SIZE="-1.0339275497845524" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="2.3" MODIFIED="2013-02-11 19:12:59 +0000" MODIFIED_BY="[Empty name]" ORDER="405" SD_1="0.5" SD_2="0.6" SE="0.45273199691566773" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="13" WEIGHT="39.95580894398506"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.5560497429859667" CI_END="1.398663607861306" CI_START="-0.7762347017941973" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="0.31121445303355433" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.04" MODIFIED="2013-02-15 16:57:47 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7572780066312612" P_Q="1.0" P_Z="0.5748538710653146" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="79" TOTAL_2="80" UNITS="" WEIGHT="100.0" Z="0.560917369521259">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.469295418912799" CI_START="-1.6692954189127982" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.1" MODIFIED="2013-02-11 19:13:24 +0000" MODIFIED_BY="[Empty name]" ORDER="396" SD_1="2.5" SD_2="3.2" SE="0.8006756406195218" STUDY_ID="STD-Ferrari-2007" TOTAL_1="27" TOTAL_2="25" WEIGHT="48.01849079708761"/>
<CONT_DATA CI_END="2.5358699372722366" CI_START="-0.9558699372722372" EFFECT_SIZE="0.7899999999999998" ESTIMABLE="YES" MEAN_1="2.03" MEAN_2="1.24" MODIFIED="2013-02-11 19:13:24 +0000" MODIFIED_BY="[Empty name]" ORDER="588" SD_1="5.0" SD_2="2.5" SE="0.8907663360364967" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="39" TOTAL_2="41" WEIGHT="38.79664282538261"/>
<CONT_DATA CI_END="3.3948225439342643" CI_START="-2.5948225439342636" EFFECT_SIZE="0.40000000000000036" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.3" MODIFIED="2013-02-11 19:13:24 +0000" MODIFIED_BY="[Empty name]" ORDER="13241" SD_1="4.2" SD_2="3.7" SE="1.527998763016587" STUDY_ID="STD-Mehta-1997" TOTAL_1="13" TOTAL_2="14" WEIGHT="13.18486637752978"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2013-04-16 14:43:50 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Breath rate after one hour</NAME>
<CONT_OUTCOME CHI2="6.664137084497133" CI_END="-1.8714459448252003" CI_START="-3.854648027924838" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.863046986375019" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2013-02-11 19:15:42 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5732646235108446" P_Q="1.0" P_Z="1.5225873157708948E-8" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="220" TOTAL_2="218" UNITS="" WEIGHT="100.0" Z="5.658998674074155">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.4443750385763425" CI_START="-6.1556249614236584" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="14.7" MEAN_2="19.0" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="463" SD_1="1.9" SD_2="2.5" SE="0.9467648263236422" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="28.55574773616621"/>
<CONT_DATA CI_END="3.0900603299075993" CI_START="-7.790060329907602" EFFECT_SIZE="-2.3500000000000014" ESTIMABLE="YES" MEAN_1="26.32" MEAN_2="28.67" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="13078" SD_1="5.93" SD_2="9.37" SE="2.7755919868008303" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="3.3225116811318793"/>
<CONT_DATA CI_END="0.2964432773287662" CI_START="-6.27644327732877" EFFECT_SIZE="-2.990000000000002" ESTIMABLE="YES" MEAN_1="22.74" MEAN_2="25.73" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="13079" SD_1="5.93" SD_2="6.84" SE="1.6767875855127" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="9.103778166905084"/>
<CONT_DATA CI_END="-0.8819694212876885" CI_START="-7.118030578712311" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="31.0" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="13080" SD_1="7.0" SD_2="8.0" SE="1.5908611603615876" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="10.113773155091499"/>
<CONT_DATA CI_END="1.1913063514414541" CI_START="-3.191306351441454" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="24.0" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="13081" SD_1="3.0" SD_2="4.0" SE="1.118033988749895" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="20.4770671038981"/>
<CONT_DATA CI_END="2.6101621552522394" CI_START="-5.610162155252239" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="24.8" MEAN_2="26.3" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="13082" SD_1="4.0" SD_2="8.0" SE="2.097060041752131" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="5.820442943428483"/>
<CONT_DATA CI_END="-0.559016975124782" CI_START="-5.4409830248752105" EFFECT_SIZE="-2.9999999999999964" ESTIMABLE="YES" MEAN_1="29.3" MEAN_2="32.3" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="13083" SD_1="7.1" SD_2="7.1" SE="1.2454223874159815" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="16.502298176866898"/>
<CONT_DATA CI_END="2.594226441657014" CI_START="-6.594226441657014" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="22.0" MEAN_2="24.0" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="13084" SD_1="5.0" SD_2="5.0" SE="2.344036154692477" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="4.658532766136817"/>
<CONT_DATA CI_END="8.246613001046049" CI_START="-8.246613001046049" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="19.3" MEAN_2="19.3" MODIFIED="2013-02-11 19:14:06 +0000" MODIFIED_BY="[Empty name]" ORDER="419" SD_1="6.4" SD_2="4.5" SE="4.2075329271834985" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="1.4458482703750302"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.824310541406597" CI_END="-1.0710502366528747" CI_START="-3.702294119651106" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.3866721781519904" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.02" MODIFIED="2013-02-11 19:16:16 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7004378985980164" P_Q="1.0" P_Z="3.7715439384157306E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="151" TOTAL_2="149" UNITS="" WEIGHT="100.00000000000001" Z="3.555574260757196">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.0900603299075993" CI_START="-7.790060329907602" EFFECT_SIZE="-2.3500000000000014" ESTIMABLE="YES" MEAN_1="26.32" MEAN_2="28.67" MODIFIED="2013-02-11 19:14:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13144" SD_1="5.93" SD_2="9.37" SE="2.7755919868008303" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="5.848638566777085"/>
<CONT_DATA CI_END="2.3826127028829083" CI_START="-6.382612702882908" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="24.0" MEAN_2="26.0" MODIFIED="2013-02-11 19:14:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13145" SD_1="8.0" SD_2="6.0" SE="2.23606797749979" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="9.011478054272871"/>
<CONT_DATA CI_END="0.2964432773287662" CI_START="-6.27644327732877" EFFECT_SIZE="-2.990000000000002" ESTIMABLE="YES" MEAN_1="22.74" MEAN_2="25.73" MODIFIED="2013-02-11 19:14:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13146" SD_1="5.93" SD_2="6.84" SE="1.6767875855127" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="16.025438945095114"/>
<CONT_DATA CI_END="-0.8819694212876885" CI_START="-7.118030578712311" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="31.0" MODIFIED="2013-02-11 19:14:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13147" SD_1="7.0" SD_2="8.0" SE="1.5908611603615876" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="17.803339583851116"/>
<CONT_DATA CI_END="1.1913063514414541" CI_START="-3.191306351441454" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="24.0" MODIFIED="2013-02-11 19:14:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13148" SD_1="3.0" SD_2="4.0" SE="1.118033988749895" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="36.045912217091484"/>
<CONT_DATA CI_END="-0.05025549135398055" CI_START="-9.94974450864602" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="25.0" MEAN_2="30.0" MODIFIED="2013-02-11 19:14:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13149" SD_1="5.0" SD_2="6.0" SE="2.5254262566501082" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="7.064747603524027"/>
<CONT_DATA CI_END="2.594226441657014" CI_START="-6.594226441657014" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="22.0" MEAN_2="24.0" MODIFIED="2013-02-11 19:14:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13150" SD_1="5.0" SD_2="5.0" SE="2.344036154692477" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="8.200445029388312"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.179348676044201" CI_END="-2.229897555648926" CI_START="-4.802155583259131" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.5160265694540285" ESTIMABLE="YES" I2="3.462765055261372" I2_Q="0.0" ID="CMP-008.03" MODIFIED="2013-02-15 16:57:41 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.39438710329987103" P_Q="1.0" P_Z="8.40736238157714E-8" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.10184199839644534" TOTALS="YES" TOTAL_1="125" TOTAL_2="129" UNITS="" WEIGHT="100.00000000000001" Z="5.358160317391073">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.4443750385763425" CI_START="-6.1556249614236584" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="14.7" MEAN_2="19.0" MODIFIED="2013-02-11 19:15:32 +0000" MODIFIED_BY="[Empty name]" ORDER="471" SD_1="1.9" SD_2="2.5" SE="0.9467648263236422" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="43.13729138965126"/>
<CONT_DATA CI_END="1.7187701938273698" CI_START="-5.718770193827369" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="24.0" MEAN_2="26.0" MODIFIED="2013-02-11 19:15:32 +0000" MODIFIED_BY="[Empty name]" ORDER="13205" SD_1="6.0" SD_2="6.0" SE="1.8973665961010275" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.632016534495532"/>
<CONT_DATA CI_END="2.6101621552522394" CI_START="-5.610162155252239" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="24.8" MEAN_2="26.3" MODIFIED="2013-02-11 19:15:32 +0000" MODIFIED_BY="[Empty name]" ORDER="13206" SD_1="4.0" SD_2="8.0" SE="2.097060041752131" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="9.569921185446779"/>
<CONT_DATA CI_END="-0.559016975124782" CI_START="-5.4409830248752105" EFFECT_SIZE="-2.9999999999999964" ESTIMABLE="YES" MEAN_1="29.3" MEAN_2="32.3" MODIFIED="2013-02-11 19:15:32 +0000" MODIFIED_BY="[Empty name]" ORDER="13207" SD_1="7.1" SD_2="7.1" SE="1.2454223874159815" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="26.050816391559604"/>
<CONT_DATA CI_END="-2.2450311190353123" CI_START="-11.754968880964688" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="30.0" MODIFIED="2013-02-11 19:15:32 +0000" MODIFIED_BY="[Empty name]" ORDER="13208" SD_1="4.0" SD_2="6.0" SE="2.4260491103261463" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" WEIGHT="7.191562849723203"/>
<CONT_DATA CI_END="8.246613001046049" CI_START="-8.246613001046049" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="19.3" MEAN_2="19.3" MODIFIED="2013-02-11 19:15:32 +0000" MODIFIED_BY="[Empty name]" ORDER="407" SD_1="6.4" SD_2="4.5" SE="4.2075329271834985" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="2.4183916491236346"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6021176764779497" CI_END="2.13019545597475" CI_START="-0.9959060217409913" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5671447171168794" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.04" MODIFIED="2013-02-15 17:24:33 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9628281086366943" P_Q="1.0" P_Z="0.47698348989564643" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="109" TOTAL_2="109" UNITS="" WEIGHT="100.0" Z="0.7111625950053807">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.60349659849364" CI_START="-3.0034965984936384" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="21.2" MEAN_2="20.9" MODIFIED="2013-02-11 19:16:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13244" SD_1="6.5" SD_2="4.7" SE="1.685488419456275" STUDY_ID="STD-Bellone-2004" TOTAL_1="22" TOTAL_2="24" WEIGHT="22.38713015592572"/>
<CONT_DATA CI_END="3.2728151937999623" CI_START="-3.0728151937999595" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="21.3" MEAN_2="21.2" MODIFIED="2013-02-11 19:16:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13245" SD_1="5.1" SD_2="4.6" SE="1.6188130082117438" STUDY_ID="STD-Bellone-2005" TOTAL_1="18" TOTAL_2="18" WEIGHT="24.269263609829146"/>
<CONT_DATA CI_END="4.382612702882908" CI_START="-4.382612702882908" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="24.0" MEAN_2="24.0" MODIFIED="2013-02-11 19:16:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13246" SD_1="8.0" SD_2="6.0" SE="2.23606797749979" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="12.719790716396009"/>
<CONT_DATA CI_END="3.75054334867293" CI_START="-2.1505433486729286" EFFECT_SIZE="0.8000000000000007" ESTIMABLE="YES" MEAN_1="26.2" MEAN_2="25.4" MODIFIED="2013-02-11 19:16:10 +0000" MODIFIED_BY="[Empty name]" ORDER="474" SD_1="7.7" SD_2="5.6" SE="1.5054069217324597" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="28.063520609809174"/>
<CONT_DATA CI_END="6.410351034874242" CI_START="-2.4103510348742416" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="25.0" MEAN_2="23.0" MODIFIED="2013-02-11 19:16:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13247" SD_1="5.0" SD_2="4.0" SE="2.2502204477544114" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" WEIGHT="12.560294908039946"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2013-04-16 14:43:56 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Heart rate after one hour</NAME>
<CONT_OUTCOME CHI2="14.24882871636878" CI_END="0.14514798092923975" CI_START="-8.16367908458039" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.0092655518255755" ESTIMABLE="YES" I2="43.8550342681167" I2_Q="0.0" ID="CMP-009.01" MODIFIED="2013-02-15 17:30:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.07550596814318311" P_Q="1.0" P_Z="0.058559464371723165" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="15.811533400724658" TOTALS="YES" TOTAL_1="220" TOTAL_2="218" UNITS="" WEIGHT="100.00000000000003" Z="1.8914862528922438">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1317696552669991" CI_START="-8.931769655267011" EFFECT_SIZE="-3.9000000000000057" ESTIMABLE="YES" MEAN_1="81.1" MEAN_2="85.0" MODIFIED="2013-02-11 19:22:10 +0000" MODIFIED_BY="[Empty name]" ORDER="462" SD_1="5.5" SD_2="6.5" SE="2.5672765902623524" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="20.055241470754392"/>
<CONT_DATA CI_END="1.9807600121981466" CI_START="-19.920760012198144" EFFECT_SIZE="-8.969999999999999" ESTIMABLE="YES" MEAN_1="97.16" MEAN_2="106.13" MODIFIED="2013-02-11 19:22:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13085" SD_1="21.4" SD_2="10.33" SE="5.587225121775881" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="9.553467934486418"/>
<CONT_DATA CI_END="4.5435166368057445" CI_START="-16.883516636805748" EFFECT_SIZE="-6.170000000000002" ESTIMABLE="YES" MEAN_1="93.44" MEAN_2="99.61" MODIFIED="2013-02-11 19:22:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13086" SD_1="16.49" SD_2="24.78" SE="5.4661803590844515" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="9.833221553449583"/>
<CONT_DATA CI_END="-6.0758765562868415" CI_START="-21.924123443713157" EFFECT_SIZE="-14.0" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="103.0" MODIFIED="2013-02-15 17:30:54 +0000" MODIFIED_BY="[Empty name]" ORDER="13087" SD_1="20.0" SD_2="18.0" SE="4.042994415314584" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="13.971504864021345"/>
<CONT_DATA CI_END="7.517008187621071" CI_START="-7.917008187621077" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="100.5" MEAN_2="100.7" MODIFIED="2013-02-11 19:22:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13088" SD_1="12.6" SD_2="12.3" SE="3.9373214245220063" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="14.347765040513954"/>
<CONT_DATA CI_END="18.144406998381026" CI_START="-12.144406998381026" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="96.0" MODIFIED="2013-02-11 19:22:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13089" SD_1="24.0" SD_2="23.0" SE="7.726880247717904" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="5.949535645573324"/>
<CONT_DATA CI_END="1.1884076686977263" CI_START="-11.188407668697726" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="104.0" MEAN_2="109.0" MODIFIED="2013-02-11 19:22:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13090" SD_1="18.0" SD_2="18.0" SE="3.1574088695053053" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="17.42719458362666"/>
<CONT_DATA CI_END="24.155862423163597" CI_START="-2.1558624231635957" EFFECT_SIZE="11.0" ESTIMABLE="YES" MEAN_1="95.0" MEAN_2="84.0" MODIFIED="2013-02-15 17:30:57 +0000" MODIFIED_BY="[Empty name]" ORDER="13091" SD_1="20.0" SD_2="10.0" SE="6.712298045747452" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="7.381507935137529"/>
<CONT_DATA CI_END="40.141204896405846" CI_START="-26.341204896405834" EFFECT_SIZE="6.900000000000006" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="90.1" MODIFIED="2013-02-11 19:22:10 +0000" MODIFIED_BY="[Empty name]" ORDER="420" SD_1="25.6" SD_2="18.6" SE="16.960110062535957" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="1.480560972436807"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.1986535103193896" CI_END="-0.7027148685562676" CI_START="-6.883183470824395" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.7929491696903312" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.02" MODIFIED="2013-02-15 17:32:08 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7835325946885022" P_Q="1.0" P_Z="0.01614341384998299" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="165" UNITS="" WEIGHT="100.0" Z="2.4056569966413175">
<NAME>NPPV (CPAP and BILEVEL) X SMC - heterogeneity analysis</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1317696552669991" CI_START="-8.931769655267011" EFFECT_SIZE="-3.9000000000000057" ESTIMABLE="YES" MEAN_1="81.1" MEAN_2="85.0" MODIFIED="2013-02-15 17:31:33 +0000" MODIFIED_BY="[Empty name]" ORDER="462" SD_1="5.5" SD_2="6.5" SE="2.5672765902623524" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="37.717362361754134"/>
<CONT_DATA CI_END="1.9807600121981466" CI_START="-19.920760012198144" EFFECT_SIZE="-8.969999999999999" ESTIMABLE="YES" MEAN_1="97.16" MEAN_2="106.13" MODIFIED="2013-02-11 19:24:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13321" SD_1="21.4" SD_2="10.33" SE="5.587225121775881" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="7.963322327112958"/>
<CONT_DATA CI_END="4.5435166368057445" CI_START="-16.883516636805748" EFFECT_SIZE="-6.170000000000002" ESTIMABLE="YES" MEAN_1="93.44" MEAN_2="99.61" MODIFIED="2013-02-11 19:24:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13322" SD_1="16.49" SD_2="24.78" SE="5.4661803590844515" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="8.319911773230961"/>
<CONT_DATA CI_END="7.517008187621071" CI_START="-7.917008187621077" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="100.5" MEAN_2="100.7" MODIFIED="2013-02-11 19:24:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13323" SD_1="12.6" SD_2="12.3" SE="3.9373214245220063" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="16.035588226105318"/>
<CONT_DATA CI_END="18.144406998381026" CI_START="-12.144406998381026" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="96.0" MODIFIED="2013-02-11 19:24:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13324" SD_1="24.0" SD_2="23.0" SE="7.726880247717904" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="4.163688898306363"/>
<CONT_DATA CI_END="1.1884076686977263" CI_START="-11.188407668697726" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="104.0" MEAN_2="109.0" MODIFIED="2013-02-11 19:24:10 +0000" MODIFIED_BY="[Empty name]" ORDER="13325" SD_1="18.0" SD_2="18.0" SE="3.1574088695053053" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="24.935896482851625"/>
<CONT_DATA CI_END="40.141204896405846" CI_START="-26.341204896405834" EFFECT_SIZE="6.900000000000006" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="90.1" MODIFIED="2013-02-15 17:32:08 +0000" MODIFIED_BY="[Empty name]" ORDER="420" SD_1="25.6" SD_2="18.6" SE="16.960110062535957" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="0.8642299306386488"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.352724478985996" CI_END="1.9151998528963228" CI_START="-10.8088882095816" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.446844178342639" ESTIMABLE="YES" I2="58.19609016542695" I2_Q="0.0" ID="CMP-009.03" MODIFIED="2013-02-15 16:57:39 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.025934905253204965" P_Q="1.0" P_Z="0.17070387360561506" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="41.068542832005505" TOTALS="YES" TOTAL_1="151" TOTAL_2="149" UNITS="" WEIGHT="100.0" Z="1.3699456325070218">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9807600121981466" CI_START="-19.920760012198144" EFFECT_SIZE="-8.969999999999999" ESTIMABLE="YES" MEAN_1="97.16" MEAN_2="106.13" MODIFIED="2013-02-11 19:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13151" SD_1="21.4" SD_2="10.33" SE="5.587225121775881" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="14.57622972224359"/>
<CONT_DATA CI_END="18.832093609194324" CI_START="-12.832093609194322" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="94.0" MODIFIED="2013-02-11 19:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13152" SD_1="24.0" SD_2="27.0" SE="8.077747210701755" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="9.91033062000967"/>
<CONT_DATA CI_END="4.5435166368057445" CI_START="-16.883516636805748" EFFECT_SIZE="-6.170000000000002" ESTIMABLE="YES" MEAN_1="93.44" MEAN_2="99.61" MODIFIED="2013-02-11 19:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13153" SD_1="16.49" SD_2="24.78" SE="5.4661803590844515" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="14.85111353669594"/>
<CONT_DATA CI_END="-6.0758765562868415" CI_START="-21.924123443713157" EFFECT_SIZE="-14.0" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="103.0" MODIFIED="2013-02-11 19:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13154" SD_1="20.0" SD_2="18.0" SE="4.042994415314584" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="18.351718194766395"/>
<CONT_DATA CI_END="7.517008187621071" CI_START="-7.917008187621077" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="100.5" MEAN_2="100.7" MODIFIED="2013-02-11 19:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13155" SD_1="12.6" SD_2="12.3" SE="3.9373214245220063" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="18.625287033010505"/>
<CONT_DATA CI_END="2.989316833801176" CI_START="-24.989316833801176" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="100.0" MODIFIED="2013-02-11 19:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13156" SD_1="16.0" SD_2="15.0" SE="7.137537701787952" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="11.451121648047053"/>
<CONT_DATA CI_END="24.155862423163597" CI_START="-2.1558624231635957" EFFECT_SIZE="11.0" ESTIMABLE="YES" MEAN_1="95.0" MEAN_2="84.0" MODIFIED="2013-02-11 19:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="13157" SD_1="20.0" SD_2="10.0" SE="6.712298045747452" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="12.234199245226845"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.5913946913024017" CI_END="0.723581357339377" CI_START="-8.927709801314677" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.10206422198765" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.04" MODIFIED="2013-02-15 16:57:39 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.46411837544900136" P_Q="1.0" P_Z="0.09569803650534028" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="96" UNITS="" WEIGHT="100.0" Z="1.6660772129243975">
<NAME>CPAP X SMC - heterogeneity analysis</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9807600121981466" CI_START="-19.920760012198144" EFFECT_SIZE="-8.969999999999999" ESTIMABLE="YES" MEAN_1="97.16" MEAN_2="106.13" MODIFIED="2013-02-11 19:25:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13358" SD_1="21.4" SD_2="10.33" SE="5.587225121775881" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="19.41879696309094"/>
<CONT_DATA CI_END="18.832093609194324" CI_START="-12.832093609194322" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="94.0" MODIFIED="2013-02-11 19:25:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13359" SD_1="24.0" SD_2="27.0" SE="8.077747210701755" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="9.290394281648053"/>
<CONT_DATA CI_END="4.5435166368057445" CI_START="-16.883516636805748" EFFECT_SIZE="-6.170000000000002" ESTIMABLE="YES" MEAN_1="93.44" MEAN_2="99.61" MODIFIED="2013-02-11 19:25:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13360" SD_1="16.49" SD_2="24.78" SE="5.4661803590844515" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="20.288350871485484"/>
<CONT_DATA CI_END="7.517008187621071" CI_START="-7.917008187621077" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="100.5" MEAN_2="100.7" MODIFIED="2013-02-11 19:25:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13361" SD_1="12.6" SD_2="12.3" SE="3.9373214245220063" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="39.10325604757526"/>
<CONT_DATA CI_END="2.989316833801176" CI_START="-24.989316833801176" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="100.0" MODIFIED="2013-02-11 19:25:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13362" SD_1="16.0" SD_2="15.0" SE="7.137537701787952" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="11.89920183620026"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.102479591550071" CI_END="-0.6519304020603833" CI_START="-7.774312136042658" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.213121269051521" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.05" MODIFIED="2013-02-15 16:57:39 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5347579323556158" P_Q="1.0" P_Z="0.02040776350761936" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="125" TOTAL_2="129" UNITS="" WEIGHT="99.99999999999999" Z="2.3187653395330408">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1317696552669991" CI_START="-8.931769655267011" EFFECT_SIZE="-3.9000000000000057" ESTIMABLE="YES" MEAN_1="81.1" MEAN_2="85.0" MODIFIED="2013-02-11 19:23:11 +0000" MODIFIED_BY="[Empty name]" ORDER="472" SD_1="5.5" SD_2="6.5" SE="2.5672765902623524" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="50.08976548576595"/>
<CONT_DATA CI_END="17.734465872223165" CI_START="-15.734465872223165" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="95.0" MEAN_2="94.0" MODIFIED="2013-02-11 19:23:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13209" SD_1="27.0" SD_2="27.0" SE="8.538149682454625" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="4.528629502080099"/>
<CONT_DATA CI_END="18.144406998381026" CI_START="-12.144406998381026" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="96.0" MODIFIED="2013-02-11 19:23:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13210" SD_1="24.0" SD_2="23.0" SE="7.726880247717904" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="5.529501200840425"/>
<CONT_DATA CI_END="1.1884076686977263" CI_START="-11.188407668697726" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="104.0" MEAN_2="109.0" MODIFIED="2013-02-11 19:23:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13211" SD_1="18.0" SD_2="18.0" SE="3.1574088695053053" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="33.11560323396073"/>
<CONT_DATA CI_END="-0.9361206743841279" CI_START="-31.063879325615872" EFFECT_SIZE="-16.0" ESTIMABLE="YES" MEAN_1="84.0" MEAN_2="100.0" MODIFIED="2013-02-11 19:23:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13212" SD_1="16.0" SD_2="15.0" SE="7.685793945418298" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" WEIGHT="5.588777835336094"/>
<CONT_DATA CI_END="40.141204896405846" CI_START="-26.341204896405834" EFFECT_SIZE="6.900000000000006" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="90.1" MODIFIED="2013-02-11 19:23:11 +0000" MODIFIED_BY="[Empty name]" ORDER="408" SD_1="25.6" SD_2="18.6" SE="16.960110062535957" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="1.1477227420166936"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.7252000965286158" CI_END="4.105854531571502" CI_START="-5.219603998868047" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5568747336482728" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.06" MODIFIED="2013-02-15 16:57:39 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.8672612555450725" P_Q="1.0" P_Z="0.8149224137560087" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="91" UNITS="" WEIGHT="100.0" Z="0.23408059095181138">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.891870271270662" CI_START="-8.491870271270656" EFFECT_SIZE="-0.7999999999999972" ESTIMABLE="YES" MEAN_1="90.2" MEAN_2="91.0" MODIFIED="2013-02-11 19:23:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13248" SD_1="13.2" SD_2="13.4" SE="3.9244957213209783" STUDY_ID="STD-Bellone-2004" TOTAL_1="22" TOTAL_2="24" WEIGHT="36.74654374535273"/>
<CONT_DATA CI_END="17.832093609194324" CI_START="-13.832093609194322" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="95.0" MODIFIED="2013-02-11 19:23:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13249" SD_1="24.0" SD_2="27.0" SE="8.077747210701755" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="8.673686098360267"/>
<CONT_DATA CI_END="4.9841904005411966" CI_START="-8.78419040054118" EFFECT_SIZE="-1.8999999999999915" ESTIMABLE="YES" MEAN_1="92.2" MEAN_2="94.1" MODIFIED="2013-02-11 19:23:38 +0000" MODIFIED_BY="[Empty name]" ORDER="473" SD_1="15.2" SD_2="16.2" SE="3.512406582387637" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="45.87484947053639"/>
<CONT_DATA CI_END="20.803664096719935" CI_START="-10.803664096719933" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="84.0" MODIFIED="2013-02-11 19:23:38 +0000" MODIFIED_BY="[Empty name]" ORDER="13250" SD_1="16.0" SD_2="16.0" SE="8.063242090863515" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" WEIGHT="8.704920685750604"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2013-04-16 14:44:04 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Sistolic blood pressure after one hour</NAME>
<CONT_OUTCOME CHI2="4.2547663185904305" CI_END="4.556684777337164" CI_START="-7.8315343488223" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.6374247857425677" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.01" MODIFIED="2013-02-11 19:29:17 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5133489826065206" P_Q="1.0" P_Z="0.6043743731574254" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="93" TOTAL_2="89" UNITS="" WEIGHT="100.00000000000003" Z="0.5181202519532083">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="16.92793798052447" CI_START="-15.527937980524463" EFFECT_SIZE="0.7000000000000028" ESTIMABLE="YES" MEAN_1="117.9" MEAN_2="117.2" MODIFIED="2013-02-11 19:28:20 +0000" MODIFIED_BY="[Empty name]" ORDER="461" SD_1="12.0" SD_2="24.7" SE="8.279712335802275" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="14.569045092739765"/>
<CONT_DATA CI_END="22.06528869792278" CI_START="-8.145288697922767" EFFECT_SIZE="6.960000000000008" ESTIMABLE="YES" MEAN_1="137.63" MEAN_2="130.67" MODIFIED="2013-02-11 19:28:20 +0000" MODIFIED_BY="[Empty name]" ORDER="423" SD_1="23.94" SD_2="20.94" SE="7.706921564412084" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="16.815109734373905"/>
<CONT_DATA CI_END="15.229783902106716" CI_START="-10.569783902106748" EFFECT_SIZE="2.329999999999984" ESTIMABLE="YES" MEAN_1="131.04" MEAN_2="128.71" MODIFIED="2013-02-11 19:28:20 +0000" MODIFIED_BY="[Empty name]" ORDER="425" SD_1="24.66" SD_2="25.39" SE="6.581643338274877" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="23.05647421560536"/>
<CONT_DATA CI_END="5.997470256116237" CI_START="-15.797470256116249" EFFECT_SIZE="-4.900000000000006" ESTIMABLE="YES" MEAN_1="117.5" MEAN_2="122.4" MODIFIED="2013-02-11 19:28:20 +0000" MODIFIED_BY="[Empty name]" ORDER="426" SD_1="15.8" SD_2="19.2" SE="5.560035971106662" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="32.307725284761034"/>
<CONT_DATA CI_END="3.29575105495946" CI_START="-35.29575105495946" EFFECT_SIZE="-16.0" ESTIMABLE="YES" MEAN_1="119.0" MEAN_2="135.0" MODIFIED="2013-02-11 19:28:20 +0000" MODIFIED_BY="[Empty name]" ORDER="422" SD_1="21.0" SD_2="21.0" SE="9.844951849708403" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="10.304677184833597"/>
<CONT_DATA CI_END="28.782044438564448" CI_START="-43.38204443856447" EFFECT_SIZE="-7.300000000000011" ESTIMABLE="YES" MEAN_1="132.0" MEAN_2="139.3" MODIFIED="2013-02-11 19:28:20 +0000" MODIFIED_BY="[Empty name]" ORDER="429" SD_1="26.6" SD_2="22.7" SE="18.409544625908957" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="2.9469684876863638"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.231290536681519" CI_END="6.81208837531798" CI_START="-6.56436745653555" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="0.12386045939121496" ESTIMABLE="YES" I2="19.759799826911046" I2_Q="0.0" ID="CMP-010.02" MODIFIED="2013-02-11 19:29:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.28435958870154876" P_Q="1.0" P_Z="0.971045609869086" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="13.822923005188091" TOTALS="YES" TOTAL_1="108" TOTAL_2="103" UNITS="" WEIGHT="100.00000000000001" Z="0.036296914902866094">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="22.06528869792278" CI_START="-8.145288697922767" EFFECT_SIZE="6.960000000000008" ESTIMABLE="YES" MEAN_1="137.63" MEAN_2="130.67" MODIFIED="2013-02-11 19:29:12 +0000" MODIFIED_BY="[Empty name]" ORDER="13158" SD_1="23.94" SD_2="20.94" SE="7.706921564412084" STUDY_ID="STD-Bersten-1991" TOTAL_1="19" TOTAL_2="15" WEIGHT="15.90372340076408"/>
<CONT_DATA CI_END="26.807811242741764" CI_START="-4.807811242741764" EFFECT_SIZE="11.0" ESTIMABLE="YES" MEAN_1="132.0" MEAN_2="121.0" MODIFIED="2013-02-11 19:29:12 +0000" MODIFIED_BY="[Empty name]" ORDER="13159" SD_1="26.0" SD_2="25.0" SE="8.065358020571685" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="14.76379514276064"/>
<CONT_DATA CI_END="15.229783902106716" CI_START="-10.569783902106748" EFFECT_SIZE="2.329999999999984" ESTIMABLE="YES" MEAN_1="131.04" MEAN_2="128.71" MODIFIED="2013-02-11 19:29:12 +0000" MODIFIED_BY="[Empty name]" ORDER="13160" SD_1="24.66" SD_2="25.39" SE="6.581643338274877" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="20.378793772918282"/>
<CONT_DATA CI_END="5.997470256116237" CI_START="-15.797470256116249" EFFECT_SIZE="-4.900000000000006" ESTIMABLE="YES" MEAN_1="117.5" MEAN_2="122.4" MODIFIED="2013-02-11 19:29:12 +0000" MODIFIED_BY="[Empty name]" ORDER="13161" SD_1="15.8" SD_2="19.2" SE="5.560035971106662" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="26.029141016790277"/>
<CONT_DATA CI_END="16.531668161681466" CI_START="-18.531668161681466" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="122.0" MEAN_2="123.0" MODIFIED="2013-02-11 19:29:12 +0000" MODIFIED_BY="[Empty name]" ORDER="13162" SD_1="8.0" SD_2="27.0" SE="8.944893018427393" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="12.409822177271815"/>
<CONT_DATA CI_END="3.29575105495946" CI_START="-35.29575105495946" EFFECT_SIZE="-16.0" ESTIMABLE="YES" MEAN_1="119.0" MEAN_2="135.0" MODIFIED="2013-02-11 19:29:12 +0000" MODIFIED_BY="[Empty name]" ORDER="13163" SD_1="21.0" SD_2="21.0" SE="9.844951849708403" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="10.514724489494913"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.4982601014496707" CI_END="11.804304180993" CI_START="-7.941462003996416" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="1.9314210884982925" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.03" MODIFIED="2013-02-11 19:30:06 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9192735445929029" P_Q="1.0" P_Z="0.7014042522084714" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="46" UNITS="" WEIGHT="100.0" Z="0.38342556444485026">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="16.92793798052447" CI_START="-15.527937980524463" EFFECT_SIZE="0.7000000000000028" ESTIMABLE="YES" MEAN_1="117.9" MEAN_2="117.2" MODIFIED="2013-02-11 19:29:39 +0000" MODIFIED_BY="[Empty name]" ORDER="473" SD_1="12.0" SD_2="24.7" SE="8.279712335802275" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="37.01359855668624"/>
<CONT_DATA CI_END="23.114649721157807" CI_START="-11.114649721157807" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="127.0" MEAN_2="121.0" MODIFIED="2013-02-11 19:29:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13213" SD_1="30.0" SD_2="25.0" SE="8.73212459828649" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="33.27759706183192"/>
<CONT_DATA CI_END="21.9437274461858" CI_START="-19.9437274461858" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="124.0" MEAN_2="123.0" MODIFIED="2013-02-11 19:29:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13214" SD_1="17.0" SD_2="27.0" SE="10.685771581206211" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" WEIGHT="22.221840900478906"/>
<CONT_DATA CI_END="28.782044438564448" CI_START="-43.38204443856447" EFFECT_SIZE="-7.300000000000011" ESTIMABLE="YES" MEAN_1="132.0" MEAN_2="139.3" MODIFIED="2013-02-11 19:29:39 +0000" MODIFIED_BY="[Empty name]" ORDER="409" SD_1="26.6" SD_2="22.7" SE="18.409544625908957" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="7.486963481002948"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.983577138874823" CI_END="8.439652759181895" CI_START="-10.788252454791541" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.1742998478048225" ESTIMABLE="YES" I2="66.605730060267" I2_Q="0.0" ID="CMP-010.04" MODIFIED="2013-02-18 16:51:28 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.029510066363920284" P_Q="1.0" P_Z="0.810795014501913" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="61.24165437581467" TOTALS="YES" TOTAL_1="90" TOTAL_2="92" UNITS="" WEIGHT="99.99999999999999" Z="0.23940053616196272">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.9651938695973534" CI_START="-29.63480613040267" EFFECT_SIZE="-16.30000000000001" ESTIMABLE="YES" MEAN_1="129.2" MEAN_2="145.5" MODIFIED="2013-02-11 19:30:02 +0000" MODIFIED_BY="[Empty name]" ORDER="13251" SD_1="27.1" SD_2="17.6" SE="6.803597533212807" STUDY_ID="STD-Bellone-2004" TOTAL_1="22" TOTAL_2="24" WEIGHT="22.37565348520724"/>
<CONT_DATA CI_END="22.398475653651303" CI_START="-12.398475653651303" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="132.0" MEAN_2="127.0" MODIFIED="2013-02-11 19:30:02 +0000" MODIFIED_BY="[Empty name]" ORDER="13252" SD_1="26.0" SD_2="30.0" SE="8.87693640846886" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="17.181083128264813"/>
<CONT_DATA CI_END="17.329156421667477" CI_START="-1.5291564216674658" EFFECT_SIZE="7.900000000000006" ESTIMABLE="YES" MEAN_1="128.5" MEAN_2="120.6" MODIFIED="2013-02-11 19:30:02 +0000" MODIFIED_BY="[Empty name]" ORDER="592" SD_1="23.8" SD_2="18.8" SE="4.81088249378226" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="39" TOTAL_2="41" WEIGHT="28.51255334950785"/>
<CONT_DATA CI_END="5.362557452921687" CI_START="-9.362557452921687" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="122.0" MEAN_2="124.0" MODIFIED="2013-02-11 19:30:02 +0000" MODIFIED_BY="[Empty name]" ORDER="13253" SD_1="8.0" SD_2="7.0" SE="3.7564758898615485" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" WEIGHT="31.930710037020088"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.7513788162165236" CI_END="9.441213618889638" CI_START="-4.2988321432986085" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="2.571190737795514" ESTIMABLE="YES" I2="27.309173560104664" I2_Q="0.0" ID="CMP-010.05" MODIFIED="2013-02-18 16:53:33 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.25266558469081646" P_Q="1.0" P_Z="0.46322873270040066" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="10.56069204427178" TOTALS="YES" TOTAL_1="68" TOTAL_2="68" UNITS="" WEIGHT="100.00000000000001" Z="0.7335406782021655">
<NAME>CPAP X BILEVEL - heterogeneity analysis</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="22.398475653651303" CI_START="-12.398475653651303" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="132.0" MEAN_2="127.0" MODIFIED="2013-02-11 19:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="13402" SD_1="26.0" SD_2="30.0" SE="8.87693640846886" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="13.7490807144551"/>
<CONT_DATA CI_END="17.329156421667477" CI_START="-1.5291564216674658" EFFECT_SIZE="7.900000000000006" ESTIMABLE="YES" MEAN_1="128.5" MEAN_2="120.6" MODIFIED="2013-02-11 19:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="599" SD_1="23.8" SD_2="18.8" SE="4.81088249378226" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="39" TOTAL_2="41" WEIGHT="36.4520715937743"/>
<CONT_DATA CI_END="5.362557452921687" CI_START="-9.362557452921687" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="122.0" MEAN_2="124.0" MODIFIED="2013-02-11 19:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="13403" SD_1="8.0" SD_2="7.0" SE="3.7564758898615485" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" WEIGHT="49.79884769177061"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2013-04-16 14:44:11 +0100" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Diastolic blood pressure after one hour</NAME>
<CONT_OUTCOME CHI2="5.070980838209928" CI_END="3.4477754957264626" CI_START="-6.434223201556572" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4932238529150548" ESTIMABLE="YES" I2="21.11979659122489" I2_Q="0.0" ID="CMP-011.01" MODIFIED="2013-02-11 19:32:08 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.28009173574552726" P_Q="1.0" P_Z="0.5536346704215025" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="6.726614476522139" TOTALS="YES" TOTAL_1="72" TOTAL_2="66" UNITS="" WEIGHT="100.00000000000001" Z="0.5923224769042528">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.4264979606334593" CI_START="-11.426497960633473" EFFECT_SIZE="-4.000000000000007" ESTIMABLE="YES" MEAN_1="60.4" MEAN_2="64.4" MODIFIED="2013-02-11 19:31:32 +0000" MODIFIED_BY="[Empty name]" ORDER="460" SD_1="7.2" SD_2="10.3" SE="3.789099197338693" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="30.142739972734685"/>
<CONT_DATA CI_END="4.288074662920527" CI_START="-15.408074662920532" EFFECT_SIZE="-5.560000000000002" ESTIMABLE="YES" MEAN_1="76.94" MEAN_2="82.5" MODIFIED="2013-02-11 19:31:32 +0000" MODIFIED_BY="[Empty name]" ORDER="434" SD_1="13.62" SD_2="13.39" SE="5.024620217820779" STUDY_ID="STD-Bersten-1991" TOTAL_1="18" TOTAL_2="12" WEIGHT="19.876699888463698"/>
<CONT_DATA CI_END="5.2507705271854075" CI_START="-11.710770527185387" EFFECT_SIZE="-3.2299999999999898" ESTIMABLE="YES" MEAN_1="70.48" MEAN_2="73.71" MODIFIED="2013-02-11 19:31:32 +0000" MODIFIED_BY="[Empty name]" ORDER="432" SD_1="17.77" SD_2="14.76" SE="4.327003248059981" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="24.971977523069555"/>
<CONT_DATA CI_END="17.52014179875829" CI_START="-1.5201417987582886" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="75.0" MEAN_2="67.0" MODIFIED="2013-02-11 19:31:32 +0000" MODIFIED_BY="[Empty name]" ORDER="430" SD_1="11.0" SD_2="10.0" SE="4.857304457557359" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="20.960609761210517"/>
<CONT_DATA CI_END="22.726312657237838" CI_START="-25.32631265723786" EFFECT_SIZE="-1.3000000000000114" ESTIMABLE="YES" MEAN_1="70.6" MEAN_2="71.9" MODIFIED="2013-02-11 19:31:32 +0000" MODIFIED_BY="[Empty name]" ORDER="437" SD_1="15.0" SD_2="19.4" SE="12.25854803800189" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="4.047972854521557"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="17.173476411310954" CI_END="7.266048128616215" CI_START="-9.103236823304828" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9185943473443062" ESTIMABLE="YES" I2="76.7082685869852" I2_Q="0.0" ID="CMP-011.02" MODIFIED="2013-02-11 19:32:40 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0017885394094541152" P_Q="1.0" P_Z="0.8258910905503033" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="66.63971470707929" TOTALS="YES" TOTAL_1="87" TOTAL_2="80" UNITS="" WEIGHT="100.0" Z="0.21997440236210525">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.288074662920527" CI_START="-15.408074662920532" EFFECT_SIZE="-5.560000000000002" ESTIMABLE="YES" MEAN_1="76.94" MEAN_2="82.5" MODIFIED="2013-02-11 19:32:03 +0000" MODIFIED_BY="[Empty name]" ORDER="13164" SD_1="13.62" SD_2="13.39" SE="5.024620217820779" STUDY_ID="STD-Bersten-1991" TOTAL_1="18" TOTAL_2="12" WEIGHT="18.97804298880108"/>
<CONT_DATA CI_END="17.874114368444303" CI_START="0.12588563155569865" EFFECT_SIZE="9.0" ESTIMABLE="YES" MEAN_1="73.0" MEAN_2="64.0" MODIFIED="2013-02-11 19:32:03 +0000" MODIFIED_BY="[Empty name]" ORDER="13165" SD_1="17.0" SD_2="11.0" SE="4.527692569068709" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="20.01184408526348"/>
<CONT_DATA CI_END="5.2507705271854075" CI_START="-11.710770527185387" EFFECT_SIZE="-3.2299999999999898" ESTIMABLE="YES" MEAN_1="70.48" MEAN_2="73.71" MODIFIED="2013-02-11 19:32:03 +0000" MODIFIED_BY="[Empty name]" ORDER="13166" SD_1="17.77" SD_2="14.76" SE="4.327003248059981" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="20.428441932034552"/>
<CONT_DATA CI_END="-4.308545921694029" CI_START="-19.69145407830597" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="70.0" MEAN_2="82.0" MODIFIED="2013-02-11 19:32:03 +0000" MODIFIED_BY="[Empty name]" ORDER="13167" SD_1="9.0" SD_2="8.0" SE="3.924283374069717" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="21.255880649740178"/>
<CONT_DATA CI_END="17.52014179875829" CI_START="-1.5201417987582886" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="75.0" MEAN_2="67.0" MODIFIED="2013-02-11 19:32:03 +0000" MODIFIED_BY="[Empty name]" ORDER="13168" SD_1="11.0" SD_2="10.0" SE="4.857304457557359" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="19.3257903441607"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.4368127904087133" CI_END="-1.8550111596102772" CI_START="-12.792965652572647" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.323988406091463" ESTIMABLE="YES" I2="17.92557853143282" I2_Q="0.0" ID="CMP-011.03" MODIFIED="2013-02-11 19:33:49 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.29570109457249294" P_Q="1.0" P_Z="0.008671002617582238" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="4.229932021255829" TOTALS="YES" TOTAL_1="54" TOTAL_2="53" UNITS="" WEIGHT="100.0" Z="2.62476014292512">
<NAME>CPAP X SMC - heterogeneity analysis</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.288074662920527" CI_START="-15.408074662920532" EFFECT_SIZE="-5.560000000000002" ESTIMABLE="YES" MEAN_1="76.94" MEAN_2="82.5" MODIFIED="2013-02-11 19:33:25 +0000" MODIFIED_BY="[Empty name]" ORDER="13363" SD_1="13.62" SD_2="13.39" SE="5.024620217820779" STUDY_ID="STD-Bersten-1991" TOTAL_1="18" TOTAL_2="12" WEIGHT="26.41414727707428"/>
<CONT_DATA CI_END="5.2507705271854075" CI_START="-11.710770527185387" EFFECT_SIZE="-3.2299999999999898" ESTIMABLE="YES" MEAN_1="70.48" MEAN_2="73.71" MODIFIED="2013-02-11 19:33:25 +0000" MODIFIED_BY="[Empty name]" ORDER="13364" SD_1="17.77" SD_2="14.76" SE="4.327003248059981" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="33.92178459823205"/>
<CONT_DATA CI_END="-4.308545921694029" CI_START="-19.69145407830597" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="70.0" MEAN_2="82.0" MODIFIED="2013-02-11 19:33:25 +0000" MODIFIED_BY="[Empty name]" ORDER="13365" SD_1="9.0" SD_2="8.0" SE="3.924283374069717" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="39.664068124693664"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.4287362728054827" CI_END="4.163673479225795" CI_START="-6.093250503141763" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9647885119579842" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.04" MODIFIED="2013-02-11 19:34:13 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6988128480781028" P_Q="1.0" P_Z="0.7123387326221668" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="46" UNITS="" WEIGHT="100.00000000000003" Z="0.3687169251495537">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.4264979606334593" CI_START="-11.426497960633473" EFFECT_SIZE="-4.000000000000007" ESTIMABLE="YES" MEAN_1="60.4" MEAN_2="64.4" MODIFIED="2013-02-11 19:32:37 +0000" MODIFIED_BY="[Empty name]" ORDER="474" SD_1="7.2" SD_2="10.3" SE="3.789099197338693" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="47.687675112238765"/>
<CONT_DATA CI_END="11.874114368444301" CI_START="-5.874114368444301" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="67.0" MEAN_2="64.0" MODIFIED="2013-02-11 19:32:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13215" SD_1="17.0" SD_2="11.0" SE="4.527692569068709" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="33.39829060077991"/>
<CONT_DATA CI_END="13.534500647011587" CI_START="-13.534500647011587" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="82.0" MEAN_2="82.0" MODIFIED="2013-02-11 19:32:37 +0000" MODIFIED_BY="[Empty name]" ORDER="13216" SD_1="17.0" SD_2="8.0" SE="6.905484362860746" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" WEIGHT="14.357863095302328"/>
<CONT_DATA CI_END="22.726312657237838" CI_START="-25.32631265723786" EFFECT_SIZE="-1.3000000000000114" ESTIMABLE="YES" MEAN_1="70.6" MEAN_2="71.9" MODIFIED="2013-02-11 19:32:37 +0000" MODIFIED_BY="[Empty name]" ORDER="410" SD_1="15.0" SD_2="19.4" SE="12.25854803800189" STUDY_ID="STD-Weitz-2007" TOTAL_1="3" TOTAL_2="5" WEIGHT="4.5561711916790095"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.072207809784071" CI_END="4.373996379130928" CI_START="-9.579137884263822" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.6025707525664474" ESTIMABLE="YES" I2="62.8354463773369" I2_Q="0.0" ID="CMP-011.05" MODIFIED="2013-02-11 19:34:15 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.04454285336068098" P_Q="1.0" P_Z="0.4646851012735632" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="30.182030170824486" TOTALS="YES" TOTAL_1="90" TOTAL_2="92" UNITS="" WEIGHT="100.0" Z="0.7311539967947673">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.636066474941603" CI_START="-12.763933525058402" EFFECT_SIZE="-7.200000000000003" ESTIMABLE="YES" MEAN_1="74.1" MEAN_2="81.3" MODIFIED="2013-02-11 19:32:58 +0000" MODIFIED_BY="[Empty name]" ORDER="13254" SD_1="9.9" SD_2="9.3" SE="2.8387937579190217" STUDY_ID="STD-Bellone-2004" TOTAL_1="22" TOTAL_2="24" WEIGHT="33.13298997720088"/>
<CONT_DATA CI_END="16.536515549177548" CI_START="-4.5365155491775475" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="73.0" MEAN_2="67.0" MODIFIED="2013-02-11 19:32:58 +0000" MODIFIED_BY="[Empty name]" ORDER="13255" SD_1="17.0" SD_2="17.0" SE="5.375872022286245" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="21.445291951831866"/>
<CONT_DATA CI_END="8.233293576628924" CI_START="-5.633293576628929" EFFECT_SIZE="1.2999999999999972" ESTIMABLE="YES" MEAN_1="69.1" MEAN_2="67.8" MODIFIED="2013-02-11 19:32:58 +0000" MODIFIED_BY="[Empty name]" ORDER="593" SD_1="16.2" SD_2="15.4" SE="3.5374596836053422" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="39" TOTAL_2="41" WEIGHT="29.67588855036223"/>
<CONT_DATA CI_END="1.8985790891645387" CI_START="-25.89857908916454" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="70.0" MEAN_2="82.0" MODIFIED="2013-02-11 19:32:58 +0000" MODIFIED_BY="[Empty name]" ORDER="13256" SD_1="9.0" SD_2="17.0" SE="7.091242083423347" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" WEIGHT="15.745829520605028"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.3948960759528534" CI_END="-2.6975880439660838" CI_START="-13.028398936069364" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.862993490017724" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.06" MODIFIED="2013-02-15 16:57:19 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.5297373703858735" P_Q="1.0" P_Z="0.002849365400250502" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="31" UNITS="" WEIGHT="100.0" Z="2.983538119527041">
<NAME>CPAP X BILEVEL - heterogeneity analysis</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.636066474941603" CI_START="-12.763933525058402" EFFECT_SIZE="-7.200000000000003" ESTIMABLE="YES" MEAN_1="74.1" MEAN_2="81.3" MODIFIED="2013-02-11 19:34:08 +0000" MODIFIED_BY="[Empty name]" ORDER="13404" SD_1="9.9" SD_2="9.3" SE="2.8387937579190217" STUDY_ID="STD-Bellone-2004" TOTAL_1="22" TOTAL_2="24" WEIGHT="86.18763562463081"/>
<CONT_DATA CI_END="1.8985790891645387" CI_START="-25.89857908916454" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="70.0" MEAN_2="82.0" MODIFIED="2013-02-11 19:34:08 +0000" MODIFIED_BY="[Empty name]" ORDER="13405" SD_1="9.0" SD_2="17.0" SE="7.091242083423347" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" WEIGHT="13.81236437536919"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2013-04-16 14:44:16 +0100" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Mean blood pressure after one hour</NAME>
<CONT_OUTCOME CHI2="2.6054483484082063" CI_END="3.447788407065449" CI_START="-8.273777888942499" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.412994740938525" ESTIMABLE="YES" I2="23.237779738681205" I2_Q="0.0" ID="CMP-012.01" MODIFIED="2013-02-11 19:27:12 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.27179051920414166" P_Q="1.0" P_Z="0.4196929555545106" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="6.499875880997853" TOTALS="YES" TOTAL_1="127" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="0.8069540653000903">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="11.3149558268692" CI_START="-5.3149558268692" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="94.0" MODIFIED="2013-02-11 19:26:07 +0000" MODIFIED_BY="[Empty name]" ORDER="13092" SD_1="20.0" SD_2="20.0" SE="4.242402356602729" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="36.4995144808617"/>
<CONT_DATA CI_END="6.466896180835494" CI_START="-20.466896180835494" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="91.0" MEAN_2="98.0" MODIFIED="2013-02-11 19:26:07 +0000" MODIFIED_BY="[Empty name]" ORDER="13093" SD_1="17.0" SD_2="24.0" SE="6.8709916544694964" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="16.64779497037306"/>
<CONT_DATA CI_END="1.9529333215754177" CI_START="-11.952933321575419" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="106.0" MEAN_2="111.0" MODIFIED="2013-02-11 19:26:07 +0000" MODIFIED_BY="[Empty name]" ORDER="13094" SD_1="17.0" SD_2="23.0" SE="3.54748014576761" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="46.85269054876523"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.095763251774692E-32" CI_END="11.3149558268692" CI_START="-5.3149558268692" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.9999999999999996" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-012.02" MODIFIED="2013-02-11 19:27:42 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.47947544340132775" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="46" UNITS="" WEIGHT="100.0" Z="0.7071465051708032">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="11.3149558268692" CI_START="-5.3149558268692" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="94.0" MODIFIED="2013-02-11 19:26:42 +0000" MODIFIED_BY="[Empty name]" ORDER="13169" SD_1="20.0" SD_2="20.0" SE="4.242402356602729" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.06689506682735927" CI_END="0.7571699985920608" CI_START="-11.599018685742521" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.42092434357523" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.03" MODIFIED="2013-02-15 16:57:37 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7959123994007854" P_Q="1.0" P_Z="0.08547675479115194" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="84" TOTAL_2="83" UNITS="" WEIGHT="100.0" Z="1.7197562691470123">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.466896180835494" CI_START="-20.466896180835494" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="91.0" MEAN_2="98.0" MODIFIED="2013-02-11 19:27:08 +0000" MODIFIED_BY="[Empty name]" ORDER="13217" SD_1="17.0" SD_2="24.0" SE="6.8709916544694964" STUDY_ID="STD-Masip-2000" TOTAL_1="19" TOTAL_2="18" WEIGHT="21.04621717876149"/>
<CONT_DATA CI_END="1.9529333215754177" CI_START="-11.952933321575419" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="106.0" MEAN_2="111.0" MODIFIED="2013-02-11 19:27:08 +0000" MODIFIED_BY="[Empty name]" ORDER="13218" SD_1="17.0" SD_2="23.0" SE="3.54748014576761" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" WEIGHT="78.9537828212385"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.445335051075359" CI_START="-13.24533505107537" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.400000000000006" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.04" MODIFIED="2013-02-15 16:57:37 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.32958046930949925" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="0.9749592844340942">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>CPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CPAP</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.445335051075359" CI_START="-13.24533505107537" EFFECT_SIZE="-4.400000000000006" ESTIMABLE="YES" MEAN_1="101.0" MEAN_2="105.4" MODIFIED="2013-02-11 19:27:39 +0000" MODIFIED_BY="[Empty name]" ORDER="475" SD_1="16.2" SD_2="23.5" SE="4.513008974065972" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" MODIFIED="2013-04-16 14:44:22 +0100" MODIFIED_BY="[Empty name]" NO="13">
<NAME>PaO<SUB>2</SUB> (mmHg) after one hour</NAME>
<CONT_OUTCOME CHI2="4.98351763726008" CI_END="18.997749693451283" CI_START="1.0874940315556358" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="10.04262186250346" ESTIMABLE="YES" I2="39.801557486823924" I2_Q="0.0" ID="CMP-013.01" MODIFIED="2013-02-11 19:20:11 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.17300821512592635" P_Q="1.0" P_Z="0.027950648262631776" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="29.39786688710921" TOTALS="YES" TOTAL_1="71" TOTAL_2="69" UNITS="" WEIGHT="100.0" Z="2.197978357476785">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SMC</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NPPV</GRAPH_LABEL_2>
<CONT_DATA CI_END="14.133181498379471" CI_START="-0.9331814983794828" EFFECT_SIZE="6.599999999999994" ESTIMABLE="YES" MEAN_1="84.5" MEAN_2="77.9" MODIFIED="2013-02-11 19:17:45 +0000" MODIFIED_BY="[Empty name]" ORDER="459" SD_1="8.5" SD_2="9.5" SE="3.843530573929037" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="47.26222419395865"/>
<CONT_DATA CI_END="27.763026683285766" CI_START="-48.223026683285745" EFFECT_SIZE="-10.22999999999999" ESTIMABLE="YES" MEAN_1="140.52" MEAN_2="150.75" MODIFIED="2013-02-11 19:17:45 +0000" MODIFIED_BY="[Empty name]" ORDER="439" SD_1="78.64" SD_2="67.44" SE="19.384553483109844" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="5.152549133289622"/>
<CONT_DATA CI_END="93.90250715539108" CI_START="2.0974928446089294" EFFECT_SIZE="48.0" ESTIMABLE="YES" MEAN_1="381.0" MEAN_2="333.0" MODIFIED="2013-02-11 19:17:45 +0000" MODIFIED_BY="[Empty name]" ORDER="438" SD_1="77.0" SD_2="71.0" SE="23.42007685726074" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="3.6124039273714077"/>
<CONT_DATA CI_END="21.333172001396306" CI_START="4.666827998603692" EFFECT_SIZE="13.0" ESTIMABLE="YES" MEAN_1="73.0" MEAN_2="60.0" MODIFIED="2013-02-11 19:17:45 +0000" MODIFIED_BY="[Empty name]" ORDER="440" SD_1="12.0" SD_2="7.0" SE="4.251696493980147" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="43.97282274538033"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="26.377609152048276" CI_END="20.58711952176761" CI_START="-25.870623479166674" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.6417519786995327" ESTIMABLE="YES" I2="84.83562336168215" I2_Q="0.0" ID="CMP-013.02" MODIFIED="2013-02-11 19:20:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.6553651836458414E-5" P_Q="1.0" P_Z="0.8236125566365362" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="527.7471983522726" TOTALS="YES" TOTAL_1="89" TOTAL_2="88" UNITS="" WEIGHT="100.0" Z="0.22290100206694854">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SMC</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CPAP</GRAPH_LABEL_2>
<CONT_DATA CI_END="-10.570577845291606" CI_START="-46.729422154708374" EFFECT_SIZE="-28.64999999999999" ESTIMABLE="YES" MEAN_1="67.81" MEAN_2="96.46" MODIFIED="2013-02-11 19:18:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13139" SD_1="18.12" SD_2="37.06" SE="9.22436447675394" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="22.92005745908978"/>
<CONT_DATA CI_END="27.763026683285766" CI_START="-48.223026683285745" EFFECT_SIZE="-10.22999999999999" ESTIMABLE="YES" MEAN_1="140.52" MEAN_2="150.75" MODIFIED="2013-02-11 19:18:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13140" SD_1="78.64" SD_2="67.44" SE="19.384553483109844" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="15.54633367343916"/>
<CONT_DATA CI_END="93.90250715539108" CI_START="2.0974928446089294" EFFECT_SIZE="48.0" ESTIMABLE="YES" MEAN_1="381.0" MEAN_2="333.0" MODIFIED="2013-02-11 19:18:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13141" SD_1="77.0" SD_2="71.0" SE="23.42007685726074" STUDY_ID="STD-Lin-1991" TOTAL_1="20" TOTAL_2="20" WEIGHT="13.051126738116654"/>
<CONT_DATA CI_END="0.5639850003184534" CI_START="-36.56398500031845" EFFECT_SIZE="-18.0" ESTIMABLE="YES" MEAN_1="77.0" MEAN_2="95.0" MODIFIED="2013-02-11 19:18:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13142" SD_1="17.0" SD_2="24.0" SE="9.4715949613099" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="22.748480945127596"/>
<CONT_DATA CI_END="21.333172001396306" CI_START="4.666827998603692" EFFECT_SIZE="13.0" ESTIMABLE="YES" MEAN_1="73.0" MEAN_2="60.0" MODIFIED="2013-02-11 19:18:56 +0000" MODIFIED_BY="[Empty name]" ORDER="13143" SD_1="12.0" SD_2="7.0" SE="4.251696493980147" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="13" TOTAL_2="7" WEIGHT="25.734001184226816"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.066547582308822" CI_END="-9.828528621731078" CI_START="-34.346966731965495" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-22.087747676848284" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.03" MODIFIED="2013-02-11 19:21:42 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5866812518653229" P_Q="1.0" P_Z="4.134957075770462E-4" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="61" UNITS="" WEIGHT="100.0" Z="3.531317105240926">
<NAME>CPAP X SMC - heterogeneity analysis</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SMC</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CPAP</GRAPH_LABEL_2>
<CONT_DATA CI_END="-10.570577845291606" CI_START="-46.729422154708374" EFFECT_SIZE="-28.64999999999999" ESTIMABLE="YES" MEAN_1="67.81" MEAN_2="96.46" MODIFIED="2013-02-11 19:21:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13355" SD_1="18.12" SD_2="37.06" SE="9.22436447675394" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="45.978682160202425"/>
<CONT_DATA CI_END="27.763026683285766" CI_START="-48.223026683285745" EFFECT_SIZE="-10.22999999999999" ESTIMABLE="YES" MEAN_1="140.52" MEAN_2="150.75" MODIFIED="2013-02-11 19:21:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13356" SD_1="78.64" SD_2="67.44" SE="19.384553483109844" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" WEIGHT="10.41160840686318"/>
<CONT_DATA CI_END="0.5639850003184534" CI_START="-36.56398500031845" EFFECT_SIZE="-18.0" ESTIMABLE="YES" MEAN_1="77.0" MEAN_2="95.0" MODIFIED="2013-02-11 19:21:16 +0000" MODIFIED_BY="[Empty name]" ORDER="13357" SD_1="17.0" SD_2="24.0" SE="9.4715949613099" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="10" WEIGHT="43.609709432934395"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.280578642263517" CI_END="20.692934617143894" CI_START="-11.108561319820677" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="4.792186648661609" ESTIMABLE="YES" I2="53.27734479041309" I2_Q="0.0" ID="CMP-013.04" MODIFIED="2013-02-15 16:57:44 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.11762087441436697" P_Q="1.0" P_Z="0.5547239201596006" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="108.10741833774136" TOTALS="YES" TOTAL_1="38" TOTAL_2="41" UNITS="" WEIGHT="100.0" Z="0.5906963154933248">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SMC</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BILEVEL</GRAPH_LABEL_2>
<CONT_DATA CI_END="14.133181498379471" CI_START="-0.9331814983794828" EFFECT_SIZE="6.599999999999994" ESTIMABLE="YES" MEAN_1="84.5" MEAN_2="77.9" MODIFIED="2013-02-11 19:19:25 +0000" MODIFIED_BY="[Empty name]" ORDER="470" SD_1="8.5" SD_2="9.5" SE="3.843530573929037" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" WEIGHT="53.5620522139003"/>
<CONT_DATA CI_END="9.593595031559875" CI_START="-34.25359503155987" EFFECT_SIZE="-12.329999999999998" ESTIMABLE="YES" MEAN_1="84.13" MEAN_2="96.46" MODIFIED="2013-02-11 19:19:25 +0000" MODIFIED_BY="[Empty name]" ORDER="13203" SD_1="33.6" SD_2="37.06" SE="11.18571320926833" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="28.220128415971118"/>
<CONT_DATA CI_END="57.185695718284805" CI_START="-5.185695718284805" EFFECT_SIZE="26.0" ESTIMABLE="YES" MEAN_1="121.0" MEAN_2="95.0" MODIFIED="2013-02-11 19:19:25 +0000" MODIFIED_BY="[Empty name]" ORDER="13204" SD_1="37.0" SD_2="24.0" SE="15.911361619026469" STUDY_ID="STD-Park-2001" TOTAL_1="7" TOTAL_2="10" WEIGHT="18.21781937012858"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.8226175024820845" CI_END="-9.248915181024358" CI_START="-44.75449983257868" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-27.00170750680152" ESTIMABLE="YES" I2="29.143782384921487" I2_Q="0.0" ID="CMP-013.05" MODIFIED="2013-02-15 16:57:44 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.24382427519160554" P_Q="1.0" P_Z="0.002872400820780576" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="77.79057353537523" TOTALS="YES" TOTAL_1="69" TOTAL_2="67" UNITS="" WEIGHT="100.00000000000003" Z="2.9810732454506437">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>BILEVEL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CPAP</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4104160546415585" CI_START="-33.050416054641545" EFFECT_SIZE="-16.319999999999993" ESTIMABLE="YES" MEAN_1="67.81" MEAN_2="84.13" MODIFIED="2013-02-11 19:20:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13242" SD_1="18.12" SD_2="33.6" SE="8.536083411026395" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="54.45688146400206"/>
<CONT_DATA CI_END="3.5534067286917335" CI_START="-70.9534067286917" EFFECT_SIZE="-33.69999999999999" ESTIMABLE="YES" MEAN_1="121.4" MEAN_2="155.1" MODIFIED="2013-02-11 19:20:39 +0000" MODIFIED_BY="[Empty name]" ORDER="472" SD_1="78.2" SD_2="91.3" SE="19.007189429265967" STUDY_ID="STD-Ferrari-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="18.68570586371563"/>
<CONT_DATA CI_END="-14.425803470228772" CI_START="-73.57419652977123" EFFECT_SIZE="-44.0" ESTIMABLE="YES" MEAN_1="77.0" MEAN_2="121.0" MODIFIED="2013-02-11 19:20:39 +0000" MODIFIED_BY="[Empty name]" ORDER="13243" SD_1="17.0" SD_2="37.0" SE="15.08915304722368" STUDY_ID="STD-Park-2001" TOTAL_1="9" TOTAL_2="7" WEIGHT="26.857412672282333"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-014" MODIFIED="2013-02-18 17:24:34 +0000" MODIFIED_BY="[Empty name]" NO="14">
<NAME>Adverse events</NAME>
<DICH_OUTCOME CHI2="34.94178344207687" CI_END="1.157815500004526" CI_START="0.6271350014575072" CI_STUDY="95" CI_TOTAL="95" DF="28" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8521189032540369" ESTIMABLE="YES" EVENTS_1="232" EVENTS_2="154" I2="19.866711879730726" I2_Q="40.22136801272862" ID="CMP-014.01" LOG_CI_END="0.06363935929312382" LOG_CI_START="-0.20263895984392766" LOG_EFFECT_SIZE="-0.06949980027540197" METHOD="MH" MODIFIED="2013-02-18 17:24:34 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.17156839389452294" P_Q="0.04871387975778119" P_Z="0.30625194791999355" Q="25.09257823630681" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.09444526867629481" TOTALS="YES" TOTAL_1="6849" TOTAL_2="4480" WEIGHT="100.00000000000001" Z="1.0231182614789214">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.0068170651579766" CI_END="36.54839728239183" CI_START="1.198413150717345" DF="2" EFFECT_SIZE="6.618162882617838" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="0" I2="0.33969539507777724" ID="CMP-014.01.01" LOG_CI_END="1.5628683370620147" LOG_CI_START="0.07860656608689966" LOG_EFFECT_SIZE="0.8207374515744572" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3666277616425728" P_Z="0.030191910692363" STUDIES="11" TAU2="0.007774755779796807" TOTAL_1="318" TOTAL_2="276" WEIGHT="3.0998395102505647" Z="2.167563535362514">
<NAME>Skin damage</NAME>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521794" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849315" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1076" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="0.9429796146802597"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1043" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="50.95043024524692" CI_START="0.12872503808498176" EFFECT_SIZE="2.5609756097560976" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.707147855709426" LOG_CI_START="-0.8903369710090208" LOG_EFFECT_SIZE="0.4084054423502026" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1041" O_E="0.0" SE="1.5257754449716752" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="2.3279907084785134" WEIGHT="1.0099375268686608"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1042" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1039" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1077" O_E="0.0" SE="0.0" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="476.16597597660024" CI_START="1.7661908713135956" EFFECT_SIZE="29.0" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="0" LOG_CI_END="2.6777583600450874" LOG_CI_START="0.24703763575282506" LOG_EFFECT_SIZE="1.462397997898956" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1078" O_E="0.0" SE="1.427817385710914" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.038662486938349" WEIGHT="1.146922368701644"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1040" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="58" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1037" O_E="0.0" SE="0.0" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1038" O_E="0.0" SE="0.0" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1079" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.22873668554763266" CI_END="2.199763402175703" CI_START="0.05492213119747664" DF="1" EFFECT_SIZE="0.3475855206675064" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-014.01.02" LOG_CI_END="0.34237597234257716" LOG_CI_START="-1.2602526187523644" LOG_EFFECT_SIZE="-0.45893832320489353" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6324621641686499" P_Z="0.2616354550878244" STUDIES="3" TAU2="0.0" TOTAL_1="116" TOTAL_2="116" WEIGHT="2.6155940310035075" Z="1.122534053872382">
<NAME>Pneumonia</NAME>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213575" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1080" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="1.0510058807367952"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1044" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.379314927861917" CI_START="0.04647431937943182" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7307269704630984" LOG_CI_START="-1.3327869617910608" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1081" O_E="0.0" SE="1.2121182983647962" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.4692307692307693" WEIGHT="1.5645881502667123"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.0416669066301783E-32" CI_END="38.614668217780604" CI_START="0.06441129506192933" DF="0" EFFECT_SIZE="1.577092511013216" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="100.0" ID="CMP-014.01.03" LOG_CI_END="1.5867523076761099" LOG_CI_START="-1.1910379687746064" LOG_EFFECT_SIZE="0.19785716945075166" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.7800839382924141" STUDIES="5" TAU2="0.0" TOTAL_1="787" TOTAL_2="468" WEIGHT="0.887429063237425" Z="0.27920965055865127">
<NAME>Pulmonary aspiration</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1047" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="38.614668217780604" CI_START="0.06441129506192933" EFFECT_SIZE="1.577092511013216" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5867523076761099" LOG_CI_START="-1.1910379687746064" LOG_EFFECT_SIZE="0.19785716945075166" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1045" O_E="0.0" SE="1.631687758670781" STUDY_ID="STD-Gray-2008" TOTAL_1="680" TOTAL_2="357" VAR="2.662404941796077" WEIGHT="0.887429063237425"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1046" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1049" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="0.0" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1363578128248688" CI_END="6.886418481172739" CI_START="0.2714215673650398" DF="2" EFFECT_SIZE="1.3671585488492113" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-014.01.04" LOG_CI_END="0.8379934108376906" LOG_CI_START="-0.5663556459339162" LOG_EFFECT_SIZE="0.1358188824518872" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5665564145973526" P_Z="0.7046075218517626" STUDIES="3" TAU2="0.0" TOTAL_1="96" TOTAL_2="96" WEIGHT="3.425281485289101" Z="0.3791081949926798">
<NAME>Gastrointestinal Bleeding</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1088" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.917713720342129"/>
<DICH_DATA CI_END="21.51725971144767" CI_START="0.1858972775177273" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3327869617910608" LOG_CI_START="-0.7307269704630984" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1089" O_E="0.0" SE="1.2121182983647962" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.4692307692307693" WEIGHT="1.5645881502667123"/>
<DICH_DATA CI_END="7.391737873352934" CI_START="0.015031798071690874" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8687465574849313" LOG_CI_START="-1.8229890669242566" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1050" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="0.9429796146802597"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.759188034067087E-32" CI_END="215.1176002390474" CI_START="0.8177450712784093" DF="0" EFFECT_SIZE="13.263157894736839" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" I2="100.0" ID="CMP-014.01.05" LOG_CI_END="2.3326759444367364" LOG_CI_START="-0.08738206477930643" LOG_EFFECT_SIZE="1.122646939828715" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.06899912741177586" STUDIES="8" TAU2="0.0" TOTAL_1="253" TOTAL_2="231" WEIGHT="1.156599006679475" Z="1.8184254766117534">
<NAME>Gastric distention</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1056" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1234" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1055" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1054" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="215.1176002390474" CI_START="0.8177450712784093" EFFECT_SIZE="13.263157894736842" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" LOG_CI_END="2.3326759444367364" LOG_CI_START="-0.08738206477930643" LOG_EFFECT_SIZE="1.122646939828715" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1053" O_E="0.0" SE="1.4215540540938518" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="2.0208159287106655" WEIGHT="1.156599006679475"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1052" O_E="0.0" SE="0.0" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1051" O_E="0.0" SE="0.0" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1090" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.9732937927299317" CI_END="2.4716286637459026" CI_START="0.45515528772917013" DF="2" EFFECT_SIZE="1.0606483185330238" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" I2="0.0" ID="CMP-014.01.06" LOG_CI_END="0.3929832231319939" LOG_CI_START="-0.3418404075230104" LOG_EFFECT_SIZE="0.02557140780449173" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.3728248159766938" P_Z="0.891496324055573" STUDIES="5" TAU2="0.0" TOTAL_1="800" TOTAL_2="429" WEIGHT="9.980559030853144" Z="0.13641106856107874">
<NAME>Vomiting</NAME>
<DICH_DATA CI_END="2.5944656436141127" CI_START="0.024089738923247787" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.4140479240625126" LOG_CI_START="-1.6181679067184374" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1059" O_E="0.0" SE="1.1937336386313322" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="1.425" WEIGHT="1.6101330203862732"/>
<DICH_DATA CI_END="3.1557375135727224" CI_START="0.4741272388649306" EFFECT_SIZE="1.223201174743025" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="6" LOG_CI_END="0.4991008725006973" LOG_CI_START="-0.32410509351269245" LOG_EFFECT_SIZE="0.08749788949400242" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1058" O_E="0.0" SE="0.4835552593715166" STUDY_ID="STD-Gray-2008" TOTAL_1="681" TOTAL_2="357" VAR="0.2338256888658547" WEIGHT="7.452712290124742"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1092" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.917713720342129"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1057" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1093" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.31147592536486" CI_START="0.12446157245205744" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.01.07" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="0.8958916880819315" Z="0.6766152721562805">
<NAME>Asphyxia</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1060" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="72.31147592536486" CI_START="0.12446157245205744" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1094" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.8958916880819315"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.45525833124019754" CI_END="6.888157308526608" CI_START="0.07563853328636305" DF="1" EFFECT_SIZE="0.7218103046249027" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-014.01.08" LOG_CI_END="0.8381030567738427" LOG_CI_START="-1.1212569011889089" LOG_EFFECT_SIZE="-0.1415769222075331" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.4998484055647622" P_Z="0.7769919985000185" STUDIES="6" TAU2="0.0" TOTAL_1="894" TOTAL_2="580" WEIGHT="1.7833239651166704" Z="0.28324113437258386">
<NAME>Pneumothorax</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1062" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1235" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="38.5632024376508" CI_START="0.06432621886137925" EFFECT_SIZE="1.575" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.586173092223792" LOG_CI_START="-1.1916119759725534" LOG_EFFECT_SIZE="0.19728055812561932" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1061" O_E="0.0" SE="1.6316846993163823" STUDY_ID="STD-Gray-2008" TOTAL_1="679" TOTAL_2="356" VAR="2.662394957983193" WEIGHT="0.8874322770347388"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1064" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1063" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.034608436151645" CI_START="0.013829063605784151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1709" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.8958916880819315"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.01.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="77" WEIGHT="0.0" Z="0.0">
<NAME>Conjunctivitis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1065" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1066" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.31147592536486" CI_START="0.12446157245205744" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.01.10" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="2" TAU2="0.0" TOTAL_1="108" TOTAL_2="111" WEIGHT="0.8958916880819315" Z="0.6766152721562805">
<NAME>Sinusitis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1067" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="72.31147592536486" CI_START="0.12446157245205744" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1097" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.8958916880819315"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2019745928295052" CI_END="30.09175981531804" CI_START="0.9666823645892436" DF="2" EFFECT_SIZE="5.3934380067748275" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-014.01.11" LOG_CI_END="1.4784475867342062" LOG_CI_START="-0.014716204269881386" LOG_EFFECT_SIZE="0.7318656912321624" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.9039445966217657" P_Z="0.05469008305491849" STUDIES="7" TAU2="0.0" TOTAL_1="265" TOTAL_2="247" WEIGHT="3.0548299176955678" Z="1.921330271973657">
<NAME>Disconfort with mask</NAME>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521794" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849315" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1082" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="0.9429796146802597"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1236" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1068" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="127.32047017394626" CI_START="0.38485563187958544" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1048982337313515" LOG_CI_START="-0.4147021537028377" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1083" O_E="0.0" SE="1.4800257398019099" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.1904761904761907" WEIGHT="1.0707190787524246"/>
<DICH_DATA CI_END="132.87240294809394" CI_START="0.3687748464904458" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.123434789129965" LOG_CI_START="-0.4332387091014513" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1084" O_E="0.0" SE="1.501802668599059" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.2554112554112553" WEIGHT="1.0411312242628834"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1085" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1086" O_E="0.0" SE="0.0" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1642384265949364" CI_START="0.5830610987374003" DF="0" EFFECT_SIZE="0.8239066307554187" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="46" I2="0.0" ID="CMP-014.01.12" LOG_CI_END="0.0660419294126381" LOG_CI_START="-0.23428593331273923" LOG_EFFECT_SIZE="-0.08412200195005054" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Z="0.2722158548163264" STUDIES="1" TAU2="0.0" TOTAL_1="678" TOTAL_2="352" WEIGHT="19.483663875185467" Z="1.0979740116904941">
<NAME>Hypotension</NAME>
<DICH_DATA CI_END="1.1642384265949366" CI_START="0.5830610987374003" EFFECT_SIZE="0.8239066307554187" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="46" LOG_CI_END="0.06604192941263819" LOG_CI_START="-0.23428593331273923" LOG_EFFECT_SIZE="-0.08412200195005054" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1069" O_E="0.0" SE="0.17641407321178348" STUDY_ID="STD-Gray-2008" TOTAL_1="678" TOTAL_2="352" VAR="0.0311219252271725" WEIGHT="19.483663875185467"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3769369987568516" CI_START="0.5023338655222326" DF="0" EFFECT_SIZE="0.8316742662642091" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="23" I2="0.0" ID="CMP-014.01.13" LOG_CI_END="0.1389140697280993" LOG_CI_START="-0.29900754229903226" LOG_EFFECT_SIZE="-0.08004673628546655" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.4736733625158941" STUDIES="1" TAU2="0.0" TOTAL_1="677" TOTAL_2="350" WEIGHT="15.232008613662911" Z="0.7165150834792317">
<NAME>Arrhythmia</NAME>
<DICH_DATA CI_END="1.3769369987568516" CI_START="0.5023338655222326" EFFECT_SIZE="0.8316742662642091" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="23" LOG_CI_END="0.1389140697280993" LOG_CI_START="-0.29900754229903226" LOG_EFFECT_SIZE="-0.08004673628546655" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1070" O_E="0.0" SE="0.2572373226516776" STUDY_ID="STD-Gray-2008" TOTAL_1="677" TOTAL_2="350" VAR="0.06617104016500329" WEIGHT="15.232008613662911"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.20210644732237748" CI_END="0.8888845691484102" CI_START="0.37221914648925125" DF="1" EFFECT_SIZE="0.5752041860556016" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="36" I2="0.0" ID="CMP-014.01.14" LOG_CI_END="-0.05115463299689442" LOG_CI_START="-0.42920129106348975" LOG_EFFECT_SIZE="-0.240177962030192" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.6530259386512084" P_Z="0.012760612848810774" STUDIES="2" TAU2="0.0" TOTAL_1="722" TOTAL_2="400" WEIGHT="18.062157948098683" Z="2.490381255408327">
<NAME>Progressive respiratory distress</NAME>
<DICH_DATA CI_END="0.8796348439862653" CI_START="0.364246725105622" EFFECT_SIZE="0.5660424994740164" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="35" LOG_CI_END="-0.055697575751397034" LOG_CI_START="-0.4386043442249616" LOG_EFFECT_SIZE="-0.24715095998817935" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1071" O_E="0.0" SE="0.2249213312204447" STUDY_ID="STD-Gray-2008" TOTAL_1="679" TOTAL_2="354" VAR="0.05058960523797699" WEIGHT="16.868418841191904"/>
<DICH_DATA CI_END="16.574945233355844" CI_START="0.06904411227626016" EFFECT_SIZE="1.069767441860465" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.21945210209095" LOG_CI_START="-1.1608733498869745" LOG_EFFECT_SIZE="0.029289376101987508" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1072" O_E="0.0" SE="1.3982149532928507" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="1.9550050556117289" WEIGHT="1.1937391069067793"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3149566567356885" CI_END="1.2647783413960014" CI_START="0.2873780969817753" DF="2" EFFECT_SIZE="0.6028843942698708" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" I2="13.605293896940934" ID="CMP-014.01.15" LOG_CI_END="0.10201441994380804" LOG_CI_START="-0.5415463354448108" LOG_EFFECT_SIZE="-0.21976595775050137" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.3142777311318593" P_Z="0.18070280018116527" STUDIES="3" TAU2="0.08255375345086843" TOTAL_1="786" TOTAL_2="466" WEIGHT="16.386648247737106" Z="1.3385942465022824">
<NAME>Cardiorespiratory arrest</NAME>
<DICH_DATA CI_END="1.0345043149373137" CI_START="0.26501167796848346" EFFECT_SIZE="0.523598820058997" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" LOG_CI_END="0.014732306456134183" LOG_CI_START="-0.5767349880800727" LOG_EFFECT_SIZE="-0.28100134081196926" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1073" O_E="0.0" SE="0.34743081662089503" STUDY_ID="STD-Gray-2008" TOTAL_1="678" TOTAL_2="355" VAR="0.12070817233786199" WEIGHT="11.370996383945439"/>
<DICH_DATA CI_END="2.0904850074824664" CI_START="0.08758942546393034" EFFECT_SIZE="0.42790697674418604" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3202470572291826" LOG_CI_START="-1.0575483223692828" LOG_EFFECT_SIZE="-0.36865063257005004" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1074" O_E="0.0" SE="0.8093238261732624" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.655005055611729" WEIGHT="3.2644044848330322"/>
<DICH_DATA CI_END="28.092926570009606" CI_START="0.3203653409897097" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.44859698402184" LOG_CI_START="-0.494354474582515" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1098" O_E="0.0" SE="1.1412993045490314" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.3025641025641026" WEIGHT="1.7512473789586336"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7057578856359842" CI_START="0.012798798470474371" DF="0" EFFECT_SIZE="0.0950413223140496" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" I2="0.0" ID="CMP-014.01.16" LOG_CI_END="-0.15134426065669074" LOG_CI_START="-1.8928307992689861" LOG_EFFECT_SIZE="-1.0220875299628382" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Z="0.02141277081725077" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="46" WEIGHT="2.1443902409445803" Z="2.3006261643239134">
<NAME>Neurological failure (coma)</NAME>
<DICH_DATA CI_END="0.7057578856359842" CI_START="0.012798798470474371" EFFECT_SIZE="0.09504132231404959" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.15134426065669074" LOG_CI_START="-1.8928307992689861" LOG_EFFECT_SIZE="-1.0220875299628385" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1075" O_E="0.0" SE="1.022957813278258" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="44" TOTAL_2="46" VAR="1.0464426877470354" WEIGHT="2.1443902409445803"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.01.17" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Eye irritation</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1096" O_E="0.0" SE="0.0" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.01.18" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="0.0" Z="0.0">
<NAME>Stroke</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1099" O_E="0.0" SE="0.0" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.034608436151645" CI_START="0.013829063605784151" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-014.01.19" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="0.8958916880819315" Z="0.6766152721562805">
<NAME>Seizures</NAME>
<DICH_DATA CI_END="8.034608436151645" CI_START="0.013829063605784151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:44:04 +0000" MODIFIED_BY="[Empty name]" ORDER="1100" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.8958916880819315"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="34.66003371092746" CI_END="1.1876591054219001" CI_START="0.6322014290481477" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8665101174653242" ESTIMABLE="YES" EVENTS_1="232" EVENTS_2="153" I2="22.10047969027923" I2_Q="42.04430568972532" ID="CMP-014.02" LOG_CI_END="0.07469180269955555" LOG_CI_START="-0.1991445268023178" LOG_EFFECT_SIZE="-0.0622263620513811" METHOD="MH" MODIFIED="2013-02-18 17:24:34 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.14768860749593926" P_Q="0.03928316643586771" P_Z="0.3730571484068581" Q="25.88183987529371" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10490302131186138" TOTALS="YES" TOTAL_1="6536" TOTAL_2="4167" WEIGHT="100.0" Z="0.8907614904969916">
<NAME>NPPV (CPAP and BILEVEL) X SMC - AFTER 2000</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.0068170651579766" CI_END="36.54839728239183" CI_START="1.1984131507173448" DF="2" EFFECT_SIZE="6.6181628826178365" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="0" I2="0.33969539507777724" ID="CMP-014.02.01" LOG_CI_END="1.5628683370620147" LOG_CI_START="0.07860656608689957" LOG_EFFECT_SIZE="0.8207374515744571" MODIFIED="2013-02-11 19:50:00 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3666277616425728" P_Z="0.030191910692363037" STUDIES="8" TAU2="0.007774755779796807" TOTAL_1="267" TOTAL_2="225" WEIGHT="3.2637953621875333" Z="2.1675635353625133">
<NAME>Skin damage</NAME>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521794" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849315" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1076" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="0.9932664682745119"/>
<DICH_DATA CI_END="50.95043024524692" CI_START="0.12872503808498176" EFFECT_SIZE="2.5609756097560976" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.707147855709426" LOG_CI_START="-0.8903369710090208" LOG_EFFECT_SIZE="0.4084054423502026" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1041" O_E="0.0" SE="1.5257754449716752" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="2.3279907084785134" WEIGHT="1.0634919201337136"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1042" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1039" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1077" O_E="0.0" SE="0.0" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="476.16597597660024" CI_START="1.7661908713135956" EFFECT_SIZE="29.0" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="0" LOG_CI_END="2.6777583600450874" LOG_CI_START="0.24703763575282506" LOG_EFFECT_SIZE="1.462397997898956" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1078" O_E="0.0" SE="1.427817385710914" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.038662486938349" WEIGHT="1.2070369737793079"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1040" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="58" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1079" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.22873668554763266" CI_END="2.199763402175703" CI_START="0.05492213119747664" DF="1" EFFECT_SIZE="0.3475855206675064" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-014.02.02" LOG_CI_END="0.34237597234257716" LOG_CI_START="-1.2602526187523644" LOG_EFFECT_SIZE="-0.45893832320489353" MODIFIED="2013-02-11 19:50:06 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6324621641686499" P_Z="0.2616354550878244" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="76" WEIGHT="2.750218630811102" Z="1.122534053872382">
<NAME>Pneumonia</NAME>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213575" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1080" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="1.106544605311573"/>
<DICH_DATA CI_END="5.379314927861917" CI_START="0.04647431937943182" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7307269704630984" LOG_CI_START="-1.3327869617910608" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1081" O_E="0.0" SE="1.2121182983647962" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.4692307692307693" WEIGHT="1.6436740254995288"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.0416669066301783E-32" CI_END="38.614668217780604" CI_START="0.06441129506192933" DF="0" EFFECT_SIZE="1.577092511013216" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="100.0" ID="CMP-014.02.03" LOG_CI_END="1.5867523076761099" LOG_CI_START="-1.1910379687746064" LOG_EFFECT_SIZE="0.19785716945075166" MODIFIED="2013-02-11 19:50:25 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.7800839382924141" STUDIES="2" TAU2="0.0" TOTAL_1="707" TOTAL_2="388" WEIGHT="0.934974660814474" Z="0.27920965055865127">
<NAME>Pulmonary aspiration</NAME>
<DICH_DATA CI_END="38.614668217780604" CI_START="0.06441129506192933" EFFECT_SIZE="1.577092511013216" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5867523076761099" LOG_CI_START="-1.1910379687746064" LOG_EFFECT_SIZE="0.19785716945075166" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1045" O_E="0.0" SE="1.631687758670781" STUDY_ID="STD-Gray-2008" TOTAL_1="680" TOTAL_2="357" VAR="2.662404941796077" WEIGHT="0.934974660814474"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1046" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.04073519382289937" CI_END="15.421696285860216" CI_START="0.34832569185476475" DF="1" EFFECT_SIZE="2.317708572781815" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-014.02.04" LOG_CI_END="1.188132145898591" LOG_CI_START="-0.4580144916076447" LOG_EFFECT_SIZE="0.3650588271454732" MODIFIED="2013-02-11 19:50:33 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8400500299299817" P_Z="0.38468007076345845" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="2.6104312207567517" Z="0.8693054885164812">
<NAME>Gastrointestinal Bleeding</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1088" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.9667571952572231"/>
<DICH_DATA CI_END="21.51725971144767" CI_START="0.1858972775177273" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3327869617910608" LOG_CI_START="-0.7307269704630984" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1089" O_E="0.0" SE="1.2121182983647962" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.4692307692307693" WEIGHT="1.6436740254995288"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.759188034067087E-32" CI_END="215.1176002390474" CI_START="0.8177450712784093" DF="0" EFFECT_SIZE="13.263157894736839" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" I2="100.0" ID="CMP-014.02.05" LOG_CI_END="2.3326759444367364" LOG_CI_START="-0.08738206477930643" LOG_EFFECT_SIZE="1.122646939828715" MODIFIED="2013-02-11 19:50:53 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.06899912741177586" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="140" WEIGHT="1.2171707008344723" Z="1.8184254766117534">
<NAME>Gastric distention</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1234" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1055" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="215.1176002390474" CI_START="0.8177450712784093" EFFECT_SIZE="13.263157894736842" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" LOG_CI_END="2.3326759444367364" LOG_CI_START="-0.08738206477930643" LOG_EFFECT_SIZE="1.122646939828715" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1053" O_E="0.0" SE="1.4215540540938518" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="2.0208159287106655" WEIGHT="1.2171707008344723"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1090" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.9732937927299317" CI_END="2.4716286637459026" CI_START="0.45515528772917013" DF="2" EFFECT_SIZE="1.0606483185330238" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" I2="0.0" ID="CMP-014.02.06" LOG_CI_END="0.3929832231319939" LOG_CI_START="-0.3418404075230104" LOG_EFFECT_SIZE="0.02557140780449173" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.3728248159766938" P_Z="0.891496324055573" STUDIES="5" TAU2="0.0" TOTAL_1="800" TOTAL_2="429" WEIGHT="10.296402703862764" Z="0.13641106856107874">
<NAME>Vomiting</NAME>
<DICH_DATA CI_END="2.5944656436141127" CI_START="0.024089738923247787" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.4140479240625126" LOG_CI_START="-1.6181679067184374" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1059" O_E="0.0" SE="1.1937336386313322" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="1.425" WEIGHT="1.6911940091192352"/>
<DICH_DATA CI_END="3.1557375135727224" CI_START="0.4741272388649306" EFFECT_SIZE="1.223201174743025" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="6" LOG_CI_END="0.4991008725006973" LOG_CI_START="-0.32410509351269245" LOG_EFFECT_SIZE="0.08749788949400242" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1058" O_E="0.0" SE="0.4835552593715166" STUDY_ID="STD-Gray-2008" TOTAL_1="681" TOTAL_2="357" VAR="0.2338256888658547" WEIGHT="7.6384514994863055"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1092" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.9667571952572231"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1057" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1093" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.31147592536486" CI_START="0.12446157245205744" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.02.07" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:51:22 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="0.9438566718533085" Z="0.6766152721562805">
<NAME>Asphyxia</NAME>
<DICH_DATA CI_END="72.31147592536486" CI_START="0.12446157245205744" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1094" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.9438566718533085"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.45525833124019754" CI_END="6.888157308526608" CI_START="0.07563853328636305" DF="1" EFFECT_SIZE="0.7218103046249027" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-014.02.08" LOG_CI_END="0.8381030567738427" LOG_CI_START="-1.1212569011889089" LOG_EFFECT_SIZE="-0.1415769222075331" MODIFIED="2013-02-11 19:51:28 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.4998484055647622" P_Z="0.7769919985000185" STUDIES="5" TAU2="0.0" TOTAL_1="874" TOTAL_2="560" WEIGHT="1.878834705854239" Z="0.28324113437258386">
<NAME>Pneumothorax</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1235" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="38.5632024376508" CI_START="0.06432621886137925" EFFECT_SIZE="1.575" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.586173092223792" LOG_CI_START="-1.1916119759725534" LOG_EFFECT_SIZE="0.19728055812561932" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1061" O_E="0.0" SE="1.6316846993163823" STUDY_ID="STD-Gray-2008" TOTAL_1="679" TOTAL_2="356" VAR="2.662394957983193" WEIGHT="0.9349780340009305"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1064" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1063" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.034608436151645" CI_START="0.013829063605784151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1709" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.9438566718533085"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.02.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="77" WEIGHT="0.0" Z="0.0">
<NAME>Conjunctivitis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1065" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1066" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.31147592536486" CI_START="0.12446157245205744" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.02.10" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="2" TAU2="0.0" TOTAL_1="108" TOTAL_2="111" WEIGHT="0.9438566718533085" Z="0.6766152721562805">
<NAME>Sinusitis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1067" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="72.31147592536486" CI_START="0.12446157245205744" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1097" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.9438566718533085"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2019745928295052" CI_END="30.09175981531804" CI_START="0.9666823645892436" DF="2" EFFECT_SIZE="5.3934380067748275" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-014.02.11" LOG_CI_END="1.4784475867342062" LOG_CI_START="-0.014716204269881386" LOG_EFFECT_SIZE="0.7318656912321624" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.9039445966217657" P_Z="0.05469008305491849" STUDIES="7" TAU2="0.0" TOTAL_1="265" TOTAL_2="247" WEIGHT="3.2166656262341355" Z="1.921330271973657">
<NAME>Disconfort with mask</NAME>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521794" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849315" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1082" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="0.9932664682745119"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1236" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1068" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="127.32047017394626" CI_START="0.38485563187958544" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1048982337313515" LOG_CI_START="-0.4147021537028377" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1083" O_E="0.0" SE="1.4800257398019099" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.1904761904761907" WEIGHT="1.1272049563263826"/>
<DICH_DATA CI_END="132.87240294809394" CI_START="0.3687748464904458" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.123434789129965" LOG_CI_START="-0.4332387091014513" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1084" O_E="0.0" SE="1.501802668599059" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.2554112554112553" WEIGHT="1.096194201633241"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1085" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1086" O_E="0.0" SE="0.0" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1642384265949364" CI_START="0.5830610987374003" DF="0" EFFECT_SIZE="0.8239066307554187" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="46" I2="0.0" ID="CMP-014.02.12" LOG_CI_END="0.0660419294126381" LOG_CI_START="-0.23428593331273923" LOG_EFFECT_SIZE="-0.08412200195005054" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Z="0.2722158548163264" STUDIES="1" TAU2="0.0" TOTAL_1="678" TOTAL_2="352" WEIGHT="19.02123757448833" Z="1.0979740116904941">
<NAME>Hypotension</NAME>
<DICH_DATA CI_END="1.1642384265949366" CI_START="0.5830610987374003" EFFECT_SIZE="0.8239066307554187" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="46" LOG_CI_END="0.06604192941263819" LOG_CI_START="-0.23428593331273923" LOG_EFFECT_SIZE="-0.08412200195005054" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1069" O_E="0.0" SE="0.17641407321178348" STUDY_ID="STD-Gray-2008" TOTAL_1="678" TOTAL_2="352" VAR="0.0311219252271725" WEIGHT="19.02123757448833"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3769369987568516" CI_START="0.5023338655222326" DF="0" EFFECT_SIZE="0.8316742662642091" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="23" I2="0.0" ID="CMP-014.02.13" LOG_CI_END="0.1389140697280993" LOG_CI_START="-0.29900754229903226" LOG_EFFECT_SIZE="-0.08004673628546655" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.4736733625158941" STUDIES="1" TAU2="0.0" TOTAL_1="677" TOTAL_2="350" WEIGHT="15.124226325368104" Z="0.7165150834792317">
<NAME>Arrhythmia</NAME>
<DICH_DATA CI_END="1.3769369987568516" CI_START="0.5023338655222326" EFFECT_SIZE="0.8316742662642091" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="23" LOG_CI_END="0.1389140697280993" LOG_CI_START="-0.29900754229903226" LOG_EFFECT_SIZE="-0.08004673628546655" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1070" O_E="0.0" SE="0.2572373226516776" STUDY_ID="STD-Gray-2008" TOTAL_1="677" TOTAL_2="350" VAR="0.06617104016500329" WEIGHT="15.124226325368104"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.20210644732237748" CI_END="0.8888845691484102" CI_START="0.37221914648925125" DF="1" EFFECT_SIZE="0.5752041860556016" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="36" I2="0.0" ID="CMP-014.02.14" LOG_CI_END="-0.05115463299689442" LOG_CI_START="-0.42920129106348975" LOG_EFFECT_SIZE="-0.240177962030192" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.6530259386512084" P_Z="0.012760612848810774" STUDIES="2" TAU2="0.0" TOTAL_1="722" TOTAL_2="400" WEIGHT="17.895835662600014" Z="2.490381255408327">
<NAME>Progressive respiratory distress</NAME>
<DICH_DATA CI_END="0.8796348439862653" CI_START="0.364246725105622" EFFECT_SIZE="0.5660424994740164" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="35" LOG_CI_END="-0.055697575751397034" LOG_CI_START="-0.4386043442249616" LOG_EFFECT_SIZE="-0.24715095998817935" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1071" O_E="0.0" SE="0.2249213312204447" STUDY_ID="STD-Gray-2008" TOTAL_1="679" TOTAL_2="354" VAR="0.05058960523797699" WEIGHT="16.639778242775638"/>
<DICH_DATA CI_END="16.574945233355844" CI_START="0.06904411227626016" EFFECT_SIZE="1.069767441860465" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.21945210209095" LOG_CI_START="-1.1608733498869745" LOG_EFFECT_SIZE="0.029289376101987508" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1072" O_E="0.0" SE="1.3982149532928507" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="1.9550050556117289" WEIGHT="1.2560574198243764"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3149566567356885" CI_END="1.2647783413960012" CI_START="0.2873780969817754" DF="2" EFFECT_SIZE="0.6028843942698708" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" I2="13.605293896940934" ID="CMP-014.02.15" LOG_CI_END="0.10201441994380796" LOG_CI_START="-0.5415463354448107" LOG_EFFECT_SIZE="-0.21976595775050137" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.3142777311318593" P_Z="0.1807028001811652" STUDIES="3" TAU2="0.08255375345086838" TOTAL_1="786" TOTAL_2="466" WEIGHT="16.711385786180458" Z="1.3385942465022826">
<NAME>Cardiorespiratory arrest</NAME>
<DICH_DATA CI_END="1.0345043149373137" CI_START="0.26501167796848346" EFFECT_SIZE="0.523598820058997" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" LOG_CI_END="0.014732306456134183" LOG_CI_START="-0.5767349880800727" LOG_EFFECT_SIZE="-0.28100134081196926" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1073" O_E="0.0" SE="0.34743081662089503" STUDY_ID="STD-Gray-2008" TOTAL_1="678" TOTAL_2="355" VAR="0.12070817233786199" WEIGHT="11.468237822424243"/>
<DICH_DATA CI_END="2.0904850074824664" CI_START="0.08758942546393034" EFFECT_SIZE="0.42790697674418604" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3202470572291826" LOG_CI_START="-1.0575483223692828" LOG_EFFECT_SIZE="-0.36865063257005004" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1074" O_E="0.0" SE="0.8093238261732624" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.655005055611729" WEIGHT="3.404836588460423"/>
<DICH_DATA CI_END="28.092926570009606" CI_START="0.3203653409897097" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.44859698402184" LOG_CI_START="-0.494354474582515" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1098" O_E="0.0" SE="1.1412993045490314" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.3025641025641026" WEIGHT="1.8383113752957931"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7057578856359842" CI_START="0.012798798470474371" DF="0" EFFECT_SIZE="0.0950413223140496" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" I2="0.0" ID="CMP-014.02.16" LOG_CI_END="-0.15134426065669074" LOG_CI_START="-1.8928307992689861" LOG_EFFECT_SIZE="-1.0220875299628382" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Z="0.02141277081725077" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="46" WEIGHT="2.2472510244476727" Z="2.3006261643239134">
<NAME>Neurological failure (coma)</NAME>
<DICH_DATA CI_END="0.7057578856359842" CI_START="0.012798798470474371" EFFECT_SIZE="0.09504132231404959" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.15134426065669074" LOG_CI_START="-1.8928307992689861" LOG_EFFECT_SIZE="-1.0220875299628385" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1075" O_E="0.0" SE="1.022957813278258" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="44" TOTAL_2="46" VAR="1.0464426877470354" WEIGHT="2.2472510244476727"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.02.17" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Eye irritation</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1096" O_E="0.0" SE="0.0" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.02.18" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="0.0" Z="0.0">
<NAME>Stroke</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1099" O_E="0.0" SE="0.0" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.034608436151645" CI_START="0.013829063605784151" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-014.02.19" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="0.9438566718533085" Z="0.6766152721562805">
<NAME>Seizures</NAME>
<DICH_DATA CI_END="8.034608436151645" CI_START="0.013829063605784151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:40:12 +0000" MODIFIED_BY="[Empty name]" ORDER="1100" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="0.9438566718533085"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.923686642761467" CI_END="0.8707283796166401" CI_START="0.4538830058804311" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6286563562438525" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="146" I2="14.884968166873037" I2_Q="35.03192509780931" ID="CMP-014.03" LOG_CI_END="-0.06011730036643814" LOG_CI_START="-0.3430560776460469" LOG_EFFECT_SIZE="-0.20158668900624258" METHOD="MH" MODIFIED="2013-02-15 16:57:16 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.2983426673116796" P_Q="0.13774507694874072" P_Z="0.005224606332164282" Q="12.313740267114246" RANDOM="YES" SCALE="191.41035960398136" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.04576068512562358" TOTALS="YES" TOTAL_1="3467" TOTAL_2="3666" WEIGHT="100.0" Z="2.792849068012048">
<NAME>CPAP X SMC</NAME>
<GROUP_LABEL_1>CPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.5152908317231" CI_START="0.12946791838627933" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.03.01" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.49327758741034344" STUDIES="7" TAU2="0.0" TOTAL_1="168" TOTAL_2="175" WEIGHT="1.0554192715089985" Z="0.6851051308492764">
<NAME>Skin damage</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="161" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="162" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.0554192715089985"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="163" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="164" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.0" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.0" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Pneumonia</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="5" TAU2="0.0" TOTAL_1="440" TOTAL_2="468" WEIGHT="0.0" Z="0.0">
<NAME>Pulmonary aspiration</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="529" O_E="0.0" SE="0.0" STUDY_ID="STD-Gray-2008" TOTAL_1="333" TOTAL_2="357" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="0.0" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.391737873352934" CI_START="0.015031798071690874" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-014.03.04" LOG_CI_END="0.8687465574849313" LOG_CI_START="-1.8229890669242566" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.48716597433069364" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="11" WEIGHT="1.085032067111721" Z="0.6948234195283237">
<NAME>Gastrointestinal Bleeding</NAME>
<DICH_DATA CI_END="7.391737873352934" CI_START="0.015031798071690874" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8687465574849313" LOG_CI_START="-1.8229890669242566" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="1.085032067111721"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="189.64809967504868" CI_START="0.6380237935804614" DF="0" EFFECT_SIZE="11.000000000000002" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" I2="0.0" ID="CMP-014.03.05" LOG_CI_END="2.2779484953131304" LOG_CI_START="-0.19516312499668012" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.09881480357302887" STUDIES="7" TAU2="0.0" TOTAL_1="221" TOTAL_2="226" WEIGHT="1.281094357985626" Z="1.650626797360558">
<NAME>Gastric distention</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1214" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="179" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="189.64809967504868" CI_START="0.6380237935804614" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2779484953131304" LOG_CI_START="-0.19516312499668012" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="1.452718007869941" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="2.1103896103896105" WEIGHT="1.281094357985626"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.0" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.0" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3341484570054297" CI_END="2.5404337849911496" CI_START="0.3371468288860816" DF="1" EFFECT_SIZE="0.9254724169875792" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="0.0" ID="CMP-014.03.06" LOG_CI_END="0.4049078797471116" LOG_CI_START="-0.47218092082718394" LOG_EFFECT_SIZE="-0.03363652054003617" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.5632266371929768" P_Z="0.8805042849512492" STUDIES="3" TAU2="0.0" TOTAL_1="381" TOTAL_2="404" WEIGHT="9.310091856034044" Z="0.15032997521014">
<NAME>Vomiting</NAME>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="1.91057344896164"/>
<DICH_DATA CI_END="3.2815007397850726" CI_START="0.3481536816453862" EFFECT_SIZE="1.0688622754491017" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.5160725065007703" LOG_CI_START="-0.4582290078995129" LOG_EFFECT_SIZE="0.028921749300628692" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="528" O_E="0.0" SE="0.5723095324290048" STUDY_ID="STD-Gray-2008" TOTAL_1="334" TOTAL_2="357" VAR="0.3275382009091061" WEIGHT="7.399518407072404"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.03.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Asphyxia</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.03.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="5" TAU2="0.0" TOTAL_1="483" TOTAL_2="515" WEIGHT="0.0" Z="0.0">
<NAME>Pneumothorax</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="0.0" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1215" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="530" O_E="0.0" SE="0.0" STUDY_ID="STD-Gray-2008" TOTAL_1="333" TOTAL_2="356" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="184" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.03.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="77" WEIGHT="0.0" Z="0.0">
<NAME>Conjunctivitis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="187" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.03.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="46" WEIGHT="0.0" Z="0.0">
<NAME>Sinusitis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.03.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="130" TOTAL_2="135" WEIGHT="0.0" Z="0.0">
<NAME>Disconfort with mask</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1216" O_E="0.0" SE="0.0" STUDY_ID="STD-Frontin-2010" TOTAL_1="60" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="189" O_E="0.0" SE="0.0" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1087" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.822912581629364E-31" CI_END="1.2497284304509804" CI_START="0.5509127808790414" DF="0" EFFECT_SIZE="0.8297537977998952" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="46" I2="100.0" ID="CMP-014.03.12" LOG_CI_END="0.09681564983194539" LOG_CI_START="-0.2589171521123297" LOG_EFFECT_SIZE="-0.0810507511401921" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Z="0.3717913787222896" STUDIES="1" TAU2="0.0" TOTAL_1="332" TOTAL_2="352" WEIGHT="30.888937326734453" Z="0.8931228848532211">
<NAME>Hypotension</NAME>
<DICH_DATA CI_END="1.2497284304509804" CI_START="0.5509127808790414" EFFECT_SIZE="0.8297537977998952" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="46" LOG_CI_END="0.09681564983194539" LOG_CI_START="-0.2589171521123297" LOG_EFFECT_SIZE="-0.0810507511401921" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="531" O_E="0.0" SE="0.20895920876783633" STUDY_ID="STD-Gray-2008" TOTAL_1="332" TOTAL_2="352" VAR="0.04366395092888021" WEIGHT="30.888937326734453"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0874362601653074" CI_START="0.278203718842127" DF="0" EFFECT_SIZE="0.5500261917234154" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="23" I2="0.0" ID="CMP-014.03.13" LOG_CI_END="0.03640381029816774" LOG_CI_START="-0.5556370689456253" LOG_EFFECT_SIZE="-0.2596166293237287" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.0856266087864525" STUDIES="1" TAU2="0.0" TOTAL_1="332" TOTAL_2="350" WEIGHT="16.569770884730897" Z="1.71893280042462">
<NAME>Arrhythmia</NAME>
<DICH_DATA CI_END="1.0874362601653074" CI_START="0.278203718842127" EFFECT_SIZE="0.5500261917234154" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="23" LOG_CI_END="0.03640381029816774" LOG_CI_START="-0.5556370689456253" LOG_EFFECT_SIZE="-0.2596166293237287" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="532" O_E="0.0" SE="0.34776774311742115" STUDY_ID="STD-Gray-2008" TOTAL_1="332" TOTAL_2="350" VAR="0.12094240315298461" WEIGHT="16.569770884730897"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.26053490313656863" CI_END="0.9200148090987776" CI_START="0.3072029101650926" DF="1" EFFECT_SIZE="0.5316307240464255" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="36" I2="0.0" ID="CMP-014.03.14" LOG_CI_END="-0.036205181939098934" LOG_CI_START="-0.5125746745042797" LOG_EFFECT_SIZE="-0.2743899282216893" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.6097529493055236" P_Z="0.023952670013251003" STUDIES="2" TAU2="0.0" TOTAL_1="376" TOTAL_2="400" WEIGHT="23.07445459622509" Z="2.257887565969419">
<NAME>Progressive respiratory distress</NAME>
<DICH_DATA CI_END="0.9037382695033606" CI_START="0.29501027192502577" EFFECT_SIZE="0.5163449163449163" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="35" LOG_CI_END="-0.04395732679066147" LOG_CI_START="-0.5301628621144061" LOG_EFFECT_SIZE="-0.2870600944525338" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="533" O_E="0.0" SE="0.28559953820538314" STUDY_ID="STD-Gray-2008" TOTAL_1="333" TOTAL_2="354" VAR="0.08156709622312812" WEIGHT="21.69386719295637"/>
<DICH_DATA CI_END="16.574945233355844" CI_START="0.06904411227626016" EFFECT_SIZE="1.069767441860465" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.21945210209095" LOG_CI_START="-1.1608733498869745" LOG_EFFECT_SIZE="0.029289376101987508" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1035" O_E="0.0" SE="1.3982149532928507" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="1.9550050556117289" WEIGHT="1.3805874032687238"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.005268032948761393" CI_END="0.9051273033301969" CI_START="0.18278513492353488" DF="1" EFFECT_SIZE="0.40674785342050096" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="21" I2="0.0" ID="CMP-014.03.15" LOG_CI_END="-0.04329033433549424" LOG_CI_START="-0.7380591263439046" LOG_EFFECT_SIZE="-0.39067473033969935" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.9421393746510629" P_Z="0.027509529939958928" STUDIES="2" TAU2="0.0" TOTAL_1="376" TOTAL_2="401" WEIGHT="14.20615418242203" Z="2.2042106955386664">
<NAME>Cardiorespiratory arrest</NAME>
<DICH_DATA CI_END="1.0094612127842106" CI_START="0.15832195286178477" EFFECT_SIZE="0.3997747747747748" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="0.004089636407536803" LOG_CI_START="-0.8004588618545507" LOG_EFFECT_SIZE="-0.3981846127235069" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="534" O_E="0.0" SE="0.4725957704584468" STUDY_ID="STD-Gray-2008" TOTAL_1="333" TOTAL_2="355" VAR="0.22334676225521297" WEIGHT="10.264420421797318"/>
<DICH_DATA CI_END="2.0904850074824664" CI_START="0.08758942546393034" EFFECT_SIZE="0.42790697674418604" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3202470572291826" LOG_CI_START="-1.0575483223692828" LOG_EFFECT_SIZE="-0.36865063257005004" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1034" O_E="0.0" SE="0.8093238261732624" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.655005055611729" WEIGHT="3.9417337606247114"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7057578856359842" CI_START="0.012798798470474371" DF="0" EFFECT_SIZE="0.0950413223140496" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" I2="0.0" ID="CMP-014.03.16" LOG_CI_END="-0.15134426065669074" LOG_CI_START="-1.8928307992689861" LOG_EFFECT_SIZE="-1.0220875299628382" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Z="0.02141277081725077" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="46" WEIGHT="2.5290454572471432" Z="2.3006261643239134">
<NAME>Neurological failure (coma)</NAME>
<DICH_DATA CI_END="0.7057578856359842" CI_START="0.012798798470474371" EFFECT_SIZE="0.09504132231404959" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.15134426065669074" LOG_CI_START="-1.8928307992689861" LOG_EFFECT_SIZE="-1.0220875299628385" MODIFIED="2013-02-11 19:45:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1036" O_E="0.0" SE="1.022957813278258" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="44" TOTAL_2="46" VAR="1.0464426877470354" WEIGHT="2.5290454572471432"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.723704200320533" CI_END="1.4594044684111966" CI_START="0.7588909953833067" CI_STUDY="95" CI_TOTAL="95" DF="24" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0523919943155302" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="136" I2="16.44531696670174" I2_Q="32.39623113641383" ID="CMP-014.04" LOG_CI_END="0.16417567164349167" LOG_CI_START="-0.11982060026164454" LOG_EFFECT_SIZE="0.022177535690923626" METHOD="MH" MODIFIED="2013-02-15 16:57:16 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.23070285893901543" P_Q="0.10932823014153792" P_Z="0.7595202415138229" Q="20.708904600052417" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0852998740723357" TOTALS="YES" TOTAL_1="3380" TOTAL_2="3443" WEIGHT="99.99999999999997" Z="0.30611085792408765">
<NAME>BILEVEL X SMC</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.8618029148136446" CI_END="40.49566801600132" CI_START="1.265708453128216" DF="2" EFFECT_SIZE="7.159309276943327" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="0" I2="0.0" ID="CMP-014.04.01" LOG_CI_END="1.6074085674771161" LOG_CI_START="0.10233368057928693" LOG_EFFECT_SIZE="0.8548711240282015" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.394198255225956" P_Z="0.02598142056164052" STUDIES="6" TAU2="0.0" TOTAL_1="148" TOTAL_2="148" WEIGHT="3.4341860872585306" Z="2.226489364887383">
<NAME>Skin damage</NAME>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521794" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849315" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="1015" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="1.0764393292918288"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.0474982744952597"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="0.0" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="476.16597597660024" CI_START="1.7661908713135956" EFFECT_SIZE="29.0" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="0" LOG_CI_END="2.6777583600450874" LOG_CI_START="0.24703763575282506" LOG_EFFECT_SIZE="1.462397997898956" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="1.427817385710914" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.038662486938349" WEIGHT="1.3102484834714423"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="258" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="259" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.22873668554763266" CI_END="2.199763402175703" CI_START="0.05492213119747664" DF="1" EFFECT_SIZE="0.3475855206675064" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-014.04.02" LOG_CI_END="0.34237597234257716" LOG_CI_START="-1.2602526187523644" LOG_EFFECT_SIZE="-0.45893832320489353" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6324621641686499" P_Z="0.2616354550878244" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="76" WEIGHT="2.990439447207669" Z="1.122534053872382">
<NAME>Nosocomial pneumonia</NAME>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213575" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="1016" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="1.200240923651092"/>
<DICH_DATA CI_END="5.379314927861917" CI_START="0.04647431937943182" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7307269704630984" LOG_CI_START="-1.3327869617910608" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="260" O_E="0.0" SE="1.2121182983647962" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.4692307692307693" WEIGHT="1.790198523556577"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2019745928295052" CI_END="30.09175981531804" CI_START="0.9666823645892436" DF="2" EFFECT_SIZE="5.3934380067748275" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-014.04.03" LOG_CI_END="1.4784475867342062" LOG_CI_START="-0.014716204269881386" LOG_EFFECT_SIZE="0.7318656912321624" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9039445966217657" P_Z="0.05469008305491849" STUDIES="5" TAU2="0.0" TOTAL_1="135" TOTAL_2="139" WEIGHT="3.4882031262032758" Z="1.921330271973657">
<NAME>Disconfort with mask</NAME>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521794" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849315" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="1017" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="1.0764393292918288"/>
<DICH_DATA CI_END="127.32047017394626" CI_START="0.38485563187958544" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1048982337313515" LOG_CI_START="-0.4147021537028377" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="261" O_E="0.0" SE="1.4800257398019099" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.1904761904761907" WEIGHT="1.222843717277937"/>
<DICH_DATA CI_END="132.87240294809394" CI_START="0.3687748464904458" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.123434789129965" LOG_CI_START="-0.4332387091014513" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="262" O_E="0.0" SE="1.501802668599059" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.2554112554112553" WEIGHT="1.18892007963351"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="263" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="1422" O_E="0.0" SE="0.0" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.04073519382289937" CI_END="15.421696285860216" CI_START="0.34832569185476475" DF="1" EFFECT_SIZE="2.317708572781815" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-014.04.04" LOG_CI_END="1.188132145898591" LOG_CI_START="-0.4580144916076447" LOG_EFFECT_SIZE="0.3650588271454732" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8400500299299817" P_Z="0.38468007076345845" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="2.8376967980518364" Z="0.8693054885164812">
<NAME>Gastrointestinal bleeding</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="264" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.0474982744952597"/>
<DICH_DATA CI_END="21.51725971144767" CI_START="0.1858972775177273" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3327869617910608" LOG_CI_START="-0.7307269704630984" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="265" O_E="0.0" SE="1.2121182983647962" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.4692307692307693" WEIGHT="1.790198523556577"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="262.3037172941704" CI_START="0.9597695134025691" DF="0" EFFECT_SIZE="15.866666666666665" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" I2="0.0" ID="CMP-014.04.05" LOG_CI_END="2.4188044453326576" LOG_CI_START="-0.017833049330996407" LOG_EFFECT_SIZE="1.2004856980008307" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.05344903372079379" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="1.3041470346817792" Z="1.9312751586479586">
<NAME>Gastric dilatation</NAME>
<DICH_DATA CI_END="262.3037172941704" CI_START="0.9597695134025691" EFFECT_SIZE="15.866666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.4188044453326576" LOG_CI_START="-0.017833049330996407" LOG_EFFECT_SIZE="1.2004856980008307" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="1.4312929259155551" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="2.0485994397759106" WEIGHT="1.3041470346817792"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8008811728017404" CI_END="3.1148261013127865" CI_START="0.47240561825871624" DF="2" EFFECT_SIZE="1.2130380662448537" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" I2="0.0" ID="CMP-014.04.06" LOG_CI_END="0.49343380529745673" LOG_CI_START="-0.3256849460198921" LOG_EFFECT_SIZE="0.08387442963878236" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.40639061284382905" P_Z="0.6881369236067804" STUDIES="5" TAU2="0.0" TOTAL_1="419" TOTAL_2="429" WEIGHT="9.70726798861118" Z="0.40138468580158954">
<NAME>Vomiting</NAME>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="268" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="1.1643709326300553"/>
<DICH_DATA CI_END="3.9127158232298926" CI_START="0.4809242199053015" EFFECT_SIZE="1.3717579250720462" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5924783066574291" LOG_CI_START="-0.3179233507981902" LOG_EFFECT_SIZE="0.13727747792961945" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="535" O_E="0.0" SE="0.534774440150316" STUDY_ID="STD-Gray-2008" TOTAL_1="347" TOTAL_2="357" VAR="0.2859837018380839" WEIGHT="7.495398781485866"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="269" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="1.0474982744952597"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="270" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="271" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.31147592536486" CI_START="0.12446157245205744" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.04.07" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="1.0225064383579474" Z="0.6766152721562805">
<NAME>Claustrophobia</NAME>
<DICH_DATA CI_END="72.31147592536486" CI_START="0.12446157245205744" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="272" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="1.0225064383579474"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9351017244542652" CI_END="9.626623079654637" CI_START="0.10577242703236207" DF="1" EFFECT_SIZE="1.0090744706218777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-014.04.08" LOG_CI_END="0.9834739678024202" LOG_CI_START="-0.9756275303005025" LOG_EFFECT_SIZE="0.003923218750958837" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.3335409023530602" P_Z="0.9937367568014956" STUDIES="2" TAU2="0.0" TOTAL_1="411" TOTAL_2="421" WEIGHT="2.035846243058236" Z="0.007849891863997401">
<NAME>Pneumothorax</NAME>
<DICH_DATA CI_END="75.50650634325044" CI_START="0.12616404829401512" EFFECT_SIZE="3.086455331412104" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8779843760957389" LOG_CI_START="-0.8990643840137746" LOG_EFFECT_SIZE="0.48945999604098195" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="536" O_E="0.0" SE="1.6312521883013933" STUDY_ID="STD-Gray-2008" TOTAL_1="346" TOTAL_2="356" VAR="2.660983701838084" WEIGHT="1.0133398047002884"/>
<DICH_DATA CI_END="8.034608436151645" CI_START="0.013829063605784151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="273" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="1.0225064383579474"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.04.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Eye irritation</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="274" O_E="0.0" SE="0.0" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.31147592536486" CI_START="0.12446157245205744" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.04.10" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="1.0225064383579474" Z="0.6766152721562805">
<NAME>Sinusitis</NAME>
<DICH_DATA CI_END="72.31147592536486" CI_START="0.12446157245205744" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8592072258638475" LOG_CI_START="-0.9049647164245224" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="275" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="1.0225064383579474"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6325974242923138" CI_END="3.612947404702113" CI_START="0.2546253127006454" DF="1" EFFECT_SIZE="0.9591391258275626" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" I2="38.74791267458525" ID="CMP-014.04.11" LOG_CI_END="0.5578616393942317" LOG_CI_START="-0.594098424642417" LOG_EFFECT_SIZE="-0.018118392624092657" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.20134422584172484" P_Z="0.9508384778488379" STUDIES="2" TAU2="0.46159009870356155" TOTAL_1="410" TOTAL_2="420" WEIGHT="13.500833788053587" Z="0.061653868236612834">
<NAME>Cardiac arrest</NAME>
<DICH_DATA CI_END="1.397433922827936" CI_START="0.2959697114371218" EFFECT_SIZE="0.6431159420289855" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.14533128158196065" LOG_CI_START="-0.5287527309301704" LOG_EFFECT_SIZE="-0.19171072467410483" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="537" O_E="0.0" SE="0.3959602857193024" STUDY_ID="STD-Gray-2008" TOTAL_1="345" TOTAL_2="355" VAR="0.15678454786691162" WEIGHT="11.495652798192301"/>
<DICH_DATA CI_END="28.092926570009606" CI_START="0.3203653409897097" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.44859698402184" LOG_CI_START="-0.494354474582515" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="276" O_E="0.0" SE="1.1412993045490314" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="1.3025641025641026" WEIGHT="2.005180989861286"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-014.04.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="0.0" Z="0.0">
<NAME>Stroke</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="277" O_E="0.0" SE="0.0" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.034608436151645" CI_START="0.013829063605784151" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-014.04.13" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.49865009120161063" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="1.0225064383579474" Z="0.6766152721562805">
<NAME>Seizures</NAME>
<DICH_DATA CI_END="8.034608436151645" CI_START="0.013829063605784151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9049647164245223" LOG_CI_START="-1.8592072258638475" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="1.6236882817719773" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="2.6363636363636362" WEIGHT="1.0225064383579474"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.852830144518068E-32" CI_END="75.50115918008183" CI_START="0.1261526725120289" DF="0" EFFECT_SIZE="3.086206896551724" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="100.0" ID="CMP-014.04.14" LOG_CI_END="1.8779536194655917" LOG_CI_START="-0.8991035446316799" LOG_EFFECT_SIZE="0.4894250374169559" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Z="0.4896641261562332" STUDIES="1" TAU2="0.0" TOTAL_1="347" TOTAL_2="357" WEIGHT="1.0133338620257073" Z="0.6908431406245278">
<NAME>Gastric aspiration</NAME>
<DICH_DATA CI_END="75.50115918008183" CI_START="0.1261526725120289" EFFECT_SIZE="3.086206896551724" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8779536194655917" LOG_CI_START="-0.8991035446316799" LOG_EFFECT_SIZE="0.4894250374169559" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="538" O_E="0.0" SE="1.6312571248454029" STUDY_ID="STD-Gray-2008" TOTAL_1="347" TOTAL_2="357" VAR="2.6609998073588903" WEIGHT="1.0133338620257073"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2288286832298376" CI_START="0.5449160176652154" DF="0" EFFECT_SIZE="0.8182960542849962" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="46" I2="0.0" ID="CMP-014.04.15" LOG_CI_END="0.08949134007599122" LOG_CI_START="-0.2636704259344405" LOG_EFFECT_SIZE="-0.08708954292922469" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.0" P_Z="0.3337177482133864" STUDIES="1" TAU2="0.0" TOTAL_1="346" TOTAL_2="352" WEIGHT="21.684805919490618" Z="0.9666525881303547">
<NAME>Hypotension</NAME>
<DICH_DATA CI_END="1.2288286832298376" CI_START="0.5449160176652152" EFFECT_SIZE="0.8182960542849962" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="46" LOG_CI_END="0.08949134007599122" LOG_CI_START="-0.2636704259344406" LOG_EFFECT_SIZE="-0.08708954292922469" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="539" O_E="0.0" SE="0.20744896953346365" STUDY_ID="STD-Gray-2008" TOTAL_1="346" TOTAL_2="352" VAR="0.043035074960495925" WEIGHT="21.684805919490618"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9044326585031708" CI_START="0.6384937102493292" DF="0" EFFECT_SIZE="1.1027095148078134" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="23" I2="0.0" ID="CMP-014.04.16" LOG_CI_END="0.2797656204427273" LOG_CI_START="-0.19484337657983486" LOG_EFFECT_SIZE="0.04246112193144622" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Z="0.7258147475037188" STUDIES="1" TAU2="0.0" TOTAL_1="345" TOTAL_2="350" WEIGHT="17.07076914838456" Z="0.3506982389751965">
<NAME>Arrhythmia</NAME>
<DICH_DATA CI_END="1.904432658503171" CI_START="0.6384937102493292" EFFECT_SIZE="1.1027095148078134" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="23" LOG_CI_END="0.27976562044272735" LOG_CI_START="-0.19484337657983486" LOG_EFFECT_SIZE="0.04246112193144622" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="540" O_E="0.0" SE="0.27878767420347816" STUDY_ID="STD-Gray-2008" TOTAL_1="345" TOTAL_2="350" VAR="0.07772256728778468" WEIGHT="17.07076914838456"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0328771930403295" CI_START="0.3648447819945049" DF="0" EFFECT_SIZE="0.6138728323699422" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="35" I2="0.0" ID="CMP-014.04.17" LOG_CI_END="0.01404868787443906" LOG_CI_START="-0.43789186064112934" LOG_EFFECT_SIZE="-0.21192158638334518" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="1.0" P_Z="0.06604590062094542" STUDIES="1" TAU2="0.0" TOTAL_1="346" TOTAL_2="354" WEIGHT="17.86495124189917" Z="1.8381120181502915">
<NAME>Progressive respiratory distress</NAME>
<DICH_DATA CI_END="1.0328771930403295" CI_START="0.3648447819945049" EFFECT_SIZE="0.6138728323699422" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="35" LOG_CI_END="0.01404868787443906" LOG_CI_START="-0.43789186064112934" LOG_EFFECT_SIZE="-0.21192158638334518" MODIFIED="2013-02-11 19:45:52 +0000" MODIFIED_BY="[Empty name]" ORDER="541" O_E="0.0" SE="0.26547211533984016" STUDY_ID="STD-Gray-2008" TOTAL_1="346" TOTAL_2="354" VAR="0.07047544402300941" WEIGHT="17.86495124189917"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.48300651646272" CI_END="1.4801462284879507" CI_START="0.9397539871990096" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1793953195850524" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="126" I2="0.0" I2_Q="0.0" ID="CMP-014.05" LOG_CI_END="0.17030462288706338" LOG_CI_START="-0.026985822980625452" LOG_EFFECT_SIZE="0.07165939995321895" METHOD="MH" MODIFIED="2013-02-15 16:57:16 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.970545017700978" P_Q="0.8813860625672079" P_Z="0.1545079726013958" Q="6.624708439854541" RANDOM="YES" SCALE="62.81831458281831" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3869" TOTAL_2="3724" WEIGHT="99.99999999999997" Z="1.4237875782008411">
<NAME>CPAP X BILEVEL</NAME>
<GROUP_LABEL_1>BILEVEL</GROUP_LABEL_1>
<GROUP_LABEL_2>CPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BILEVEL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.13198670205661922" CI_END="2.158654851037256" CI_START="0.18943730901487332" DF="1" EFFECT_SIZE="0.6394761653669354" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="0.0" ID="CMP-014.05.01" LOG_CI_END="0.33418320821064046" LOG_CI_START="-0.722534484131013" LOG_EFFECT_SIZE="-0.19417563796018616" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7163810747438317" P_Z="0.4713398671731348" STUDIES="5" TAU2="0.0" TOTAL_1="400" TOTAL_2="390" WEIGHT="3.4857332656037388" Z="0.7203007195492416">
<NAME>Skin damage</NAME>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="0.7068604969058672"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="517" O_E="0.0" SE="0.0" STUDY_ID="STD-Gray-2008" TOTAL_1="291" TOTAL_2="287" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.229393424689328" CI_START="0.14610910668782168" EFFECT_SIZE="0.5707317073170731" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3481867158981695" LOG_CI_START="-0.835322714517355" LOG_EFFECT_SIZE="-0.2435679993095927" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1221" O_E="0.0" SE="0.6951992978922437" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="0.4833020637898686" WEIGHT="2.778872768697872"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="0.0" STUDY_ID="STD-Mehta-1997" TOTAL_1="19" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="70.63375581538563" CI_START="0.11804951138229444" DF="0" EFFECT_SIZE="2.887608069164265" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.05.02" LOG_CI_END="1.849012299646752" LOG_CI_START="-0.9279358061660458" LOG_EFFECT_SIZE="0.4605382467403532" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5156316360369739" STUDIES="2" TAU2="0.0" TOTAL_1="365" TOTAL_2="350" WEIGHT="0.5047502941294985" Z="0.6500938027793038">
<NAME>Pneumothorax</NAME>
<DICH_DATA CI_END="70.63375581538563" CI_START="0.11804951138229444" EFFECT_SIZE="2.887608069164265" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.849012299646752" LOG_CI_START="-0.9279358061660458" LOG_EFFECT_SIZE="0.4605382467403532" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="522" O_E="0.0" SE="1.6311930634692557" STUDY_ID="STD-Gray-2008" TOTAL_1="346" TOTAL_2="333" VAR="2.6607908103102154" WEIGHT="0.5047502941294985"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="0.0" STUDY_ID="STD-Mehta-1997" TOTAL_1="19" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="70.43113565526838" CI_START="0.11770970302693129" DF="0" EFFECT_SIZE="2.8793103448275863" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-014.05.03" LOG_CI_END="1.8477646911587666" LOG_CI_START="-0.9291877359894748" LOG_EFFECT_SIZE="0.459288477584646" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.5167724274894262" STUDIES="3" TAU2="0.0" TOTAL_1="407" TOTAL_2="389" WEIGHT="0.5047487232033151" Z="0.6483286251357043">
<NAME>Pulmonary aspiration</NAME>
<DICH_DATA CI_END="70.43113565526838" CI_START="0.11770970302693129" EFFECT_SIZE="2.8793103448275863" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8477646911587666" LOG_CI_START="-0.9291877359894748" LOG_EFFECT_SIZE="0.459288477584646" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="523" O_E="0.0" SE="1.6311956018430862" STUDY_ID="STD-Gray-2008" TOTAL_1="347" TOTAL_2="333" VAR="2.660799091472228" WEIGHT="0.5047487232033151"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1224" O_E="0.0" SE="0.0" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.0" STUDY_ID="STD-Mehta-1997" TOTAL_1="19" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.9961210686026387" CI_START="0.5553066322575486" DF="0" EFFECT_SIZE="1.4896551724137932" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" I2="0.0" ID="CMP-014.05.04" LOG_CI_END="0.6016386373691506" LOG_CI_START="-0.25546713953723854" LOG_EFFECT_SIZE="0.17308574891595604" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.4285948146250863" STUDIES="3" TAU2="0.0" TOTAL_1="89" TOTAL_2="83" WEIGHT="5.298381968745981" Z="0.7915985243661885">
<NAME>Gastric distension</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1222" O_E="0.0" SE="0.0" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.0" STUDY_ID="STD-Mehta-1997" TOTAL_1="19" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.9961210686026387" CI_START="0.5553066322575486" EFFECT_SIZE="1.4896551724137932" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.6016386373691506" LOG_CI_START="-0.25546713953723854" LOG_EFFECT_SIZE="0.17308574891595604" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.5034681760968347" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.2534802043422733" WEIGHT="5.298381968745981"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8951224429443505" CI_END="2.190019811988349" CI_START="0.4278601784476111" DF="2" EFFECT_SIZE="0.9679991051448026" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="0.0" ID="CMP-014.05.05" LOG_CI_END="0.34044804369778786" LOG_CI_START="-0.36869813203731033" LOG_EFFECT_SIZE="-0.014125044169761262" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6391851100517335" P_Z="0.9377655129982734" STUDIES="4" TAU2="0.0" TOTAL_1="437" TOTAL_2="420" WEIGHT="7.73999318380432" Z="0.0780786213056054">
<NAME>Vomiting</NAME>
<DICH_DATA CI_END="7.723921203524791" CI_START="0.014385324265142151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8878378346245852" LOG_CI_START="-1.84208034406391" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Crane-2004" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.5222913671582241"/>
<DICH_DATA CI_END="3.6593421537870845" CI_START="0.4500994048739954" EFFECT_SIZE="1.2833813640730067" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5634030185476978" LOG_CI_START="-0.3466915612897164" LOG_EFFECT_SIZE="0.10835572862899072" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="520" O_E="0.0" SE="0.5345940612373236" STUDY_ID="STD-Gray-2008" TOTAL_1="347" TOTAL_2="334" VAR="0.28579081031021525" WEIGHT="4.699363645259739"/>
<DICH_DATA CI_END="2.985063026028877" CI_START="0.17050241009190487" EFFECT_SIZE="0.7134146341463414" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.47495350516977436" LOG_CI_START="-0.7682694777728469" LOG_EFFECT_SIZE="-0.14665798630153626" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1223" O_E="0.0" SE="0.7302753342335127" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="0.5333020637898686" WEIGHT="2.518338171386357"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8270168409752263" CI_END="1.9970956904021075" CI_START="0.5292464184850393" DF="2" EFFECT_SIZE="1.028083528472868" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" I2="0.0" ID="CMP-014.05.06" LOG_CI_END="0.30039887449412456" LOG_CI_START="-0.2763420722550733" LOG_EFFECT_SIZE="0.012028401119525665" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.6613262516160774" P_Z="0.9348429062377892" STUDIES="4" TAU2="0.0" TOTAL_1="375" TOTAL_2="360" WEIGHT="11.701742485253465" Z="0.08175328323315137">
<NAME>Disconfort with mask</NAME>
<DICH_DATA CI_END="2.1036692276237523" CI_START="0.508833451109273" EFFECT_SIZE="1.0346097201767306" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.32297745415524964" LOG_CI_START="-0.2934243455620179" LOG_EFFECT_SIZE="0.014776554296615861" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="518" O_E="0.0" SE="0.3620774683920413" STUDY_ID="STD-Gray-2008" TOTAL_1="291" TOTAL_2="281" VAR="0.13110009311718968" WEIGHT="10.244347751306446"/>
<DICH_DATA CI_END="20.150326280025773" CI_START="0.1796136792638711" EFFECT_SIZE="1.9024390243902438" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.304282082758394" LOG_CI_START="-0.7456605908169044" LOG_EFFECT_SIZE="0.2793107459707449" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1227" O_E="0.0" SE="1.2041464738380192" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="1.4499687304565354" WEIGHT="0.9262509707352664"/>
<DICH_DATA CI_END="7.021859875081781" CI_START="0.013784114918081134" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8464521586403041" LOG_CI_START="-1.8606211148345155" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.5901482410679288" STUDY_ID="STD-Mehta-1997" TOTAL_1="14" TOTAL_2="13" VAR="2.528571428571428" WEIGHT="0.5311437632117535"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2004" TOTAL_1="29" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.0160540344126847" CI_START="0.6728514910151673" DF="0" EFFECT_SIZE="1.4245548266166823" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="11" I2="0.0" ID="CMP-014.05.07" LOG_CI_END="0.4794391179129385" LOG_CI_START="-0.1720807808723332" LOG_EFFECT_SIZE="0.15367916852030267" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.355161266958843" STUDIES="1" TAU2="0.0" TOTAL_1="291" TOTAL_2="285" WEIGHT="9.16973404074851" Z="0.9246245157989453">
<NAME>Increased breathing discomfort</NAME>
<DICH_DATA CI_END="3.0160540344126847" CI_START="0.6728514910151673" EFFECT_SIZE="1.4245548266166823" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="11" LOG_CI_END="0.4794391179129385" LOG_CI_START="-0.1720807808723332" LOG_EFFECT_SIZE="0.15367916852030267" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="519" O_E="0.0" SE="0.3827060136219809" STUDY_ID="STD-Gray-2008" TOTAL_1="291" TOTAL_2="285" VAR="0.14646389286242786" WEIGHT="9.16973404074851"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0026131421462647682" CI_END="1.4831816398472721" CI_START="0.6511092668905869" DF="1" EFFECT_SIZE="0.9827071334769764" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="40" I2="0.0" ID="CMP-014.05.08" LOG_CI_END="0.1711943407470445" LOG_CI_START="-0.18634612352761346" LOG_EFFECT_SIZE="-0.007575891390284485" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.9592307925801358" P_Z="0.9338046372471989" STUDIES="2" TAU2="0.0" TOTAL_1="387" TOTAL_2="371" WEIGHT="30.448205991842556" Z="0.08305898637720771">
<NAME>Hypotension</NAME>
<DICH_DATA CI_END="1.5212314958507087" CI_START="0.6393329796761734" EFFECT_SIZE="0.9861913937058445" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" LOG_CI_END="0.1821953085437546" LOG_CI_START="-0.1942728921218198" LOG_EFFECT_SIZE="-0.0060387917890326066" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="524" O_E="0.0" SE="0.2211392846186066" STUDY_ID="STD-Gray-2008" TOTAL_1="346" TOTAL_2="332" VAR="0.048902583201629095" WEIGHT="27.46347649128701"/>
<DICH_DATA CI_END="3.542128114224875" CI_START="0.2554448995639243" EFFECT_SIZE="0.9512195121951219" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5492642650117926" LOG_CI_START="-0.5927027643982652" LOG_EFFECT_SIZE="-0.021719249693236308" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1225" O_E="0.0" SE="0.6707970859034312" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="0.4499687304565353" WEIGHT="2.984729500555546"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.924270999303283" CI_START="1.0242276871242302" DF="0" EFFECT_SIZE="2.004830917874396" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="12" I2="0.0" ID="CMP-014.05.09" LOG_CI_END="0.5937589909194624" LOG_CI_START="0.010396511590887465" LOG_EFFECT_SIZE="0.30207775125517494" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.04237445607284152" STUDIES="1" TAU2="0.0" TOTAL_1="345" TOTAL_2="332" WEIGHT="11.437605765200175" Z="2.029823768139594">
<NAME>Arrhythmia</NAME>
<DICH_DATA CI_END="3.924270999303283" CI_START="1.0242276871242302" EFFECT_SIZE="2.004830917874396" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="12" LOG_CI_END="0.5937589909194624" LOG_CI_START="0.010396511590887465" LOG_EFFECT_SIZE="0.30207775125517494" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="525" O_E="0.0" SE="0.34267000804844966" STUDY_ID="STD-Gray-2008" TOTAL_1="345" TOTAL_2="332" VAR="0.11742273441592456" WEIGHT="11.437605765200175"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2133519538496604" CI_START="0.6385965057261143" DF="0" EFFECT_SIZE="1.1888813328799728" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" I2="0.0" ID="CMP-014.05.10" LOG_CI_END="0.34505047830203334" LOG_CI_START="-0.1947734621636561" LOG_EFFECT_SIZE="0.07513850806918859" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="0.5853287031392114" STUDIES="1" TAU2="0.0" TOTAL_1="346" TOTAL_2="333" WEIGHT="13.356966186516223" Z="0.5456177787914988">
<NAME>Progressive respiratory distress</NAME>
<DICH_DATA CI_END="2.2133519538496604" CI_START="0.6385965057261141" EFFECT_SIZE="1.1888813328799728" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.34505047830203334" LOG_CI_START="-0.19477346216365618" LOG_EFFECT_SIZE="0.07513850806918859" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="526" O_E="0.0" SE="0.3170952548011476" STUDY_ID="STD-Gray-2008" TOTAL_1="346" TOTAL_2="333" VAR="0.1005494006174047" WEIGHT="13.356966186516223"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.3766454393109155" CI_START="0.5912980014507881" DF="0" EFFECT_SIZE="1.608695652173913" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" ID="CMP-014.05.11" LOG_CI_END="0.6411413649846323" LOG_CI_START="-0.22819358888582814" LOG_EFFECT_SIZE="0.20647388804940212" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Z="0.3518464785576253" STUDIES="1" TAU2="0.0" TOTAL_1="345" TOTAL_2="333" WEIGHT="5.150362826468992" Z="0.931013719218484">
<NAME>Cardiorespiratory arrest</NAME>
<DICH_DATA CI_END="4.3766454393109155" CI_START="0.5912980014507881" EFFECT_SIZE="1.608695652173913" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.6411413649846323" LOG_CI_START="-0.22819358888582814" LOG_EFFECT_SIZE="0.20647388804940212" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="527" O_E="0.0" SE="0.5106516551809325" STUDY_ID="STD-Gray-2008" TOTAL_1="345" TOTAL_2="333" VAR="0.260765112939026" WEIGHT="5.150362826468992"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="14.686201665184054" CI_START="0.06161011410634109" DF="0" EFFECT_SIZE="0.9512195121951219" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-014.05.12" LOG_CI_END="1.166909487474908" LOG_CI_START="-1.2103479868613802" LOG_EFFECT_SIZE="-0.021719249693236308" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Z="0.9714310739669998" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.6887469132936868" Z="0.035813493178193254">
<NAME>Pharyngeal damage</NAME>
<DICH_DATA CI_END="14.686201665184054" CI_START="0.06161011410634109" EFFECT_SIZE="0.9512195121951219" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.166909487474908" LOG_CI_START="-1.2103479868613802" LOG_EFFECT_SIZE="-0.021719249693236308" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1226" O_E="0.0" SE="1.3964128080394191" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="1.9499687304565354" WEIGHT="0.6887469132936868"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.566864495038661" CI_START="0.013318733701136613" DF="0" EFFECT_SIZE="0.31746031746031744" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-014.05.13" LOG_CI_END="0.8789159568321235" LOG_CI_START="-1.8755370644113247" LOG_EFFECT_SIZE="-0.49831055378960054" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.47822664578263796" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.5130283551895244" Z="0.7091576665213378">
<NAME>Cough</NAME>
<DICH_DATA CI_END="7.566864495038661" CI_START="0.013318733701136613" EFFECT_SIZE="0.31746031746031744" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8789159568321235" LOG_CI_START="-1.8755370644113247" LOG_EFFECT_SIZE="-0.49831055378960054" MODIFIED="2013-02-11 19:46:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1228" O_E="0.0" SE="1.6179793394407553" STUDY_ID="STD-Martin_x002d_Bermudez-2002" TOTAL_1="41" TOTAL_2="39" VAR="2.617857142857143" WEIGHT="0.5130283551895244"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-015" MODIFIED="2013-04-16 14:44:33 +0100" MODIFIED_BY="[Empty name]" NO="15">
<NAME>Hospital or 7-day mortality</NAME>
<DICH_OUTCOME CHI2="22.732865498209698" CI_END="0.9374256301883919" CI_START="0.5523173051703304" CI_STUDY="95" CI_TOTAL="95" DF="20" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7195529152628397" ESTIMABLE="YES" EVENTS_1="139" EVENTS_2="140" I2="12.021649881423533" I2_Q="0.0" ID="CMP-015.01" LOG_CI_END="-0.028063176592189987" LOG_CI_START="-0.2578113492763347" LOG_EFFECT_SIZE="-0.14293726293426232" METHOD="MH" MODIFIED="2013-02-15 16:57:06 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3021011308053303" P_Q="1.0" P_Z="0.01473719856791789" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="21" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.04171748473310702" TOTALS="YES" TOTAL_1="1364" TOTAL_2="899" WEIGHT="100.00000000000001" Z="2.4387735852422727">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7366979722073639" CI_START="0.03273937506443277" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.13271052555758273" LOG_CI_START="-1.4849296147426083" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="570" O_E="0.0" SE="0.7943001865797283" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.6309127864005912" WEIGHT="2.7077148534873245"/>
<DICH_DATA CI_END="4.745176453876752" CI_START="0.05268507977100682" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6762523667148672" LOG_CI_START="-1.2783123580428297" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="567" O_E="0.0" SE="1.148120994574099" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.3181818181818183" WEIGHT="1.3392837044257682"/>
<DICH_DATA CI_END="2.427899066052217" CI_START="0.1029696841584531" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.38523062805078434" LOG_CI_START="-0.9872906193787466" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="566" O_E="0.0" SE="0.8062257748298549" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.6499999999999999" WEIGHT="2.6329983212100676"/>
<DICH_DATA CI_END="1.2008537868107867" CI_START="0.14457306378005058" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.07949013192673515" LOG_CI_START="-0.8399126153499471" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="569" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="0.2916666666666667" WEIGHT="5.463040064762831"/>
<DICH_DATA CI_END="2.1374255087371723" CI_START="0.3866550097832482" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3298909880981643" LOG_CI_START="-0.41267635841461436" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="568" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.19025974025974024" WEIGHT="7.851162872174536"/>
<DICH_DATA CI_END="1.394273284892921" CI_START="0.6439740580819944" EFFECT_SIZE="0.9475630983463882" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="36" LOG_CI_END="0.144347906106805" LOG_CI_START="-0.1911316274519361" LOG_EFFECT_SIZE="-0.02339186067256555" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="596" O_E="0.0" SE="0.1970623386628783" STUDY_ID="STD-Gray-2008" TOTAL_1="766" TOTAL_2="390" VAR="0.03883356531928295" WEIGHT="22.610393965930466"/>
<DICH_DATA CI_END="1.2498387186188826" CI_START="0.021525131079781504" EFFECT_SIZE="0.164021164021164" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.09685397450170918" LOG_CI_START="-1.667054195179652" LOG_EFFECT_SIZE="-0.7851001103389715" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="564" O_E="0.0" SE="1.0361283903570913" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="1.0735620413039768" WEIGHT="1.633035426128106"/>
<DICH_DATA CI_END="1.7553147303648262" CI_START="0.47899411270804515" EFFECT_SIZE="0.9169435215946844" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.24435499738647806" LOG_CI_START="-0.3196698244437294" LOG_EFFECT_SIZE="-0.037657413528625644" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="565" O_E="0.0" SE="0.33131097231096013" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.1097669603736338" WEIGHT="12.022957042028843"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="562" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="2.970403149056007"/>
<DICH_DATA CI_END="2.115709729958969" CI_START="0.6969244292065352" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3254560833421525" LOG_CI_START="-0.1568143119420807" LOG_EFFECT_SIZE="0.08432088570003587" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="563" O_E="0.0" SE="0.28328801746691673" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.08025210084033613" WEIGHT="14.932337168246287"/>
<DICH_DATA CI_END="2.2198220326012796" CI_START="0.2002162506350232" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34631815762298346" LOG_CI_START="-0.6985006757343459" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="560" O_E="0.0" SE="0.6137317546507323" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.3766666666666666" WEIGHT="4.3531547979542005"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="561" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="0.7761802572005044"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="558" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="6.308024825705962"/>
<DICH_DATA CI_END="43.49940689111513" CI_START="0.08662568892945194" EFFECT_SIZE="1.9411764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.638483335444938" LOG_CI_START="-1.062353298445711" LOG_EFFECT_SIZE="0.2880650184996135" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="559" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="2.516934046345811" WEIGHT="0.7118167339051164"/>
<DICH_DATA CI_END="0.8913237996836371" CI_START="0.06520125872785698" EFFECT_SIZE="0.24107142857142858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="-0.04996449700715811" LOG_CI_START="-1.1857440200152305" LOG_EFFECT_SIZE="-0.6178542585111942" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="556" O_E="0.0" SE="0.6671625140142543" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.4451058201058201" WEIGHT="3.74117458624238"/>
<DICH_DATA CI_END="1.7270985884096945" CI_START="0.14475143554497316" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.23731712921785653" LOG_CI_START="-0.8393771205458188" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="557" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="4.123203266799309"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="554" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="0.7761802572005044"/>
<DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="555" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="1.4667514941576156"/>
<DICH_DATA CI_END="0.9757912475554729" CI_START="0.02091447665310805" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.010643081648438522" LOG_CI_START="-1.6795529983800752" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="552" O_E="0.0" SE="0.9803259463254868" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.961038961038961" WEIGHT="1.8162844863606193"/>
<DICH_DATA CI_END="9.457412222749872" CI_START="0.026434292395400003" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9757723191583028" LOG_CI_START="-1.5778323104862653" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="553" O_E="0.0" SE="1.5" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="2.25" WEIGHT="0.7947275299800002"/>
<DICH_DATA CI_END="22.801387382009104" CI_START="0.11227386987951042" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3579612730539414" LOG_CI_START="-0.9497213077420916" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2013-02-11 19:35:20 +0000" MODIFIED_BY="[Empty name]" ORDER="551" O_E="0.0" SE="1.355544171172596" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="1.8375" WEIGHT="0.9691751970435648"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-016" MODIFIED="2013-04-16 14:44:38 +0100" MODIFIED_BY="[Empty name]" NO="16">
<NAME>Hospital or 30-day mortality</NAME>
<DICH_OUTCOME CHI2="22.787227742417095" CI_END="0.9462124796784065" CI_START="0.5955467268608128" CI_STUDY="95" CI_TOTAL="95" DF="21" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7506755259013899" ESTIMABLE="YES" EVENTS_1="185" EVENTS_2="171" I2="7.8431117756824555" I2_Q="0.0" ID="CMP-016.01" LOG_CI_END="-0.024011328302116112" LOG_CI_START="-0.22508415790634326" LOG_EFFECT_SIZE="-0.12454774310422971" METHOD="MH" MODIFIED="2013-02-15 16:57:10 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.35542718447091626" P_Q="1.0" P_Z="0.015179563845882567" Q="0.0" RANDOM="YES" SCALE="124.56381228807871" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.02301142140855677" TOTALS="YES" TOTAL_1="1426" TOTAL_2="961" WEIGHT="100.00000000000003" Z="2.4280664008212196">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7366979722073639" CI_START="0.03273937506443277" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.13271052555758273" LOG_CI_START="-1.4849296147426083" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="530" O_E="0.0" SE="0.7943001865797283" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.6309127864005912" WEIGHT="2.1333129430443734"/>
<DICH_DATA CI_END="4.745176453876752" CI_START="0.05268507977100682" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6762523667148672" LOG_CI_START="-1.2783123580428297" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="527" O_E="0.0" SE="1.148120994574099" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.3181818181818183" WEIGHT="1.0401371965723296"/>
<DICH_DATA CI_END="2.427899066052217" CI_START="0.1029696841584531" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.38523062805078434" LOG_CI_START="-0.9872906193787466" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="526" O_E="0.0" SE="0.8062257748298549" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="0.6499999999999999" WEIGHT="2.072810255388568"/>
<DICH_DATA CI_END="1.2008537868107867" CI_START="0.14457306378005058" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.07949013192673515" LOG_CI_START="-0.8399126153499471" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="529" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="0.2916666666666667" WEIGHT="4.433181175156417"/>
<DICH_DATA CI_END="2.1374255087371723" CI_START="0.3866550097832482" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3298909880981643" LOG_CI_START="-0.41267635841461436" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="528" O_E="0.0" SE="0.43618773510925346" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.19025974025974024" WEIGHT="6.541085842909186"/>
<DICH_DATA CI_END="2.4058145475693893" CI_START="0.30538258998112994" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.381262146664905" LOG_CI_START="-0.5151557259261313" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="596" O_E="0.0" SE="0.5265602957000086" STUDY_ID="STD-Frontin-2010" TOTAL_1="62" TOTAL_2="62" VAR="0.27726574500768053" WEIGHT="4.645791063432183"/>
<DICH_DATA CI_END="1.2154336615631844" CI_START="0.6782744679580847" EFFECT_SIZE="0.9079634464751958" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="60" LOG_CI_END="0.0847312600092436" LOG_CI_START="-0.1685945306183211" LOG_EFFECT_SIZE="-0.04193163530453874" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="531" O_E="0.0" SE="0.14880482339751908" STUDY_ID="STD-Gray-2008" TOTAL_1="766" TOTAL_2="390" VAR="0.022142875466366837" WEIGHT="30.89462294482144"/>
<DICH_DATA CI_END="1.2498387186188826" CI_START="0.021525131079781504" EFFECT_SIZE="0.164021164021164" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.09685397450170918" LOG_CI_START="-1.667054195179652" LOG_EFFECT_SIZE="-0.7851001103389715" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="523" O_E="0.0" SE="1.0361283903570913" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="1.0735620413039768" WEIGHT="1.2721673683753907"/>
<DICH_DATA CI_END="1.7553147303648262" CI_START="0.47899411270804515" EFFECT_SIZE="0.9169435215946844" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.24435499738647806" LOG_CI_START="-0.3196698244437294" LOG_EFFECT_SIZE="-0.037657413528625644" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="522" O_E="0.0" SE="0.33131097231096013" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.1097669603736338" WEIGHT="10.506416463017981"/>
<DICH_DATA CI_END="4.399951460098166" CI_START="0.2272752345267212" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.643447885411688" LOG_CI_START="-0.6434478854116878" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="525" O_E="0.0" SE="0.7559289460184544" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.5714285714285714" WEIGHT="2.346788562511001"/>
<DICH_DATA CI_END="2.115709729958969" CI_START="0.6969244292065352" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3254560833421525" LOG_CI_START="-0.1568143119420807" LOG_EFFECT_SIZE="0.08432088570003587" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="524" O_E="0.0" SE="0.28328801746691673" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.08025210084033613" WEIGHT="13.509368515698194"/>
<DICH_DATA CI_END="2.2198220326012796" CI_START="0.2002162506350232" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34631815762298346" LOG_CI_START="-0.6985006757343459" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="519" O_E="0.0" SE="0.6137317546507323" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.3766666666666666" WEIGHT="3.490371421179177"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="518" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="0.599295885301822"/>
<DICH_DATA CI_END="1.7658569541775953" CI_START="0.25168768251187906" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24695552000741336" LOG_CI_START="-0.599138038118776" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="521" O_E="0.0" SE="0.49699954427398324" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.24700854700854702" WEIGHT="5.166377081173413"/>
<DICH_DATA CI_END="43.49940689111513" CI_START="0.08662568892945194" EFFECT_SIZE="1.9411764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.638483335444938" LOG_CI_START="-1.062353298445711" LOG_EFFECT_SIZE="0.2880650184996135" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="520" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="2.516934046345811" WEIGHT="0.549234223332626"/>
<DICH_DATA CI_END="0.8913237996836371" CI_START="0.06520125872785698" EFFECT_SIZE="0.24107142857142858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="-0.04996449700715811" LOG_CI_START="-1.1857440200152305" LOG_EFFECT_SIZE="-0.6178542585111942" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="516" O_E="0.0" SE="0.6671625140142543" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.4451058201058201" WEIGHT="2.980076042011047"/>
<DICH_DATA CI_END="1.7270985884096945" CI_START="0.14475143554497316" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.23731712921785653" LOG_CI_START="-0.8393771205458188" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="517" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.4" WEIGHT="3.297842341098251"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="514" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="0.599295885301822"/>
<DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="515" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="1.1406475457789484"/>
<DICH_DATA CI_END="0.9757912475554729" CI_START="0.02091447665310805" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.010643081648438522" LOG_CI_START="-1.6795529983800752" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="512" O_E="0.0" SE="0.9803259463254868" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.961038961038961" WEIGHT="1.417635723914466"/>
<DICH_DATA CI_END="9.457412222749872" CI_START="0.026434292395400003" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9757723191583028" LOG_CI_START="-1.5778323104862653" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="513" O_E="0.0" SE="1.5" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="2.25" WEIGHT="0.6137342571841605"/>
<DICH_DATA CI_END="22.801387382009104" CI_START="0.11227386987951042" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3579612730539414" LOG_CI_START="-0.9497213077420916" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2013-02-11 18:31:04 +0000" MODIFIED_BY="[Empty name]" ORDER="511" O_E="0.0" SE="1.355544171172596" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="1.8375" WEIGHT="0.7498072627972084"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-017" MODIFIED="2013-04-16 14:44:45 +0100" MODIFIED_BY="[Empty name]" NO="17">
<NAME>General or 7-day ETI rate</NAME>
<DICH_OUTCOME CHI2="37.9078848362483" CI_END="0.7774308017018458" CI_START="0.3831556721446011" CI_STUDY="95" CI_TOTAL="95" DF="20" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5457811112268239" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="156" I2="47.24052769919891" I2_Q="0.0" ID="CMP-017.01" LOG_CI_END="-0.10933825667601081" LOG_CI_START="-0.4166247408684405" LOG_EFFECT_SIZE="-0.26298149877222565" METHOD="MH" MODIFIED="2013-02-15 16:57:13 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.009087861620204696" P_Q="1.0" P_Z="7.943748670834588E-4" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="23" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.2760418782814251" TOTALS="YES" TOTAL_1="1441" TOTAL_2="976" WEIGHT="99.99999999999997" Z="3.354747395080027">
<NAME>NPPV (CPAP and BILEVEL) X SMC</NAME>
<GROUP_LABEL_1>NPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>SMC</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SMC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8743483718723556" CI_START="0.15889046552143893" EFFECT_SIZE="0.37272727272727274" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="-0.05831549432563452" LOG_CI_START="-0.7989021625513445" LOG_EFFECT_SIZE="-0.4286088284384895" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="591" O_E="0.0" SE="0.43502427487891365" STUDY_ID="STD-Agmy-2008" TOTAL_1="88" TOTAL_2="41" VAR="0.18924611973392463" WEIGHT="7.0022928659365045"/>
<DICH_DATA CI_END="1.8953147119657667" CI_START="0.032976053847636085" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2776813337352318" LOG_CI_START="-1.4818013163911565" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="590" O_E="0.0" SE="1.033528818263825" STUDY_ID="STD-Bautin-2005" TOTAL_1="11" TOTAL_2="11" VAR="1.0681818181818183" WEIGHT="2.423765358162507"/>
<DICH_DATA CI_END="1.0942083056670993" CI_START="0.004061790082771148" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.039100006997564246" LOG_CI_START="-2.391282525108927" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="589" O_E="0.0" SE="1.4276187299469136" STUDY_ID="STD-Bersten-1991" TOTAL_1="20" TOTAL_2="20" VAR="2.0380952380952384" WEIGHT="1.4079039682013623"/>
<DICH_DATA CI_END="50.95043024524692" CI_START="0.12872503808498176" EFFECT_SIZE="2.5609756097560976" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.707147855709426" LOG_CI_START="-0.8903369710090208" LOG_EFFECT_SIZE="0.4084054423502026" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="588" O_E="0.0" SE="1.5257754449716752" STUDY_ID="STD-Crane-2004" TOTAL_1="40" TOTAL_2="20" VAR="2.3279907084785134" WEIGHT="1.2511682248810199"/>
<DICH_DATA CI_END="2.364625144143514" CI_START="0.3495041415078417" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.3737623033261822" LOG_CI_START="-0.4565476736426324" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="587" O_E="0.0" SE="0.4877281905721545" STUDY_ID="STD-Delclaux-2000" TOTAL_1="22" TOTAL_2="20" VAR="0.23787878787878786" WEIGHT="6.339661048176387"/>
<DICH_DATA CI_END="4.943824870337866" CI_START="0.05056813430021737" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6940630779397805" LOG_CI_START="-1.296123069267743" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="586" O_E="0.0" SE="1.1690451944500122" STUDY_ID="STD-Ferrer-2003" TOTAL_1="15" TOTAL_2="15" VAR="1.3666666666666667" WEIGHT="1.983360249222856"/>
<DICH_DATA CI_END="3.8526364229800345" CI_START="0.11536111785515027" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5857580261570842" LOG_CI_START="-0.9379405442684468" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="597" O_E="0.0" SE="0.8950280826975231" STUDY_ID="STD-Frontin-2010" TOTAL_1="62" TOTAL_2="62" VAR="0.8010752688172043" WEIGHT="3.024817530651034"/>
<DICH_DATA CI_END="2.1540447202137223" CI_START="0.48136770565524795" EFFECT_SIZE="1.0182767624020888" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.33325471546170277" LOG_CI_START="-0.3175230493459498" LOG_EFFECT_SIZE="0.007865833057876458" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="597" O_E="0.0" SE="0.382270080449905" STUDY_ID="STD-Gray-2008" TOTAL_1="766" TOTAL_2="390" VAR="0.14613041440717683" WEIGHT="7.717424581228862"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="585" O_E="0.0" SE="0.0" STUDY_ID="STD-Kelly-2002" TOTAL_1="27" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.773110492974689" CI_START="0.1031695619921994" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4429671741336449" LOG_CI_START="-0.9864484132576323" LOG_EFFECT_SIZE="-0.2717406195619937" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="584" O_E="0.0" SE="0.8396457917549096" STUDY_ID="STD-L_x0027_Her-2004" TOTAL_1="43" TOTAL_2="46" VAR="0.705005055611729" WEIGHT="3.3210264632085384"/>
<DICH_DATA CI_END="1.8942671028263436" CI_START="0.26934115092396554" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.27744121706681374" LOG_CI_START="-0.5696972884232897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="583" O_E="0.0" SE="0.4976133515281193" STUDY_ID="STD-Levitt-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.24761904761904763" WEIGHT="6.221741336736657"/>
<DICH_DATA CI_END="0.8834048901615281" CI_START="0.19192804443201444" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.053840200997608285" LOG_CI_START="-0.7168615617304259" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="582" O_E="0.0" SE="0.38946202930312424" STUDY_ID="STD-Lin-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.15168067226890758" WEIGHT="7.6172809334385665"/>
<DICH_DATA CI_END="0.9267001555176237" CI_START="0.21315509986851866" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.033060764096141525" LOG_CI_START="-0.6713042721265834" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="581" O_E="0.0" SE="0.3749073959733998" STUDY_ID="STD-Lin-1995" TOTAL_1="50" TOTAL_2="50" VAR="0.14055555555555557" WEIGHT="7.820698267631883"/>
<DICH_DATA CI_END="1.2617285296697793" CI_START="0.022015653228549727" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10096592325294027" LOG_CI_START="-1.6572684240202276" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="580" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Masip-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.0666666666666667" WEIGHT="2.426500405741231"/>
<DICH_DATA CI_END="1.550251766402913" CI_START="0.4258380892103588" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.19040223486730365" LOG_CI_START="-0.37075549556547965" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="579" O_E="0.0" SE="0.32962682863178194" STUDY_ID="STD-Nava-2003" TOTAL_1="65" TOTAL_2="65" VAR="0.10865384615384616" WEIGHT="8.469246269611103"/>
<DICH_DATA CI_END="1.6715906045340252" CI_START="0.13144759362969213" EFFECT_SIZE="0.46875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.2231299214507131" LOG_CI_START="-0.8812473599791626" LOG_EFFECT_SIZE="-0.32905871926422475" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="578" O_E="0.0" SE="0.6487166818676188" STUDY_ID="STD-Park-2001" TOTAL_1="16" TOTAL_2="10" VAR="0.4208333333333333" WEIGHT="4.675274388881366"/>
<DICH_DATA CI_END="0.5001136511201912" CI_START="0.06146351276125322" EFFECT_SIZE="0.17532467532467533" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.3009312907727554" LOG_CI_START="-1.2113826225821962" LOG_EFFECT_SIZE="-0.7561569566774757" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="577" O_E="0.0" SE="0.5348036191116428" STUDY_ID="STD-Park-2004" TOTAL_1="56" TOTAL_2="27" VAR="0.28601491101491106" WEIGHT="5.796714657939994"/>
<DICH_DATA CI_END="1.0681664778949462" CI_START="0.23404591435286307" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.02863894444973777" LOG_CI_START="-0.6306989357777002" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="572" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-R_x00e4_s_x00e4_nen-1985" TOTAL_1="20" TOTAL_2="20" VAR="0.15000000000000002" WEIGHT="7.647329981388851"/>
<DICH_DATA CI_END="9.872894922206104" CI_START="1.6205986315131156" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="4" LOG_CI_END="0.9944445148172463" LOG_CI_START="0.20967546783867852" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="571" O_E="0.0" SE="0.4609772228646444" STUDY_ID="STD-Sharon-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.21250000000000002" WEIGHT="6.6689939469875705"/>
<DICH_DATA CI_END="1.2221392528015427" CI_START="0.022728815651818755" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.0871206930405403" LOG_CI_START="-1.6434231938078274" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="574" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Takeda-1997" TOTAL_1="15" TOTAL_2="15" VAR="1.0333333333333334" WEIGHT="2.488272880231788"/>
<DICH_DATA CI_END="0.9217243669784655" CI_START="0.06780768984645952" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="-0.03539893122073283" LOG_CI_START="-1.1687210514351918" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="573" O_E="0.0" SE="0.6657190234489458" STUDY_ID="STD-Takeda-1998" TOTAL_1="11" TOTAL_2="11" VAR="0.4431818181818181" WEIGHT="4.529999282740916"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="576" O_E="0.0" SE="0.0" STUDY_ID="STD-Thys-2002" TOTAL_1="3" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.543919735107691" CI_START="0.02298881919248082" EFFECT_SIZE="0.5151515151515151" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.062353298445711" LOG_CI_START="-1.638483335444938" LOG_EFFECT_SIZE="-0.2880650184996136" MODIFIED="2013-02-11 19:36:00 +0000" MODIFIED_BY="[Empty name]" ORDER="575" O_E="0.0" SE="1.5864848081043232" STUDY_ID="STD-Weitz-2007" TOTAL_1="10" TOTAL_2="16" VAR="2.516934046345811" WEIGHT="1.1665273590009915"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-04-16 13:31:27 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-12-14 11:45:50 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>QUOROM statement flow diagram of 2005</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Figure 4.  Quorom statement flow diagram of the update.JPG" FILE_TYPE="JPG" ID="FIG-02" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Figure 4. PRISMA statement flow diagram of 2011</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-04-16 13:31:27 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2013-04-16 13:31:27 +0100" MODIFIED_BY="[Empty name]" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAigAAADnCAMAAAAD8l3/AAADAFBMVEUAAADAAAAAwAAAAMDg4ADAAMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdCQkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYAAJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkAmcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwzAP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8zzAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBmMzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNmzGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZM5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZzMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zMM//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP//2b//5n//8z///9BjlLGAAAoM0lEQVR42u19C5QcVbnuX6+urn5MP6Y7T5jFI8SDg4vDayAmUTCBkCsXlHtlce/FB0dPfByWiuLjeFVEBRwIBOR1JcEoHpRjQE0CJoQRE8ZIGBF0QfAkZBLNkJnMdPfud1d1VXfV3XtXVU/3vNKTmcAk7H+tZHftx7//2vXV3n/V7L8+ACZMmhAOImwQmBxR0jwbAybNCAMKEwYUJgwoTBhQmDCgMGFAYcKAwoQJiGwIxpM0G4K6t7EMKMfjbHusLKuOOLbY0sOE+ShMGFCYMKAwORGA0tI9M62PNx7eFGuyXcvYFQ2Gh6aAIgqCFBqzVvmKt9nMxWPumgkcbDy+xxzj+T86RkP1cTuVuhqyY2EGiKZmlGAi8Pcx7yqLextNlPHlW9M7RkHIVBozuF+OaIlhP7RvjJbmNXZaOrchO6tGGSKaAcoT0SHYhWEhiT6Ehzl6g+DH07tH8AK+VQ1ZuATf16siXuFe/LvFbhKRBB+us0pYhVsMyLxvFamDV6pVKhge3jusx/AKi0M4TyB59P6VFyvesNsW6z35XnDL5fAqxbEjcDhfQUuVuv5JPTrPpUb0r37EbR/3LhZarPOLIvr6AjBWCWK4ZgdFVNW7WMHVggvgXo/gR64en8oQ0QRQrN54KL4UIFxSy/herWZ/tl3thpykPVThAPkE7S/Zbtiavzf0Mb8/WKSXG+UeTuDBzz2u9Z4KcJ2YlB/BmNp0PsDWeRD4fBlOdfUgn7V9TRLnadapdnd5fo1imG7brTl5740xt9zMb8g5dqRn+V+OmnNr/dv1SN8Dr47o/zRw2qOsuVdLDfb51OhWC/ke0wIHYu752FOJ91MGblCx4DshTd3o6hGYl9IMULhr9upDZAaWpE/OAbjQn13K/3dU2SddLwHsHuqV0tIK6A98GrUG0P5kkDSJ8jdAAozKnnkvGoCe+H00LeJVKvESwCHOMK6CTsPVowz5lnZIJO8O+2qgw7kOJHBGZXDeixWAfn9WESpueUcgLTl2SMB3QAdX65/WoxNKrKOxf+jnnPYLB7MJSZozwEs4D/csZeaojh32mW7JXO8t43QDpHHFLzp6YG+CIWUcqd9cLQa4XCSJZ5SyGSnloC2fBlkZWL4TwOPLRN6NU9/7t0j+DAghhLgzkqRN9wfMghLtnWMBr0WzVTzByzlSjpXxvbMtnlcdPdz+NzowsJw8smjlSG2vYLcFotejCHVtXDtkJYOPoa5/j5Iljzwps7F/rMPpM5xLEm+D1JP8XBbX81c1244M6ZsYGFJ1koa1S54JZm09eHkrS7XhSLNX+FZk7MF4Ii2fj6A7t7+cxvNCP6kJmafwTcZZwD2FPQJzByzBJRdtxEUDtMnSQb8fHYKCrmsgJJHt9150CNCF3MbWfxhl1dXTD+/BqZuHZSiJ5yCTc9pSvVZDG9cO8geH/ob+bd96D5dq7B+XOe03p3a7PvgSrj+F61V5xw57oHFaFUkaaw9u8ViOHpjLS2zuaMZHge3bboMrub5YNUPRgfPmxlpRGGNla+xU9AddBvL4set8CNpNUHc0BUE1jmsYkDjzFNRCQPnSbDT/BWjnzyC5jp5X41cbyMB5yHldIc0Orp9vmq/OCtOcXmpMrRy3ce1YRo/r+7eNjorvauwflznt2+OX9iADlldInhq7HcX0Bxw77DP9KOrR15CjSu+emLHK0QNVhpPmlp4MhA8s3DPXEO/80vali19PkwUhfKBVqXjx5HwxlwhzILYg4KNJxJGVBAzF4nUO4mmLEzVoKSz6q4En91DhotcKIRTPmBf9WQNHT3zhCxDIxbJz2nAekYFTLV8hkHbaEr24llNO2iDHjq7LOQMf1/VPlh8gS5Pa2D8uc9qrLUMxpRDJ8QbO676Y7/gD59pBQSpWqnJOAmnLuXNmH5ZL0QFbj/ep5cCWnjGXHgGG30WY+AJqSqmzqsNW/afQp9Es7dUHqlXs+K23yuU7cA5eGKwSdCpr6WJv6ghnlkw9fSt2L/VfPyAKZZy++l1LJbm/fghcPaU+PfNdnJcieUTuqlTz/Lb1Tluil9Syy0kb145Hk98V8HFd/6aNNE0O6g39m6rbXjLF9PdAS314Lc5bb7X+8Y6aHdQPTn7lq7cK+PDRzmoKdL1sn0cE1tWNksbN4Nv72Ig1MkOpG4xpjhS0Hc1mxMfd9uXP3D+VvtDupdNqexTVH7EZpX5GmXagrP9qosmaccMS0AxelRlQjilQThxhWyHrtkKm2VbIIw8SE2D7UZgwoDBhQGHCgMJkZgpzZtlTT1MOPQPK8TjbsgAwJuyuYcKAwoQBhQmTqQPFio8XSjVlaU6vMcqeJrUPjJkdZ3iYbqCs5MnffT2/gFJ13DptU/ljyQR664Axq/EY2zNKpLGCuortdio0xvEYLQwQ0wsU9Az3MtA4Gm7DmBVW4cvzSu8U7BpHLxXZCWcM+0a86sD2NAIHW1HaP5Z2J6Qw0RgdltHZHwKnFyinrJDvAhpHY/WRyCwSXxX38nNaINAmkKCtdfk2NP90kteGi5ZFFD7gzO4reaFlRL6Ttyy9Ei8lN0kCCc3Cer3hlULA8JJQs/gynpTZ9QOHFZHuY1H9GCwy76uVn0aiynjvYRqtJrT4K3kRXb6AlJJ5xdu10g0Aw2CjcWJzF7j92XoUjSFiWoGiffmZn9M4GuBuRIqgBdtjKGtG+1IgqYlzdsNBPtAbPQ9Qjivn8irsyEs7+qgDgLLPtWqpxnw7D/JdgefwUrKupOkKvudvhPMKu7b3BZSW9yBclnwOt7frp2eX/kiWDFQZAFTwJ/HE5ZRjewpy8mP/BEiB7Yk9fUKgL7oD9/lCckuuG867fGfkTdsN4Qq+lsopAOYvnf4cPeK5DBHjTfFHs+0ilk5EJZ0jW5XFYL+2MAFeYetZv7neLvXKWScWR3jjjQ7weAqkrr1FMvaGVyH/1+dLNA9xC62EHdIpe7MgBtNt2SwILWmjsHCPU+bocXZI07geUc5ItbaSf9tFUdANVdVOpz4UjesR3whIIIvFtn9wJECJ+iYtafC/bwuN73H6I3pYXM9IJzAytcH4Fn9yADw0FofbMK81gUe+WoarqN9wg5dGV9xNYnEej3Vgb7ICS6JuLE6llUChMb8CJO9lyOawSuhSvBWL+ij92DZrE+Sh/7XW7PmkzNHDOTEXRGO4Q4lArZxbgbXg5WMe7HNrLOEqMXzxxf8D/dGGgRa7aHyP0x/VA/lUns0d04dNdLsu8F8Y6iYxNlZff8og8VXXAom56j6wRhPJdbyRxPP0JUmRUBeLszlFYsca8zcDybsWingqAPWygEaiUrGPQvFAIojm9aaKW3GZq8eyde21egCSnUYWDZdvSu3UdRU22dvHSb1eGEjiepXHGuJ6yN0jkdTtj+qBhXH2OYNpBMrpKS6XWz13he2jqLEYip/n3Xv2pQYyyvF8/HyiFk9iHdxVcRHFjI2knnOF2md9DiGjMb991mdx3t7ZeBlAMJ/bM2BmqI/SgUsXvURmlKtIWQ+4ekSd6op6yoBiHZVFMFzePusSoqX9iqiBBoBLkzw1vhwNVDxUn/P9Dk5Hhr6JzFtOf7YeMFkA2HT6KCS8GCCkvD57y3LsS3RfAiQyS33XX2PKwTlVXhe3L41mBb0tn47mwFSKIG1Z7oZxdH9g6MxCoTHfzuteVuGFMpozOEdSCwrxUfJpEAoK9lESuEzgy259EtdFdIWMUs8izrpxNQyXdy8bPHuwDLGMCYFcNCOVsUOjBi1QCnYMtJdaIci6JXZ3YB9ln93fq7Ye2V8XFsB8lGnfhT8g0xnbyOPEwL4lTlDQvjlpXuNbLZrTmG8f2W1wa2P0je3qsw/Abux7ZqmraLjcKUxxxAqrdUwryKdRavXt/kiVrmX1kVUMKCdMuAZSlGnV190QT8aAwuJ6mhIGlHqgsB1u44vJLBsWBpRxhU21b8UkxoQBhQkDChMmDChMmDN7bB6P2RCwALB36Gx7pDNiAWBM2F3DhAGFCQMKEwYUmEQkVtMSmoCDLD5d9rEAsOkBitjVbE1p2kkqtA+Of9UPjm2DHfl1SWQC+8TG6LBfhBggpgMoVvMRXbUNQJ6J/rQmN0/NVsdBtqzxcob8Sr2+ms7Sfvq7s3cC+9TG6LDlZbZldjqAwn2N8n/5AHpkQQiBIZ+82OEE8xsy2VO9ssvLKwbdQ0/4vQy4t5KTUFyusX4NeHnC4yerAN6IdbiwGMW9i8UWN39ll8IHBmSs22lvrwgeQSGP9JYkKgisJ4oiCti8XUQID1iLXYL1UZ1yZJUCwdPpb8odVrPT55yJadt55ekQ8CwmdGcR0gdjAJs2H2VrXi5oMfRebrvmQT5x/+v7YzhPCb3p9wdEBNv+mxLW45Szr6CtMeOwSAgcjOZk7RKb9Qudwpf9K7rBeAnA4CqzfWsga+5VU27+tn+Ri32n+IJnIac9lZykPVjBc0CkpIYUqMz2q1EppKm7bZUDr+ILX1L1BUD0kX9RM7chB+dx9u+5w3bKhbId+26qtp3bCAnDGm03oHw2kQPYyLyUaQHKE9DvI/xbSsK3VErsHtonped8C/oDaZcTjPelkXIdiZdB58VP1srQwT05F1WentdtTw67D2eljHg5cOeTaA7J4jsWDgYSkuTm89mM0upLJ54KOu0pFAzCQYZnlIyE+wMJOInydtnMqbtJjBDhCqsC0Uf+wRLCH/aiaf/manZi2/mKfdY1OyGT7JA+CFHuYawY2v+KGCTGlnp2jSMuPe99ipc1EMV1j6NOgN/wq/ECYuwTPBpwKen7+iklUqzsMoGX7+017hE+sA/4RU89fOhXWhXoFfoNj4HprVZ4XcJ1NEnSPMKbnXX5Xqxq2/o/3+dZ57THslbD/ZBOwpe8WZHKIIhlCMOlb3gojj65noRvgXDQKAPWR/+ZhgaOfjD1X7h2Uttpo2E7tR91iYZchuLeb0VU+L5+lzDsP3Mn3NU+0hlNwK4xSR/lQhobcy0sIIc08mtHXfwN/QZBRiQ+yuZUUTe20Db9Dj8Xlk2kSUUgoXwINpAdfZtTC+vySXvuKqw96bYncwYp5ExQc3/SPmnH5hDeLsk+q3dzBnTnD1CuMLJDkPwj8T8wb4Pzu95ON66nZmfsmrxGGMCUv9x4JoJ5V7DAnul46gHoo03U2IUGim+NtaK47qV5lBNsHpgfQobHS3yU9lmhHhIVged6l58Ly0XxVtRd8QBvGiclriGkoO2zCj3IcPMJH3GSmNTntsdCOcgOczCf29u9NQOE16vy4p6Y4+lGxblw5UV93WbVJhkl/yj/8aE++7dZbydvo2vYzmoM4hXKZPbTXUEwXmGImIalR9j0aBHP2YJ0S+vrYvff1j3/6hf78DHJ415Yn72lLAifunbx4D86SZVDdz8spv4MLWcN3tZaEAWFLj1CkX/+e74ctOQlr8ejbf2JdNuO9Wvv/OE2J1/Aa4U/iVexZ2522hNp+cf9vE8oH1qz43bdLEmpkPrmXZ26t9RaIqWBstH/5Yf/Y/XTz6/H+qrPPSJV9afxBCY+R/RX3z94X52dZAUjdnB3OHbuR6/q+gU/P/2xRfv82ERv3Xcv2NIzHcROxiuUKW5EYJUY7N3XUatC3EPoOUdqqNezgMZ62VFaiNS2C+38hi7AXQeoDpJ20Fgt0gqnPU5P/qRSX4KGLaj9HmmnkYdaLUcT6X/9J46TALBjtX68ZXE9JObzLZfp4wFTG2ZXBpRjF9cTeDs+gjZ9b1MVYDL+qsXCV8YRthWSMYBNbpCYANuPwoQBhQkDChMGFCYzU5gzy556mnLoGVBOxNn2aC1nAWBMmI/ChAGFCQMKk3cwUNDA8I7TcTi2plOm0MM4/GIDDA/jijB9fzIN3P7y58Luxp/quzeO7uvHG4/OxjHbBX7UVGxFGz8GB09VsjPFUEPhI3K57ug43rh0tJZP057ZiSV+9tDvkkM1U29sLCWxWNpVk9c6bruQhZpq3DtWAJjLLzbUWJgpd7Gp45gvPb96QYGoRKK1SLSXxYGBf/Xg+Zzwe1mH8wIKKN4I4cRBhqcWESaHZR84x3JEnkPSuHcx4QfzhmWv0w5W2lxhMZn3yfZLIC1JangVyvllkN8raUyXsYrykRG9ASPfhoKnY73eOX6gvay04wjN/ylT2+ZudKLKIOJZjKt4r2SIOOZAWSr7W/CIf9g7BC/Tezbg1eBSQG2E3ys9269FzZ1yCV9sPvpvdh16ydp9WXCOzbxPr5wCKMttJvxglcLTeacdPGtziOWF5NYKfSuEzscLz6LCUznIy8mPxfHv4gvhc2OAfP8xFGjvpnoPCoHeKOHMyMkb1AEISEPpbfbkyhd9v68sxyVfgt+FB20GsM0+AElniBh3NZu+bReW4OnX50c4dekWENdeJ+/gLjdLsTcoGZd0/6dJXiEgeQKD3u1XkzrUS/BnwXCOxQc+TXi5us9y+MGUnNvuetHgQPI9e0ZAcmg6ui/GeCEcYT0XReETD6jQlsvA5x/WVMJHtmxXkeh1eMjS4hdXgxgcKpCSlyi7hhjIUAYwMUje0xONgpIme3uxfbXTSbM3s8dqz6walOXe2RbPaSD5+d45FvBaOEfZ1whHm+TPrPpPKTO0ANfhHB+T0L5FnWPyO1yodK3A9gYq2uLX07V25Lfk53JVcJhUbJ44PIVFcjxviSX6O6TqkSzO95sqpZMj/+F8knh8a9btBJcMhuztxT2RNLzouYo/B7EMYNAgzooyoIwJlGkdDOWuyiEIGWWN+CiHWmnc1+bUXNefxn7LL1VNjpI6TkQYjchyj8nvigwy4QczBBqH47az44mGkj2AqtSl38M58TubkjvLeslmqK0KYPOROZFehPML51uUD+qrLxjg+r8kfsiQSdqd+1OZMoANeXMIdp/NPmdwzH2UWDegr3Hq1SUE9HsGKv91EvfVPutahAwQbqF+S2/lbAVondTw84d7zH0HpfSN0E74wSoboZ8+Gtvt+ilmpNnvi3zbfoaLfnKXzXPscH7BkgpCZS+osVb04nle+7nmE1WH95BgJiEEu+ZXnUjBm5FBwjs486pFe2PmdwHFo2ms98oEQ8Qx91HCB2Lzh/JSPGPCZcRHuT6WsThRg+5LEmcOcBEZ6cK660GefRCvG7jOxb+zfZS119eOhcuetaTnOyAa6Cf8YMSRAKcdXT2UbKxg+os20Wi4rFJOL4hlqycNadA2VK2ueCyKnReO8JFRves/RXnISL9SIB3LL/lzyV56RI9uSf1REoc01xDvvH1De3x+vy8HXqVubwFbeo6Rj4LetWeYCAzqftEEwWjKrxHHkn//aN4wNCIcw5CL9lsgv4zqG4stg07AmMNHRhsHG2OJEXdGkqQ9C8ZkAAubOWBAeQuc2SmK/QwyoRPEc2XB8W7QwmR9kUOGPIH4raJ42ZaJahw3DGDHuzM7RcnvO1KNwEYh4L50jyYbi47oXuyTQ6EtE78KYq7IW/Ie5QQTthWSBYBNbpCYANuPwoQBhQkDChMGFCYzU5gzy556mnLoGVCmMNuesNOx++KNBYAxYT4KEwYUJgwoTBhQZqhYMXb130FAEQVxsaflCCE+4lgbHD2P26nEYnneETNKsLI5W5pfOxxFKiaHAIbG2r/QcY2dls5lKHgnAOUJiCq+/jgM0DiwgNEuuvFlce9iocU6vyiiry+oxYVFbxD8dsMXq97FJPQruADutfnEIqtchjAmJxxQKM/hb6EC18m7rDgc5F9To4HPa9apgLLmXi012OdTo1st5HtMe+BADKrZn21XHcLTkvdTxqkAFQu+E9LUjYByixJ+hohxRDjOv+stPK8BrL5/8z2fC379B3ylU/QYBv+DdfdsMx45WNUFYXVJNqDo/Vp2jvZU2DQWpXPrhSfpJrmTNjy80WdU4KTHHtVKgqer3Ck+86Wb61QfOUidO1FRUXsjOxykfrwDhSe8KmsP/f6esn6vwFfIcfzQk1IXV/EIuU7iyIplEDZu5YuUYowzbI4wLIWLN4LXqJI0DJfu9ZRhx4/viKgMKGMDhT8Rzunm+N5NqVJZV2nM18bWfxhlFTanKDslif5SP9KfSgFUOSc+yIbYjQCmSFLCJ+bBOUsH/RnGKXii+ig8oNCXAtH2s8MIevD5fBza+TNIDFp7/NIeZBC+MDgN1NjtKDag0NhBBymWgXr0NQRJld49MWMVYQFLQZBBYrzZ8/jeGiomYhe9RB5Zupdd8KJQhmhW0GPZOW1/1kBtGYophUiON8QWpAa4C/9aADuGmQZ2SGKl6slLIG05d87sw3IpOqBYvF63mqTZX4/rwjWOdx/FVKy+KnEs1lefvP02vMqkbhFKZurXD2EkmGL6e6ClPrzWVEGyDn30ewB92D0x7YCPcvIrX71VwIePdlZToOtlwdTRHcyZHcdHYeEa4wqbUWZqABiTmbzGsyEYf1mbcgUGlHeCsDX5HbHMMmFAYcKAwoQBhQlzZk9MYQFgLADseJ9trbe+H7b0MGE+ChMGFCYMKEyON6CE1HG5sibpE8Vn/Di0sHCwyQLFO8fdDqjNAShVp6ETjzEyp+0If0hpOyZ/aJHC4x5Py3m+o4Bi6EOn1z0duVxZzcuIEKxVYfo9+hHySm99OYxq8Urv2MpX/Xis2mNZMVb8X2n/uMeTP893OlBiHqVEEllQTMJK0auQiCmH10sOr1pZ+23zavV4BSHk5mG56XBeRHGZb7MvoH8dPuy1XP4u72G7l/kuLxctNzw84eOS15O+AuvybQiXx71Ux7KIIgRc4wKd/9qGDJnGcsGw/mVh2QvxZfxKPHPd5BEUBIHD14nUHtwL5fqSfyQrcPkCpw/AOrDV5Ngpt/rqzoHJaBm1FdIMiCVdAFP4w//4mVQG4Wkf4lpL1/1XXr6/DPw5O14WrtuTk+8rw/yk702u//+eyR/894fcciw7Ir7cN24VSmK+RL42P3iXP3BzUfc++4O2kin3Jz5r70O8MKHZ7b9Cyn3evPxzrH0j6Wv/6sCh1Rcm+m/jqY4+u61t3OEHA4e+cY+nEG1XnRyqv8/47Y8Ecy+6IaTB65kKd7NUjFg7FtAboRyQtV9g3U8FvKU+WeU3kT7evId/7s7P3kWOnXLhOc05r5poHIPH+Fshuy9OREVfrsfl2sK/QfInvNuvLkERhIDN1/XNfy+BcCPh1erXTksDzSPldOEPpLvPIq09BeqfYCWSzuH02YuikPDZgTOE84K2T+NyQy6KEbPk9JWxebuEN2wddtsDuz/c1/ar9iguoxxfstintP3qw31qlOpXcoC4hZajnVA/uZ/GJxQdgapKmcYIj5Pdx4Bm05LhY7c8OOScV03S7M3sBFshL39fm58vweUxyeFF+hVJZyWXZQzs7nH4JiO/v2Lie3Ud/mfNA+JNuOV0tbeg3Ipbeyp2XySuJkrSFZDNyU43/W57Uj57Uciv/4vbFx2FfnicWCBVYAltG1x+dTi3nJbNa03g618t4+Orw0FbvwDwcms2R4JzuhRvxbJtp9Y8gStfhNMngfL72H3MAxq2To7d8g3ueTFpxkdB6nm8UDa7+WQPjZkhazdON7mcXRy5hsN8XeSIzE6b6ji9sPQRGi6Dr3VwGk03pXbqulpDk92elB96oajr9+NVr8/pk5RTHrCKQHHIg1R+uFwut5Iym+OLn4uPHy5LNf19qaJuqKBeFtAIo5flnBix37B9EFrPPR86p55WX97feA5MJgTKy+LqXI6TLk/GL0ChimnzF3NWe1x1eL0IceDwb7DUeNRAhltOvZ5b4CrK4bXJhgRemfo5sr/U5eoi0sE57Um5yocJVxiN3eNM4KukvMYDxtXPtLiMcHzFz/PWHlcc/VfNDhHt87k9A1W86ogO3yh3g8P1RXiYcT3nfK7AVg/Q41q5e15MxpQRPsrKnYTaKJzbdWk+dbJOfJQgjZhyeL2EELL5uvDvxX9DlFcrDVaVc/KIdF2XMqI5IBxeRKIZqezwd3Uvu6BvsOz6KE57Uh5Px5KiRvvy+DIkhguXOzqcto59hNOr+xIgHF+OuPqhe1lF4MtozgUvSWpBIXFf1EeRzt1lc32lKaePez5pEwI5cjxcXncOzEcZ5aOMG9czkqMrxUXHKbOPhsspZ9dwFWS1Dq9sMPrbR7S8XnuNt2ukCbWyxto1/bZ2h9HL6Uracm5d/6PPp6G8sUMGlJnKAHYshHILHl05A8o7CSjRQeloyxlQ6oFyou9wQ9LRl7Nn5fqplw3BeMICwCZ4PGbChAGFCQMKEwYUJgwoTBhQmDCgMGFAYcKEAWWykn6b288sBQwoTNiMwoQBhclbLOyDxMduhT8B5J2zzWBaRukogTbVW3AGKGBLDxPmozBhQHmrJT4ci9zT7Hcx0Bjf+EBH91GNnmEF3VM7kQnaOxEqPSNS0ugPzJltSgw/f96rOYiUrUAC/FKmqUa+yifW+7IALYVFL4AJapTfNxcCQrbpXsMHWlOxKr5Ms/mqLwfRsjmJ3rF4B/B/V+x09UzcfuA0nRLnGQEw5UItVaOcL9lgNWPXmEBaPNqakgpqFhUhYjV5pbL6w8ECiY+Td5omCZGSz4BopXmcgHmSGSHRufPk8lCxG4qZbZPoHUu/ZVkn/aWmZ+L2fX4/3agdksolLVpLv7DDq8L6apYtPU1N1+Ut0PGFKJh5fKeV+ppsJQEMJvNuxC1AbqNpFPon88LC3tNtDHgh6l0BH88Dlyq92Xz7aDRa1jI1PRO370h2EjvRIQUkuVxLf7qAN40XDtXXPN4ZwI6h/PjNG9fCH99/ILB65WE+c/ckZqLLPgOglLz+gU7w3/1Thf9/751Et15VDvZ3wgsPpjpBMaqX/O9H5Z5X7p6U5Q8olZqeI7U/swfXfQT1rwZFr7qp/67yQ8+u/qe6ahqbUcaVg7AALx3PQ9a/qSrOtXqabddV3or/T6z7QfFkPKEoz6fUL7ZMIqb5QIuaawM4z5ldVmf2m91zA5P5wk+k8vdhPUdqf6edeKA+ze3Lf8FzRYPVbEYZV1657zudoHkqUJpdkivBtZUmndGtInEPhY1bgwdFAUo/vDKR8XmaR0qnxrUcfHUt6NetBemSfSD8tOSpyHc0rwDdGrilTs8R2ocq2JHp/f5dAsjVqpvCXX/8iZD1iwabUZqQBTF8D/kFPPK5gubd1yROBgqlRP3daYQ36dr+8qR6/i/4IORj7wGoXo57v7r7o1v3TWJKOtXaX6fnSO2pjyK37gISse2mgJYfMP7QeyF7PG7uSZcrGnJrAhQFWZFtS5u72Mv+eCj4ygIa7O4Pvh4Fvyftv/+64KQ+vGKJCdwQij2LIknwyembHnlmafNQ8/BavZ4jtL/pflLbb5UM7/altdTnyQSkoct/N/x4zIAywRw+FyqBLHR9qAADp1np5tZo+ueRhQnwG6bgRxDRixDP83Lzf2G0PByXwX2hORzpPWxgBUULNe0hIO60dJ2eidsPnGzCoteyYAQs05cDN42US2C0gIIYUJqT2G87AOJ7okeDst1yB9Gwd7KNjXn9Tjw07Tg2IB3l60JbT7PtDZCG025qewP+GVCYNDVRMmeWSVPCgMKEAYUJAwoTBhQmDChMjlup21zNdp0zGSWRMYDC3qgwGSlptvQwYT4KEwYUJgwoTBhQmJxQj8cTPCjP2OchZunbCpSR84x53NhfmbmWjqCytI4vnByDpWc0JzkK+UK0ZOBtPNGHYkdbD4UV2/z422rn2zyuzQNFCE9YXOM+H81Jfpr2DKU7Lm11ZoH1x3iWJ/rbRuwsu31iqvSaTaPrbSg+SM1XnQ3KUnjaLKVjGpBx9+Hx7Jwp49o8ULiJJ8tel/t83ihOckNcSndsUl4/LENXHVugxL6E/xs41JjZPzGLcc2m0fW+KF9Pze9wSkbysU9lOSJjeivhWd0/np0zZVybB4rN+xn3ptvCIK8HhPGLJBoVJYdlHwRPh4hnsR/gUB9EZTtayuY8v0nVhB57WZYpV/ncBdAiEb5zCMu8b/rPiUZzcvPquN75EImlistpyrVu9y1HZHvD8UrCwz5XgahHUGjMVUS25464dzE+V0svSXTR6TO9i0n7KxfAvbLgwyoikjC1qCg6pn0YLcEFhGfeJ0eAq64kVO8zblwnOaOgLBfI5VXxBngt8W+wgKd7cM12XxYWASr4N/sI16hxZhfNRz5BC7R3f0OWNcpqzp3ja6mcguv/EvjSkK6QFsneY+A2/sZGi5mTD6gDaLG1PZmEJRzkNes5fMnX0b7BzPvsiNxni0/nwdyJctlEAHC9eC5D9xnjc92ey6lpSTm8h97r6lN/24YdhWctuPnv2jm7Ab07mMhNzdJyOBS6H+O6YkFeSMqVKiwp7oz8s+2OzKhxrdtcnR6XNtskJUKQUIGe9UYHeDxSUQ9YuvH5n9BxIvzqlBtdSUuEu7wQsGPnKef5sl1F76of2ivyg58G//u2gLCO8PgRvnNRzkhTMn/kp8UqxNL0b66v42rfdBYNX2jL93JncEPDXOuUW50u7SROQVx7vSj/Hl+HtlzRZxc451pQeJtvlZKuVzSaAiz7Uw7aUn1N77FPj3zqoWMq8rxl8GWQ/Nsc7vq2DNaby7zN4zoKE+lJzijlWAfhSH9m0NAyHcaDKXtW4uy1dbumdOF6RXAWXMp5vqsK/CPO7PU17Ak+S/mNuxSZ8J2H/1k5Bq8TYmTNHui3udrNKynHNrbv5dZctp5r/Umn+oWCvc7n9UXYG+wvdRyw851zrT3YXohToUrTiNf7e3z0mB6PTu029arF0mqO+D8rKHc97h9D/zDMvHGdpI9C+c0NoWOOyEstIifV+QQmLB3yrkDQEeBOcvwyynnO1b4AQdKKTFJ1hb9M+M6Tm43s9HNSE85ssF5y7LK53rF91zpc6yv8lGu94xqnep9jmzLo/1APcMpL8x0XwT7X2gsQUu9fJZLG9uc1CV+PpYM39qKpWErH9PMW0TmU7AGEB4t+rcKaeeM6yRnF5TeXxDthp+iEwFNO9CUcikfTuM6LVqlsn6jLec7d6tTTUUrfSOrPg72E7xzFon9alJ92oMgeA6IXtjdwvWP79s56kHCtO33Di+5rxH77HLAxe1rPgSV8wbiX5rvn6j7t9RsI/VAm9R+P5+PFLKCB6O2xKb04o2MaIPMISLPfF/k27msJV/u2yowa17qvGWjDv0aupwq9NTU/d3N81rdLyiOQzb1W6lr96EYbbO/Hqal/4bsna/7vAi/rreUQCWjtfH7t6r6PPwfiqS/a9T7w2TvFz6zF9R+8+wf3yWbp2vuFdR+Z0jPdyCB7k1ga1lHwze8vpXbx8i3REkY1Z+q37Ljpm8Ld1X67b4mXnRBdgXycin//BRH1P80KPg99x/+yzQ/b5+pxPnMmcD/7ppgWcP1Pre8s39Tz/On38VLljmYtHfnYTceU2EC+HsB7tIiur3rao5m6BhL9XNbbOa6jMKE178y60rNg3HV5NPX5gFzPeY4fA10fy+E7H4ssfcrOLFablKNj2WVztDt9N2F+Q46B71H3ELfHWsZkhp+MMzuyO7mozIxxHe3MTh4oM0rGAcpMtPRIQFF4rixoM83qo3jqYXJsJbBRCGgz1zz2ifOZIonlM9q8sYFy/JDNV44bS63jG8djAuX42VPDLH2rhPkoTBhQmDCgMGFAYcKAwoQBhcmJLfWPx+y7F0yaAQr76gUTtvQwYUBhwoDChAGFCQMKEwYUJgwoTJgwYTJV+f+HpD7pn1iPfgAAAABJRU5ErkJggg==</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2013-02-15 17:04:46 +0000" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.01" SETTINGS="SHOW_CI_LINES:YES;DISTINGUISH_SUBGROUPS:YES;SHOW_EFFECT_ESTIMATE:YES;SHOW_STUDY_NAMES:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Hospital Mortality, outcome: 1.1 NPPV (CPAP and BILEVEL) x SMC.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="cumulative metanalysis 2012 figure.jpg" FILE_TYPE="JPG" ID="FIG-06" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Cumulative meta-analysis</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2011-08-11 19:21:06 +0100" MODIFIED_BY="[Empty name]"/>
<APPENDICES MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-09-24 14:53:25 +0100" MODIFIED_BY="[Empty name]">Search strategies 2009</TITLE>
<APPENDIX_BODY MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE (Ovid)</HEADING>
<P>1 exp Heart Failure/ (66770)<BR/>2 exp Myocardial Infarction/ (126033)<BR/>3 cardiogenic oedema$.tw. (7)<BR/>4 cardiogenic edema$.tw. (39)<BR/>5 pulmonary oedema.tw. (2354)<BR/>6 pulmonary edema.tw. (9499)<BR/>7 cardiac failure.tw. (9005)<BR/>8 heart failure.tw. (73909)<BR/>9 cardiac insufficiency.tw. (3578)<BR/>10 Pulmonary Edema/ (13680)<BR/>11 heart insufficiency.tw. (672)<BR/>12 Ventricular Dysfunction, Left/ (14770)<BR/>13 wet lung.tw. (307)<BR/>14 or/1-13 (245334)<BR/>15 exp Respiration, Artificial/ (49052)<BR/>16 exp Ventilators, Mechanical/ (7535)<BR/>17 mechanical ventilation.tw. (17741)<BR/>18 artificial ventilation.tw. (2502)<BR/>19 assisted ventilation.tw. (1817)<BR/>20 artificial respiration.tw. (1465)<BR/>21 (respirator or respirators).tw. (3713)<BR/>22 bipap.tw. (366)<BR/>23 nippv.tw. (262)<BR/>24 nppv.tw. (290)<BR/>25 niv.tw. (750)<BR/>26 niav.tw. (0)<BR/>27 cpap.tw. (3643)<BR/>28 aprv.tw. (61)<BR/>29 ippb.tw. (267)<BR/>30 ippv.tw. (628)<BR/>31 peep.tw. (3253)<BR/>32 positive pressure ventilation.tw. (3426)<BR/>33 pulmonary ventilation.tw. (2151)<BR/>34 non invasive ventilation.tw. (573)<BR/>35 noninvasive ventilation.tw. (747)<BR/>36 pressure support ventilation.tw. (571)<BR/>37 positive end expiratory pressure.tw. (3381)<BR/>38 bi-level positive airway pressure.tw. (93)<BR/>39 bilevel positive airway pressure.tw. (169)<BR/>40 or/15-39 (69840)<BR/>41 14 and 40 (3618)<BR/>42 randomized controlled trial.pt. (283687)<BR/>43 controlled clinical trial.pt. (81002)<BR/>44 Randomized controlled trials/ (64251)<BR/>45 random allocation/ (66529)<BR/>46 double blind method/ (104848)<BR/>47 single-blind method/ (13580)<BR/>48 or/42-47 (478246)<BR/>49 exp animal/ not humans/ (3476457)<BR/>50 48 not 49 (445629)<BR/>51 clinical trial.pt. (461395)<BR/>52 exp Clinical Trials as Topic/ (224000)<BR/>53 (clin$ adj25 trial$).ti,ab. (168562)<BR/>54 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab. (101838)<BR/>55 placebos/ (28620)<BR/>56 placebo$.ti,ab. (120725)<BR/>57 random$.ti,ab. (467107)<BR/>58 research design/ (58374)<BR/>59 or/51-58 (1009730)<BR/>60 59 not 49 (935775)<BR/>61 50 or 60 (966076)<BR/>62 61 and 41 (369)<BR/>63 (2005$ or 2006$ or 2007$ or 2008$ or 2009$).em. (3387916)<BR/>64 63 and 62 (160)<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL (The Cochrane Library)</HEADING>
<P>#1 MeSH descriptor Heart Failure explode all trees 4000<BR/>#2 MeSH descriptor Myocardial Infarction explode all trees 6778<BR/>#3 myocardial next infarction in All Text 12934<BR/>#4 (cardiogenic in All Text near/6 edema in All Text) 64<BR/>#5 (cardiogenic in All Text near/6 oedema in All Text) 24<BR/>#6 (pulmonary in All Text near/6 edema in All Text) 389<BR/>#7 (pulmonary in All Text near/6 oedema in All Text) 210<BR/>#8 heart next failure in All Text 8265<BR/>#9 cardiac next failure in All Text 768<BR/>#10 cardiac next insufficiency in All Text 187<BR/>#11 heart next insufficiency in All Text 27<BR/>#12 left next ventricular next insufficiency in All Text 8<BR/>#13 left next ventricular next dysfunction in All Text 764<BR/>#14 wet next lung in All Text 3<BR/>#15 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14) 20230<BR/>#16 MeSH descriptor Respiration, Artificial explode all trees 3377<BR/>#17 MeSH descriptor Ventilators, Mechanical explode all trees 211<BR/>#18 mechanical next ventilation in All Text 3047<BR/>#19 artificial next ventilation in All Text 483<BR/>#20 assisted next ventilation in All Text 413<BR/>#21 artificial next respiration in All Text 52<BR/>#22 (positive in All Text near/6 pressure in All Text near/6 ventilation in All Text) 982<BR/>#23 (respirator in All Text or respirators in All Text) 8427<BR/>#24 pulmonary next ventilat* in All Text 782<BR/>#25 non next invasive next ventilation in All Text 164<BR/>#26 noninvasive next ventilation in All Text 127<BR/>#27 non-invasive next ventilation in All Text 164<BR/>#28 positive next airway next pressure in All Text 1088<BR/>#29 positive next pressure next respiration in All Text 1056<BR/>#30 pressure next support next ventilation in All Text 219<BR/>#31 mask next ventilation in All Text 120<BR/>#32 bipap in All Text 135<BR/>#33 nippv in All Text 66<BR/>#34 nppv in All Text 78<BR/>#35 niv in All Text 152<BR/>#36 cpap in All Text 1007<BR/>#37 niav in All Text 3<BR/>#38 aprv in All Text 11<BR/>#39 ippb in All Text 59<BR/>#40 ippv in All Text 133<BR/>#41 peep in All Text 375<BR/>#42 positive next end next expiratory next pressure in All Text 464<BR/>#43 (#16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25) 11353<BR/>#44 (#26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35) 2260<BR/>#45 (#36 or #37 or #38 or #39 or #40 or #41 or #42) 1632<BR/>#46 (#43 or #44 or #45) 12336<BR/>#47 (#15 and #46) 536<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE (Ovid)</HEADING>
<P>1 exp Congestive Heart Failure/ (29823)<BR/>2 exp Heart Infarction/ (124630)<BR/>3 cardiogenic oedema$.tw. (8)<BR/>4 cardiogenic edema$.tw. (29)<BR/>5 pulmonary oedema.tw. (1856)<BR/>6 pulmonary edema.tw. (7171)<BR/>7 cardiac failure.tw. (6888)<BR/>8 heart failure.tw. (66554)<BR/>9 cardiac insufficiency.tw. (1235)<BR/>10 Lung Edema/ (15202)<BR/>11 heart insufficiency.tw. (254)<BR/>12 heart left ventricle function/ (14936)<BR/>13 wet lung.tw. (246)<BR/>14 or/1-13 (220649)<BR/>15 exp Ventilator/ (5189)<BR/>16 exp Artificial Ventilation/ (56813)<BR/>17 mechanical ventilation.tw. (16434)<BR/>18 artificial ventilation.tw. (1731)<BR/>19 assisted ventilation.tw. (1491)<BR/>20 artificial respiration.tw. (477)<BR/>21 (respirator or respirators).tw. (2181)<BR/>22 bipap.tw. (343)<BR/>23 nippv.tw. (233)<BR/>24 nppv.tw. (282)<BR/>25 niv.tw. (653)<BR/>26 niav.tw. (0)<BR/>27 cpap.tw. (3121)<BR/>28 aprv.tw. (64)<BR/>29 ippb.tw. (138)<BR/>30 ippv.tw. (465)<BR/>31 peep.tw. (3010)<BR/>32 positive pressure ventilation.tw. (2867)<BR/>33 pulmonary ventilation.tw. (1053)<BR/>34 non invasive ventilation.tw. (571)<BR/>35 noninvasive ventilation.tw. (774)<BR/>36 pressure support ventilation.tw. (579)<BR/>37 positive end expiratory pressure.tw. (3039)<BR/>38 bi-level positive airway pressure.tw. (82)<BR/>39 bilevel positive airway pressure.tw. (180)<BR/>40 or/15-39 (68033)<BR/>41 14 and 40 (4482)<BR/>42 controlled clinical trial/ (67441)<BR/>43 random$.tw. (410939)<BR/>44 randomized controlled trial/ (174578)<BR/>45 follow-up.tw. (369197)<BR/>46 double blind procedure/ (74328)<BR/>47 placebo$.tw. (113396)<BR/>48 placebo/ (132301)<BR/>49 factorial$.ti,ab. (8626)<BR/>50 (crossover$ or cross-over$).ti,ab. (40537)<BR/>51 (double$ adj blind$).ti,ab. (86993)<BR/>52 (singl$ adj blind$).ti,ab. (7707)<BR/>53 assign$.ti,ab. (112821)<BR/>54 allocat$.ti,ab. (35785)<BR/>55 volunteer$.ti,ab. (101863)<BR/>56 Crossover Procedure/ (21843)<BR/>57 Single Blind Procedure/ (8587)<BR/>58 or/42-57 (1066875)<BR/>59 (exp animals/ or nonhuman/) not human/ (2748065)<BR/>60 58 not 59 (974762)<BR/>61 60 and 41 (561)<BR/>62 (2005$ or 2006$ or 2007$ or 2008$ or 2009$).em. (2870201)<BR/>63 61 and 62 (300)<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL (EBCSO)</HEADING>
<P>( (MH "Ventilators, Mechanical") or (MH "Positive Pressure Ventilation+") or ventilat* or CPAP or NPPV or bipap or nippv or aprv or ippb or ippv or peep ) and S4 and ( (MH "Clinical Trials+") or random$ or trial or clinical study or group$ or placebo$ )  </P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-08-14 21:08:30 +0100" MODIFIED_BY="[Empty name]">Search strategies 2011</TITLE>
<APPENDIX_BODY MODIFIED="2013-04-16 13:31:26 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL and DARE (The Cochrane Library)</HEADING>
<P>#1 MeSH descriptor Heart Failure explode all trees<BR/>#2 MeSH descriptor Myocardial Infarction explode all trees<BR/>#3 myocardial next infarction in All Text<BR/>#4 (cardiogenic in All Text near/6 edema in All Text)<BR/>#5 (cardiogenic in All Text near/6 oedema in All Text)<BR/>#6 (pulmonary in All Text near/6 edema in All Text)<BR/>#7 (pulmonary in All Text near/6 oedema in All Text)<BR/>#8 heart next failure in All Text<BR/>#9 cardiac next failure in All Text<BR/>#10 cardiac next insufficiency in All Text<BR/>#11 heart next insufficiency in All Text<BR/>#12 left next ventricular next insufficiency in All Text<BR/>#13 left next ventricular next dysfunction in All Text<BR/>#14 wet next lung in All Text<BR/>#15 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14)<BR/>#16 MeSH descriptor Respiration, Artificial explode all trees<BR/>#17 MeSH descriptor Ventilators, Mechanical explode all trees<BR/>#18 mechanical next ventilation in All Text<BR/>#19 artificial next ventilation in All Text<BR/>#20 assisted next ventilation in All Text<BR/>#21 artificial next respiration in All Text<BR/>#22 (positive in All Text near/6 pressure in All Text near/6 ventilation in All Text)<BR/>#23 (respirator in All Text or respirators in All Text)<BR/>#24 pulmonary next ventilat* in All Text<BR/>#25 non next invasive next ventilation in All Text<BR/>#26 noninvasive next ventilation in All Text<BR/>#27 non-invasive next ventilation in All Text<BR/>#28 positive next airway next pressure in All Text<BR/>#29 positive next pressure next respiration in All Text<BR/>#30 pressure next support next ventilation in All Text<BR/>#31 mask next ventilation in All Text<BR/>#32 bipap in All Text<BR/>#33 nippv in All Text<BR/>#34 nppv in All Text<BR/>#35 niv in All Text<BR/>#36 cpap in All Text<BR/>#37 niav in All Text<BR/>#38 aprv in All Text<BR/>#39 ippb in All Text<BR/>#40 ippv in All Text<BR/>#41 peep in All Text<BR/>#42 positive next end next expiratory next pressure in All Text<BR/>#43 (#16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25)<BR/>#44 (#26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35)<BR/>#45 (#36 or #37 or #38 or #39 or #40 or #41 or #42)<BR/>#46 (#43 or #44 or #45)<BR/>#47 (#15 and #46)<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE (Ovid)</HEADING>
<P>1. exp Heart Failure/<BR/>2. exp Myocardial Infarction/<BR/>3. cardiogenic edema$.tw.<BR/>4. cardiogenic oedema$.tw.<BR/>5. pulmonary oedema.tw.<BR/>6. pulmonary edema.tw.<BR/>7. cardiac failure.tw.<BR/>8. heart failure.tw.<BR/>9. cardiac insufficiency.tw.<BR/>10. Pulmonary Edema/<BR/>11. heart insufficiency.tw.<BR/>12. Ventricular Dysfunction, Left/<BR/>13. wet lung.tw.<BR/>14. or/1-13<BR/>15. exp Respiration, Artificial/<BR/>16. exp Ventilators, Mechanical/<BR/>17. mechanical ventilation.tw.<BR/>18. artificial ventilation.tw.<BR/>19. assisted ventilation.tw.<BR/>20. artificial respiration.tw.<BR/>21. (respirator or respirators).tw.<BR/>22. bipap.tw.<BR/>23. nippv.tw.<BR/>24. nppv.tw.<BR/>25. niv.tw.<BR/>26. niav.tw.<BR/>27. cpap.tw.<BR/>28. aprv.tw.<BR/>29. ippb.tw.<BR/>30. ippv.tw.<BR/>31. peep.tw.<BR/>32. positive pressure ventilation.tw.<BR/>33. pulmonary ventilation.tw.<BR/>34. non invasive ventilation.tw.<BR/>35. noninvasive ventilation.tw.<BR/>36. pressure support ventilation.tw.<BR/>37. positive end expiratory pressure.tw.<BR/>38. bi-level positive airway pressure.tw.<BR/>39. bilevel positive airway pressure.tw.<BR/>40. or/15-39<BR/>41. 14 and 40<BR/>42. randomized controlled trial.pt.<BR/>43. controlled clinical trial.pt.<BR/>44. randomized.ab.<BR/>45. placebo.ab.<BR/>46. drug therapy.fs.<BR/>47. randomly.ab.<BR/>48. trial.ab.<BR/>49. groups.ab.<BR/>50. 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49<BR/>51. exp animals/ not humans.sh.<BR/>52. 50 not 51<BR/>53. 41 and 52<BR/>54. ((2001009* or 201010* or 201011* or 201012* or 2011*) not ("20100921" or "20100922" or "20100923" or "20100924" or "20100925" or "20100926" or "20100927" or "20100928" or "20100929" or "20100930")).ed.<BR/>55. 53 and 54<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE (Ovid)</HEADING>
<P>1. exp Congestive Heart Failure/<BR/>2. exp Heart Infarction/<BR/>3. cardiogenic oedema$.tw.<BR/>4. cardiogenic edema$.tw.<BR/>5. pulmonary oedema.tw.<BR/>6. pulmonary edema.tw.<BR/>7. cardiac failure.tw.<BR/>8. heart failure.tw.<BR/>9. cardiac insufficiency.tw.<BR/>10. Lung Edema/<BR/>11. heart insufficiency.tw.<BR/>12. heart left ventricle function/<BR/>13. wet lung.tw.<BR/>14. or/1-13<BR/>15. exp Ventilator/<BR/>16. exp Artificial Ventilation/<BR/>17. mechanical ventilation.tw.<BR/>18. artificial ventilation.tw.<BR/>19. assisted ventilation.tw.<BR/>20. artificial respiration.tw.<BR/>21. (respirator or respirators).tw.<BR/>22. bipap.tw.<BR/>23. nippv.tw.<BR/>24. nppv.tw.<BR/>25. niv.tw.<BR/>26. niav.tw.<BR/>27. cpap.tw.<BR/>28. aprv.tw.<BR/>29. ippb.tw.<BR/>30. ippv.tw.<BR/>31. peep.tw.<BR/>32. positive pressure ventilation.tw.<BR/>33. pulmonary ventilation.tw.<BR/>34. non invasive ventilation.tw.<BR/>35. noninvasive ventilation.tw.<BR/>36. pressure support ventilation.tw.<BR/>37. positive end expiratory pressure.tw.<BR/>38. bi-level positive airway pressure.tw.<BR/>39. bilevel positive airway pressure.tw.<BR/>40. or/15-39<BR/>41. 14 and 40<BR/>42. random$.tw.<BR/>43. factorial$.tw.<BR/>44. crossover$.tw.<BR/>45. cross over$.tw.<BR/>46. cross-over$.tw.<BR/>47. placebo$.tw.<BR/>48. (doubl$ adj blind$).tw.<BR/>49. (singl$ adj blind$).tw.<BR/>50. assign$.tw.<BR/>51. allocat$.tw.<BR/>52. volunteer$.tw.<BR/>53. crossover procedure/<BR/>54. double blind procedure/<BR/>55. randomized controlled trial/<BR/>56. single blind procedure/<BR/>57. 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56<BR/>58. (animal/ or nonhuman/) not human/<BR/>59. 57 not 58<BR/>60. 41 and 59<BR/>61. ("201038" or "201039" or "201040" or "201041" or "201042" or "201043" or "201044" or "201045" or "201046" or "201047" or "201048" or "201049" or "201050" or "201051" or "201052" or 2011*).em.<BR/>62. 60 and 61<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL</HEADING>
<P>S47 S43 and S46<BR/>S46 S44 or S45<BR/>S45 EM 2010<BR/>S44 EM 2009<BR/>S43 S14 and S39 and S42<BR/>S42 S40 or S41<BR/>S41 TI (random* or trial or clinical study or group* or placebo*) or AB (random* or trial or clinical study or group* or placebo*)<BR/>S40 (MH "Clinical Trials+")<BR/>S39 S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38<BR/>S38 TI (bi-level positive airway pressure) or AB (bi-level positive airway pressure)<BR/>S37 TI (positive end expiratory pressure) or AB (positive end expiratory pressure)<BR/>S36 TI (pressure support ventilation) or AB (pressure support ventilation)<BR/>S35 TI (noninvasive ventilation) or AB (noninvasive ventilation)<BR/>S34 TI (non invasive ventilation) or AB (non invasive ventilation)<BR/>S33 TI (pulmonary ventilation) or AB (pulmonary ventilation)<BR/>S32 TI (positive pressure ventilation) or AB (positive pressure ventilation)<BR/>S31 TI (peep) or AB (peep)<BR/>S30 TI (ippv) or AB (ippv)<BR/>S29 TI (ippb) or AB (ippb)<BR/>S28 TI (aprv) or AB (aprv)<BR/>S27 TI (cpap) or AB (cpap)<BR/>S26 TI (niav) or AB (niav)<BR/>S25 TI (niv) or AB (niv)<BR/>S24 TI (nppv) or AB (nppv)<BR/>S23 TI (nippv) or AB (nippv)<BR/>S22 TI (bipap) or AB (bipap)<BR/>S21 TI (respirator or respirators) or AB (respirator or respirators)<BR/>S20 TI (artificial respiration) or AB (artificial respiration)<BR/>S19 TI (assisted ventilation) or AB (assisted ventilation)<BR/>S18 TI (artificial ventilation) or AB (artificial ventilation)<BR/>S17 TI (mechanical ventilation) or AB (mechanical ventilation)<BR/>S16 (MH "Ventilation, Mechanical, Differentiated")<BR/>S15 (MH "Ventilators, Mechanical")<BR/>S14 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13<BR/>S13 TI (wet lung) or AB (wet lung)<BR/>S12 (MH "Ventricular Dysfunction, Left")<BR/>S11 TI (heart insufficiency) or AB (heart insufficiency)<BR/>S10 (MH "Pulmonary Edema")<BR/>S9 TI (cardiac insufficiency) or AB (cardiac insufficiency)<BR/>S8 TI (heart failure) or AB (heart failure)<BR/>S7 TI (cardiac failure) or AB (cardiac failure)<BR/>S6 TI (pulmonary edema*) or AB (pulmonary edema*)<BR/>S5 TI (pulmonary oedema*) or AB (pulmonary oedema*)<BR/>S4 TI (cardiogenic edema*) or AB (cardiogenic edema*)<BR/>S3 TI (cardiogenic oedema*) or AB (cardiogenic oedema*)<BR/>S2 (MH "Myocardial Infarction+")<BR/>S1 (MH "Heart Failure, Congestive+")<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2011-08-11 19:21:06 +0100" MODIFIED_BY="[Empty name]"/>
</COCHRANE_REVIEW>